Email address,Domain name,Organization,Country,State,City,Postal code,Street,Confidence score,Type,Number of sources,Pattern,First name,Last name,Department,Position,Twitter handle,LinkedIn URL,Phone number,Source 1,Source 2,Source 3,Source 4,Source 5,Source 6,Source 7,Source 8,Source 9,Source 10,Source 11,Source 12,Source 13,Source 14,Source 15,Source 16,Source 17,Source 18,Source 19,Source 20,Source 21,Source 22,Source 23,Source 24,Source 25,Source 26,Source 27,Source 28,Source 29,Source 30
emmanuelle.coppens@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Emmanuelle,Coppens,,,,,,http://iabs.org/documents/2023-meetings-and-webinars/reference-standards-ottawa/biosketches-21/biosketch-emmanuelle-coppens,http://iabs.org/documents/2023-meetings-and-webinars/reference-standards-ottawa/e-book-reference-standards-meeting-ottawa-2023,,,,,,,,,,,,,,,,,,,,,,,,,,,
patrice.riou@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Patrice,Riou,,,,,,http://iabs.org/documents/2023-meetings-and-webinars/globally-harmonized-specifications/ebook-3rd-iabs-globally-harmonized-specifications-workshop,,,,,,,,,,,,,,,,,,,,,,,,,,,,
robert.charlebois@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Robert,Charlebois,,,,,,http://iabs.org/documents/2022-meetings-and-webinars/3rd-next-generation-sequencing/ebook-iabs-3rd-ngs-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
norbert.nagel@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Norbert,Nagel,,,,,,http://p-arch.it/bitstream/handle/11050/907/book%20of%20abstracts.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jochen.maas@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,5,{first}.{last},Jochen,Maas,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pf2019_tagungsband_web_0.pdf,http://pharmaforum-sw.de/sites/default/files/2019-10/pf_maas_cv_1.pdf,http://pharmaforum-sw.de/sites/default/files/2019-10/pf_tagungsband_2018_web.pdf,http://pharmaforum-sw.de/sites/default/files/2019-10/pharmaforum12_maas.pdf,http://pharmaforum-sw.de/sites/default/files/2019-10/prof__dr__maas.pdf,,,,,,,,,,,,,,,,,,,,,,,,
synnove.jespersen@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Synnove,Jespersen,,,,,,http://sanofi.no/dam/jcr:54205a3b-da94-4755-8fd1-0129c061f534/mat-no-2000059%20efpia%20v10%20062020%20efpia%20disclosure%20metodenotat%202019.pdf,http://sanofi.no/dam/jcr:e552c94b-e488-47b3-a682-0ab15fb710e1/metodenotet%202020.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
vanina.laurent-ledru@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Vanina,Ledru,,,,,,http://bostonboosther.com/event-details/professor-julie-battilana-talk-boston-boosther-launch,,,,,,,,,,,,,,,,,,,,,,,,,,,,
valentine.delore@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Valentine,Delore,,,,,,http://gdac-dengue.org/wp-content/uploads/2017/06/diagnostic-workshop-2017-report.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
danielle.brennan@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Danielle,Brennan,,,,,,http://sanofi.com.au/en/news/press-releases,http://sanofi.com.au/en/news,,,,,,,,,,,,,,,,,,,,,,,,,,,
wolfgang.landgraf@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Wolfgang,Landgraf,,,,,,http://touchendocrinology.com/wp-content/uploads/sites/5/2015/11/devriesfinal.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yannis.hara@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Yannis,Hara,,,,,,http://ash.silverchair.com/bloodadvances/article/7/11/2317/494228/sgk1-inhibition-induces-fetal-hemoglobin,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dilara.firat@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Dilara,Firat,,,,,,http://sanofi.com.tr/dam/jcr:e624133b-a3fa-4f20-b0ec-6c3f137b29f7/sanofisurdurulebilirlik_tr.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
clarisse.demont@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,5,{first}.{last},Clarisse,Demont,,,,,,http://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-021-06399-8.pdf,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.dumitriu@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,4,{first}.{last},Alexandra,Dumitriu,,,,,,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.hansen@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Thomas,Hansen,,,,,,http://nyemetoder.no/documents/bestillerforum%20rhf%20-%20%28%20innkallinger%20og%20referater%29/bestillerforum%20rhf%2022.03.2021%20sakspapirer%20offentlige.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.czarnecki@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Alexandra,Czarnecki,,,,,,http://sanofi.de/dam/jcr:cfc11c7b-ebbc-4630-9f80-cb59a0f175b9/newsletter-standort-gesundheit-sonderausgabe-europaeische-impfwoche_april-2019.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hanna.hennes-rauth@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Hanna,Rauth,,,,,,http://sanofi.de/dam/jcr:775d521d-7fe0-40b0-a175-772947ef7ff0/newsletter-standort-gesundheit_maerz-2023_en.pdf,http://sanofi.de/dam/jcr:91ed78d9-432b-4ea9-9b8f-7de12f2e2bee/newsletter-standort-gesundheit_maerz-2023.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
bernhard.prager@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,3,{first}.{last},Bernhard,Prager,,,,,,http://sanofi.at/dam/jcr:7714aa22-ee1a-414b-97de-d6e659335954/191204_pm%20sanofi_%20influenza-impfung%20gerade%20mit%2050plus%20wichtig.pdf,http://sanofi.at/dam/jcr:cffe0a80-649b-42a4-a613-7e9c5e64c4a4/pi%20sanofi_influenza-impfung%20als%20beitrag%20zur%20entlastung%20der%20spitalskapazitten.pdf,http://sanofi.at/dam/jcr:f1031c12-2f9d-4183-b5bc-2a70e7f23e9c/191203_pm%20sanofi_influenza-impfung%20reduziert%20herzinfarktrisiko.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
andreas.kovar@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,4,{first}.{last},Andreas,Kovar,,,,,,http://agah.eu/about-agah/structure/board,http://agah.eu/event/24-pharmacokinetics-pharmacodynamics-expertentreffen,http://agah.eu/event/25th-pk-pd-expert-meeting-pharmacokinetics-pharmacodynamics-2,http://agah.eu/wer-ist-die-agah/struktur/vorstand,,,,,,,,,,,,,,,,,,,,,,,,,
raghu.vishwanath@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Raghu,Vishwanath,,,,,,http://ssiemvirtual.org/partners/sa_ssiem2020,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniele.dufour@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,3,{first}.{last},Daniele,Dufour,,,,,,http://insulin.library.utoronto.ca/islandora/object/insulin:connaught,http://lifesciencesbc.ca/members/health-canada-accepts-nirsevimab-regulatory-submission-for-infant-rsv,http://insulin.library.utoronto.ca/islandora/object/insulin%3aconnaught,,,,,,,,,,,,,,,,,,,,,,,,,,
susan.manganello@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Susan,Manganello,,,,,,http://nadona.org/corporate-leadership-council,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vanessa.kolnik@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Vanessa,Kolnik,,,,,,http://ce-crva.fr,http://ce-crva.fr/index.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandre.zerbib@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Alexandre,Zerbib,Marketing,Marketing Manager,"","","",http://aihemato.com/lassociation/partenaires,http://aihemato.com/laih/partenaires,,,,,,,,,,,,,,,,,,,,,,,,,,,
catherine.rosier@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Catherine,Rosier,,"","","","",http://mondial-metiers.com/exposants/sanofi.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lorraine.beverley@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Lorraine,Beverley,,,,,,http://eastkenttraininghub.nhs.uk/post/funded-pitstop-courses-dates-still-available,,,,,,,,,,,,,,,,,,,,,,,,,,,,
courtney.peters@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,3,{first}.{last},Courtney,Peters,,"","","","",http://amga.org/amga/media/rise-to-immunize/pdfs/newsletter/rize-montlthy-august-2022.pdf,http://amga.org/getmedia/0c6602b0-0351-4cfa-95f7-1d18af3e786d/amga_2022_industry_partners_directory.pdf,http://amga.org/membership-partners/industry-support/corporate-partner-profiles/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
marion.eberlin@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Marion,Eberlin,Medical & health,Medical Affairs,"","","",http://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-020-01338-4,http://efsm.online/pl_pl/article-overview/101/2021/macrogol-guideline-based-treatment-for-constipation,,,,,,,,,,,,,,,,,,,,,,,,,,,
francois-xavier.routhier@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},François,Routhier,,,,,,http://mondedesgrandesecoles.fr/agir-pour-la-sante-mondiale-chez-sanofi-linterview-de-francois-xavier-routhier,,,,,,,,,,,,,,,,,,,,,,,,,,,,
arun.gopal@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Arun,Gopal,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
berland@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Evan,Berland,,"","","",+1 215 432 0234,http://northdakotadigitalnews.com/2022/08/17/sanofi-provides-update-on-amcenestrant,,,,,,,,,,,,,,,,,,,,,,,,,,,,
miriam.henn@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Miriam,Henn,,"","","",+49 6 9305 5085,http://sanofi.de/dam/jcr:f74f6ef5-b111-4a49-a39c-3a8d579af894/20220407_pm_sanofi-braun-reuschenbach.pdf,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220407,,,,,,,,,,,,,,,,,,,,,,,,,,,
birgitt.sickenberger@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Birgitt,Sickenberger,,"","","",+49 69 3053 0167,http://sanofi.de/dam/jcr:f74f6ef5-b111-4a49-a39c-3a8d579af894/20220407_pm_sanofi-braun-reuschenbach.pdf,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220407,,,,,,,,,,,,,,,,,,,,,,,,,,,
nanette.rutherford@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Nanette,Rutherford,Management,Manager,"","","",http://psoh.org/corporate-members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michel.moussa@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Michel,Moussa,,"","","","",http://lesimmocuriens.com/produit/soiree-poker-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
paolo.pellegrino@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,3,{first}.{last},Paolo,Pellegrino,,"","","","",http://efsm.online/be_nl/article-overview/101/2022/probiotics-quality-matters,http://efsm.online/de_de/article-overview/101/2022/probiotics-quality-matters,http://efsm.online/int_en/article-overview/101/2022/probiotics-quality-matters,,,,,,,,,,,,,,,,,,,,,,,,,,
xun.chen@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Xun,Chen,,"","","","",http://icsa.org/about/current-leadership,http://icsa.org/about/committees,,,,,,,,,,,,,,,,,,,,,,,,,,,
tobias.mueck@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,4,{first}.{last},Tobias,Mueck,,,,,,http://apothekerkammer.de/ueber+uns/delegierte,http://efsm.online/pl_pl/article-overview/101/2021/relief-of-acute-cough-by-cough-syrup-with-mucoprotection,http://efsm.online/pl_pl/article-overview/101/2021/marshmallow-root-extract-and-honey-cough-relief-through-mucoprotection,http://efsm.online/de_de/article-overview/101/2021/acute-cough-for-the-first-time-a-clear-recommendation-for-ambroxol-as-symptomatic-treatment,,,,,,,,,,,,,,,,,,,,,,,,,
kate.conway@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,26,{first}.{last},Kate,Conway,Medical & health,Clinical Development,"","",+1 508 364 4931,http://blackstone.com/news/press/sanofi-announces-e300-million-collaboration-with-blackstone-life-sciences-to-advance-an-innovative-treatment-for-multiple-myeloma,http://sanofi.cz/dam/jcr:4db0e3be-88a9-4d6d-a24d-57e5765f59d0/sanofi_a_gsk%20pozadaji_o_registraci_vakciny_na_covid.pdf,http://medicaex.com/businesswire/sanofi-and-innate-pharma-expand-collaboration-for-natural-killer-cell-therapeutics-in-oncology,http://biospace.com/article/releases/nirsevimab-significantly-protected-infants-against-rsv-disease-in-phase-3-trial,http://biospace.com/article/releases/press-release-fda-accepts-nirsevimab-application-as-first-protective-option-against-rsv-disease-for-all-infants,http://pharmashots.com/press-releases/press-release-sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://sanofi.de/dam/jcr:1825a729-fb35-4dca-8148-580c2d244cbc/20220223_pm_sanofi-und-gsk-werden-die-zulassung-fuer-covid19-impfstoff-beantragen.pdf,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20221028,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203,http://sanofi.com/en/media-room/press-releases/2023/2023-01-11-16-30-00-2587330,http://pharmiweb.com/press-release/2022-08-05/sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://biotech-365.com/category/globenewswire,http://northdakotadigitalnews.com/2023/01/05/fda-accepts-nirsevimab-application-as-first,http://northdakotadigitalnews.com/2022/08/17/sanofi-provides-update-on-amcenestrant,http://northdakotadigitalnews.com/2022/12/19/sanofi-and-innate-pharma-expand,http://biotech-365.com/author/biotech365/page/2,http://sanofi.com/en/media-room/contact,http://coldagglutinindisease.org/enjaymo-news,http://markets.businessinsider.com/news/stocks/sanofi-flu-vaccines-licensed-and-approved-for-2022-2023-influenza-season-including-cdc-preferred-higher-dose-vaccines-for-adults-65-1031564247,http://biospace.com/article/releases/press-release-new-nirsevimab-data-analyses-reinforce-efficacy-against-rsv,http://pharmiweb.com/press-release/2022-06-30/nexviadyme-avalglucosidase-alfa-approved-by-european-commission-as-a-potential-new-standard-of-care-for-the-treatment-of-pompe-disease,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220728,http://inpda.org/chmp-recommends-approval-xenpozyme-olipudase-alfa-first-treatment-asmd,http://inpda.org/press-release-xenpozyme-olipudase-alfa-approved-european-commission-first-treatment-asmd,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://biotech-365.com/author/biotech365,,,
nathalie.pham@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,24,{first}.{last},Nathalie,Pham,,"","","",+1 617 764 6418,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220203,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220428,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20221028,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203,http://forextv.com/top-news/dupixent-dupilumab-approved-by-european-commission-as-the-first-and-only-targeted-medicine-indicated-for-eosinophilic-esophagitis,http://sanofi.com/en/media-room/press-releases/2023/2023-01-11-16-30-00-2587330,http://sanofi.com/en/media-room/press-releases/2023/2023-01-27-06-00-00-2596599,http://sanofi.com/en/media-room/press-releases/2022/2022-04-14-05-00-00-2422388,http://inpda.org/chmp-recommends-approval-xenpozyme-olipudase-alfa-first-treatment-asmd,http://inpda.org/press-release-xenpozyme-olipudase-alfa-approved-european-commission-first-treatment-asmd,http://inpda.org/xenpozyme-olipudase-alfa-approved-japan-first-approved-therapy-indicated-treat-acid-sphingomyelinase-deficiency,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://scceu.org/fda-approves-dupixent-dupilumab-as-first,http://itbusinessnet.com/2022/05/press-release-update-on-cialis-rx-to-otc-switch-actual-use-trial,http://english.bashable.tech/2022/02/10/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199","http://biznes.newseria.pl/biuro-prasowe/sanofi-przedstawia-nowa,b577308199",http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/category/globenewswire,,,,,
serge.weinberg@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Serge,Weinberg,,,,,,http://changerparledon.com/communiques-de-presse,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jamie.foreman@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Jamie,Foreman,,,,,,http://spnp.enpnetwork.com/nurse-practitioner-news/214388-september-spnpa-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
guillaume.haushalter@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Guillaume,Haushalter,Executive,Managing Director,"","","",http://cadran.pro/en/guillaume-haushalter-general-director-of-sanofi-pasteur-russia-and-belarus,http://cadran.pro/guillaume-haushalter-dg-de-sanofi-pasteur-russie-bielorussie,,,,,,,,,,,,,,,,,,,,,,,,,,,
dennis.urbaniak@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Dennis,Urbaniak,Executive,Vice President,durbaniak,http://www.linkedin.com/in/dennisurbaniak,"",http://pharmaphorum.com/views-and-analysis/top_ten_innovators_in_pharma_dennis_urbaniak,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurent.vanlerberghe@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Laurent,Vanlerberghe,,,,,,http://mondedesgrandesecoles.fr/construisez-la-sante-de-demain-chez-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
philippe.brun@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Philippe,Brun,Medical & health,Medical Manager,"","","",http://e-pediatrie.org/e-pediatrie/le-programme/comite-scientifique-scientifique,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nathalie.piton@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Nathalie,Piton,Management,Operations Manager,"","","",http://imi.europa.eu/about-imi/governance/strategic-governing-groups,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lance.webb@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Lance,Webb,,"","","",+1 713 898 5118,http://annagulfcoast.nursingnetwork.com/nursing-news/178115-march-12-2020-educational-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
angela.li@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Angela,Li,,,,,,http://yaozh.com/qita/3455.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
armin.bauer@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Armin,Bauer,,"","","","",http://pubs.rsc.org/en/content/articlelanding/2014/np/c3np70058e,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tony.damore@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Tony,Damore,Executive,Vice President And Global,"","","",http://bioprocessintl.com/manufacturing/vaccines/advances-and-challenges-in-vaccine-development-and-manufacture,,,,,,,,,,,,,,,,,,,,,,,,,,,,
benoit.mothes@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Benoit,Mothes,,Process Scientist,"","","",http://bioprocessintl.com/downstream-processing/downstream-single-use-technologies/accelerated-seamless-antibody-purification-process-intensification-with-continuous-disposable-technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,
clotilde.houze@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Clotilde,Houze,,"","","",+1 617 866 0616,http://prnewswire.com/news-releases/educational-campaign-helps-teens-and-their-caregivers-tackle-everyday-challenges-of-living-with-moderate-to-severe-atopic-dermatitis-300920388.html,http://biospace.com/article/releases/educational-campaign-helps-teens-and-their-caregivers-tackle-everyday-challenges-of-living-with-moderate-to-severe-atopic-dermatitis,,,,,,,,,,,,,,,,,,,,,,,,,,,
helene.bonnet@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Helene,Bonnet,Education,Phd Student,"","","",http://muhaz.org/landry-blanc-37-avenue-doccitanie.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jason.pelletier@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,4,{first}.{last},Jason,Pelletier,Management,Executive Director,"","","",http://mainesoccerreferee.com/adminstration,http://mainesoccerreferee.com/assignors,http://soccermaine.com/contact-us/contact-us,http://soccermaine.com/about/board-of-directors,,,,,,,,,,,,,,,,,,,,,,,,,
michaela.paudler-debus@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Michaela,Debus,,,,,,http://analist.nl/corporatenieuws/persberichten/1809109-sanofi-invests-300-million-to-expand-biologics-site-in-belgium,http://sanofi.com/en/media-room/press-releases/2016/2016-04-19-07-00-00,,,,,,,,,,,,,,,,,,,,,,,,,,,
pascal.robin@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,6,{first}.{last},Pascal,Robin,,,,,,http://campus.sanofi/kr/privacy-policy,http://pentaxim.co.kr/event-2022-notice,http://pentaxim.co.kr/tetraxim,http://pentaxim.co.kr/event-2020,http://pentaxim.co.kr/sanofi,http://pentaxim.co.kr/event,,,,,,,,,,,,,,,,,,,,,,,
chris.wimer@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Chris,Wimer,Management,Capacity Manager,"","","",http://slideshare.net/bmcsoftware/managing-growth-at-sanofi-how-true-sight-capacity-optimization-helped-align-it-to-busines,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ingrid.sassoon@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Ingrid,Sassoon,,"","","","",http://medecinesciences.org/en/articles/medsci/abs/2014/09/medsci20143010p855/medsci20143010p855.html,http://medecinesciences.org/en/articles/medsci/full_html/2014/09/medsci20143010p855/medsci20143010p855.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
lotta.vassilev@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,3,{first}.{last},Lotta,Vassilev,,,,,,http://sanofi.fi/dam/jcr:36a79fd3-6fb9-4fc6-b0b1-edab5897306f/methodological%20note_finland_eng_2021.pdf,http://sanofi.fi/dam/jcr:91b37a58-7fdf-48ab-ab44-0fe30aee9477/methodological%20note_finland_fin_2021.pdf,http://epressi.com/tiedotteet/terveys/tunnistatko-okasolusyovan-yli-puolet-suomalaisista-ei-tieda-mika-se-on.html,,,,,,,,,,,,,,,,,,,,,,,,,,
audrey.zhou@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Audrey,Zhou,,,,,,http://mszj.com/thread-11196-1-1.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jolie.zhu@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,5,{first}.{last},Jolie,Zhu,,,,,,http://sanofi.cn/cepia,http://sanofi.cn/zh/cepia,http://sanofi.cn/zh/cepia/api,http://sanofi.cn/zh/cepia/compliance,http://sanofi.cn/zh/cepia/production,,,,,,,,,,,,,,,,,,,,,,,,
mathias.ziegeler@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,4,{first}.{last},Mathias,Ziegeler,,"","","","",http://sanofi.at/dam/jcr:5605add4-377b-47cc-94d5-f06e959e928c/allgemeine%20verkaufs-%20und%20lieferbedingungen%20der%20sanofi-aventis%20gmbh.pdf,http://sanofi.at/de/agb,http://sanofi.de/agb,http://sanofi.de/de/agb,,,,,,,,,,,,,,,,,,,,,,,,,
daniela.carriero@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Daniela,Carriero,,,,,,http://digitalmarketingfarmaceutico.it/sanofi-viva-technology,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joachim.lopez@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Joachim,Lopez,Management,Program Lead,"","","",http://alumnius.net/university_of_paris_-2545-year-1997-1999,http://alumnius.net/university_of_paris_-2545-16,,,,,,,,,,,,,,,,,,,,,,,,,,,
a.faldetta@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Ann,Faldetta,Management,Executive Director,"","",+1 617 562 4518,http://abot.org/about/members,http://abot.org/about/officers-directors,,,,,,,,,,,,,,,,,,,,,,,,,,,
camelia.nitu@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Camelia,Nitu,Sales,Account Manager,"","","",http://jurmed.ro/pacienti/riscurile-gripei-si-importanta-vaccinarii-antigripale,http://realitatea.net/zentiva-n-v-ini-iaza-oferta-publica-de-cumparare-a-ac-iunilor-zentiva-s-a-fosta-sicomed-s-a-p_2137311_foto_1630516.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
liz.zhou@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Liz,Zhou,Education,Outcomes Research,"","","",http://academyhealth.org/blog/2018-08/researchers-experience-real-world-evidence-have-potential-transform-care,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joanna.lis@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Joanna,Lis,,"","","","",http://jhpor.com/home/editors,,,,,,,,,,,,,,,,,,,,,,,,,,,,
diane.buron@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Diane,Buron,,,,,,http://periscope-project.eu/media,,,,,,,,,,,,,,,,,,,,,,,,,,,,
johanna.cornwell@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Johanna,Cornwell,Management,Area Director,"","","",http://alumnius.net/elon_university-8772,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hernan.spika@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Hernan,Spika,Management,Project Manager,"","","",http://agilemanifesto.org/display/000000366.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laura.coronas@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Laura,Coronas,Management,Project Manager,"","","",http://docplayer.es/9650295-formacion-de-pacientes-a-traves-de-las-redes-sociales.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christian.possmann@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,2,{first}.{last},Christian,Possmann,,,,,,http://selfmedic.de/mediathek,http://selfmedic.de/thomae-akademie/downloads,,,,,,,,,,,,,,,,,,,,,,,,,,,
xiaodong.luo@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,8,{first}.{last},Xiaodong,Luo,Management,Office Manager,"","","",http://dirk.eddelbuettel.com/cranberries/cran/new,http://dirk.eddelbuettel.com/cranberries/cran/new/index.html,http://sonny.eddelbuettel.com/cranberries/cran/new,http://icsa.org/about/current-leadership,http://icsa.org/about/past-leadership,http://dirk.eddelbuettel.com/cranberries/index.html,http://dirk.eddelbuettel.com/cranberries/2017/03/04,http://dirk.eddelbuettel.com/cranberries,,,,,,,,,,,,,,,,,,,,,
sven.ruf@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,7,{first}.{last},Sven,Ruf,,,,,,http://rcsb.org/structure/4az3,http://worldwidescience.org/topicpages/c/crystal+deposition+disease.html,http://worldwidescience.org/topicpages/n/nanoparticles+alter+cathepsin.html,http://worldwidescience.org/topicpages/m/multiple+nucleopolyhedrovirus+cathepsin.html,http://rcsb.org/structure/4az0,http://worldwidescience.org/topicpages/r/requires+microglial+cathepsin.html,http://worldwidescience.org/topicpages/b/bradykinin.html,,,,,,,,,,,,,,,,,,,,,,
katja.kroll@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,6,{first}.{last},Katja,Kroll,IT / Engineering,Software Support,"","","",http://worldwidescience.org/topicpages/c/crystal+deposition+disease.html,http://worldwidescience.org/topicpages/n/nanoparticles+alter+cathepsin.html,http://worldwidescience.org/topicpages/m/multiple+nucleopolyhedrovirus+cathepsin.html,http://worldwidescience.org/topicpages/r/requires+microglial+cathepsin.html,http://worldwidescience.org/topicpages/b/bradykinin.html,http://science.gov/topicpages/a/abstract+crystal+structure.html,,,,,,,,,,,,,,,,,,,,,,,
david.reyero@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,13,{first}.{last},David,Reyero,Sales,Business Partner,tito_evar,https://www.linkedin.com/in/davidreyerotrapiello/,"",http://davidreyero.com/en/mythemes/grit-success-is-determination-over-and-above-innate-talent,http://davidreyero.com/en/mythemes/how-to-maintain-the-desire-to-excel-lessons-learned-from-sport,http://davidreyero.com/me-gusta/como-mejorar-tu-empleabilidad-laboral-y-marca-personal-10-consejos,http://davidreyero.com/mis-temas/grit-exito-es-determinacion-mas-que-talento-innato,http://davidreyero.com/mis-temas/personas-mis-temas/el-liderazgo-autentico-es-servir-y-no-servirse,http://grandespymes.com.ar/2020/10/13/compromiso-laboral-la-nueva-ventaja-competitiva,http://globedia.com/paradojas-gestion-empresarial-actual,http://do.globedia.com/paradojas-gestion-empresarial-actual,http://asociacion-centro.org/2013/07/01/la-esencia-de-recursos-humanos-clave-del-exito-empresarial,http://asociacion-centro.org/2019/02/26/david-reyero-mentoring-de-carrera-apuesta-por-tu-ikigai,http://grandespymes.com.ar/2018/12/16/10-paradojas-de-la-gestion-empresarial-actual,http://manuelgross.blogspot.com/2019/02/como-afrontar-10-mitos-sobre-la.html,http://manuelgross.blogspot.com/2018/02/20-factores-de-mejoramiento-del.html,,,,,,,,,,,,,,,,
katrin.koehler@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,6,{first}.{last},Katrin,Köhler,,,,,,http://meinpraktikum.de/stellen/praktikantin-im-bereich-talent-management-bei-sanofi-aventis-deutschland-gmbh-in-berlin-9f9a060e-755d-5913-803b-96fb6861dab2,http://absolventa.de/unternehmen/1289047-p-sanofi-aventis-deutschland-gmbh,http://berufsstart.de/unternehmen/sanofi/firmengeschichte.php,http://berufsstart.de/unternehmen/sanofi/jobs.php,http://berufsstart.de/unternehmen/sanofi/karriere.php,http://berufsstart.de/unternehmen/sanofi-aventis/karriere.php,,,,,,,,,,,,,,,,,,,,,,,
carole.tricoire@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,1,{first}.{last},Carole,Tricoire,,"","","","",http://gtldresult.icann.org/applicationstatus/applicationdetails/244,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joanne.kennedy@sanofi.com,sanofi.com,Sanofi,,,,,,99,personal,7,{first}.{last},Joanne,Kennedy,Writing & communication,Regulatory Affairs,"","",+1 514 956 4188,http://newswire.ca/fr/news-releases/jewish-general-hospital-becomes-home-of-new-centre-of-excellence-in-thrombosis-and-anticoagulation-care-511396751.html,http://ipra.org/news/itle/change-management-understanding-the-communicators-critical-role,http://newswire.ca/news-releases/jon-fairest-named-president-and-ceo-of-sanofi-canada-509999631.html,http://newswire.ca/news-releases/jewish-general-hospital-becomes-home-of-new-centre-of-excellence-in-thrombosis-and-anticoagulation-care-511396751.html,http://newswire.ca/news-releases/sanofi-recognizes-nurses-as-part-of-national-nursing-week-512383881.html,http://newswire.ca/news-releases/sanofi-canada-inaugurates-new-corporate-head-office-in-laval-quebec-512374021.html,http://sanoficanada.fr.mediaroom.com/etude-de-cas-en-gestion-de-changement,,,,,,,,,,,,,,,,,,,,,,
murray.fulmer@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Murray,Fulmer,,,,,,http://smithlab.ca/uploads/1/2/0/5/120564888/grad_for1575_urbanforestconservation_outline_assignments_2018.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
filiz.yaz@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Yaz,Filiz,,,,,,http://sanofi.com.tr/dam/jcr:4b291cb4-2ccc-4ab0-bc2a-035326bccf58/sanofi-surdurulebilirlik-raporu-2021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alicia.granados@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Alicia,Granados,,,,,,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,
jason.walther@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Jason,Walther,,,,,,http://engconf.us/conferences/biotechnology/integrated-continuous-biomanufacturing-vi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alain.krick@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Alain,Krick,,,,,,http://research.pasteur.fr/en/job/phd-position-in-mass-spectrometry-cifre-grant-with-sanofi,http://research.pasteur.fr/fr/job/phd-position-in-mass-spectrometry-cifre-grant-with-sanofi,http://gmp.asso.fr/wp-content/uploads/2023/04/20230413_offre-phd-cifre-sanofi-pasteur-jcr-002.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
stefan.kentrup@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Stefan,Kentrup,,,,,,http://sanofi.de/dam/jcr:543e72ad-eb8d-4439-bab8-5f6ff7ae2987/newsletter-standort-gesundheit_februar-2022.pdf,http://sanofi.de/dam/jcr:6886a46f-e99f-401c-be64-e866f3d9cfbe/newsletter-standort-gesundheit_oktober-2022.pdf,http://sanofi.de/dam/jcr:775d521d-7fe0-40b0-a175-772947ef7ff0/newsletter-standort-gesundheit_maerz-2023_en.pdf,http://sanofi.de/dam/jcr:91ed78d9-432b-4ea9-9b8f-7de12f2e2bee/newsletter-standort-gesundheit_maerz-2023.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
sylvain.nicolas@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Sylvain,Nicolas,,,,,,http://efspi.org/documents/news/efspi%20newsletter%20-%20august%202017.pdf,http://efspi.org/documents/news/efspi%20newsletter%20sep%202017.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrea.asztalos@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,5,{first}.{last},Andrea,Asztalos,,,,,,http://sanofi.hu/dam/jcr:1389ab12-fad6-40e3-8a29-bc95d0df69aa/sajtokozlemeny_ismet_ev_gyara_dijat_nyert_a_anofi.pdf,http://sanofi.hu/dam/jcr:1a6bc499-10d2-461a-9cde-9e8481606f68/sajtokozlemeny-sanofi-es-gsk-egyuttmukodes_20200416_vegl.pdf,http://sanofi.hu/dam/jcr:721faa0c-0fe7-4a04-ba5e-46be40982e2d/sajtokozlemeny_globalis_kompetenciakozpontot_adott_at_budapesten_a_sanofi.pdf,http://sanofi.hu/dam/jcr:c37b3962-fd77-4e5d-a048-c7c17cccc420/sajtokozlemeny_otven_szazalekkal_tobb_eletmento_injekcio_keszulhet_a_0917.pdf,http://sanofi.hu/dam/jcr:d117f74b-50fc-415e-b1ed-39b678a25dbd/sajtokozlemeny_a_sanofi_bemutatja_uj_vallalati_arculatat.pdf,,,,,,,,,,,,,,,,,,,,,,,,
romane.potin@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Romane,Potin,,,,,,http://mysanofi.be/nl-be/news/immunology-capsuleallergist,,,,,,,,,,,,,,,,,,,,,,,,,,,,
asha.kaur@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Asha,Kaur,,,,,,http://sanofi.co.uk/dam/jcr:ec1f6c55-d539-474f-a901-9ea854be134c/multiple%20myeloma%20in%20black%20communities%20parliamentary%20infographic_approved.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shannon.kelley@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Shannon,Kelley,,,,,,http://phrma.org/-/media/project/phrma/phrma-org/phrma-refresh/certifications/compliance-officers-03-09-2023.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
suzette.roan@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Suzette,Roan,,,,,,http://pdadelval.org/wp-content/uploads/2019/04/pda-west-present-combination-products-combination-product-development-regulatory-best-practices-drug-biologic-pmoa-perspective.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicolas.basse@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Nicolas,Basse,,,,,,http://biofunctional.eu/uploads/6/9/9/6/69969003/offre_cifre_sanofi-bfc.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lily.pao@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Lily,Pao,,,,,,http://facultyopinions.com/article/741708278,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrew.scholte@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Andrew,Scholte,,,,,,http://nesacs.org/about/governance/board-of-directors,http://nesacs.org/committees/summerthing-committee,,,,,,,,,,,,,,,,,,,,,,,,,,,
maryann.giel-moloney@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Maryann,Moloney,,,,,,http://epub.uni-regensburg.de/47938,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jean-paul.nicolas@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Jean,Nicolas,,,,,,http://ce-crva.fr,http://ce-crva.fr/index.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
gabor.meszaros@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Gabor,Meszaros,,"","",https://www.linkedin.com/in/gabor-meszaros-a4b9085a/,"",http://creditcee.eu/presenters-cmxi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chris.osner-hackett@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Chris,Hackett,,,,,,http://anaaimm.net/members/sanofi-us-consumer-healthcare,,,,,,,,,,,,,,,,,,,,,,,,,,,,
patrick.rousseau@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Patrick,Rousseau,,,,,,http://estba.org/sanofi-techniciens-de-laboratoire-microbiologie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rocco.di-salvatore@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Rocco,Salvatore,,,,,,http://estba.org/sanofi-technicien-fabrication-formes-injectables-h-f-ouverte,,,,,,,,,,,,,,,,,,,,,,,,,,,,
megan.loy@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Megan,Loy,,"","","","","http://archivesofmedicalscience.com/treatment-adherence-and-effect-of-concurrent-statin-intensity-on-the-efficacy-and,143476,0,2.html",,,,,,,,,,,,,,,,,,,,,,,,,,,,
miranda.walden@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Miranda,Walden,Sales,Pharmaceutical Regional Account Director,"","","",http://flhealthvalue.org/about/affiliate-members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lorena.petcu@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Lorena,Petcu,,,,,,http://efsm.online/be_nl/article-overview/101/2022/meta-analysis-and-narrative-review-confirm-the-benefit-of-essential-phospholipids-in-non-alcoholic-fatty-liver-disease,http://efsm.online/de_de/article-overview/101/2022/meta-analysis-and-narrative-review-confirm-the-benefit-of-essential-phospholipids-in-non-alcoholic-fatty-liver-disease,http://efsm.online/int_en/article-overview/101/2022/meta-analysis-and-narrative-review-confirm-the-benefit-of-essential-phospholipids-in-non-alcoholic-fatty-liver-disease,,,,,,,,,,,,,,,,,,,,,,,,,,
anne-laure.tardy@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Anne,Tardy,,,,,,http://efsm.online/be_nl/article-overview/101/2022/daily-intake-of-panax-ginseng-extract-g115-r-supplemented-with-vitamins-and-minerals-reduces-self-perception-of-mental-and-physical-fatigue,http://efsm.online/de_de/article-overview/101/2022/daily-intake-of-panax-ginseng-extract-g115-r-supplemented-with-vitamins-and-minerals-reduces-self-perception-of-mental-and-physical-fatigue,http://efsm.online/int_en/article-overview/101/2022/daily-intake-of-panax-ginseng-extract-g115-r-supplemented-with-vitamins-and-minerals-reduces-self-perception-of-mental-and-physical-fatigue,,,,,,,,,,,,,,,,,,,,,,,,,,
sabine.landes@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Sabine,Landes,Medical & health,Medical Affairs,"","","",http://efsm.online/pl_pl/article-overview/101/2021/female-specific-characteristics-in-the-occurrence-and-treatment-of-constipation,http://efsm.online/be_nl/article-overview/101/2022/circadian-rhythm-and-its-potential-influence-on-gut-motility,http://efsm.online/de_de/article-overview/101/2022/circadian-rhythm-and-its-potential-influence-on-gut-motility,http://efsm.online/int_en/article-overview/101/2022/circadian-rhythm-and-its-potential-influence-on-gut-motility,,,,,,,,,,,,,,,,,,,,,,,,,
suresh.sahu@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Suresh,Sahu,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ruth.jacob@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Ruth,Jacob,,,,,,http://ojrd.biomedcentral.com/articles/10.1186/s13023-020-01354-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
martina.wolters@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Martina,Wolters,,"","","",+1 302 575 2664,http://sanofi.de/dam/jcr:b4cf53ff-6f69-42ca-96fd-149de6526d4b/20220513_pm_umzug-berlin.pdf,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220513,,,,,,,,,,,,,,,,,,,,,,,,,,,
bruce.beyer@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Bruce,Beyer,,,,,,http://dntshome.org/meetings/exhibits-sponsors/sponsorship-opportunities,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christophe.andre@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Christophe,Andre,Management,Project Manager,"","","",http://processproject.eu/partners,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bruno.donini@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Bruno,Donini,Education,Company Coach And Administrative Finance Officer,"","","",http://processproject.eu/partners,,,,,,,,,,,,,,,,,,,,,,,,,,,,
branko.popovic@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,5,{first}.{last},Branko,Popovic,,"","","","",http://efsm.online/de_de/article-overview/101/2022/real-world-evidence-for-beneficial-effects-of-essential-phospholipids-in-patients-with-non-alcoholic-fatty-liver-disease,http://efsm.online/be_nl/article-overview/101/2022/high-compliance-and-treatment-satisfaction-with-essential-phospholipid-treatment-of-patients-with-non-alcoholic-fatty-liver-disease,http://efsm.online/be_nl/article-overview/101/2022/real-world-evidence-for-beneficial-effects-of-essential-phospholipids-in-patients-with-non-alcoholic-fatty-liver-disease,http://efsm.online/int_en/article-overview/101/2022/high-compliance-and-treatment-satisfaction-with-essential-phospholipid-treatment-of-patients-with-non-alcoholic-fatty-liver-disease,http://efsm.online/int_en/article-overview/101/2022/real-world-evidence-for-beneficial-effects-of-essential-phospholipids-in-patients-with-non-alcoholic-fatty-liver-disease,,,,,,,,,,,,,,,,,,,,,,,,
chris.driscoll@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Chris,Driscoll,Management,Project Manager,"","","",http://voiceofmobusiness.com/post/sanofi-pharmaceutical-manufacturing-facility-offering-located-in-kansas-city-mo,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anita.tveter@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Anita,Tveter,Writing & communication,Business Relations Manager,"","","",http://legeforeningen.no/foreningsledd/fagmed/norsk-forening-for-dermatologi-og-venerologi/aktuelt/2020/webinar-i-easi-skaring,,,,,,,,,,,,,,,,,,,,,,,,,,,,
theo.fouts@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Theo,Fouts,,,,,,http://ce.mayo.edu/content/sanofi-virtual-exhibit-hall-mayo-clinic-southeastern-clinical-update-nephrology-hypertension,,,,,,,,,,,,,,,,,,,,,,,,,,,,
frederique.guilbert@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Frederique,Guilbert,,,,,,http://jpet.aspetjournals.org/content/early/2021/02/18/jpet.120.000238,http://jpet.aspetjournals.org/content/early/2021/02/18/jpet.120.000238/tab-figures-data,http://jpet.aspetjournals.org/content/suppl/2021/02/18/jpet.120.000238.dc1,,,,,,,,,,,,,,,,,,,,,,,,,,
marco.meloni@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Marco,Meloni,Education,Research Development,"","","",http://insight.jci.org/articles/view/134888,,,,,,,,,,,,,,,,,,,,,,,,,,,,
claire.terrazas@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Claire,Terrazas,,"","","","",http://afje.org/agenda/commission-corporate-et-m-a-la-digitalisation-des-conseils--21,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marc.waite@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Marc,Waite,,"","","",+1 715 340 4675,http://ce.mayo.edu/node/107906,http://ce.mayo.edu/node/114883,http://ce.mayo.edu/content/exhibitor-sanofi-genzyme-virtual-exhibit-hall-hematology-oncology-bmt-nppa,http://ce.mayo.edu/node/100598,,,,,,,,,,,,,,,,,,,,,,,,,
diane.lehn@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,5,{first}.{last},Diane,Lehn,,"","","",+1 612 817 0962,http://ce.mayo.edu/node/107906,http://ce.mayo.edu/content/sanofi-genzyme-virtual-exhibit-hall-onco-nephrology-symposium-2021,http://ce.mayo.edu/content/exhibitor-sanofi-genzyme-virtual-exhibit-hall-hematology-oncology-bmt-nppa,http://ce.mayo.edu/node/114883,http://ce.mayo.edu/node/100598,,,,,,,,,,,,,,,,,,,,,,,,
carine.cohen@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Carine,Cohen,,,,,,http://mymedr.afpm.org.my/publications/66953,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lionel.hovsepian@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Lionel,Hovsepian,,"","","","",http://medrxiv.org/content/10.1101/2020.05.15.20103101v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
luzia.derflinger@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,5,{first}.{last},Luzia,Derflinger,Management,Manager,"","","",http://sanofi.at/dam/jcr:7b32c97a-1fc4-4729-89fa-53d1276bf768/sanofi%20pressemitteilung_aufmerksamkeit%20fur%20multiple%20sklerose%202021.pdf,http://sanofi.at/dam/jcr:87875014-eaa0-464b-ba18-fdfe6a5880d6/at_pi%20selfcare%20day%202021.pdf,http://sanofi.at/dam/jcr:ce9b7679-efa1-4d76-82c6-2666c84b0bc9/sanofi%20presse_bettina%20resl%20wird%20europe%20head%20of%20public%20affairs%20bei%20sanofi%20chc.pdf,http://sanofi.at/dam/jcr:f7a67379-631a-40d3-b746-7863be222f20/sanofi%20presse_pamme%20neue%20head%20of%20communication%20bei%20sanofi%20osterreich.pdf,http://sanofi.at/de/media-center/journalistenkontakt,,,,,,,,,,,,,,,,,,,,,,,,
koss@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,6,{first}.{last},Ashleigh,Koß,Medical & health,Infectious Disease,"","",+1 908 205 2572,http://globenewswire.com/news-release/2020/06/11/2046612/0/en/sanofi-to-present-growth-opportunities-and-development-strategy-for-dupixent-dupilumab-in-type-2-inflammatory-diseases.html,http://sanofi.com/en/media-room/press-releases/2020/2020-06-02-07-00-00,http://sanofi.com/en/media-room/press-releases/2020/2020-06-11-07-00-00,http://sanofi.com/en/media-room/press-releases/2020/2020-06-23-07-00-00,http://sanofi.com/fr/media-room/communiques-de-presse/2020/2020-06-23-07-00-00,http://globenewswire.com/news-release/2020/06/02/2041884/0/en/sanofi-to-present-oncology-strategy-provide-update-on-portfolio-and-emerging-pipeline.html,,,,,,,,,,,,,,,,,,,,,,,
sally.bain@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,30,{first}.{last},Sally,Bain,,,,,,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://magazine-pr.com/fda-aprueba-tratamiento-para-la-esofagitis-eosinofilica,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://itbusinessnet.com/2023/03/dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-aged-12-years-and-older-accepted-for-fda-review,http://pharmiweb.com/press-release/2022-08-05/sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://biospace.com/article/releases/press-release-new-nirsevimab-data-analyses-reinforce-efficacy-against-rsv,http://coachmansresearch.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://life-sciences-europe.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://biotech-365.com/author/biotech365/page/3,http://blackstone.com/news/press/sanofi-announces-e300-million-collaboration-with-blackstone-life-sciences-to-advance-an-innovative-treatment-for-multiple-myeloma,http://northdakotadigitalnews.com/2022/11/10/sanofi-and-gsks-next-generation-covid-19,http://northdakotadigitalnews.com/2023/01/04/press-release-availability-of-the-q4-2022-memorandum-for-modelling-purposes,http://northdakotadigitalnews.com/2023/01/05/fda-accepts-nirsevimab-application-as-first,http://healthtechnologynet.com/2022/07/14/press-release-dupixent-dupilumab-phase-3-trial-shows-positive-results-in-children-1-to-11-years-of-age-with-eosinophilic-esophagitis,http://roboticulized.com/latest-news,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://sanofi.com/en/media-room/press-releases/2021/2021-12-13-06-00-00-2350402,http://medicaex.com/businesswire/sanofi-and-innate-pharma-expand-collaboration-for-natural-killer-cell-therapeutics-in-oncology,http://biospace.com/article/releases/nirsevimab-significantly-protected-infants-against-rsv-disease-in-phase-3-trial,http://itbusinessnet.com/2022/01/chmp-recommends-approval-of-dupixent-dupilumab-for-children-aged-6-to-11-years-with-severe-asthma-with-type-2-inflammation,http://scceu.org/fda-approves-dupixent-dupilumab-as-first,http://biospace.com/article/releases/dupixent-dupilumab-late-breaking-phase-3-copd-results-presented-at-ats-and-simultaneously-published-in-the-new-england-journal-of-medicine,http://biospace.com/article/releases/press-release-dupixent-dupilumab-late-breaking-phase-3-copd-results-presented-at-ats-and-simultaneously-published-in-the-new-england-journal-of-medicine,http://biospace.com/article/releases/press-release-fda-accepts-nirsevimab-application-as-first-protective-option-against-rsv-disease-for-all-infants,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/category/globenewswire
suzana.petrovic@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Suzana,Petrovic,Management,Team Manager,"","","",http://bebpa.org/2023-hcp-abstracts,http://bebpa.org/2021-hcp-abstracts,http://bioprocessintl.com/analytical/downstream-development/host-cell-protein-analysis-to-support-downstream-process-development-a-high-throughput-platform-with-automated-sample-preparation,http://bioprocessintl.com/2019/november-december-2019/host-cell-protein-analysis-to-support-downstream-process-development-a-high-throughput-platform-with-automated-sample-preparation,,,,,,,,,,,,,,,,,,,,,,,,,
yann.fromentin@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Yann,Fromentin,Management,Team Manager,"","","",http://bebpa.org/2021-hcp-abstracts,http://bioprocessintl.com/analytical/downstream-development/host-cell-protein-analysis-to-support-downstream-process-development-a-high-throughput-platform-with-automated-sample-preparation,http://bioprocessintl.com/2019/november-december-2019/host-cell-protein-analysis-to-support-downstream-process-development-a-high-throughput-platform-with-automated-sample-preparation,,,,,,,,,,,,,,,,,,,,,,,,,,
ann.cools@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Ann,Cools,,,,,,http://vrijemeid.nl/2018/03/jamaica-avontuurlijke-rondreis.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alejandra.martinez@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Alejandra,Martinez,,"","","","",http://community.canvaslms.com/profile-people.jspa,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nonna.holpne-kozlova@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Nonna,Kozlova,,,,,,http://europharma.kz/magne-v6-premium-no-20-tabl-po,http://europharma.kz/kz/magne-v6-premium-no-60-tabl-pokrytyye-obolochkoy,http://europharma.kz/magne-v6-premium-no-60-tabl-pokrytyye-obolochkoy,,,,,,,,,,,,,,,,,,,,,,,,,,
fatimah.ferial@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Ferial,Fatimah,,,,,,http://farmasi.ui.ac.id/2019/05/penerimaan-mahasiswa-magang-sanofi-indonesia,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jack.pollard@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Jack,Pollard,,,,,,http://seqanswers.com/forums/archive/index.php/t-20511.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
iris.legris@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Iris,Legris,,"","","","",http://pharmandcie.fr/2019/07/16/alternant-charge-de-validation-sanofi-le-trait-normandie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christele.da-silva@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Christele,Silva,,,,,,http://em-consulte.com/article/1276491/article/etude-exploratoire-d-une-combinaison-de-plantes-de,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zack.mccormack@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Zack,Mccormack,Medical & health,Radiation Oncology,"","",+1 908 332 4038,http://astro.org/meetings-and-education/live-meetings/2019/2019-astro-annual-meeting/exhibits/attend-an-industry-expert-theater,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emmanuelle.vigne@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Emmanuelle,Vigne,,"","","","",http://medecinesciences.org/en/articles/medsci/abs/2014/09/medsci20143010p855/medsci20143010p855.html,http://medecinesciences.org/en/articles/medsci/full_html/2014/09/medsci20143010p855/medsci20143010p855.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
bernard.sebastien@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Bernard,Sebastien,,"","","","",http://openscience.fr/assessing-dunnett-and-mcp-mod-based-approaches-in-two-stage-dose-finding-trials,http://openscience.fr/evaluation-des-approches-basees-sur-le-test-de-dunnett-et-mcp-mod-dans-des,,,,,,,,,,,,,,,,,,,,,,,,,,,
josep.catlla@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,8,{first}.{last},Josep,Catlla,,"","","",+33 7 89 07 80 33,http://sanofi.com.tw/dam/jcr:343e6215-8a47-4b0d-8555-fb45d5938fe4/paul%20hudson%20to%20succeed%20olivier%20brandicourt%20as%20chief%20executive%20officer.pdf,http://sanofi.pl/dam/jcr:fb79dff7-aaec-41a7-a08d-f0c258ed49eb/2486_press%20release%20board-%20pl.pdf,http://states1105.rssing.com/chan-7107163/all_p1873.html,http://francebourse.com/fiche_news_144425.fb,http://sanofi.com/fr/media-room/communiques-de-presse/2019/2019-06-07-07-00-00,http://sanofi.com/en/media-room/press-releases/2019/2019-06-07-07-00-00,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/paul-hudson-succedera-a-olivier-brandicourt-comme-directeur-general,http://globenewswire.com/news-release/2019/06/07/1865727/0/en/paul-hudson-to-succeed-olivier-brandicourt-as-chief-executive-officer.html,,,,,,,,,,,,,,,,,,,,,
joachim.jost@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Joachim,Jost,,"","","","",http://limes-chor.de/ansprechpartner,http://limes-chor.de/impressum,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.wagner@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Daniel,Wagner,Operations & logistics,"","","","",http://journal.pda.org/content/early/2021/11/15/pdajpst.2021.012633/tab-article-info,http://journal.pda.org/content/early/2021/11/15/pdajpst.2021.012633,http://journal.pda.org/content/early/2016/10/21/pdajpst.2016.006999,http://journal.pda.org/content/early/2016/10/21/pdajpst.2016.006999.abstract,,,,,,,,,,,,,,,,,,,,,,,,,
elizabeth.monk@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Elizabeth,Monk,Management,Manager,"","","",http://chnc.ca/en/2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,
clement.chatelain@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Clement,Chatelain,,Model,"","","",http://dirk.eddelbuettel.com/cranberries,http://dirk.eddelbuettel.com/cranberries/cran/new/index.html,http://dirk.eddelbuettel.com/cranberries/index.html,http://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-018-2229-8,,,,,,,,,,,,,,,,,,,,,,,,,
jennifer.murphy@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,4,{first}.{last},Jennifer,Murphy,,"","","","",http://ferrybankgaa.blogspot.com/2017/09/abp-sponsored-ferrybank-gaa-weekly-notes_24.html,http://ferrybankgaa.blogspot.com/2017/09/abp-sponsored-ferrybank-gaa-weekly-notes_10.html,http://ferrybankgaa.blogspot.com/2017/09/abp-sponsored-ferrybank-gaa-weekly-notes_18.html,http://ferrybankgaa.blogspot.com/2017/09/sanofi-wellbeing-conference.html,,,,,,,,,,,,,,,,,,,,,,,,,
karolina.lindbom@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Karolina,Lindbom,Management,Area Manager,"","","",http://mynewsdesk.com/se/sanofi/pressreleases/sanofi-faar-europeiskt-godkaennande-foer-zaltrap-aflibercept-foer-behandling-av-metastaserad-kolorektal-cancer-834136,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anke.schulte@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Anke,Schulte,Operations & logistics,Scientific Coordinator,"","","",http://link.springer.com/article/10.1007/s00125-017-4500-3,http://innovations-report.de/html/berichte/biowissenschaften-chemie/neue-gene-die-mit-ausfall-insulinproduzierender-zellen-bei-diabetes-in-verbindung-stehen-entdeckt.html,http://innovations-report.com/html/reports/life-sciences/novel-transcriptomic-signature-of-type-2-diabetic-islets-identified.html,,,,,,,,,,,,,,,,,,,,,,,,,,
brian.ellerman@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Brian,Ellerman,Sales,Vice President Research Business Technology,"","","",http://prismeforum.org/top-content-for-sig-members/meetings/2014-fall,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mattias.wieloch@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Mattias,Wieloch,Writing & communication,"","","","",http://mynewsdesk.com/se/sanofi/pressreleases/byte-till-toujeo-r-utvaerderat-i-observationsstudie-1442038,http://mynewsdesk.com/se/sanofi/pressreleases/suliqua-eu-godkaend-foer-behandling-av-vuxna-med-diabetes-typ-2-1755482,http://mynewsdesk.com/se/sanofi/pressreleases/praluent-alirokumab-nu-godkaent-inom-laekemedelsfoermaanen-foersta-pcsk9-haemmaren-som-ger-individanpassad-behandling-av-hoegt-ldl-kolesterol-1786578,,,,,,,,,,,,,,,,,,,,,,,,,,
paulo.justus@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Paulo,Justus,,"",diariomentalorg,"","",http://acontecenoticias.com.br/post/2016/09/05/programa-m%c3%basica-nos-hospitais-fechar%c3%a1-a-12%c2%aatemporada-em-campinas,http://acontecenoticias.com.br/post/2016/09/23/programa-m%c3%basica-nos-hospitais-encerra-12%c2%aatemporada-em-campinas,http://agencia.fiocruz.br/museu-da-vida-leva-exposicao-vias-do-coracao-para-minas-gerais,,,,,,,,,,,,,,,,,,,,,,,,,,
herman.schreuder@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,6,{first}.{last},Herman,Schreuder,IT / Engineering,Software Support,"","","",http://worldwidescience.org/topicpages/n/nanoparticles+alter+cathepsin.html,http://worldwidescience.org/topicpages/m/multiple+nucleopolyhedrovirus+cathepsin.html,http://worldwidescience.org/topicpages/r/requires+microglial+cathepsin.html,http://worldwidescience.org/topicpages/b/bradykinin.html,http://science.gov/topicpages/a/abstract+crystal+structure.html,http://osti.gov/scitech/biblio/22416308-crystal-structure-cathepsin-novel-target-treatment-cardiovascular-diseases,,,,,,,,,,,,,,,,,,,,,,,
brian.swanson@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Brian,Swanson,,"","","","",http://pstos.org/instruments/wa/seattle/granada-organloft.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dana.lee@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Dana,Lee,Medical & health,Medical Affairs,"","","",http://students.pharmacy.pitt.edu/classof2021/2018/04/12/rx2021-fw-facebook-live-find-webinar-about-industry-fellowships,,,,,,,,,,,,,,,,,,,,,,,,,,,,
charles.xie@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,2,{first}.{last},Charles,Xie,Medical & health,Health Education,"","",+1 908 229 2240,http://bioct.org/member/sino-american-pharmaceutical-professionals-association-connecticut-chapter-sapa-ct,http://laozhong.net/list/116/318207.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
arnaud.martin@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,1,{first}.{last},Arnaud,Martin,Marketing,Marketing Manager,"","","",http://bioisrael.com/mablaunch-offers-new-cmo-services,,,,,,,,,,,,,,,,,,,,,,,,,,,,
catherine.cunningham@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,12,{first}.{last},Catherine,Cunningham,Support,Patient Representative,"","",+1 514 956 6120,http://allergiesalimentairescanada.ca/mise-a-jour-de-sanofi-canada-sur-le-rappel-volontaire-dallerject,http://survivornet.ca/connect/media/2014-archives/january-14-2014-finding-flexible-work-difficult-for-cancer-patients-and-caregivers,http://survivornet.ca/les-patients-atteints-du-cancer-et-les-aidants-ont-de-la-difficulte-a-trouver-un-travail-flexible,http://fondationact.ca/act-media-items/la-formation-en-rcr-et-en-defibrillation-externe-automatisee-arrive-dans-les-ecoles-secondaires-de-laval,http://sanoficanada.fr.mediaroom.com/deux-chercheurs-canadiens-recoivent-le-prix-sanofi-acro,http://sanoficanada.fr.mediaroom.com/le-projet-national-daccessibilite-aux-analyses-oncologiques-prend-de-lelan,http://jackiemanthornescancerblog.blogspot.com/2014/01,http://jackiemanthornescancerblog.blogspot.com/search/label/patients,http://actfoundation.ca/act-media-items/laval-high-schools-to-receive-cpr-and-automated-external-defibrillator-training,http://jackiemanthornescancerblog.blogspot.com/2014/01/finding-flexible-work-difficult-for.html,http://jackiemanthornescancerblog.blogspot.com/search/label/access%20to%20medications,http://jackiemanthornescancerblog.blogspot.com/search/label/action,,,,,,,,,,,,,,,,,
aparna.thomas@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,6,{first}.{last},Aparna,Thomas,Writing & communication,Senior Director Communications,"","",+33 4 37 37 50 38,http://healthissuesindia.com/2020/10/13/sanofi-india-appoints-vaibhav-karandikar-as-chief-financial-officer,http://healthissuesindia.com/2020/10/01/sanofi-pasteur-launches-tetraxim-the-first-full-dose-dtap-booster-vaccine-in-india-for-preschoolers,http://prfeed.blogspot.com/2014/09/bwi-apollo-hospitals-and-sanofi.html,http://prfeed.blogspot.com/2014/09,http://brainbuxa.com/education-news/fight-against-diabetes-by-schools-lead-4025,http://prfeed.blogspot.com/2014_09_01_archive.html,,,,,,,,,,,,,,,,,,,,,,,
antoine.alam@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,6,{first}.{last},Antoine,Alam,Medical & health,Molecular Biology,"","","",http://canceropole-gso.org/download/fichiers/3276/jgso2014_livret_def_web.pdf,http://worldwidescience.org/topicpages/a/activator+regulates+myeloid-cell.html,http://worldwidescience.org/topicpages/m/macrophage+activation+immunosuppression.html,http://worldwidescience.org/topicpages/b/bromide+specifically+inhibits.html,http://worldwidescience.org/topicpages/i/inhibits+tumor+regrowth.html,http://worldwidescience.org/topicpages/i/inhibition+increases+tyrosine.html,,,,,,,,,,,,,,,,,,,,,,,
yanyan.chang@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,6,{first}.{last},Yanyan,Chang,Writing & communication,Global Communications,"","",+1 908 981 6566,http://news.europawire.eu/sanofi-and-medtronic-partner-to-improve-patient-experience-and-outcomes-for-people-with-diabetes-around-the-world-98765432123456789/eu-press-release/2014/06/16,http://presseportal.ch/de/pm/100007059/100627488,http://presseportal.ch/de/pm/100007059/100627489,http://bio-medicine.org/medicine-technology-1/initiation-of-lantus-ae-leads-to-better-glycemic-control-at-similar-weight-gain-versus-other-comparators-in-patients-with-type-2-diabetes-20165-1,http://globenewswire.com/news-release/2014/06/14/644123/10085771/en/Sanofi-and-Medtronic-to-Form-Strategic-Alliance-in-Diabetes-to-Improve-Patient-Experience-and-Outcomes.html,http://globenewswire.com/news-release/2014/06/14/644123/10085771/en/sanofi-and-medtronic-to-form-strategic-alliance-in-diabetes-to-improve-patient-experience-and-outcomes.html,,,,,,,,,,,,,,,,,,,,,,,
milena.saleh@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,3,{first}.{last},Milena,Saleh,Medical & health,Medical Management,"","",+49 17 3689 6040,http://prnewswire.co.uk/news-releases/sanofi-announces-upcoming-launch-of-mystar-connect-275554291.html,http://presseportal.ch/de/pm/100022080/100733318,http://presseportal.ch/de/pm/100022080/100744420,,,,,,,,,,,,,,,,,,,,,,,,,,
carrie.brown@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,9,{first}.{last},Carrie,Brown,,"",,,,http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-new-data-on-dupixent-dupilumab-for-moderate-to-severe-atopic-dermatitis-at-upcoming-medical-congresses-300413658.html,http://prnewswire.com/news-releases/phase-ii-trial-of-sanofi-jak2-inhibitor-in-myelofibrosis-met-primary-endpoint-182727541.html,http://markets.financialcontent.com/prnews/news/read/22958017/phase_ii_trial_of_sanofi_jak2_inhibitor_in_myelofibrosis_met_primary_endpoint,http://sanofi.com/en/media-room/press-releases/2017/2017-03-28-17-55-21,http://biospace.com/article/releases/sanofi-france-pozen-inc-sign-exclusive-pact-for-commercialization-of-aspirin-products-b-pozn-b-stock-rises-10-59-percent-at-market-close-september,http://mynewsdesk.com/se/sanofi/pressreleases/u-s-fda-approves-zaltrap-r-ziv-aflibercept-after-priority-review-for-previously-treated-metastatic-colorectal-cancer-782871,http://biospace.com/news/sanofi-france-pozen-inc-sign-exclusive-pact-for/307701,http://sanofi.com/fr/media-room/communiques-de-presse/2017/2017-05-22-23-52-05,http://bio-medicine.org/medicine-technology-1/have-you-been-counted-3f--regeneron-and-sanofi-us-join-forces-with-leading-cardiovascular-organizations-to-raise-awareness-of-cholesterol-41715-1,,,,,,,,,,,,,,,,,,,,
marisol.peron@sanofi.com,sanofi.com,Sanofi,,,,,,98,personal,17,{first}.{last},Marisol,Peron,Writing & communication,Global Product Communications,dndi_espanol,"",+33 1 53 77 46 25,http://biospace.com/article/releases/collaboration-between-sanofi-france-and-joslin-diabetes-center-to-focus-on-new-drugs-for-diabetes-,http://biospace.com/article/releases/sanofi-france-release-lyxumia-lixisenatide-in-combination-with-basal-insulin-plus-oral-anti-diabetics-significantly-reduced-hba1c-and-post-prand,http://biospace.com/news/sanofi-france-regeneron-pharmaceuticals-inc-s/226743,http://biospace.com/news/sanofi-france-says-zaltrap-approved-in-europe-for/286672,http://europapress.es/comunicados/empresas-00908/noticia-comunicado-impact-of-early-insulin-initiation-on-glycemic-control-in-asian-people-with-type-diabetes-20111205141254.html,http://oncowikia.blogspot.com/2011/07/sarilumab-succeeds-in-treating.html,http://oncowikia.blogspot.com/search/label/ankylosing%20spondylitis,http://oncowikia.blogspot.com/search/label/rheumatoid%20arthritis,http://oncowikia.blogspot.com/search/label/sarilumab,http://benzinga.com/pressreleases/12/11/n3097699/zaltrap-ziv-aflibercept-receives-chmp-positive-opinion-in-the-european-,http://biospace.com/news/sanofi-france-new-drug-application-for/288035/source=morenews,http://vidal.ru/novosti/sanofi-snimaet-s-mezhdunarodnoj-registratsii-issleduemyj-preparat-semuloparin-2628,http://vidal.ru/novosti/shprits-ruchki-lantusr-solostarr-nachinayut-proizvoditsya-v-pekine-2405,http://prnewswire.co.uk/news-releases/sanofi-and-regeneron-announce-publication-of-positive-phase-2-results-for-lipid-lowering-pcsk9-antibody-in-the-lancet-154478135.html,http://oncowikia.blogspot.com/2011/07,http://markets.financialcontent.com/prnews/news/read/22958017/phase_ii_trial_of_sanofi_jak2_inhibitor_in_myelofibrosis_met_primary_endpoint,http://markets.financialcontent.com/prnews/news/read/23136897/sanofi's_chattem_acquires_over,,,,,,,,,,,,
samuel.pine@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Samuel,Pine,,,,,,http://e-i-p.eu/media/pages/symposiums/2022-lisbon/622bddf119-1651754015/eip-2022-sebastian-spindeldreher.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lisa.cameron@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Lisa,Cameron,,,,,,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/22-058.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
greg.stephenson@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Greg,Stephenson,,,,,,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/23-019.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marissa.smith@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Marissa,Smith,,,,,,http://mysms-code.com/is-dupixent-covered-by-insurance-in-canada,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pierre.mancini@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Pierre,Mancini,,,,,,http://efspi.org/efspi/about_efspi/efspi_council/council_members/efspi/about_efspi/council_members.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
loren.mcmurtrie@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Loren,Mcmurtrie,,,,,,http://sanofi.com.au/en/news/press-releases,http://sanofi.com.au/en/news,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarah.lindeman@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Sarah,Lindeman,,,,,,http://sanofi.com.au/en/news/press-releases,http://sanofi.com.au/en/news,,,,,,,,,,,,,,,,,,,,,,,,,,,
ann.lucas@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Ann,Lucas,,,,,,http://patients.flasco.org/clinicaltrials/study-to-assess-a-diagnostic-protocol-for-individuals-with-unexplained-splenomegaly-and-thrombocytopenia,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tiziano.poletti@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Tiziano,Poletti,,,,,,http://rcgpac.org.uk/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.frank@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,5,{first}.{last},Thomas,Frank,,,,,,http://jpet.aspetjournals.org/content/early/2023/05/10/jpet.122.001511/tab-article-info,http://jpet.aspetjournals.org/content/early/2023/05/10/jpet.122.001511/tab-e-letters,http://jpet.aspetjournals.org/content/early/2023/05/10/jpet.122.001511/tab-figures-data,http://jpet.aspetjournals.org/content/jpet/early/2023/05/10/jpet.122.001511.full.pdf,http://jpet.aspetjournals.org/content/early/2023/05/10/jpet.122.001511,,,,,,,,,,,,,,,,,,,,,,,,
sandrine.belland@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Sandrine,Belland,,,,,,http://ellye.fr/f/c0de0859bb09c7eac836d2a27b0b88caa8d1bcca/livret-greffe---edition2016.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
monica.casagrande@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,4,{first}.{last},Monica,Casagrande,,,,,,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,
roger.jung@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,6,{first}.{last},Roger,Jung,,,,,,http://mein.sanofi.de/dam/jcr:d90adde7-43fd-4f39-82ff-50b6e0f929df/csr-report-2022-sanofi-deutschland.pdf,http://sanofi.de/dam/jcr:24f5e9e0-79b7-4c20-8207-c552c92ad50e/csr-report-2022-sanofi-deutschland.pdf,http://sanofi.de/dam/jcr:7cb801f6-aee6-4200-95f9-c4f864477a21/csr-report-2020-sanofi-deutschland.pdf,http://sanofi.de/dam/jcr:950d86f3-6d79-4ec5-b70f-3cf12fa9abfb/csr-bericht2017.pdf,http://sanofi.de/dam/jcr:95b90747-43f7-43a8-941f-e84d0c3ca56f/csr-report-2021-sanofi-deutschland.pdf,http://sanofi.de/dam/jcr:d64cbcbb-43a2-432b-8db9-8e39cadbba31/csr-report-2019-sanofi-deutschland.pdf,,,,,,,,,,,,,,,,,,,,,,,
meenal.joshi@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Meenal,Joshi,,,,,,http://centralhealth.nl.ca/_files/ugd/d55165_9e88c046bf0045099e11191e60e82d8f.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nancy.verheyden@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Nancy,Verheyden,,,,,,http://mysanofi.be/nl-be/news/oncology-lung-academy,http://mysanofi.be/nl-be/oncology-lung-academy-up,,,,,,,,,,,,,,,,,,,,,,,,,,,
elliott.lafont@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,4,{first}.{last},Elliott,Lafont,,,,,,http://mysanofi.be/nl-be/diabetes/diabeticpatients,http://mysanofi.be/nl-be/education-up0,http://mysanofi.be/nl-be/education-up1,http://mysanofi.be/nl-be/news/exercise-and-diabetes,,,,,,,,,,,,,,,,,,,,,,,,,
herve.bouchard@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Herve,Bouchard,,,,,,http://biofunctional.eu/uploads/6/9/9/6/69969003/2021_cifre_sanofi-bfc_offer.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marina.volonte@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Marina,Volonte,,,,,,http://worldallergyorganizationjournal.org/article/s1939-4551(22)00034-5/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vincent.bonelli@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,3,{first}.{last},Vincent,Bonelli,,,,,,http://extranet.lesedc.org/groupe/region-idf-ouest-78-92-95-3779,http://extranet.lesedc.org/groupe/region-idf-ouest-78-92-95-3779/page/presentation,http://extranet.lesedc.org/groupe/secteur-boucle-de-seine-4268,,,,,,,,,,,,,,,,,,,,,,,,,,
matthias.polan@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Matthias,Polan,,,,,,http://ffpi.net/mitglieder,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fabrice.morency@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Fabrice,Morency,,,,,,http://ce-crva.fr,http://ce-crva.fr/index.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
ercole.rao@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Ercole,Rao,,"","","","",http://betasciencepress-publishing.com/10-17145/fulltext/jab/engineered-technologies-and-bioanalysis-of-multispecific-antibody-formats,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alaina.gibson@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Alaina,Gibson,,"","","","",http://apg.org/event/southeast-regional-meeting-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,
william.ulrick@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},William,Ulrick,,,,,,http://anaaimm.net/members/sanofi-us-consumer-healthcare,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stuart.persky@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Stuart,Persky,Management,HR,"","","",http://nationalilg.org/regional-ilgs,,,,,,,,,,,,,,,,,,,,,,,,,,,,
grit.landgraf@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Grit,Landgraf,,,,,,http://hautnetz-leipzig.de/around-webinare-zu-pn-bp-und-csu,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aditya.narayan@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Aditya,Narayan,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laila.khan@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,6,{first}.{last},Laila,Khan,,,,,,http://sanofi.com.pk/dam/jcr:0f64d18e-79b5-4572-9947-ad2160e9699e/sidc-2018.pdf,http://sanofi.com.pk/dam/jcr:155f1093-ef7a-405d-bf71-a84ec70a72cc/press%20release_91720.pdf,http://sanofi.com.pk/dam/jcr:384f5984-37db-4e76-a800-07fccefa49d2/sanofi%20humsafar%20230819.pdf,http://sanofi.com.pk/dam/jcr:a4d2bbcb-39f0-441a-8ac1-7a268488794e/sanofi-bima%20partnership.pdf,http://sanofi.com.pk/dam/jcr:e2351672-c182-47ec-b9be-e454390039f5/sanofi%20signs%20mou%20with%20akhuwat%20for%20the%20global%20kids%20program%20.%20june%2013.2022.pdf,http://voicenvision.tv/2022/03/06/31735,,,,,,,,,,,,,,,,,,,,,,,
jody.robertson@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,10,{first}.{last},Jody,Robertson,,,,,,http://cpd-2020.production.parallax.dev/industries/healthcare-medical,http://cpd.exposecms.com/industries/construction,http://cpduk.co.uk/industries/healthcare-medical,http://cpduk.co.uk/directory/events/view/8633-emotional-health-and-well-being,http://cpd.exposecms.com/events,http://cpduk.co.uk/directory/events/filter/date:2019-09/sector:business,http://cpd-2020.production.parallax.dev/events,http://cpduk.co.uk/events,http://cpduk.co.uk/industries/construction/manufacturing,http://cpd-2020.production.parallax.dev/industries/construction,,,,,,,,,,,,,,,,,,,
silvia.sabo@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,5,{first}.{last},Silvia,Sabo,,,,,,http://meinpraktikum.de/stellen/initiativbewerbung-studierende-mwd-thesis-bei-sanofi-aventis-deutschland-gmbh-in-frankfurt-am-main-589aa92b-0849-447c-bc58-73e73b634354,http://meinpraktikum.de/stellen/pharmaziepraktikant-mwd-im-bereich-liquida-fuer-mai-2023-bei-sanofi-aventis-deutschland-gmbh-in-koeln-82e32e8c-a0f2-4ded-a369-35fe67fb1001,http://meinpraktikum.de/stellen/pharmaziepraktikantin-pharmacy-engagement-fuer-november-2023-bei-sanofi-aventis-deutschland-gmbh-in-frankfurt-am-main-7d30f550-8504-4b1f-855d-937d33fab6d6,http://meinpraktikum.de/stellen/werkstudent-mwd-talent-management-bei-sanofi-aventis-deutschland-gmbh-in-berlin-24b84b5c-ca6b-45bf-a4ec-7e0462affd30,http://praktikumsanzeigen.info/stellenangebote/praktikum-personalwesen-berlin-15867,,,,,,,,,,,,,,,,,,,,,,,,
stefan.dietrich@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Stefan,Dietrich,,"","","",+49 69 3053 0165,http://sanofi.de/dam/jcr:f74f6ef5-b111-4a49-a39c-3a8d579af894/20220407_pm_sanofi-braun-reuschenbach.pdf,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220407,,,,,,,,,,,,,,,,,,,,,,,,,,,
bryan.downey@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Bryan,Downey,Executive,Vice President,"","","",http://pm360online.com/innovators-products-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lionel.noah@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,3,{first}.{last},Lionel,Noah,,"","","","",http://efsm.online/be_nl/article-overview/101/2022/a-novel-combination-reduces-objective-measures-and-subjective-stress-perception,http://efsm.online/de_de/article-overview/101/2022/a-novel-combination-reduces-objective-measures-and-subjective-stress-perception,http://efsm.online/int_en/article-overview/101/2022/a-novel-combination-reduces-objective-measures-and-subjective-stress-perception,,,,,,,,,,,,,,,,,,,,,,,,,,
ferran.verges@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,6,{first}.{last},Ferran,Verges,,"","","","",http://sanofi.es/dam/jcr:9f9667a3-c2ee-43fc-a642-ff6835c1867e/np_foundations%20sant%20joan%20de%20d%c3%a9u_def.pdf,http://sanofi.es/dam/jcr:a4bab269-4bad-4bce-958d-cf47204ba3c4/ndp_fenomenal%20experience_def.pdf,http://sanofi.es/dam/jcr:bcbe2d8c-11e3-428b-b64c-ef1bd77712a1/npsgzue%20aprueba%20dupilumab%20para%20nis%20con%20dag.pdf,http://sanofi.es/dam/jcr:d47b689c-aed7-4982-85d5-a78f40cfd584/np_sgz_dupixent_premio%20panorama.pdf,"http://sanofi.es/dam/jcr:ef08e90c-9032-4003-8f12-e0bba2509a11/sanofi%20completa%20la%20adquisici%c3%b3n%20de%20provention%20bio,%20inc..pdf",http://aedem.org/la-comunidad-de-esclerosis-multiple-en-espana-se-moviliza-en-la-campana-de-sanofi-genzyme-exige-mas-a-tu-vida-con-em,,,,,,,,,,,,,,,,,,,,,,,
thomas.richards@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Thomas,Richards,Sales,Account Specialist,"","","",http://paneurosociety.org/2020-exhibitors.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.weiser@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,5,{first}.{last},Thomas,Weiser,Medical & health,Medical Affairs,"","","",http://efsm.online/pl_pl/article-overview/101/2021/guideline-recommendations-for-the-treatment-of-abdominal-pain-in-irritable-bowel-syndrome,http://efsm.online/be_nl/article-overview/101/2021/caffeine-stimulating-and-aromatic-but-safe,http://efsm.online/de_de/article-overview/101/2021/caffeine-stimulating-and-aromatic-but-safe,http://efsm.online/int_en/article-overview/101/2021/caffeine-stimulating-and-aromatic-but-safe,http://efsm.online/de_de/article-overview/101/2021/meta-analysis-on-the-role-of-exercise-in-the-treatment-of-constipation,,,,,,,,,,,,,,,,,,,,,,,,
evan.berland@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,28,{first}.{last},Evan,Berland,,"","","",+1 215 432 0234,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://itbusinessnet.com/2022/07/sanofi-global-health-launches-nonprofit-impact-brand-for-30-medicines-in-low-income-countries,http://coachmansresearch.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://coachmansresearch.com/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,http://life-sciences-europe.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://life-sciences-usa.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://roboticulized.com/latest-news,http://startup365.fr/author/862global/page/4,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20221028,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203,http://dndi.org/press-releases-translations/2022/acoziborole-etude-nouveau-traitement-oral-dose-unique-suscite-espoir-eliminer-la-maladie-du-sommeil-en-afrique,http://dndi.org/press-releases/2022/acoziborole-investigational-single-dose-oral-treatment-raises-hope-elimination-sleeping-sickness,http://sanofi.com/fr/media-room/communiques-de-presse/2023/2023-01-05-07-00-00-2583365,http://biospace.com/article/releases/press-release-sanofi-gsk-next-generation-covid-19-booster-delivers-strong-immune-response-against-variants-of-concern-including-omicron,http://northdakotadigitalnews.com/2022/11/10/sanofi-and-gsks-next-generation-covid-19,http://northdakotadigitalnews.com/2023/01/05/fda-accepts-nirsevimab-application-as-first,http://northdakotadigitalnews.com/2022/08/17/sanofi-provides-update-on-amcenestrant,http://northdakotadigitalnews.com/2022/11/30/press-release-acoziborole-investigational-single-dose,http://sanofi.com/en/media-room/contact,http://markets.businessinsider.com/news/stocks/sanofi-flu-vaccines-licensed-and-approved-for-2022-2023-influenza-season-including-cdc-preferred-higher-dose-vaccines-for-adults-65-1031564247,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220728,http://biotech-365.com/category/globenewswire/page/2,http://itbusinessnet.com/2022/05/press-release-update-on-cialis-rx-to-otc-switch-actual-use-trial,http://biotech-365.com/author/biotech365,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/author/biotech365/page/3,http://biotech-365.com/category/globenewswire,
sanket.patke@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,5,{first}.{last},Sanket,Patke,,"","","","",http://journal.pda.org/content/76/6/461,http://journal.pda.org/content/76/6/461/tab-article-info,http://journal.pda.org/content/76/6/461/tab-figures-data,http://journal.pda.org/content/76/6/461/tab-references,http://journal.pda.org/content/early/2022/02/15/pdajpst.2021.012722,,,,,,,,,,,,,,,,,,,,,,,,
anke.steinmetz@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Anke,Steinmetz,,,,,,http://nanostem.qmul.ac.uk/people/pi,http://nanostem.qmul.ac.uk/people/anke-steinmetz,,,,,,,,,,,,,,,,,,,,,,,,,,,
victor.rouault@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,28,{first}.{last},Victor,Rouault,,"","","",+1 215 432 0234,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://coachmansresearch.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://coachmansresearch.com/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,http://biotech-365.com/author/biotech365/page/2,http://pharmaceuticaldaily.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://sanofi.pl/dam/jcr:89994640-99d4-474b-986b-f5c367151560/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final.pdf,http://sanofi.cz/dam/jcr:4db0e3be-88a9-4d6d-a24d-57e5765f59d0/sanofi_a_gsk%20pozadaji_o_registraci_vakciny_na_covid.pdf,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220203,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20221028,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203,http://dndi.org/press-releases-translations/2022/acoziborole-etude-nouveau-traitement-oral-dose-unique-suscite-espoir-eliminer-la-maladie-du-sommeil-en-afrique,http://dndi.org/press-releases/2022/acoziborole-investigational-single-dose-oral-treatment-raises-hope-elimination-sleeping-sickness,http://northdakotadigitalnews.com/2022/11/10/sanofi-and-gsks-next-generation-covid-19,http://northdakotadigitalnews.com/2022/11/30/press-release-acoziborole-investigational-single-dose,http://northdakotadigitalnews.com/2023/01/04/press-release-availability-of-the-q4-2022-memorandum-for-modelling-purposes,http://sanofi.com/en/media-room/contact,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://itbusinessnet.com/2022/04/press-release-euroapi-listing-on-euronext-paris-expected-on-may-6-2022,http://english.bashable.tech/2022/02/10/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199","http://biznes.newseria.pl/biuro-prasowe/sanofi-przedstawia-nowa,b577308199",http://biotech-365.com/author/biotech365/page/3,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/category/globenewswire,
eva.schaefer-jansen@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,30,{first}.{last},Eva,Jansen,,,,,,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://magazine-pr.com/fda-aprueba-tratamiento-para-la-esofagitis-eosinofilica,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://itbusinessnet.com/2023/03/dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-aged-12-years-and-older-accepted-for-fda-review,http://pharmiweb.com/press-release/2022-08-05/sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://biospace.com/article/releases/press-release-new-nirsevimab-data-analyses-reinforce-efficacy-against-rsv,http://coachmansresearch.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://coachmansresearch.com/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,http://northdakotadigitalnews.com/2022/11/30/press-release-acoziborole-investigational-single-dose,http://northdakotadigitalnews.com/2022/11/10/sanofi-and-gsks-next-generation-covid-19,http://northdakotadigitalnews.com/2023/01/04/press-release-availability-of-the-q4-2022-memorandum-for-modelling-purposes,http://northdakotadigitalnews.com/2023/01/05/fda-accepts-nirsevimab-application-as-first,http://healthtechnologynet.com/2022/07/14/press-release-dupixent-dupilumab-phase-3-trial-shows-positive-results-in-children-1-to-11-years-of-age-with-eosinophilic-esophagitis,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://itbusinessnet.com/2023/03/press-release-dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-accepted-for-fda-review,http://life-sciences-usa.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://sanofi.cz/dam/jcr:4db0e3be-88a9-4d6d-a24d-57e5765f59d0/sanofi_a_gsk%20pozadaji_o_registraci_vakciny_na_covid.pdf,http://itbusinessnet.com/2023/02/kevzara-sarilumab-approved-by-fda-as-first-and-only-biologic-indicated-for-patients-with-polymyalgia-rheumatica,http://roboticulized.com/latest-news,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://startup365.fr/author/862global/page/4,http://medicaex.com/businesswire/sanofi-and-innate-pharma-expand-collaboration-for-natural-killer-cell-therapeutics-in-oncology,http://biospace.com/article/releases/nirsevimab-significantly-protected-infants-against-rsv-disease-in-phase-3-trial,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/category/globenewswire
chrystel.baude@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,27,{first}.{last},Chrystel,Baude,,"","","",+33 1 57 63 25 04,http://biomerieux.com/content/dam/biomerieux-com/investor/regulated-informations/2016/releases/press_release_realism_2016_10_10_0.pdf,http://csa.eu/csa-content/uploads/2018/06/cp_csa-fondation-sanofi-vdef.pdf,http://biolabs.io/post/sanofi-et-biolabs-global-annoncent-un-nouveau-partenariat-strat%c3%a9gique-en-france,http://gs1.fr/media/1031/download,http://roboticulized.com/latest-news,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://startup365.fr/author/862global/page/4,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://sanofi.pl/dam/jcr:89994640-99d4-474b-986b-f5c367151560/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final.pdf,http://biospace.com/article/releases/nirsevimab-significantly-protected-infants-against-rsv-disease-in-phase-3-trial,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20221028,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203,http://sanofi.com/fr/media-room/nous-contacter,http://vivendi.com/communique/orange-edf-sanofi-et-vivendi-se-pretent-au-jeu-de-leloquence,http://vivendi.com/en/press-release/orange-edf-sanofi-and-vivendi-launch-a-public-speaking-competition,http://northdakotadigitalnews.com/2022/12/19/sanofi-and-innate-pharma-expand,http://sanofi.com/en/media-room/contact,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220203,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220728,http://gs1.fr/communique-presse/creapharm-clinical-supplies-sanofi-adoptent-nouveau-standard-gs1-essais-cliniques,http://gustaveroussy.fr/fr/lassociation-paris-saclay-cancer-cluster-annonce-sa-creation-officielle,http://english.bashable.tech/2022/02/10/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199","http://biznes.newseria.pl/biuro-prasowe/sanofi-przedstawia-nowa,b577308199",http://biotech-365.com/author/biotech365/page/3,http://biotech-365.com/category/globenewswire,,
celine.amara@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Celine,Amara,Education,Research Development,"","","",http://gmp.asso.fr/about-us/board-members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicolas.obrist@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,25,{first}.{last},Nicolas,Obrist,,"","","",+33 6 77 21 27 55,http://itbusinessnet.com/2022/07/sanofi-global-health-launches-nonprofit-impact-brand-for-30-medicines-in-low-income-countries,http://coachmansresearch.com/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,http://life-sciences-europe.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://sanofi.pl/dam/jcr:89994640-99d4-474b-986b-f5c367151560/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final.pdf,http://life-sciences-usa.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://sanofi.cz/dam/jcr:4db0e3be-88a9-4d6d-a24d-57e5765f59d0/sanofi_a_gsk%20pozadaji_o_registraci_vakciny_na_covid.pdf,http://sanofi.com/fr/media-room/nous-contacter,http://biospace.com/article/releases/press-release-sanofi-gsk-next-generation-covid-19-booster-delivers-strong-immune-response-against-variants-of-concern-including-omicron,http://northdakotadigitalnews.com/2023/01/04/press-release-availability-of-the-q4-2022-memorandum-for-modelling-purposes,http://sanofi.com/en/media-room/contact,http://biospace.com/article/releases/press-release-new-nirsevimab-data-analyses-reinforce-efficacy-against-rsv,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://startup365.fr/category/business-wire/page/3,http://markets.businessinsider.com/news/stocks/sanofi-offers-all-employees-worldwide-14-weeks-paid-parental-leave-to-ensure-workplace-equality-1031012442,http://olbia-conseil.com/2021/07/13/sanofi-devient-partenaire-premium-des-jeux-olympiques-et-paralympiques-de-paris-2024,http://english.bashable.tech/2022/02/10/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199","http://biznes.newseria.pl/biuro-prasowe/sanofi-przedstawia-nowa,b577308199",http://biotech-365.com/author/biotech365/page/2,http://techclot.com/index.php/2021/11/18/sanofi-invests-180-million-equity-in-owkins-artificial-globenewswire,http://biotech-365.com/author/biotech365,http://biotech-365.com/category/globenewswire,http://biotech-365.com/category/globenewswire/page/2,,,,
albert.maffei@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,5,{first}.{last},Albert,Maffei,Management,Manager,"","","",http://hasdc.org/category/events/page/2,http://eloctate.com/resources/spanish,http://hasdc.org/author/hasdc_admin_2,http://hasdc.org/category/events,http://hasdc.org/events/event-sponsors/sanofi-genzyme,,,,,,,,,,,,,,,,,,,,,,,,
florian.capito@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Florian,Capito,,,,,,http://biopharminternational.com/view/continuous-preparative-sec-for-purification-of-difficult-to-manufacture-proteins-a-feasibility-study,,,,,,,,,,,,,,,,,,,,,,,,,,,,
foysal.lodi@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Foysal,Lodi,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
veronique.taupin@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Veronique,Taupin,Medical & health,Model,"","","",http://jpet.aspetjournals.org/content/early/2021/06/16/jpet.121.000590,http://jpet.aspetjournals.org/content/early/2021/06/16/jpet.121.000590/tab-figures-data,,,,,,,,,,,,,,,,,,,,,,,,,,,
caroline.noke@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Caroline,Noke,Sales,Regional Account Director,"","","",http://flhealthvalue.org/event/anc-2019-sponsors,,,,,,,,,,,,,,,,,,,,,,,,,,,,
monique.nel@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Monique,Nel,,"","","","",http://sajo.org.za/index.php/sajo/article/view/138/386,,,,,,,,,,,,,,,,,,,,,,,,,,,,
martine.latta-mahieu@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,5,{first}.{last},Martine,Mahieu,,,,,,http://azurcharenton.fr/la-gazette/page/18,http://azurcharenton.fr/la-gazette-de-la-semaine-du-5-fevrier-2018,http://azurcharenton.fr/la-gazette-des-foulees,http://azurcharenton.fr/la-gazette-de-la-semaine-du-5-juin-2016,http://azurcharenton.fr/la-gazette-du-29-mai-2017,,,,,,,,,,,,,,,,,,,,,,,,
nancy.wong@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Nancy,Wong,,"","","","",http://nedmdg.org/steering-committee,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrea.welch@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Andrea,Welch,Writing & communication,Communications Lead,"","",+44 77 2576 5377,http://biotech-365.com/author/biotech365,,,,,,,,,,,,,,,,,,,,,,,,,,,,
corinne.sidler@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,3,{first}.{last},Corinne,Sidler,,,,,,http://saez.ch/journalfile/download/issue/ezm_saez/de/saez.2020.40/7b17d7a09c56fb6ccfab4ab397d6bb2c2297eb5e/saez_2020_40_de.pdf/rsrc/jf,http://bullmed.ch/article/doi/bms.2020.19227,http://saez.ch/article/doi/saez.2020.19227,,,,,,,,,,,,,,,,,,,,,,,,,,
claire.davies@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Claire,Davies,Executive,Associate Vice President,adaviesdhcg,"","",http://bioprocessintl.com/analytical/pat/analytical-development-turning-data-into-information-requires-teamwork,,,,,,,,,,,,,,,,,,,,,,,,,,,,
esteban.puentes@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Esteban,Puentes,,,,,,http://mymedr.afpm.org.my/publications/66953,,,,,,,,,,,,,,,,,,,,,,,,,,,,
paul.deutsch@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Paul,Deutsch,,,,,,http://medrxiv.org/content/10.1101/2020.05.15.20103101v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
martin.sandvoss@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Martin,Sandvoss,,"","","","",http://intl-isotope-soc.org/officers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
philippe.bordes@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,3,{first}.{last},Philippe,Bordes,Management,Project Manager,"","","",http://trialsathome.com/contact,http://trialsathome.com/innovative-medicines-initiative-launches-trialshome,http://imi.europa.eu/about-imi/governance/strategic-governing-groups,,,,,,,,,,,,,,,,,,,,,,,,,,
marine.marius@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,5,{first}.{last},Marine,Marius,,"","","","",http://journal.pda.org/content/74/4/394,http://journal.pda.org/content/74/4/394/tab-figures-data,http://journal.pda.org/content/early/2020/03/16/pdajpst.2019.010389/tab-references,http://journal.pda.org/content/early/2020/03/16/pdajpst.2019.010389,http://journal.pda.org/content/early/2020/03/16/pdajpst.2019.010389/tab-article-info,,,,,,,,,,,,,,,,,,,,,,,,
terry.means@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Terry,Means,,,,,,http://massgeneral.org/medicine/ciid/research-labs/luster-lab-alumni,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elena.santini@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,6,{first}.{last},Elena,Santini,Management,General Manager,"","","",http://informareunh.it/the-smeakers-le-scarpe-per-andare-oltre-la-sclerosi-multipla,http://informareunh.it/torna-piu-unici-che-rari-la-campagna-di-educazione-alle-diversita-rivolta-ai-piu-piccoli,http://ipresslive.it/comunicates/4034/la-carica-positiva-dei-changemakers,http://whin.media/private/appuntamenti/%e2%80%9cpassa-vantaggio-contro-la-dermatite-atopica%e2%80%9d,http://whin.media/private/appuntamenti/media-tutorial-influenza-e-vaccini-il-valore-della-prevenzione-nellera-dei,http://whin.media/private/appuntamenti/il-significato-di-vivere-una-%e2%80%9cvita-rara%e2%80%9d,,,,,,,,,,,,,,,,,,,,,,,
qun.zhou@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Qun,Zhou,Medical & health,Molecular Biology,"","","",http://ghrnet.org/index.php/jbmbr/article/view/1763/2161,,,,,,,,,,,,,,,,,,,,,,,,,,,,
claire.whitmarsh@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Claire,Whitmarsh,Writing & communication,Communications Lead,"","",+44 79 3550 3416,http://pharmiweb.com/press-release/2020-01-10/toujeo-insulin-glargine-eu-licence-extended-for-use-in-adolescents-and-children-from-the-age-of-6-years-with-diabetes-mellitus,,,,,,,,,,,,,,,,,,,,,,,,,,,,
valerie.heron@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Valerie,Heron,Management,Project Management,"","","",http://a3p.org/strategie-de-validation-des-procedes-et-mise-en-application-de-lannexe-15-des-bpf-et-des-guidances-fda-verification-continue-des-procedes-cpv,,,,,,,,,,,,,,,,,,,,,,,,,,,,
weiliang.qiu@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Weiliang,Qiu,,"","","","",http://dirk.eddelbuettel.com/cranberries/2019/03/15,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gordon.fischer@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,4,{first}.{last},Gordon,Fischer,,"","","","",http://sanofi.at/dam/jcr:5605add4-377b-47cc-94d5-f06e959e928c/allgemeine%20verkaufs-%20und%20lieferbedingungen%20der%20sanofi-aventis%20gmbh.pdf,http://sanofi.at/de/agb,http://sanofi.de/agb,http://sanofi.de/de/agb,,,,,,,,,,,,,,,,,,,,,,,,,
guy.griebel@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,3,{first}.{last},Guy,Griebel,,,,,,http://actionforprimates.org/public/afp_take_action_2021.php,http://psychiatrist.com/jcp/article/pages/2012/v73n11/v73n1107.aspx,http://frontiersin.org/articles/10.3389/fendo.2014.00049/full,,,,,,,,,,,,,,,,,,,,,,,,,,
jean.cavallo@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Jean,Cavallo,,,,,,http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
timothy.soos@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Timothy,Soos,Education,Research And Development,"","","",http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
armin.opitz@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Armin,Opitz,Management,Senior Director,"","","",http://bioprocessintl.com/upstream-processing/bioreactors/oxygen-mass-transfer-correlation-for-a-rocking-motion-bioreactor-system,,,,,,,,,,,,,,,,,,,,,,,,,,,,
attila.voros@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Attila,Voros,IT / Engineering,Process Engineering,"","","",http://pubs.rsc.org/en/content/articlelanding/2014/ob/c4ob00854e/unauth,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rachel.gross@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Rachel,Groß,,,,,,http://lookmedica.ro/blog/sanofi-genzyme-sustine-a-noua-editie-anuala-a-zilei-mondiale-a-sclerozei-multiple/7019,http://businesswire.com/news/home/20170531005029/en/sanofi-genzyme-recognizes-ninth-annual-world-ms,,,,,,,,,,,,,,,,,,,,,,,,,,,
thorsten.sadowski@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,7,{first}.{last},Thorsten,Sadowski,,"","","","",http://rcsb.org/structure/4ci9,http://rcsb.org/structure/4cia,http://worldwidescience.org/topicpages/n/nanoparticles+alter+cathepsin.html,http://rcsb.org/structure/4cib,http://worldwidescience.org/topicpages/m/multiple+nucleopolyhedrovirus+cathepsin.html,http://worldwidescience.org/topicpages/r/requires+microglial+cathepsin.html,http://worldwidescience.org/topicpages/b/bradykinin.html,,,,,,,,,,,,,,,,,,,,,,
alice.manfredini@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,8,{first}.{last},Alice,Manfredini,Marketing,Health Digital Marketing,patimostefano,"",+39 366 672 7323,http://assobiotec.federchimica.it/docs/default-source/default-document-library/0930-programma-ebw-2020finaleaa78676265c4fec80167667934aa40e.pdf,http://assobiotec.federchimica.it/docs/default-source/default-document-library/il-programma-dell'edizione-20194bae49e5e0534ac888773e0fa7970465.pdf,http://medicinachannel.it/2015/11/diretta-live-i-5-finalisti-del-progetto.html,http://whin.media/private/appuntamenti/%e2%80%9cpassa-vantaggio-contro-la-dermatite-atopica%e2%80%9d,http://whin.media/private/appuntamenti/media-tutorial-influenza-e-vaccini-il-valore-della-prevenzione-nellera-dei,http://whin.media/private/appuntamenti/il-significato-di-vivere-una-%e2%80%9cvita-rara%e2%80%9d,http://digitalmarketingfarmaceutico.it/sanofi-viva-technology,http://ipresslive.it/comunicates/4034/la-carica-positiva-dei-changemakers,,,,,,,,,,,,,,,,,,,,,
ashleigh.koss@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,12,{first}.{last},Ashleigh,Koß,Writing & communication,"",ptjournal780,"",+1 908 981 8745,http://lookmedica.ro/blog/sanofi-si-regeneron-anunta-rezultate-pozitive-pentru-primele-studii-care-vizeaza-evaluarea-praluent-alirocumab-la-persoanele-cu-diabet-zaharat-si-hipercolesterolemie/7140,http://globenewswire.com/news-release/2017/04/28/974036/0/en/sanofi-and-regeneron-announce-kevzara-sarilumab-biologics-license-application-resubmission-accepted-for-review-by-us-fda.html,http://medindia.net/health-press-release/the-lancet-publishes-results-from-two-positive-phase-3-trials-of-dupixent-dupilumab-in-severe-chronic-rhinosinusitis-with-nasal--432380-1.htm,http://biospace.com/article/releases/alnylam-and-sanofi-genzyme-initiate-atlas-phase-iii-program-with-investigational-rnai-therapeutic-fitusiran-in-patients-with-hemophilia-a-and-b-with-o,http://globenewswire.com/news-release/2019/06/28/1875916/0/en/sanofi-chmp-recommends-approval-of-dupixent-dupilumab-for-moderate-to-severe-atopic-dermatitis-in-adolescents.html,http://globenewswire.com/news-release/2019/07/01/1876748/0/en/sanofi-libtayo-cemiplimab-approved-for-advanced-cutaneous-squamous-cell-carcinoma-in-the-european-union.html,http://pr-inside.com/sanofi-appellate-court-orders-a-new-trial-and-vaca-r4640125.htm,http://sanofi.com/en/media-room/press-releases/2019/2019-06-28-13-00-00,http://prnewswire.com/news-releases/fda-approves-libtayo-cemiplimab-rwlc-as-first-and-only-treatment-for-advanced-cutaneous-squamous-cell-carcinoma-300721188.html,http://einpresswire.com/article/404247521/sanofi-and-regeneron-announce-positive-study-results-for-dupixent-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis,http://acnnewswire.rssing.com/chan-39994335/all_p206.html,http://businesswire.com/news/home/20170710005395/en/alnylam-sanofi-genzyme-report-positive-results-ongoing,,,,,,,,,,,,,,,,,
camilo.gonzalez@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,2,{first}.{last},Camilo,Gonzalez,Management,Project Manager,bctainitiative,"","",http://businesscalltoaction.org/news/improved-diabetes-care-for-healthier-lives-in-colombia,http://businesscalltoaction.squarespace.com/news/improved-diabetes-care-for-healthier-lives-in-colombia,,,,,,,,,,,,,,,,,,,,,,,,,,,
charles.thomas@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,1,{first}.{last},Charles,Thomas,,,,,,http://greatershilohchurchpa.com/diaconate,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gary.nabel@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,7,{first}.{last},Gary,Nabel,Executive,CSO,"","","",http://rcsb.org/structure/4olw,http://rcsb.org/structure/4q6i,http://science.sciencemag.org/content/368/6495/1035.full,http://rcsb.org/structure/4olz,http://rcsb.org/structure/4om1,http://rcsb.org/structure/4olu,http://retrovirology.biomedcentral.com/articles/10.1186/1742-4690-10-150,,,,,,,,,,,,,,,,,,,,,,
philip.mcnamara@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,16,{first}.{last},Philip,Mcnamara,Executive,Officer Vice President Medical Affairs,"","",+1 908 981 5497,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-sanofi-et-mannkind-annoncent-la-mise-disposition-d-afrezza-la-seule-insuline-inhaler-aux-tats-unis,http://boursorama.com/actualites/sanofi-annonce-les-resultats-positifs-de-phase-3-de-l-association-experimentale-a-dose-fixe-d-insuline-glargine-et-de-lixisenatide-88fff96e4e8c3556e08f5fe369968953,http://sanofi.com/en/media-room/press-releases/2016/2016-06-12-21-45-00,http://pm360online.com/sanofi-receives-fda-approval-of-soliquatm-10033-for-the-treatment-of-adults-with-type-2-diabetes-2,http://sanofi.com/en/media-room/press-releases/2015/2015-11-06-07-00-00,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-annonce-les-premi-res-donn-es-d-une-tude-sur-les-r-sultats-cardiovasculaires-de-lyxumia-lixis-natide,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/la-fda-accepte-l-examen-de-la-demande-d-approbation-du-lixis-natide-de-sanofi,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-obtient-lapprobation-de-la-fda-pour-soliquatm-10033-dans-le-traitement-du-diabete-de-type-2-de-ladulte,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-annonce-les-premiers-r-sultats-positifs-de-la-deuxi-me-tude-pivot-de-phase-iii-consacr-e-lixilan,http://aktiespararna.se/nyheter/sanofi-fda-accepts-sanofi-new-drug-application-once-daily-fixed-ratio-combination-insulin-0,http://mif-ua.com/archive/article/36957,http://biospace.com/news/data-show-sanofi-francenbspsan-pas-lyxumia0174/309482/source=topbreaking,http://news.europawire.eu/sanofis-soliqua-10033-now-available-by-prescription-in-u-s-for-the-treatment-of-adults-with-type-2-diabetes-6523134567890/eu-press-release/2017/01/04,http://prnewswire.com/news-releases/data-show-sanofis-lyxumia-added-to-basal-insulin-lowered-blood-sugar-especially-when-fasting-plasma-glucose-was-controlled-224996252.html,http://crweworld.com/article/press-releases/9111/sanofi-and-lexicon-pharmaceuticals-to-collaborate-on-sotagliflozin-an-investigational-new-oral-medicine-for-people-with-diabetes,http://biospace.com/News/data-show-sanofi-francenbspsan-pas-lyxumia0174/309482/Source=TopBreaking,,,,,,,,,,,,,
lauren.musto@sanofi.com,sanofi.com,Sanofi,,,,,,97,personal,15,{first}.{last},Lauren,Musto,Executive,Chief Executive,"","",+1 617 768 1993,http://mynewsdesk.com/se/sanofi/pressreleases/sanofi-compounds-to-be-featured-in-178-abstracts-at-american-society-of-hematology-annual-meeting-818449,http://mynewsdesk.com/se/sanofi/pressreleases/u-s-fda-approves-zaltrap-r-ziv-aflibercept-after-priority-review-for-previously-treated-metastatic-colorectal-cancer-782871,http://vidal.ru/novosti/sanofi-snimaet-s-mezhdunarodnoj-registratsii-issleduemyj-preparat-semuloparin-2628,http://cnbc.com/id/100149639,http://prnewswire.com/news-releases/zaltrap-ziv-aflibercept-approved-in-the-eu-for-patients-with-previously-treated-metastatic-colorectal-cancer-189768711.html,http://bio-medicine.org/medicine-technology-1/phase-ii-trial-of-sanofi-jak2-inhibitor-in-myelofibrosis-met-primary-endpoint-29541-1,http://mynewsdesk.com/se/sanofi/pressreleases/curie-cancer-and-sanofi-cooperate-in-research-on-ovarian-cancer-878186,http://bio-medicine.org/biology-technology-1/sanofi-oncology-and-colon-cancer-coalition-join-forces-to-raise-awareness-of-colorectal-cancer-24899-1,http://biospace.com/news/sanofi-france-massachusetts-general-hospital/275549,http://prnewswire.com/news-releases/phase-ii-trial-of-sanofi-jak2-inhibitor-in-myelofibrosis-met-primary-endpoint-182727541.html,http://biospace.com/news/sanofi-oncology-and-colon-cancer-coalition-join/289921,http://prnewswire.com/news-releases/sanofi-oncology-and-colon-cancer-coalition-join-forces-to-raise-awareness-of-colorectal-cancer-195609791.html,http://markets.financialcontent.com/prnews/news/read/22958017/phase_ii_trial_of_sanofi_jak2_inhibitor_in_myelofibrosis_met_primary_endpoint,http://biospace.com/news/sanofi-france-says-zaltrap-approved-in-europe-for/286672,http://biospace.com/news/sanofi-france-plans-to-file-jak2-inhibitor-after/297084,,,,,,,,,,,,,,
anne-lise.vataire@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://fseg.u-pec.fr/medias/fichier/livret-de-l-etudiant-m2es-2022-2023_1663226400066-pdf,http://fseg.u-pec.fr/medias/fichier/livret-de-l-etudiant-m2es-2022-2023_1663226648168-pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
shaum.kabadi@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,4,{first}.{last},,,,,,,,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,
jonathan.dhenin@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,3,{first}.{last},,,,,,,,http://research.pasteur.fr/en/job/phd-position-in-mass-spectrometry-cifre-grant-with-sanofi,http://research.pasteur.fr/fr/job/phd-position-in-mass-spectrometry-cifre-grant-with-sanofi,http://gmp.asso.fr/wp-content/uploads/2023/04/20230413_offre-phd-cifre-sanofi-pasteur-jcr-002.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
christine.geffriaud-ricouard@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://stichtingduos.nl/wp-content/uploads/cancers-13-01284.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
riccardo.ghini@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://messinamedica.it/wp-content/uploads/2020/04/2020_169all1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
charlotte.bernigaud@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://expertscape.com/ar/psoriasis/i/universite_paris_5_descartes,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jean-marc.nazaret@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,3,{first}.{last},,,,,,,,http://ru.sanofi.com/dam/jcr:80826a03-77a9-44af-ac1e-21b616695d39/sanofi_supplier_code_of_conduct_en.pdf,http://ru.sanofi.com/dam/jcr:dc0d207a-31a7-4732-9370-dbefd77da8eb/sanofi_supplier_code_of_conduct_ru.pdf,http://sanofi.co.uk/dam/jcr:8396aaa4-ce3b-4477-8b55-65992d9623ef/supplier-code-of-conduct.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
laurence.gauzy@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://new.societechimiquedefrance.fr/wp-content/uploads/2019/12/2016-413-decembre-p63-gauzy-hd.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
per.aabakken@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://sanofi.no/no/nyheter/pressemelding-ny-daglig-leder,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,,,,,,,,,,
quiterie.mertian@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,3,{first}.{last},,,,,,,,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/category/business-wire,http://biotech-365.com/category/business-wire/page/4,,,,,,,,,,,,,,,,,,,,,,,,,,
selim.tarragano@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://trpharmaexporters.org/members/sanofi-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,
semra.yoruk@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,3,{first}.{last},,,,,,,,http://eurekaselect.com/journal/145/editorial-board,http://eurekaselect.com/journal/201/editorial-board,http://benthamscience.com/journal/201/editorial-board,,,,,,,,,,,,,,,,,,,,,,,,,,
aristi.fernandes@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,20,{first}.{last},,,,,,,,http://sanofi.dk/da/podcast/adoptive-t-cell-therapy,http://sanofi.dk/da/podcast/biology-natural-killer-cells,http://sanofi.dk/da/podcast/cancer-immunotherapy-role-of-microbiome,http://sanofi.dk/da/podcast/nk-cell-based-cancer-immunotherapies,http://sanofi.dk/da/podcast/non-viral-rna-cancer-immunotherapy,http://sanofi.no/no/podcast/biology-natural-killer-cells,http://sanofi.no/no/podcast/cancer-cell-gene-therapies-challenges-access-market,http://sanofi.no/no/podcast/therapeutic-rna-vaccines-cancer-immunotherapy,http://sanofi.fi/fi/podcast/targeting-neutrophils-effector-cells-cancer-therapy,http://sanofi.fi/fi/podcast/therapeutic-rna-vaccines-cancer-immunotherapy,http://sanofi.fi/fi/podcast/tumor-infiltrating-lymphocyte-adoptive-cellular-therapy,http://sanofi.no/no/podcast/adoptive-t-cell-therapy,http://sanofi.no/no/podcast/non-viral-rna-cancer-immunotherapy,http://sanofi.fi/fi/podcast/adoptive-t-cell-therapy,http://sanofi.fi/fi/podcast/non-viral-rna-cancer-immunotherapy,http://sanofi.se/sv/podcast/adoptive-t-cell-therapy,http://sanofi.se/sv/podcast/biology-natural-killer-cells,http://sanofi.se/sv/podcast/nk-cell-based-cancer-immunotherapies,http://sanofi.se/sv/podcast/targeting-neutrophils-effector-cells-cancer-therapy,http://sanofi.se/sv/podcast/tumor-infiltrating-lymphocyte-adoptive-cellular-therapy,,,,,,,,,
vinifer.gandhi@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,9,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:4a67b4b4-e9d6-4cdc-b50f-e0b84be22581/sanofi_india_limited_unlocks_value_through_demerger.pdf,http://sanofi.in/dam/jcr:4eac4672-d6bb-431b-9536-a5d34c2d4487/sanofi-india-receives-marketing-approval-for-its-diabetes-drug-soliqua-in-india.pdf,http://sanofi.in/dam/jcr:8cd1b1cc-2d0d-4c44-aa04-dc6ba95403a3/sil%20press%20release%20-%20md%20appointment%20(18.04.2022)%20(1).pdf,http://sanofi.in/dam/jcr:9f13911b-77e4-48fa-b92f-67f0ec290e6f/sil-pr%20-%20jan%2013%202021.pdf,http://sanofiindialtd.com/dam/jcr:28154483-4de0-47c7-8ea6-d5c3a8fa571c/resignation%20of%20managing%20director.pdf,http://sanofiindialtd.com/dam/jcr:5600a901-bdd0-425f-9c88-2cb2b8458e84/housestyle.pdf,http://sanofiindialtd.com/dam/jcr:fa44285c-d0d0-40d8-9eac-cdac927186f1/reg_30_scheme_of_arrangement.pdf,http://sanofi.in/dam/jcr:1fe79e4d-d4bb-4f0a-b4f6-d9afc341e9b5/sanofi-reaffirms-commitment-to-rare-diseases-in-india.pdf,http://healthissuesindia.com/2020/10/13/sanofi-india-appoints-vaibhav-karandikar-as-chief-financial-officer,,,,,,,,,,,,,,,,,,,,
invoices.apbe@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,4,{first}.{last},,,Sales,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,
gomathi.sundaraganesh@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://ranganatha.org/donations/donor-list,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hr.pek@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,4,{first}.{last},,,HR,,,,,http://hewta.com/tzgg/13544.htm,http://hewta.com/xstd/xstd_tzgg/11590.htm,http://albainah.com/tzgg/13544.htm,http://albainah.com/xstd/xstd_tzgg/11590.htm,,,,,,,,,,,,,,,,,,,,,,,,,
nicolas.pouchain@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://processproject.eu/partners,,,,,,,,,,,,,,,,,,,,,,,,,,,,
libor.kytyr@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,5,{first}.{last},,,,,,,,http://sanofi.cz/dam/jcr:a64aca12-b5a5-48ae-a267-62f03933a76a/sanofi_tiskov%c3%a1%20zpr%c3%a1va_o%c4%8dkov%c3%a1n%c3%ad%20proti%20ch%c5%99ipce.pdf,http://sanofi.cz/dam/jcr:d84f340a-479a-4d85-9bc9-247276ea2289/cena%20sanofi%20za%20farmacii%202022_v1.pdf,http://sanofi.cz/dam/jcr:d87e2b41-295c-4306-a93d-184166c4bd69/sanofi%20podpo%c5%99ila%20%c5%a1koln%c3%ad%20ob%c4%9bdy%20pro%20soci%c3%a1ln%c4%9b%20znev%c3%bdhodn%c4%9bn%c3%a9%20d%c4%9bti.pdf,http://sanofi.cz/dam/jcr:ee6116e7-6592-45e2-938f-a93ec7194eca/cz_methodological%20note_2021.pdf,http://sanofi.cz/cs/tiskove-centrum,,,,,,,,,,,,,,,,,,,,,,,,
stephane.gokou@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://sanofi.ci/fr/nous-connaitre/sanofi-cameroun-cote-ivoire-senegal,,,,,,,,,,,,,,,,,,,,,,,,,,,,
annalisa.stassaldi@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://mrmjournal.org/mrm/article/view/813,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jean-rene.authelin@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://journal.pda.org/content/early/2022/02/15/pdajpst.2021.012722,,,,,,,,,,,,,,,,,,,,,,,,,,,,
corentine.driancourt@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,30,{first}.{last},,,,,,,,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://magazine-pr.com/fda-aprueba-tratamiento-para-la-esofagitis-eosinofilica,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://itbusinessnet.com/2023/03/dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-aged-12-years-and-older-accepted-for-fda-review,http://pharmiweb.com/press-release/2022-08-05/sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://biospace.com/article/releases/press-release-new-nirsevimab-data-analyses-reinforce-efficacy-against-rsv,http://coachmansresearch.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://coachmansresearch.com/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,http://northdakotadigitalnews.com/2022/11/30/press-release-acoziborole-investigational-single-dose,http://northdakotadigitalnews.com/2022/11/10/sanofi-and-gsks-next-generation-covid-19,http://northdakotadigitalnews.com/2023/01/04/press-release-availability-of-the-q4-2022-memorandum-for-modelling-purposes,http://northdakotadigitalnews.com/2023/01/05/fda-accepts-nirsevimab-application-as-first,http://healthtechnologynet.com/2022/07/14/press-release-dupixent-dupilumab-phase-3-trial-shows-positive-results-in-children-1-to-11-years-of-age-with-eosinophilic-esophagitis,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://itbusinessnet.com/2023/03/press-release-dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-accepted-for-fda-review,http://life-sciences-usa.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://sanofi.cz/dam/jcr:4db0e3be-88a9-4d6d-a24d-57e5765f59d0/sanofi_a_gsk%20pozadaji_o_registraci_vakciny_na_covid.pdf,http://itbusinessnet.com/2023/02/kevzara-sarilumab-approved-by-fda-as-first-and-only-biologic-indicated-for-patients-with-polymyalgia-rheumatica,http://roboticulized.com/latest-news,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://startup365.fr/author/862global/page/4,http://medicaex.com/businesswire/sanofi-and-innate-pharma-expand-collaboration-for-natural-killer-cell-therapeutics-in-oncology,http://biospace.com/article/releases/nirsevimab-significantly-protected-infants-against-rsv-disease-in-phase-3-trial,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/category/globenewswire
priya.nanduri@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,30,{first}.{last},,,,,,,,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://magazine-pr.com/fda-aprueba-tratamiento-para-la-esofagitis-eosinofilica,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://pharmiweb.com/press-release/2022-08-05/sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://biospace.com/article/releases/press-release-new-nirsevimab-data-analyses-reinforce-efficacy-against-rsv,http://itbusinessnet.com/2022/07/sanofi-global-health-launches-nonprofit-impact-brand-for-30-medicines-in-low-income-countries,http://blackstone.com/news/press/sanofi-announces-e300-million-collaboration-with-blackstone-life-sciences-to-advance-an-innovative-treatment-for-multiple-myeloma,http://northdakotadigitalnews.com/2022/12/19/sanofi-and-innate-pharma-expand,http://northdakotadigitalnews.com/2023/01/05/fda-accepts-nirsevimab-application-as-first,http://healthtechnologynet.com/2022/07/14/press-release-dupixent-dupilumab-phase-3-trial-shows-positive-results-in-children-1-to-11-years-of-age-with-eosinophilic-esophagitis,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://sanofi.pl/dam/jcr:89994640-99d4-474b-986b-f5c367151560/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final.pdf,http://sanofi.cz/dam/jcr:4db0e3be-88a9-4d6d-a24d-57e5765f59d0/sanofi_a_gsk%20pozadaji_o_registraci_vakciny_na_covid.pdf,http://medicaex.com/businesswire/sanofi-and-innate-pharma-expand-collaboration-for-natural-killer-cell-therapeutics-in-oncology,http://biospace.com/article/releases/nirsevimab-significantly-protected-infants-against-rsv-disease-in-phase-3-trial,http://scceu.org/fda-approves-dupixent-dupilumab-as-first,http://biospace.com/article/releases/press-release-fda-accepts-nirsevimab-application-as-first-protective-option-against-rsv-disease-for-all-infants,http://sanofi.com/en/media-room/press-releases/2022/2022-04-14-05-00-00-2422388,http://procurement-newz.com/sanofi-launches-2022-global-employee-stock-purchase-plan-for-86-000-people,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199",http://pharmiweb.com/press-release/2022-06-30/nexviadyme-avalglucosidase-alfa-approved-by-european-commission-as-a-potential-new-standard-of-care-for-the-treatment-of-pompe-disease,http://mvsand.com/article/update-on-ongoing-dupixent-dupilumab-chronic-spontaneous-urticaria-phase-3-program-sanofi,http://pharmashots.com/press-releases/press-release-sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://vesect.com/article/update-on-ongoing-dupixent-dupilumab-chronic-spontaneous-urticaria-phase-3-program-sanofi,http://english.bashable.tech/2022/02/10/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,http://itbusinessnet.com/2022/05/press-release-update-on-cialis-rx-to-otc-switch-actual-use-trial,http://roboticulized.com/latest-news/page/1419,http://azbio.org/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,http://coldagglutinindisease.org/enjaymo-news
khristina.fauvelle@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://jmir.org/2020/11/e15185,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurence.pollissard@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://ashpublications.org/blood/article/137/7/969/474384/cost-effectiveness-of-caplacizumab-in-acquired,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mostafa.nakach@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://journal.pda.org/content/75/1/24,,,,,,,,,,,,,,,,,,,,,,,,,,,,
juliane.pamme@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,7,{first}.{last},,,,,,,,http://sanofi.at/dam/jcr:76c4a669-14f2-417e-93c2-8f5299fdb4fc/sanofi%20und%20wk%c3%96%20pr%c3%a4sentieren%20das%20jahrbuch%20f%c3%bcr%20gesund-heitspolitik%20und%20gesundheitswirtschaft%202021.pdf,http://sanofi.at/dam/jcr:ee4defa4-2027-46ce-937a-9ac9ade8e630/sanofi%20presse_julia%20guizani%20neue%20gesch%c3%a4ftsf%c3%bchrerin%20bei%20sanofi%20%c3%96sterreich.pdf,http://brusselssays.com/2022/06/22/cholesterol-regular-measurement-prevents-heart-attack-and-stroke,http://prva.at/mitglieder/mitgliedersuche/4707-2021-08-12-15-02-38,http://sanofi.at/de/media-center/journalistenkontakt,http://sanofi.at/de/media-center,http://sanofi.at/media-center,,,,,,,,,,,,,,,,,,,,,,
amy.ba@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,2,{first}.{last},,,,,,,,http://sanofi.co.jp/dam/jcr:a81adfdd-491a-40c7-b8cc-7ae57bc04d28/20151126.pdf,http://sanofiventures.com,,,,,,,,,,,,,,,,,,,,,,,,,,,
es-chc-atencion.clientes@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,3,{first}.{last},,,,,,,,http://pharmaton.es/aviso-legal,http://bisolherbal.es/aviso-legal,http://mucosan.es/condiciones,,,,,,,,,,,,,,,,,,,,,,,,,,
kelly.alidor-ext@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://cse-cpv.fr,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.turska@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://msonetoone.pl/node/27,,,,,,,,,,,,,,,,,,,,,,,,,,,,
virginia.savova@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://biorxiv.org/content/10.1101/2021.02.01.429207v3,http://dirk.eddelbuettel.com/cranberries/cran/new,,,,,,,,,,,,,,,,,,,,,,,,,,,
cs@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,9,{first}.{last},,,,,,,,http://foodallergyawareness.org/alerts/sanofi-us-issues-voluntary-nationwide-recall-of-auvi-q-due-to-potential-inaccurate-dosage-delivery,http://thediabeticnews.com/auvi-q-recall,http://vickerypediatrics.com/auvi-q-recall,http://commonwealthpeds.com/2015/10/30/auvi-q-recall-notice,http://allergylosangeles.com/allergy-blog/auvi-q-recall,http://allergysuperheroesblog.com/2015/10/auvi-q-recall,http://doctorallred.com/2015/10/reshare-sanofi-us-issues-voluntary-nationwide-recall-of-auvi%e2%80%91q-due-to-potential-inaccurate-dosage-delivery,http://anchormedical.org/news/post/nationwide-recall-of-auviq-epinephrine-injection-auto-injector,http://wvoems.org/news/2015/oct/auvi-q-recall,,,,,,,,,,,,,,,,,,,,
thomas.debeir@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,3,{first}.{last},,,,,,,,http://plcf.org/en/the-pharma-licensing-club-france,http://plcf.org/pharma-licensing-club-france,http://plcf.org/the-pharma-licensing-club-france,,,,,,,,,,,,,,,,,,,,,,,,,,
yannick.traversino@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://em-consulte.com:443/article/1353705/figures/telemonitoring-and-experimentation-in-telemedicine,http://em-consulte.com/article/1353705/article/telemonitoring-and-experimentation-in-telemedicine,,,,,,,,,,,,,,,,,,,,,,,,,,,
bettina.resl@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,6,{first}.{last},,,,,,,,http://sanofi.at/dam/jcr:0dd41ec0-9022-4961-9e13-069a7a1226bf/sanofi%20presse_sanofi%20mit%20dem%20equalita%20gutesiegel%20ausgezeichnet.pdf,http://sanofi.at/dam/jcr:1679877e-3137-49a0-a621-726bacd616a2/sanofi%20personalia_%20johanna%20hummer%20steigt%20in%20globale%20fhrungsposition%20auf.pdf,http://sanofi.at/dam/jcr:7b32c97a-1fc4-4729-89fa-53d1276bf768/sanofi%20pressemitteilung_aufmerksamkeit%20fur%20multiple%20sklerose%202021.pdf,http://sanofi.at/dam/jcr:a97889ac-5092-4abc-859a-722ae40f1f7e/pressemitteilung_sanofi%20erhalt%20erneut%20zertifikat%20beruf%20und%20familie.pdf,http://sanofi.at/dam/jcr:e77c18aa-62b3-421e-bd4d-755048200929/sanofi%20pressemitteilung_anita%20widmann%20neuer%20head%20of%20human%20resources.pdf,http://oepav.at/zielgerichtet-evidenzbasiert-interaktiv,,,,,,,,,,,,,,,,,,,,,,,
alena.khromava@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://mymedr.afpm.org.my/publications/66953,http://flutrackers.com/forum/forum/welcome-to-the-scientific-library/vaccines/819788-why-we-need-more-collaboration-in-europe-to-enhance-post-marketing-surveillance-of-vaccines,,,,,,,,,,,,,,,,,,,,,,,,,,,
brian.possi@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://wheatoncollege.edu/news/insightful-intervention,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tanya.akhund@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://ojobo.blogspot.com/2013/07/quality-assurance-manager-in-sanofi.html,http://ojobo.blogspot.com/2013/09/sanofi-is-looking-for-diabetes-educators.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
serena.bellaluna@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://assobiotec.federchimica.it/docs/default-source/default-document-library/il-programma-dell'edizione-20194bae49e5e0534ac888773e0fa7970465.pdf,http://uniamo.org/da-uniamo/2343-2,,,,,,,,,,,,,,,,,,,,,,,,,,,
jihane.aouni@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://openscience.fr/assessing-dunnett-and-mcp-mod-based-approaches-in-two-stage-dose-finding-trials,http://openscience.fr/evaluation-des-approches-basees-sur-le-test-de-dunnett-et-mcp-mod-dans-des,,,,,,,,,,,,,,,,,,,,,,,,,,,
company.secretary@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,5,{first}.{last},,,Management,,,,,http://sanofi.com.pk/dam/jcr:3dc5b9b3-5c14-47d4-a773-193c930c9f8f/sanofi%20ar%202017%2028march18%20%20final.pdf,http://sanofi.com.pk/dam/jcr:69231147-c7ba-43f2-b991-29b21fe5fc42/notice%20of%20extra-ordinary%20general%20meeting.pdf,http://sanofi.com.pk/dam/jcr:e69f6c4d-605c-45d3-b862-dc009c5506fc/annual-report-for-the-year-ended-december-31-2020.pdf,http://sanofi.com.pk/dam/jcr:f959cd62-bc1d-4869-bf7e-4f6eee5aba41/accounts%20for%20the%20year%20ended%20on%20dec%2031%202019.pdf,http://sanofi.com.pk/en/investors,,,,,,,,,,,,,,,,,,,,,,,,
nicolas.kressmann@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,29,{first}.{last},,,,,,,,http://ml-eu.globenewswire.com/resource/download/13d27ec6-5488-4976-8628-cc543fde688a,http://saubio.com/sanofi-and-sobi-donate-up-to-500-million-additional-ius-of-clotting-factor-to-wfh-humanitarian-aid-program,http://sanofi-pacifico-caribe.com/dam/jcr:0f02950d-9692-45f6-98f4-391e609c1ba4/sanofi%20to%20acquire%20principia%20biopharma.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:6333bcbc-1270-4f03-8b8b-a93b35ee7cd7/sanofi%20adquirira%20principia%20biopharma.pdf,http://globenewswire.com/news-release/2019/04/26/1810885/0/en/sanofi-fda-approves-praluent-alirocumab-to-prevent-heart-attack-stroke-and-unstable-angina-requiring-hospitalization.html,http://sanofi.de/dam/jcr:8ec4f416-7c1f-45ad-ab3b-29caeb06b201/20210127_medien-update_sanofi-unterstuetzt-biontech-bei-der-fertigung.pdf,http://nlvpartners.com/news-august-17-2020,http://sanofi.pl/dam/jcr:bf24c184-97f7-4852-b49a-9b3dfd458b1a/sanofi_and_gsk_initiate_global_phase_3_clinical_efficacy_study_of_covid%20(2).pdf,http://sanofi.pl/dam/jcr:f5b6b6a6-b893-4eb2-8f00-e95741157085/sanofi_and_gsk_initiate_global_phase_3_clinical_efficacy_study_of_covid.pdf,http://pharmiweb.com/press-release/2021-04-13/sanofi-to-invest-in-a-leading-edge-production-site-in-singapore-continues-to-strengthen-its-vaccines-manufacturing-capacities,http://sanofi.com/en/media-room/press-releases/2019/2019-08-28-22-35-00,http://sanofi.com/fr/media-room/communiques-de-presse/2019/2019-02-25-22-14-20-1741991,http://ml-eu.globenewswire.com/resource/download/fd6119ed-c8d4-414f-aeb7-413ce2a73371,http://gabio.org/sanofi-to-help-manufacture-moderna-covid-19-vaccine-supporting-global-supply-demands,http://biospace.com/article/releases/nirsevimab-shows-positive-topline-results-in-rsv-phase-2-3-medley-trial,http://pm360online.com/sanofi-chmp-recommends-approval-of-praluent-alirocumab-to-reduce-cardiovascular-risk-in-people-with-established-atherosclerotic-cardiovascular-disease,http://biospace.com/article/fda-approves-dengvaxia-for-the-prevention-of-dengue-in-individuals-ages-9-through-16-living-in-u-s-endemic-areas,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20210127,http://michbio.org/sanofi-to-help-manufacture-moderna-covid-19-vaccine-supporting-global-supply-demands,http://pharmiweb.com/press-release/2021-02-23/sanofi-and-gsk-initiate-new-phase-2-study-of-their-adjuvanted-recombinant-protein-based-covid-19-vaccine-candidate,http://pharmalive.com/chmp-recommends-zynquista-for-treating-adults-with-type-1-diabetes,http://einpresswire.com/article/479407266/praluent-alirocumab-now-approved-in-european-union-to-reduce-the-risk-of-cardiovascular-events-in-patients-with-established-cardiovascular-disease,http://kingdom854.rssing.com/chan-7124883/all_p1846.html,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-le-chmp-recommande-zynquistatm-sotagliflozine-pour-le-traitement-du-diabete-de-type-1-chez-ladulte,http://epicos.com/article/590203/sanofi-and-sobi-donate-500-million-additional-ius-clotting-factor-wfh-humanitarian,http://francebourse.com/fiche_news_143177.fb,http://snacksafely.com/2020/05/fda-approves-dupixent-as-first-biologic-for-treatment-of-children-aged-6-11-with-moderate-to-severe-eczema,http://united795.rssing.com/chan-13731600/all_p1380.html,http://lelezard.com/en/news-18732230.html
presse.at@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,5,{first}.{last},,,Writing & communication,,,,,http://sanofi.at/dam/jcr:0ee2e9f4-9c15-46c6-98b5-5da70d88bba3/weissbuch%20onkologie.pdf,http://sanofi.at/dam/jcr:ce9b7679-efa1-4d76-82c6-2666c84b0bc9/sanofi%20presse_bettina%20resl%20wird%20europe%20head%20of%20public%20affairs%20bei%20sanofi%20chc.pdf,http://sanofi.at/de/kontakt,http://sanofi.at,http://sanofi.at/de,,,,,,,,,,,,,,,,,,,,,,,,
maic.fredersdorf@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://tubiblio.ulb.tu-darmstadt.de/80765,http://tuprints.ulb.tu-darmstadt.de/5454,,,,,,,,,,,,,,,,,,,,,,,,,,,
philippe.maugendre@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,4,{first}.{last},,,,,,,,http://frenchhealthcare-association.fr/en/our-team,http://frenchhealthcare-association.fr/equipe,http://journal-therapie.org/articles/therapie/abs/2014/04/th142240/th142240.html,http://journal-therapie.org/articles/therapie/abs/2014/04/th142247/th142247.html,,,,,,,,,,,,,,,,,,,,,,,,,
nian.tian@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eric.abachin@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://aipbl.com/fili%c3%a8re-internat/d-e-s-de-biologie-m%c3%a9dicale/offres-de-stage,,,,,,,,,,,,,,,,,,,,,,,,,,,,
haruka.nishimura@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2014.html,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
pierre-yves.lastic@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://slideplayer.com/slide/3335917,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo-chc.de@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,27,{first}.{last},,,,,,,,http://5092shop.adg.de/artikel/details/56089-3046735-thomapyrin-classic-schmerztabletten.html,http://grupegido.com/spero-health-dickson/39615215,http://janusinfo.se/download/18.6a51817e17d14bd8f01a8af7/1637153245169/buscopan%20sanofi%20tyskland.pdf,http://selfmedic.de,http://selfmedic.de/kontakt,http://selfmedic.de/thomae-akademie,http://selfmedic.de/thomae-akademie/downloads,http://10300shop.adg.de/artikel/details/21030-1327387-effortil-tabletten.html,http://10300shop.adg.de/artikel/details/21983-3194795-effortil-tropfen.html,http://5092shop.adg.de/artikel/details/55582-5954715-antistax-extra-venentabletten.html,http://digestio.de/de/impressum,http://kopfschmerzen.de/impressum,http://sanofi.de/de,http://sanofi.de/de/kontakt,http://digestio.de/impressum,http://doc-europe.de/artikel/details/17891-7269952-bronchoforton-salbe.html,http://sanofi.de,http://5092shop.adg.de/artikel/details/51740-2312-antistax-extra-venentabletten.html,http://selfmedic.de/datenschutz,http://5092shop.adg.de/artikel/details/51741-2335-antistax-extra-venentabletten.html,http://10300shop.adg.de/artikel/details/23093-624605-thomapyrin-intensiv-tabletten.html,http://10300shop.adg.de/artikel/details/56089-3046735-thomapyrin-classic-schmerztabletten.html,http://10300shop.adg.de/artikel/details/66189-6800196-dulcolax-dragees-magensaftresistente-tabletten-dose.html,http://doc-europe.de/artikel/details/23093-624605-thomapyrin-intensiv-tabletten.html,http://doc-europe.de/artikel/details/56089-3046735-thomapyrin-classic-schmerztabletten.html,http://doc-europe.de/artikel/details/66189-6800196-dulcolax-dragees-magensaftresistente-tabletten-dose.html,http://5092shop.adg.de/artikel/details/61803-7314486-mucoangin-gegen-halsschmerzen-waldbeere-lutschtabletten.html,,
nathalie.ducoudret@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,7,{first}.{last},,,,"",,,,http://businesswire.com/news/home/20180628005057/fr,http://airg-france.fr/journee-mondiale-des-maladies-rares-2018-au-dela-du-regard-des-autres-une-tournee-unique-en-france,http://businesswire.com/news/home/20180122005892/fr,http://echosciences-centre-valdeloire.fr/evenements/journee-internationale-des-maladies-rares-ecoute-donc-voir,http://businesswire.com/news/home/20171207005996/fr,http://businesswire.com/news/home/20170223005592/fr,http://businesswire.com/news/home/20170608005590/fr,,,,,,,,,,,,,,,,,,,,,,
jukka.westerbacka@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://mynewsdesk.com/fi/pressreleases/diabetes-liksisenatidi-sai-myyntiluvan-euroopassa-ensimmaeinen-kerran-paeivaessae-annosteltava-glp-1-agonisti-joka-on-kehitetty-aterianjaelkeisten-833880,http://epressi.com/tiedotteet/terveys/sanofi-aloittaa-uuden-aikakauden-diabeteksen-hoidossa.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
volker.derdau@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://intl-isotope-soc.org/elections-to-the-board-of-trustees,http://intl-isotope-soc.org/officers,,,,,,,,,,,,,,,,,,,,,,,,,,,
jens.atzrodt@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://intl-isotope-soc.org/officers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexander.daranyi@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,3,{first}.{last},,,,,,,,http://altzofingia.ch/fr/paris-2,http://altzofingia.ch/de/paris,http://altzofingia.ch/az-sektionen/paris,,,,,,,,,,,,,,,,,,,,,,,,,,
bruno.chaumet@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,1,{first}.{last},,,,,,,,http://capindus.com/offre-de-poste,,,,,,,,,,,,,,,,,,,,,,,,,,,,
katarzyna.lichosik@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,2,{first}.{last},,,,,,,,http://sanofidlalekarzy.pl/nota-prawna,http://sanofidlaaptek.pl/nota-prawna,,,,,,,,,,,,,,,,,,,,,,,,,,,
monika.chmielewska-zehaluk@sanofi.com,sanofi.com,Sanofi,,,,,,96,personal,16,{first}.{last},,,,,,,,http://rezasta.net/wp-content/uploads/2016/01/sarilumab2.pdf,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://sanofi.pl/dam/jcr:d46b7241-95ea-4b82-9850-31be0dd5efba/te_informacja_prasowa_25_01_2021.pdf,http://sanofi.pl/dam/jcr:e5fc9885-a808-4dad-8e1d-963a06ec5dc5/sanofi%20and%20regeneron%20report%20positive%20top-line%20results.pdf,http://sanofi.pl/dam/jcr:fd5322b3-51a7-46b9-8f69-6000a27dc398/ip_tydzien_szczepien_sanofi_final.pdf,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199","http://biznes.newseria.pl/biuro-prasowe/sanofi-przedstawia-nowa,b577308199",http://wsparcie.sosnowiec.pl/aktualnosci/ruszyla-siodma-edycja-miedzynarodowego-programu-genzyme-pal-award,http://leksykon.com.pl/leki-produkowane-przez-firm%c4%99-sanofi-pasteur-sp--z-o-o--117131.html,http://sanofi.pl/pl/media/dzial-komunikacji-sanofi,http://leksykon.com.pl/leki-produkowane-przez-firm%c4%99-sanofi-pasteur-117131.html,http://drwidget.pl/preparaty-produkowane-przez-firm%c4%99-sanofi-pasteur-sp-z-o-o--117131.html,http://sanofidlalekarzy.pl/wycofanie-serii-2561215-2510216-2010216-leku-atram,http://masarnia.pl/branza-miesna/weterynaria/16-merial-rozpoczyna-dzialalnosc.html,http://veterynaria.pl/news/hodowcy-aktualnosci/2809-swiatowy-dzien-wscieklizny,http://sanofidlaaptek.pl/wycofanie-serii-2561215-2510216-2010216-leku-atram,,,,,,,,,,,,,
presse@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,30,{first}.{last},,,Writing & communication,,,,,http://politikexpress.de/arbeit-oder-abstellgleis-berufstatig-mit-multipler-sklerose-das-blogger-projekt-einblick-stellt-arbeitnehmer-mit-ms-in-den-fokus-foto-1408644.html,http://waschen-wie-walter.de/der-unsichtbare-verlust-wenn-die-welt-geruchlos-wird,http://waschen-wie-walter.de/die-grippesaison-haelt-noch-an-jetzt-noch-impfen-lassen-zum-jahresanfang-gleich-einen-impftermin-vereinbaren,http://waschen-wie-walter.de/familienleben-staerkt-und-stresst-zugleich-laut-sanofi-gesundheitstrend-sind-unternehmen-bei-der-unterstuetzung-gefordert,http://waschen-wie-walter.de/leben-mit-neurodermitis-reloaded-website-unterstuetzt-betroffene-mit-neuen-inhalten,http://waschen-wie-walter.de/rare-disease-day-2022-bringt-die-seltenen-ans-licht-light-up-for-rare,http://gateo.de/arbeit-oder-abstellgleis-berufstatig-mit-multipler-sklerose-1408619.html,http://presens.de/company/news/artikel/developing-a-novel-platform-for-more-efficient-and-safe-biopharmaceutical-production-145.html,http://frankfurt-business.net/bundesgesundheitsminister-spahn-startet-hochleistungs-abfuellanlage-fuer-kuenftigen-sanofi-impfstoff-gegen-covid-19-in-frankfurt,http://biolabs.io/post/sanofi-und-biolabs-global-k%c3%bcndigen-neue-strategische-partnerschaft-in-deutschland-und-frankreich-an,http://neue-pressemitteilungen.de/ms-persoenlich-kognition-und-multiple-sklerose-im-fokus.html,http://rating-news.com/darf-ich-vorstellen-morbus-fabry-fabry-disease-awareness-month-2021,http://rating-news.com/darf-ich-vorstellen-morbus-fabry-fabry-disease-awareness-month-2021-2,http://rating-news.com/darf-ich-vorstellen-morbus-fabry-fabry-disease-awareness-month-2021-3,http://gateo.de/neurodermitis-schube-im-fruhling-auch-die-haut-kann-wahrend-der-pollensaison-leiden-foto-1821362.html,http://medizin.pr-gateway.de/familie-leben-und-ms-aktiv-bleiben-mit-multipler-sklerose,http://my-pr.de/pressemitteilung/medizin-gesundheit-wellness/welt-ms-tag-2018-ich-fuehle-was-das-du-nicht-siehst_172663.html,http://news-nachrichten.ch/der-welt-ms-tag-verbindet-miteinander-stark,http://news-nachrichten.ch/neue-website-fuer-menschen-mit-multipler-sklerose-www-ms-begleiter-de,http://pressboard.de/spendenuebergabe-zu-ab-ins-rosenbeet,http://innovations-intelligenz.de/ich-spuere-was-was-du-nicht-siehst-blogger-projekt-einblick-entkraeftet-simulationsvorwuerfe-foto-1310413.html,http://pressboard.de/diagnose-multiple-sklerose-ms-und-nun,http://curacado.de/curacado/exklusiv-in-frankfurt-apotheken-vor-ort-liefern-kopfschmerztabletten-innerhalb-von-zwei-stunden-2,http://neue-pressemitteilungen.de/mit-koerperlicher-aktivitaet-gegen-fatigue-bei-multipler-sklerose.html,http://nachrichten-heute.net/455710-neue-doppelspitze-bei-ovid.html,http://politikexpress.de/multiple-sklerose-im-arbeitsalltag-die-broschure-multiple-skleroseund-berufstatigkeit-gibt-tipps-und-beantwortet-offene-fragen-foto-1284773.html,http://news8.de/der-muedigkeit-auf-der-spur,http://news8.de/ein-normales-leben-mit-multipler-sklerose,http://pr-neuigkeiten.de/familie-leben-und-ms-aktiv-bleiben-mit-multipler-sklerose,http://nachrichten-heute.net/390156-seltene-erkrankung-mps-challenge-accepted.html
contact-us@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,13,{first}.{last},,,Support,,,,,http://college.acaai.org/about-us/partners/clinical-trial-resources,http://clinicaltrials.gov/ct2/show/results/nct00930553,http://clinicaltrials.gov/show/nct04242147,http://clinicaltrials.gov/ct2/show/results/nct03510715,http://biopharmanalyses.fr/wp-content/uploads/2020/02/sample-pages-2.pdf,http://clinicaltrials.gov/show/nct00196742,http://clinicaltrials.gov/show/nct04401020,http://nnpdf.org/research/sanofi,http://oif.org/category/research,http://oif.org/currentstudies,http://oif.org/poise1,http://conslancio.it/prove-attive-sla,http://curegm1.org/clinical-trials-and-clinical-studies,,,,,,,,,,,,,,,,
mr@sanofi.com,sanofi.com,Sanofi,,,,,,96,generic,30,{first}.{last},,,,,,,,http://sanofi.be/dam/jcr:41e29028-6acd-45d9-bfbc-7361a586403a/20180514---ablynx-closing_fr.pdf,http://sanofi.be/dam/jcr:786a225b-e908-47a6-87f6-cfe51c20b355/20180514---ablynx-closing_eng.pdf,http://ru.sanofi.com/dam/jcr:c92384a7-e2c7-46c3-9fce-dbc45e02db3a/pr_sanofi%20and%20gsk%20join%20forces%20in%20unprecedented%20partnership_rus.pdf,http://tn.sanofi.com/dam/jcr:e2997060-9a02-45ef-b614-c44a5096b0ef/cp6.pdf,http://lyon-entreprises.com/entreprise/sanofi-pasteur-2/presentation-marcy-l-etoile,http://pasteur.fr/en/four-prestigious-awards-support-innovative-biomedical-research,http://sanofi.pl/dam/jcr:01e1324c-c51e-4468-b6ef-35a098a1ffe3/sanofi-i-gsk-lacza-sily-w-bezprecedensowej-wspolpracy-nad-stworzeniem-szczepionki-przeciwko-covid-19.pdf,http://sanofi.pl/dam/jcr:bf24c184-97f7-4852-b49a-9b3dfd458b1a/sanofi_and_gsk_initiate_global_phase_3_clinical_efficacy_study_of_covid%20(2).pdf,http://enlamichoacana.com/sanofi-delivered-close-to-double-digit-q4-2020-business-eps1-growth-at-cer.html,http://sanofi.com/fr/media-room/communiques-de-presse/2018/2018-03-08-13-59-18-1418467,http://sanofi.com/fr/media-room/communiques-de-presse/2018/2018-01-29-07-19-03-1313306,http://taiwanwire.com/sanofi-q3-well-on-track,http://sanofiventures.com,http://sanofi.ma/dam/jcr:75aad9d7-6117-4167-88a3-54ae247b1725/02-juillet-falsification-de-medicaments-en-afrique.pdf,http://sanofi.ma/dam/jcr:8c98098c-f21d-4950-b99c-e013e9f5c2dc/pdf%20d.pdf,http://trueusa.org/boycott,http://globenewswire.com/news-release/2018/03/08/1418077/0/en/evotec-and-sanofi-in-exclusive-talks-to-create-an-evotec-led-infectious-disease-open-innovation-r-d-platform.html,http://frenchbiobeach.com/2013/11/23/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial,http://frenchbiobeach.com/category/biotech-news/page/6,http://frenchbiobeach.com/join-our-email-list/page/13,http://sanofi.com.tr/dam/jcr:c9511666-751b-4c62-b7dc-b72855132559/2b5871c9-f4bf-4021-9f5c-8e6c21e40aa8.pdf,http://togopressgazette.com/sanofi-le-fexinidazole-premier-traitement-entierement-par-voie-orale-contre-la-maladie-du-sommeil-approuve-en-republique-democratique-du-congo,http://sanofi.com.tw/dam/jcr:008c4041-22de-43e5-846d-fd43b2b15b6d/sanofi%20and%20google%20to%20develop%20new%20healthcare%20innovation%20lab.pdf,http://sanofi.es/dam/jcr:df9999cf-6410-4c1e-8a09-dd3c09b69ce4/ndp_capital_market_day_2021_def.pdf,http://sanofi.es/dam/jcr:eeee41a7-7a8a-478f-8f1c-de4c0dbda474/ndp_resultadosq1_2021.pdf,http://sanofi.dz/dam/jcr:2f075e90-5e6b-4aac-9cd7-b0ea611c278f/cp11.pdf,http://sanofi.com.pe/dam/jcr:6c1fd616-7214-4a09-ade2-6c10917b7abc/2021_04_28_press_release_en.pdf,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20190729,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20200424,http://sanofi.pl/dam/jcr:f5b6b6a6-b893-4eb2-8f00-e95741157085/sanofi_and_gsk_initiate_global_phase_3_clinical_efficacy_study_of_covid.pdf
fabienne.drappier@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://bsth.be/professionals,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marie-olivia.amedee-manesme@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,1,{first}.{last},,,,,,,,http://univ-catholille.fr/evenement/journee-grand-public-dermatite-atopique,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maria-teresa.peracchia@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://splc-crs.org/meeting-2020/sites/default/files/docs/maria_teresa_peracchia.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
manana.khoshtaria@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://vidal.ge/health/tkivili-wipis-areshi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gregory.lamory@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://accessobservatory.org/_files/ugd/37a51e_a96a20b7dd7e44bcb70776ae02bc7a45.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laura.guest@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,1,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:c8d16319-7a8b-47e2-a978-1d4cd6c1e8fd/newsletter-standort-gesundheit_mai-2020.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
till.bussemer@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://formulation.org.uk/images/mibio2015/mibio2015.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elena.rizova@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://femmesetsciences.fr/_files/ugd/5836fc_1fe4796fbad14e77b2b4485c99d7294d.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alex.perezalvarez@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,4,{first}.{last},,,,,,,,http://sanofi.es/dam/jcr:4d6b98f5-b34f-4e51-9834-a6feeeb19564/sanofi-anuncia-mas-de-15-millones-de-euros-en-nuevas-inversiones-para-su-centro-industrial-en-espa%c3%b1a.pdf,http://sanofi.es/dam/jcr:c44dad0d-263f-460a-b7ae-b0249a01ccf7/sanofi-anuncia-cambios-en-su-comite-de-direcci%c3%b3n-de-espana.pdf,http://emsevilla.es/dos-de-cada-diez-espanoles-cree-tener-em,http://emsevilla.es/la-comision-europea-aprueba-lemtrada-para-em,,,,,,,,,,,,,,,,,,,,,,,,,
srinidhi.reddy@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://floridaent.org/2020-florida-combined-otolaryngology-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tatiana.goldina@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://aipm.org/projects/rwdrwe,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tarik.elgoutni@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,30,{first}.{last},,,,,,,,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://itbusinessnet.com/2023/03/dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-aged-12-years-and-older-accepted-for-fda-review,http://coachmansresearch.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://coachmansresearch.com/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,http://life-sciences-europe.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://itbusinessnet.com/2023/03/press-release-dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-accepted-for-fda-review,http://life-sciences-usa.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://itbusinessnet.com/2023/02/kevzara-sarilumab-approved-by-fda-as-first-and-only-biologic-indicated-for-patients-with-polymyalgia-rheumatica,http://roboticulized.com/latest-news,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://startup365.fr/author/862global/page/4,http://biospace.com/article/releases/dupixent-dupilumab-late-breaking-phase-3-copd-results-presented-at-ats-and-simultaneously-published-in-the-new-england-journal-of-medicine,http://biospace.com/article/releases/press-release-dupixent-dupilumab-late-breaking-phase-3-copd-results-presented-at-ats-and-simultaneously-published-in-the-new-england-journal-of-medicine,http://wireassociation.eu/newsroom/sanofi/releases/en/annual-general-meeting-of-may-25-2023-frederic-oudea-new-chairman-of-the-board-of-directors-1161,http://wireassociation.eu/newsroom/sanofi/releases/en/dupixent-dupilumab-late-breaking-phase-3-copd-results-presented-at-ats-and-simultaneously-published-in-the-new-england-journal-of-medicine-1152,http://wireassociation.eu/newsroom/sanofi/releases/en/media-update-new-late-breaking-data-at-ats-2023-demonstrate-significant-advancements-across-dupixent-and-broader-respiratory-pipeline-1103,http://wireassociation.eu/newsroom/sanofi/releases/en/nirsevimab-delivers-83-reduction-in-rsv-infant-hospitalizations-in-a-real-world-clinical-trial-setting-1135,http://wireassociation.eu/newsroom/sanofi/releases/en/press-release-nirsevimab-delivers-83-reduction-in-rsv-infant-hospitalizations-in-a-real-world-clinical-trial-setting-1134,http://trivano.com/persbericht/press-release-nirsevimab-delivers-83-reduction-in-rsv-infant-hospitalizations-in-a-real-world-clinical-trial-setting-466798.html,http://sanofi.de/dam/jcr:6668e5aa-71a7-4824-8239-a5a1269cd5f5/20230203_pm_q4-2022-results-sanofi_de.pdf,http://sanofi.com/en/media-room/press-releases/2023/2023-04-11-06-00-00-2644042,http://sanofi.com/en/media-room/press-releases/2023/2023-04-27-12-40-19-2656379,http://sanofi.com/fr/media-room/communiques-de-presse/2023/2023-04-27-12-40-19-2656379,http://biotech-365.com/author/biotech365,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/author/biotech365/page/3,http://biotech-365.com/category/globenewswire,http://biotech-365.com/category/globenewswire/page/2,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203
marc.trellu@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://pharmpk.com/pkjob.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kristin.mesteig@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,,,,,,,,,,,
multichannel.marketing@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,7,{first}.{last},,,Marketing,,,,,http://campus.sanofi/pl/prawny/polityka-prywatnosci,http://campus.sanofi/pl/prawny/regulamin-serwisu-internetowego,http://kardiologiawieczorowapora.pl/files/informacja_sanofi.pdf,http://czwartkichirurgiczne.pl/files/polityka-prywatno%c5%9bci-2021.pdf,http://dulcobis.pl/dam/jcr:2175cf84-c9cf-4629-8cf2-343e972e4dc8/polityka%20prywatno%c5%9bci%20opella%20healthcare%20poland%20dulcobis.pdf,http://msonetoone.pl/node/28,http://choroba-gauchera.pl/pl/polityka-prywatnosci,,,,,,,,,,,,,,,,,,,,,,
marianne.arnemo@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://farmatid.no/vitenskap-og-fag/vitenskapelige-artikler/vaksinetyper-fra-levende-virus-til-mrna,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pv.sin@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,7,{first}.{last},,,,,,,,http://hsa.gov.sg/docs/default-source/hprg-vcb/pem-pmg-pac/dengvaxia_pem_mat-sg-2300097-v1-apr-2023_13122022.pdf,http://hsa.gov.sg/docs/default-source/hprg-vcb/pem-pmg-pac/lemtrada_pem_mat-sg-2300002(012023)_29112022.pdf,http://hsa.gov.sg/docs/default-source/hprg-vcb/pem-pmg-pac/soliqua_pem_mat-sg-2300008-1-0-012023_06122022.pdf,http://campus.sanofi/sg,http://sanofi.com.sg/en/contactus,http://sanofi.com.sg/en/newsroom/important-note,http://sanofi.com.sg/en/terms-of-use,,,,,,,,,,,,,,,,,,,,,,
marcos.gerassopoulos@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://whoiswhogreece.com/gerasopoulos-markos,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daphna.mackover@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://vaccines.sanofi.co.il/accessibility,,,,,,,,,,,,,,,,,,,,,,,,,,,,
manoj.kharde@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://nipm.in/nipm/region-chapters/chapter-chairmen-hon-secretaries,,,,,,,,,,,,,,,,,,,,,,,,,,,,
manuel.vangelisti@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://unboundmedicine.com/medline/citation/33685778/next_generation_live_attenuated_yellow_fever_vaccine_candidate:_safety_and_immuno_efficacy_in_small_animal_models_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yves.girerd-chambaz@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://unboundmedicine.com/medline/citation/33685778/next_generation_live_attenuated_yellow_fever_vaccine_candidate:_safety_and_immuno_efficacy_in_small_animal_models_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
elhadj.djeriou@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.16-0731,,,,,,,,,,,,,,,,,,,,,,,,,,,,
junfen.ma@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,4,{first}.{last},,,,,,,,http://journal.pda.org/content/76/4/339,http://journal.pda.org/content/early/2021/12/16/pdajpst.2021.012681,http://journal.pda.org/content/early/2021/12/16/pdajpst.2021.012681/tab-article-info,http://journal.pda.org/content/early/2021/12/16/pdajpst.2021.012681/tab-references,,,,,,,,,,,,,,,,,,,,,,,,,
muriel.morel-pecheux@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://apeb.eu/invitations,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sharon.olich@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,2,{first}.{last},,,,,,,,http://stoptbindonesia.org/single-post/2019/04/25/lokakarya-media-sosial-untuk-promosi-tbc-dan-tbc-laten,http://stoptbindonesia.org/post/2019/04/25/lokakarya-media-sosial-untuk-promosi-tbc-dan-tbc-laten,,,,,,,,,,,,,,,,,,,,,,,,,,,
vincent.bocart@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://frenchhealthcare-association.fr/2019/01/30/destination-eti-sante-les-pme-en-sante-se-renforcent-avec-lappui-des-grands-groupes,,,,,,,,,,,,,,,,,,,,,,,,,,,,
loic.notelet@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://conect4children.org/academy-monitoring,,,,,,,,,,,,,,,,,,,,,,,,,,,,
katia.handelberg@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://www2.hematologie-amc.nl/pdy16370_studie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eric.vacaresse@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://rdweek.b2match.io,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephanie.ladaique@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://hautsdefrance.chambre-agriculture.fr/articles/detail-de-lactualite/actualites/masques-alternatifs-et-gels-ou-se-les-procurer,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sandrine.guendoul@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,30,{first}.{last},,,,,,,,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://pharmiweb.com/press-release/2022-08-05/sanofi-and-innovent-biologics-enter-strategic-collaboration-to-accelerate-development-of-oncology-medicines-and-expand-presence-in-china,http://biospace.com/article/releases/press-release-new-nirsevimab-data-analyses-reinforce-efficacy-against-rsv,http://coachmansresearch.com/press-release-altuviiio-late-breaking-data-at-isth-demonstrates-highly-effective-bleed-protection-in-children-with-severe-hemophilia-a-with-once-weekly-dosing,http://coachmansresearch.com/press-release-sanofi-prevails-in-zantac-arbitration-initiated-by-boehringer-ingelheim,http://northdakotadigitalnews.com/2022/11/30/press-release-acoziborole-investigational-single-dose,http://biotech-365.com/author/biotech365/page/3,http://northdakotadigitalnews.com/2022/11/10/sanofi-and-gsks-next-generation-covid-19,http://northdakotadigitalnews.com/2023/01/04/press-release-availability-of-the-q4-2022-memorandum-for-modelling-purposes,http://stada.com/blog/posts/2021/june/stada-further-grows-european-consumer-healthcare-portfolio-by-acquiring-16-well-established-brands-from-sanofi,http://northdakotadigitalnews.com/2023/01/05/fda-accepts-nirsevimab-application-as-first,http://healthtechhotspot.com/exscientia-and-sanofi-establish-strategic-research-collaboration-to-develop-ai-driven-pipeline-of-precision-engineered-medicines,http://yakuji.jp/entry120026.html,http://pharmiweb.com/press-release/2021-07-29/dupixent-dupilumab-significantly-improved-itch-and-hives-in-patients-with-chronic-spontaneous-urticaria-a-step-forward-in-demonstrating-the-role-o,http://sanofi.pl/dam/jcr:1638f8cb-04db-4e18-9834-ca91778012d8/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final%20(1).pdf,http://sanofi.pl/dam/jcr:89994640-99d4-474b-986b-f5c367151560/sanofi_przedstawia_nowa_marke_i_logo_korporacyjne_informacja_prasowa_final.pdf,http://life-sciences-usa.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://qlifepro.com/press/20220110-17-92708/exscientia-17,http://roboticulized.com/latest-news,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://startup365.fr/author/862global/page/4,http://medicaex.com/businesswire/sanofi-and-innate-pharma-expand-collaboration-for-natural-killer-cell-therapeutics-in-oncology,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/category/globenewswire,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/author/biotech365
dorota.haratyk@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,2,{first}.{last},,,,,,,,http://svopl.cz/clenove,http://svopl.cz/clenove-,,,,,,,,,,,,,,,,,,,,,,,,,,,
philippe.rocolle@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://imi.europa.eu/about-imi/governance/strategic-governing-groups,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kamal.ubaysi@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://e-pediatrie.org/e-pediatrie/le-programme/comite-scientifique-scientifique,,,,,,,,,,,,,,,,,,,,,,,,,,,,
xavier.benain@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://medrxiv.org/content/10.1101/2020.05.15.20103101v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nader.shafiei@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://journal.pda.org/content/69/6/762,,,,,,,,,,,,,,,,,,,,,,,,,,,,
filip.catrycke@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,7,{first}.{last},,,,,,,,http://bonavie.be/re-otv-bonavi-activiteit-tijdens-nieuwjaarsreceptie-15-feb-3,http://bonavie.be/re-otv-bonavi-activiteit-tijdens-nieuwjaarsreceptie-15-feb,http://otvnazareth.be/tag/sponsoring,http://otvnazareth.be/tag/telefoonnummer,http://otvnazareth.be/tag/adres,http://otvnazareth.be/tag/rekeningnummer,http://otvnazareth.be/team,,,,,,,,,,,,,,,,,,,,,,
shailendra.bidye@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://gpma-assn.org/members.php,,,,,,,,,,,,,,,,,,,,,,,,,,,,
serge.mathonet@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,5,{first}.{last},,,,,,,,http://journal.pda.org/content/70/4/392/tab-references,http://journal.pda.org/content/early/2016/04/13/pdajpst.2015.006189,http://journal.pda.org/content/70/4/392.full,http://journal.pda.org/content/70/4/392,http://journal.pda.org/content/early/2016/04/13/pdajpst.2015.006189.abstract,,,,,,,,,,,,,,,,,,,,,,,,
sylvie.coumel@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://connecting-nurses.com/legal-notice,,,,,,,,,,,,,,,,,,,,,,,,,,,,
olivier.bogillot@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://mondedesgrandesecoles.fr/sanofi-soigne-lavenir-de-ses-talents,,,,,,,,,,,,,,,,,,,,,,,,,,,,
qi.zhang@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-018-0951-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emmanuel.feroldi@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,3,{first}.{last},,,,,,,,http://journals.lww.com/pidj/fulltext/2018/08000/immunogenicity_and_safety_of_primary_and_booster.21.aspx,http://journals.lww.com/pidj/fulltext/2019/03000/evaluation_of_a_hexavalent_pentavalent_hexavalent.25.aspx,http://journals.lww.com/pidj/abstract/publishahead/evaluation_of_a_hexavalent_pentavalent_hexavalent.96497.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,
scott.ditchey@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://worldslargestgolfouting.com/wlgo-team/royce-brook-golf-club/6089025656374493184,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.ph@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,7,{first}.{last},,,,,,,,http://campus.sanofi/ph/data-privacy-notice-and-personal-data-consent-form,http://campus.sanofi/ph/login,http://campus.sanofi/ph/registration,http://campus.sanofi/ph/search,http://sanofi.ph/contact,http://campus.sanofi/ph,http://healthcarephilippines.com/directory/sanofi-aventis-philippines-inc,,,,,,,,,,,,,,,,,,,,,,
donghui.zhang@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,3,{first}.{last},,,,,,,,http://community.amstat.org/biop/aboutus/executivecommittee,http://dirk.eddelbuettel.com/cranberries/2019/03/15,http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,
anu.soininen@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://epressi.com/tiedotteet/terveys/tuore-kysely-kertoo-influenssarokotteen-ottamisella-halutaan-suojata-myos-lahimmaisia.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pauline.jurasinski@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,2,{first}.{last},,,,,,,,http://yankee.org/tournaments/upcoming-tournaments/cr-c-1-21-2018,http://yankee.org/tournaments/cr-c-1-21-2018,,,,,,,,,,,,,,,,,,,,,,,,,,,
paraskevi.gkeka@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,5,{first}.{last},,,,,,,,http://research.pasteur.fr/en/job/phd-rna-structure-prediction-binding-site-detection-and-small-molecules-virtual-screening,http://research.pasteur.fr/fr/job/phd-rna-structure-prediction-binding-site-detection-and-small-molecules-virtual-screening,http://career.aegean.gr/2019/10/31/%ce%b8%ce%ad%cf%83%ce%b7-%ce%b5%cf%81%ce%b3%ce%b1%cf%83%ce%af%ce%b1%cf%82-deciphering-protein-function-with-artificial-intelligence-31-10-2019,http://pubs.rsc.org/en/content/articlelanding/2016/nr/c6nr05853a,http://pubs.rsc.org/en/content/articlelanding/2016/nr/c6nr05853a/unauth,,,,,,,,,,,,,,,,,,,,,,,,
mohammad.sameti@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://asips.net/list-of-members-m-z.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
svitlana.dovgych@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,9,{first}.{last},,,,,,,,http://4mama.ua/news/events/8548-peremozhtsi-ix-konkursu-malyunka-sered-ditey-iz-tsukrovim-diabetom-vidpravlyatsya-pidkoryuvati-goverlu,http://4mama.ua/ru/news/people/8975-diabet-vershinam-ne-pomeha-pobediteli-konkursa-risunka-sredi-detey-s-diabetom-pokoryayut-goverlu,http://4mama.ua/news/people/8975-diabet-vershinam-ne-pereshkoda-peremozhtsi-konkursu-malyunka-sered-ditey-iz-diabetom-pidkoryuyut-goverlu,http://health-ua.com/news/60551-sanof-vukran-vta--rshennya-apelyatcjnogo-sudu-pro-bezpdstavnst-vimog-usprav,http://health-ua.com/article/37253-sanof-vukran-nagorodila-peremozhtcv-konkursu--dlya-molodih-naukovtcv-zadosl,http://health-ua.com/article/40823-sanof-vukran-zaproshu-vchenih-douchast-vkonkurs-medichnih-dosldzhen,http://health-ua.com/article/40383-ukrantc-mozhut-zahistitisya-vd-gripu-novoyu-chotirivalentnoyu-vaktcinoyu,http://health-ua.com/news/24854-sanof-v-ukran-predstavila-lkarskij-zasb--dlya-borotbi-z-bolem-pd-chas--krit,http://xn--80aa4apjd3a.com/aktual-no/vos-moj-vseukrainskij-konkurs-risunka-sredi-detej-s-saharnym-diabetom-10318287.html,,,,,,,,,,,,,,,,,,,,
olivier.gien@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://prismeforum.org/top-content-for-sig-members/meetings/2014-fall,,,,,,,,,,,,,,,,,,,,,,,,,,,,
serge.spierckel@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,6,{first}.{last},,,,,,,,http://biospace.com/article/reduction-in-blood-sugar-levels-in-soliqua-suliqua-1-phase-3-trial-sustained-to-52-weeks,http://presseportal.ch/de/pm/100007059/100789294,http://health-ua.com/news/4134-kompanya-sanof-predstavlya-povn-rezultati-fkfd-dosldzhennya-z-porvnyannya-p,http://presseportal.ch/de/pm/100007059/100792860,http://presseportal.ch/de/pm/100007059/100795521,http://presseportal.ch/de/pm/100007059/100792702,,,,,,,,,,,,,,,,,,,,,,,
es-farmacovigilancia@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,16,{first}.{last},,,,,,,,http://vigimed.es/files/producte/1658491820_guia_profesionales_2022.pdf,http://med-abstracts.com/s/seth.es1.html,http://emonetoone.es/profesional-sanitario/terminos-legales/terminos-y-condiciones-de-uso,http://emonetoone.es/terminos-y-condiciones-de-uso,http://healthdrugpdf.com/s/seth.es1.html,http://vigimed.es/particular/contacto,http://vigimed.es/profesional/contacto,http://sanofi.es/es/contacto,http://ak9demia.es/contacto,http://rarasperoreales.es/es/terminos-y-condiciones,http://emssolutionsint.blogspot.com/search/label/cliclobenzaprina,http://dosingpdf.com/s/seth.es1.html,http://pdfmedsearch.com/s/seth.es1.html,http://agrealuchadoras.blogspot.com/2013/12/errores-de-medicacion-potenciales-en-la.html,http://emssolutionsint.blogspot.com/2013/06/tetrazepam-myolastan-suspension-de-la.html,http://medpdffinder.com/s/seth.es1.html,,,,,,,,,,,,,
info@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,24,{first}.{last},,,Support,,,,,http://diabetesgbg.se/sites/default/files/diabetesbladet/diabetesbladet_nr_3-2011_0.pdf,http://diabetesgbg.se/sites/default/files/diabetesbladet/diabetesbladet_nr_4-2011.pdf,http://sanofi.cz/dam/jcr:2cb10f18-9b74-485b-99fc-a3af0adf8b6c/paralen%20cipky%20-%20ot%c3%a1zky%20a%20odpov%c4%9bdi%20pro%20pacienty.pdf,http://sanofi.com.tr/dam/jcr:6681eb73-d4f6-4a68-ae7e-50642f8343bd/sanofi-surdurulebilirlik-raporu-2020.pdf,http://sanofi.com.tr/dam/jcr:709e0993-f2f9-4ff7-8ba8-0f8786461bdf/23346c0e-52e1-4a16-80b9-48e5a223d8d0%20(1).pdf,http://sanofi.com.tr/dam/jcr:70df7d14-c02d-4e87-9575-7b401db015b8/raporu-2017.pdf,http://sanofi.com.tr/dam/jcr:cb6dfde1-1c35-4ea7-aa9a-b3b9d42e8a76/sanofi-tr-surdurulebilirlik-raporu-2019.pdf,http://sanofi.com.tr/dam/jcr:e624133b-a3fa-4f20-b0ec-6c3f137b29f7/sanofisurdurulebilirlik_tr.pdf,http://biocampus-rtz.de/bcc/de/unternehmen,http://biocampus-rtz.de/unternehmen,http://biocampuscologne.com/bcc/de/unternehmen,http://biocampuscologne.com/unternehmen,http://intolife.in/index,http://msms.nl/sponsoren/sanofi,http://rtz.de/companies/sanofi-chc-germany-a-nattermann-cie-gmbh,http://biocampuscologne.de/companies/sanofi-chc-germany-a-nattermann-cie-gmbh,http://biocampus-rtz.de/companies/sanofi-chc-germany-a-nattermann-cie-gmbh,http://biocampuscologne.com/companies/sanofi-chc-germany-a-nattermann-cie-gmbh,http://edna.bg/zdravoslovno/kak-da-se-predpazim-ot-kashlicata-i-vyzpalenoto-gyrlo-4660663,http://angel-jobs.com/virtualization-expert-jobs-in-mumbai-at-sanofi-india-ltd-1578629236,http://ladyzone.bg/ladyzone-inside/pr-i-plateni-materiali/kak-da-prekasnem-porochnija-cikal-na-kashlicata-nezabavno.html,http://intolife.in,http://msdebaas.nl/huisregels,http://msdebaas.nl/huisregels-instagram,,,,,
medinfo.de@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,30,{first}.{last},,,,,,,,http://frag-die-katze-tipps.zugwerk.com/medizin-fur-die-katze,http://marktcenter-uelzen.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://pharmeo.de/12551047-thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.html,http://pharmeo.de/15420191-thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.html,http://geisseestrasse.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://forum-steglitz.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://goerlitz.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://goerlitz.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.759088.html,http://kudamm.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://straubing.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://main-park-center.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://bruchkoebel.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://hainburg.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.759088.html,http://sanofi.de,http://hainburg.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://laxoberal.de/service/kontakt,http://maerkische-zeile.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://eschweiler.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://duderstadt.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://infoline-schilddruese.de/datenschutzhinweise,http://heidelberg.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://sanofi.de/de/kontakt,http://siegen.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.759088.html,http://flensburg-galerie.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.759088.html,http://friedrich-ebert-strasse.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://flensburg-galerie.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://mein.sanofi.de/therapiegebiete/krebs/schilddruesenkrebs,http://mein.sanofi.de/therapiegebiete/krebs/schilddruesenkrebs/wohlfuehlorgan,http://im-medicum.easyapotheken.de/product/thomapyrin-tension-duo-400-mg-100-mg-filmtabletten.450849.html,http://mein.sanofi.de/morbus-pompe-therapie
olaf.ritzeler@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,1,{first}.{last},,,,,,,,http://vfa.de/de/verband-mitglieder/biotech-partnering,,,,,,,,,,,,,,,,,,,,,,,,,,,,
contact_us@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,4,{first}.{last},,,Support,,,,,http://clinicaltrials.gov/ct2/show/results/nct01151137,http://clinicaltrials.gov/ct2/show/results/nct00993473,http://clinicaltrials.gov/ct2/show/results/NCT00069784,http://clinicaltrials.gov/ct2/show/results/nct00069784,,,,,,,,,,,,,,,,,,,,,,,,,
malsahaura.arrasuli@sanofi.com,sanofi.com,Sanofi,,,,,,95,personal,21,{first}.{last},,,,,,,,http://bstarspot.blogspot.com/2012/08/lowongan-kerja-jambi_9.html,http://infoterkiniterbaru.blogspot.com/2013/05/informasi-lowongan-kerja-bangka-mei-2013.html,http://infoterkiniterbaru.blogspot.com/2013/05/lowongan-kerja-belitung-mei-2013.html,http://lowongan-kerja-oil-bumn.blogspot.com/2012/09/lowongan-kerja-2012-sanofi-group.html,http://nofq.blogspot.com/2013/04/lowongan-kerja-sulawesi-tengah-mei-2013.html,http://infobarubaru.blogspot.com/2013/04/lowongan-kerja-kalimantan-timur-mei-2013.html,http://infobarubaru.blogspot.com/2013/04/info-lowongan-kerja-gorontalo-april-2013.html,http://lowongankerjaterbaruapril.blogspot.com/2013/04/daftar-lowongan-kerja-riau-april-2013.html,http://lowongankerjaterbaruapril.blogspot.com/2013/04/daftar-lowongan-kerja-lampung-april-2013.html,http://lowongankerjabaru-baru.blogspot.com/2013/05/info-lowongan-kerja-gorontalo-mei-2013.html,http://infobarubaru.blogspot.com/2013/05/info-lowongan-kerja-gorontalo-mei-2013.html,http://lowongankerjaperusahaanterbaru.blogspot.com/2012/07/lowongan-kerja-juli-2012-market-supply.html,http://sinidong.blogspot.com/2013/03/lowongan-kerja-aceh-maret-2013.html,http://lowongankerjaterbarumei.blogspot.com/2013/04/daftar-lowongan-kerja-bengkulu-mei-2013.html,http://jobnusantara.blogspot.com/2012/10/sanofi-group-indonesia.html,http://lowongankerjaterbarumei.blogspot.com/2013/04/daftar-lowongan-kerja-gorontalo-mei-2013.html,http://lowongankerjaterbarumei.blogspot.com/2013/04/daftar-lowongan-kerja-bangka-belitung.html,http://bursalowkersumbar.blogspot.com/2012/08/lowongan-kerja-medical-representative.html,http://bursalowkersumbar.blogspot.com/2012/08/medical-representative-sanofi-group.html,http://bursalowkersumbar.blogspot.com/2012/08/medical-representative-sanofi-group_31.html,http://bursalowkersumbar.blogspot.com/2012/08/medical-representative-sanofi-group_5280.html,,,,,,,,
uk-medicalinformation@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,30,{first}.{last},,,,,,,,http://clexanepatientsupport.co.uk,http://gov.uk/drug-device-alerts/class-4-medicines-defect-information-some-batches-of-gentamicin-sulphate-active-pharmaceutical-ingredient-api,http://sanofi.co.uk/dam/jcr:34419d9c-ed3e-4450-b0b9-96364e3f7d53/pharmacy%20stickers-rmm%20mat-xu-2204782%20v1.0%20oct%202022.pdf,http://sanofi.co.uk/dam/jcr:43a1f433-7943-4ae7-9db4-5892e8847e7f/valproate%20rmm%202021%20distribution-%20patient%20booklet.pdf,http://sanofi.co.uk/dam/jcr:d9692153-06ca-44fe-95db-2e43d13421c3/valproate%20rmms%202021%20uk%20distribution%20hcp%20booklet.pdf,http://sanofi.co.uk/en/about-us/products,http://sanofi.co.uk/en/contact,http://simplymedsonline.co.uk/storage/otherdocuments/telfast_pil.pdf,http://vtematters.co.uk/dam/jcr:6beb74a3-f71f-4fd4-9943-feb332312fae/clexane%20pi%20uk%20february%202022.pdf,http://vtematters.co.uk/dam/jcr:74d829b0-e977-401d-94e2-f5e00c1f5a54/clexane%20pi%20uk%20february%202022.pdf,http://chemist2customer.com/images/pictures/eyes/opticrom/opticrom-allergy-20-single-dose.pdf,http://imedi.co.uk/proctosedyl-ointment,http://hghgear.ws/media/file/47/clomid.pdf,http://dispex.net/class-2-medicines-recall-aventis-pharma-limited-t-a-sanofi-stemetil-5mg-5ml-syrup-el22a-41,http://care4quality.co.uk/class-2-medicines-recall-aventis-pharma-limited-t-a-sanofi-stemetil-5mg-5ml-syrup-el22a-41,http://stlukessurgeryguildford.nhs.uk/wp-content/uploads/2020/12/flublokv1-1.pdf,http://dispex.net/class-2-medicines-recall-various-marketing-authorisation-holders-and-parallel-distributor-companies-irbesartan-containing-products-el21a-34-2,http://dispex.net/class-2-medicines-recall-various-marketing-authorisation-holders-and-parallel-distributor-companies-irbesartan-containing-products-el21a-34,http://dispex.net/class-2-medicines-recallvarious-marketing-authorisation-holders-and-parallel-distributor-companies-irbesartan-containing-products-el-21a-19,http://campus.sanofi/dam/jcr:e850a465-f5b0-4275-97ec-27a46126aa54/myozyme.pdf,http://dispensingdoctor.org/news/three-recalls,http://knockjobs.online/proctosedyl-witch-hazel-ointment-xabpxw.html,http://naturesbest.co.uk/images/pharmacypdf/50938544.pdf,http://naturesbest.co.uk/images/pharmacypdf/5012917077032.pdf,http://naturesbest.co.uk/images/pharmacypdf/5013011004672.pdf,http://naturesbest.co.uk/images/pharmacypdf/5013011004863.pdf,http://naturesbest.co.uk/images/pharmacypdf/5013011006409.pdf,http://epilepsysociety.org.uk/news/medication-updates,http://migateway.eu/en/gb/21/sanofi,http://imedi.co.uk/calcium-resonium
ir@sanofi.com,sanofi.com,Sanofi,,,,,,95,generic,30,{first}.{last},,,,,,,,http://lookmedica.ro/blog/sanofi-si-regeneron-anunta-rezultate-pozitive-pentru-primele-studii-care-vizeaza-evaluarea-praluent-alirocumab-la-persoanele-cu-diabet-zaharat-si-hipercolesterolemie/7140,http://cardiobrief.org/2012/06/11/basal-insulin-and-omega-3-fatty-acids-fail-to-improve-outcomes-in-diabetics-and-prediabetics,http://sanofi.com/fr/media-room/communiques-de-presse/2018/2018-03-10-14-00-00-1420167,http://francebourse.com/fiche_news_143180.fb,http://sanofi.com/fr/media-room/communiques-de-presse/2018/2018-06-28-05-00-00-1530712,http://marketbeat.com/stocks/nasdaq/sny,http://ru.sanofi.com/dam/jcr:c92384a7-e2c7-46c3-9fce-dbc45e02db3a/pr_sanofi%20and%20gsk%20join%20forces%20in%20unprecedented%20partnership_rus.pdf,http://stockspinoffinvesting.com/spin-offs/sanofi-spin-off-quick-summary-march-27-2020,http://thescipreneur.com/libtayo-received-fda-aproval-as-first-and-only-treatment-for-second-most-common-skin-cancer,http://sanofi.com/fr/media-room/communiques-de-presse/2018/2018-03-08-06-46-35-1418077,http://outsourcedpharma.com/doc/sanofi-sanofi-to-acquire-synthorx-to-bolster-its-immuno-oncology-pipeline-for-b-0001,http://sanofi.in/dam/jcr:bcfb2df5-91a1-4156-8f24-7d044cf55aad/shanthas%20pentavalent%20pediatric%20vaccine%20prequalified%20by%20world%20health%20organization.pdf,http://francebourse.com/fiche_news_143177.fb,http://life-sciences-europe.com/product/tzield-provention-bio-inc-sanofi-group-since-may-2001-35202.html,http://marketchameleon.com/pressreleases/i/689792/regn/sanofi-positive-phase-3-results-presented-for,http://businesswire.com/news/home/20140112005065/en/genzyme-alnylam-expand-collaboration-rare-genetic-diseases,http://zhardem.kz/news/17514,http://biospace.com/news/fda-approves-sanofi-frances-nasacort0174-allergy/311602,http://pompecanada.com/blog/news/press-releases/sanofi-genzyme-announces-recipients-of-patient-advocacy-leadership-pal-awards,http://snacksafely.com/2020/05/fda-approves-dupixent-as-first-biologic-for-treatment-of-children-aged-6-11-with-moderate-to-severe-eczema,http://studyscavenger.com/sanofi-first-patient-outside-u-s-treated-in-global-kevzara-sarilumab-clinical-trial-program-for-patients-with-severe-covid-19,http://biospace.com/news/sanofi-france-massachusetts-general-hospital/275549,http://vidal.ru/novosti/shprits-ruchki-lantusr-solostarr-nachinayut-proizvoditsya-v-pekine-2405,http://lerevenu.com/breves/sanofi-en-inde-les-enfants-vont-bientot-beneficier-des-premieres-doses-de-vaccin-polio,http://pm360online.com/sanofi-chmp-recommends-approval-of-praluent-alirocumab-to-reduce-cardiovascular-risk-in-people-with-established-atherosclerotic-cardiovascular-disease,http://enlamichoacana.com/sanofi-delivered-close-to-double-digit-q4-2020-business-eps1-growth-at-cer.html,http://saubio.com/sanofi-and-sobi-donate-up-to-500-million-additional-ius-of-clotting-factor-to-wfh-humanitarian-aid-program,http://globenewswire.com/news-release/2019/04/26/1810885/0/en/sanofi-fda-approves-praluent-alirocumab-to-prevent-heart-attack-stroke-and-unstable-angina-requiring-hospitalization.html,http://qlifepro.com/press/20160106-22-25784/ma-genzyme,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-approbation-de-suliquatm-dans-lunion-europeenne-pour-le-traitement-du-diabete-de-type-2-de-ladulte
myriam.triki@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,5,{first}.{last},Myriam,Triki,,,,,,http://tn.sanofi.com/dam/jcr:14a3f491-3b1f-4e93-aebc-739f1f08da91/semaine%20mondiale%20de%20la%20vaccination%20;%20atteindre%20une%20large%20immunit%c3%a9%20collective%20(version%20arabe).pdf,http://tn.sanofi.com/dam/jcr:3edf8803-7311-484d-9890-e6f6ef8d2d09/journ%c3%a9e%20mondiale%20de%20l%e2%80%99hypertension%20art%c3%a9rielle.pdf,http://tn.sanofi.com/dam/jcr:7faa2271-e40d-4423-84d1-9096a32a7ddd/2019-02-27-vf.pdf,http://tn.sanofi.com/dam/jcr:d0a76a34-925e-481d-b81f-ed919982d369/2019-05-17-va.pdf,http://tn.sanofi.com/dam/jcr:d87dd81e-2b79-4812-9670-e5824da00e67/2019-02-27-va.pdf,,,,,,,,,,,,,,,,,,,,,,,,
aditi.kumari@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Aditi,Kumari,,,,,,http://pharmanaukri.in/index.php/2023/03/14/sanofi-hiring-expert-medical-regulatory-writer-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alpana.das@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,5,{first}.{last},Alpana,Das,,,,,,http://pharmanaukri.in/index.php/2023/03/01/sanofi-hiring-for-scientific-and-publication-writers,http://pharmanaukri.in/index.php/2023/03/04/sanofi-hiring-scientific-and-publication-writers,http://pharmanaukri.in/index.php/2023/03/10/sanofi-looking-for-scientific-writers,http://pharmanaukri.in/index.php/category/clinical-research/medical-writing/page/5,http://pharmanaukri.in/index.php/2023/03/23/sanofi-hiring-for-senior-medical-writer-aggregate-reporting-role,,,,,,,,,,,,,,,,,,,,,,,,
jamaa.sadik@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,3,{first}.{last},Jamaa,Sadik,,,,,,http://sanofi.ma/dam/jcr:3eee2dd6-fa74-494a-a956-6d6bd02f4165/pdf%20p3.pdf,http://sanofi.ma/dam/jcr:a3e80b94-c1d6-4840-8bd2-92ada1d0f132/pdf%20h4.pdf,http://sanofi.ma/dam/jcr:da9fb577-5966-4221-804d-483856e2fab4/pdf%20p3.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
lionel.de-souza@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,5,{first}.{last},Lionel,Souza,,,,,,http://sanofi.com/dam/jcr:5bab7550-2364-4273-afee-2285ab1a3412/2021_06_02_performance_shares_plan_rules_13iex_en.pdf,http://sanofi.com/dam/jcr:5f661b3e-8f78-4ea9-b12f-8fb4614462c3/sanofi-performance-shares-plan-rules-n-14_eng-2.pdf,http://sanofi.com/dam/jcr:b65c9a94-ea55-448c-8422-8dd61a17d235/2020_05_04_performance_shares_plan_rules_12i_ex.pdf,http://sanofi.com/dam/jcr:b8672d3e-5450-4771-ba37-dcdc0cdde7b7/2020_05_04_performance_shares_plan_rules_12i.pdf,http://sanofi.com/dam/jcr:c7f0f4cc-d177-477d-bdb6-69e0d373009f/sanofi-performance-shares-plan-rules-n-14-ex_eng-2.pdf,,,,,,,,,,,,,,,,,,,,,,,,
magno.fernandes@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Magno,Fernandes,,,,,,http://sanofi.in/dam/jcr:dcd60ecc-1471-48da-8109-0aa898d543ca/bmw-annual-return-2019pdf.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michaela.zieger@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Michaela,Zieger,,,,,,http://sanofi.at/dam/jcr:8890f077-db32-4dd1-b848-2f6279e196e9/171011_pm%20sanofi_allstar-pro%20final.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alicia.mcmaster@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,7,{first}.{last},Alicia,Mcmaster,,,,,,http://saraa.co.za/wp-content/uploads/2020/05/medical-infodr-makan_signed-copy.pdf,http://safpj.redbricklibrary.co.za/index.php/safpj/article/download/4872/5802,http://safpj.redbricklibrary.co.za/index.php/safpj/article/download/4907/5846,http://jemdsa.co.za/index.php/jemdsa/article/download/590/973,http://jemdsa.co.za/index.php/jemdsa/article/download/591/979,http://safpj.co.za/index.php/safpj/article/download/4874/5773,http://safpj.co.za/index.php/safpj/article/download/4903/5802,,,,,,,,,,,,,,,,,,,,,,
paul.bryce@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Paul,Bryce,,,,,,http://biomap-imi.eu/new/start-of-research-project-biomap,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.hicks@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Alexandra,Hicks,,"","","","",http://biomap-imi.eu/contact,http://insight.jci.org/articles/view/163495,,,,,,,,,,,,,,,,,,,,,,,,,,,
irina.chkhikvadze2@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Irina,Chkhikvadze,,"","","","",http://apcrg.org.ge/ge/members.php,http://apcrg.org.ge/en/members.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
denise.connelly@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Denise,Connelly,,,,,,http://newenglandcountrymart.com/product/weekly-premium-select-produce-box,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sarah.zundel@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Sarah,Zundel,,"","","","",http://master2-methodologie-evaluation-essais-therapeutiques.edu.umontpellier.fr/offres-demploi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
karen.linehan@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Karen,Linehan,,,,,,http://contracts.onecle.com/valeant/sanofi-apa-2011-07-08.shtml,,,,,,,,,,,,,,,,,,,,,,,,,,,,
olivier.guichard@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Olivier,Guichard,,"","","","",http://rmngbp.cnrs-orleans.fr/journees/default.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
casey.valentine@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Casey,Valentine,,"","","","",http://vsronline.org/2022-exhibit-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bernd.scheu@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Bernd,Scheu,,"","","","",http://karl-heinz-ritzel-deul.de/vorstand.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
matteo.bertone@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Matteo,Bertone,,,,,,http://medicinachannel.it/2015/11/diretta-live-i-5-finalisti-del-progetto.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephanie.simpson@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Stephanie,Simpson,Writing & communication,Government Relations,"","","",http://nmbio.org/member/sanofi-us,,,,,,,,,,,,,,,,,,,,,,,,,,,,
edward.thommes@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Edward,Thommes,Education,"","","","",http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-09854-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,
astrid.domke@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Astrid,Domke,,"","","","",http://vom-backhaus.beepworld.de/apps/guestbook,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marie.nardi@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Marie,Nardi,,"","","","",http://connect.sla.org/blogs/dana-eckstein-berkowitz/2020/03/25/calling-all-sla-new-england-members-presenting-at,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andrei.teodorescu@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Andrei,Teodorescu,,"","","","",http://valcea.colegfarm.ro/noutati/lemtrada-alemtuzumab-indicatie-terapeutica-restrictionata-contraindicatii-suplimentare-si-masuri-de-reducere-la-minimum-a-riscului,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bengt-ivar.fransson@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,3,{first}.{last},Bengt,Fransson,,,,,,http://program.almedalsveckan.info/event/user-view/59692,http://program.almedalsveckan.info/event/user-view/59690,http://program.almedalsveckan.info/event/user-view/59691,,,,,,,,,,,,,,,,,,,,,,,,,,
magali.mathieu@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Magali,Mathieu,,"","","","",http://afc2013.afc.asso.fr/programme.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
martin.novak@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,5,{first}.{last},Martin,Novak,,"","","","",http://user2017.sched.com/event-goers/5c8351c3d3cd28e7e2eaf012014e3c7d,http://user2017.sched.com/event-goers/35499575a3ce6fd2f4e656b35ab4dfae,http://user2017.sched.com/event-goers/8b498322b9c4ae4df3ae88b4120ee4ef,http://user2017.sched.com/event-goers/31e35545d133b7bd5c5139e8dea3581f,http://user2017.sched.com/event-goers/1663e08a992fc56e8d9de836d272ce90,,,,,,,,,,,,,,,,,,,,,,,,
olivier.devens@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Olivier,Devens,,"","","","",http://asmbasket.yaentrainement.fr,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mackenzie.fetterman@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Mackenzie,Fetterman,,,,,,http://ncadmin.nc.gov/pc-stc-269b-mmcap-contract-infopdf/open,http://txsmartbuy.com/contracts/view/2079,,,,,,,,,,,,,,,,,,,,,,,,,,,
noor.verhoef@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Noor,Verhoef,,"","","","",http://kijkzuidfrankrijk.com/2015/08/14/recept-van-de-week-soupe-de-courgettes-de-madame-boulanger,,,,,,,,,,,,,,,,,,,,,,,,,,,,
claudio.folli@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Claudio,Folli,,"","","","",http://consorziodafne.com/comunicazioni/ricostituito-il-nuovo-comitato-tecnico-di-gestione-ctg-del-consorzio-dafne,,,,,,,,,,,,,,,,,,,,,,,,,,,,
heather.rizzi@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Heather,Rizzi,,"","","","",http://sites.google.com/site/chesapeakecolorectalsociety/home/industry-partners-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
amelie.moritz@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Amelie,Moritz,,"","","","",http://conference.evpa.eu.com/colab-award/philanthropy-collaboration-examples-from-the-refugee-and-migrant-sector-in-france,http://webzine.unitedfashionforpeace.com/ethical-planet/women-for-education-appel-a-candidature-2012,,,,,,,,,,,,,,,,,,,,,,,,,,,
scot.neves@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Scot,Neves,,Team Captain,"","","",http://worldslargestgolfouting.com/wlgo-team/royce-brook-golf-club/6089025656374493184,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eva.toth@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Eva,Toth,,"","","","",http://vdsz.hu/chinoin_vdsz_szakszervezet/kapcsolat__esemenyek/413,http://autonomok.hu/chinoin_vdsz_szakszervezet/kapcsolat__esemenyek/413,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.robinson@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,12,{first}.{last},Anna,Robinson,Writing & communication,Media Contact,"","",+1 908 229 6871,http://perkinelmergenomics.com/the-lantern-project-from-sanofi-genzyme-and-perkinelmer-expands-access-to-free-diagnostic-genetic-testing-for-a-number-of-lysosomal-storage-disorders,http://sanofi.com/en/media-room/press-releases/2019/2019-09-16-07-00-00,http://verily.com/press/verily-forms-strategic-alliances-with-novartis-otsuka-pfizer-and-sanofi-to-transform-clinical-research,http://businesswire.com/news/home/20190521005485/en/ve,http://pharmalive.com/sanofi-and-abbott-partner-to-integrate-glucose-sensing-and-insulin-delivery-technologies,http://biospace.com/article/releases/verily-forms-strategic-alliances-with-novartis-otsuka-pfizer-and-sanofi-to-transform-clinical-research,http://businesswire.com/news/home/20190521005485/en/verily-forms-strategic-alliances-novartis-otsuka-pfizer,http://businesswire.com/news/home/20190521005485/en,http://pharmashots.com/press-releases/verily-forms-strategic-alliances-with-novartis-otsuka-pfizer-and-sanofi-to-transformclinical-research,http://prnewswire.com/news-releases/shining-a-light-on-diagnosis-for-rare-genetic-disease-patients-300730386.html,http://medindia.net/health-press-release/sanofi-named-to-diversityincs-top-50-companies-for-diversity-368339-1.htm,http://medindia.net/health-press-release/sanofi-accelerating-future-breakthroughs-through-clinical-trials-part-2-of-3-370553-1.htm,,,,,,,,,,,,,,,,,
christopher.arendt@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Christopher,Arendt,Education,Research And Development,"","","",http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicholas.colletti@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Nicholas,Colletti,Education,Research And Development,"","","",http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lan.lee@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Lan,Lee,Education,Research And Development,"","","",http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chie.kato@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Chie,Kato,,,,,,http://jaden1996.com/workshop/application_2012.html,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
stephen.wilkey@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,1,{first}.{last},Stephen,Wilkey,,Registered Nurses,"","",+1 317 435 0038,http://capni.enpnetwork.com/nurse-practitioner-events/111861-region-11-may-program,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lei.tang@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,5,{first}.{last},Lei,Tang,,"","","","",http://njacs.org/events-calendar/dmdg-2020-04,http://njacs.org/dmdg-meeting,http://njacs.org/events-calendar/dmdg-2019-05,http://njacs.org/drug-metabolism-topical-group,http://njacs.org/topical-groups/drug-metabolism,,,,,,,,,,,,,,,,,,,,,,,,
jennifer.silvera@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,6,{first}.{last},Jennifer,Silvera,,"","","",+507 305 1412,http://revistaamiga.com/mente-y-cuerpo/gaucher-una-enfermedad-compleja,http://rrppguate.blogspot.com/2018/08/las-erupciones-volcanicas-aumentan-la.html,http://rrppguate.blogspot.com/2013/08/vacuna-pediatrica-6-en-1-de-sanofi.html,http://sercas.blogspot.com/2013/11/mitos-y-realidades-de-la-insulina.html,http://sercas.blogspot.com/2013,http://sercas.blogspot.com/2013/11,,,,,,,,,,,,,,,,,,,,,,,
katherine.hamlet@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Katherine,Hamlet,,"","","",+1 908 981 5848,http://biospace.com/article/releases/regeneron-and-sanofi-to-present-data-from-phase-3-praluent-alirocumab-injection-clinical-trials-at-b-aha-b-scientific-sessions-2016-,http://biospace.com/news/regeneron-and-sanofi-to-present-data-from-phase-3/438877,,,,,,,,,,,,,,,,,,,,,,,,,,,
heather.guzzi@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,4,{first}.{last},Heather,Guzzi,Writing & communication,"","","",+1 908 981 3164,http://prnewswire.com/news-releases/sanofi-announces-results-of-first-of-its-kind-social-experiment-revealing-real-life-impact-of-symptoms-on-allergy-sufferers-in-the-us-300426248.html,http://prnewswire.com/news-releases/sanofi-launches-first-ever-act-kids-toothpaste-in-the-us-300433010.html,http://prnewswire.com/news-releases/new-survey-finds-men-in-the-us-want-to-take-charge-of-their-own-health-and-wellness-300365412.html,http://medindia.net/health-press-release/new-survey-finds-men-in-the-us-want-to-take-charge-of-their-own-health-and-wellness-307866-1.htm,,,,,,,,,,,,,,,,,,,,,,,,,
lisa.clemence@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,7,{first}.{last},Lisa,Clemence,,CDO,"","",+1 617 768 6699,http://businesswire.com/news/home/20170209005661/en/sanofi-genzyme-commitment-patients-rare-diseases-highlighted,http://biospace.com/article/releases/alnylam-and-sanofi-genzyme-initiate-atlas-phase-iii-program-with-investigational-rnai-therapeutic-fitusiran-in-patients-with-hemophilia-a-and-b-with-o,http://biospace.com/article/releases/alnylam-and-sanofi-genzyme-report-positive-results-from-ongoing-phase-ii-open-label-extension-study-with-investigational-rnai-therapeutic-fitusiran-in,http://businesswire.com/news/home/20170626006159/en/alnylam-sanofi-genzyme-present-clinical-trial-results,http://businesswire.com/news/home/20170710005395/en/alnylam-sanofi-genzyme-report-positive-results-ongoing,http://businesswire.com/news/home/20170707005070/en/alnylam-sanofi-genzyme-initiate-atlas-phase-3,http://businesswire.com/news/home/20170214005771/en/sanofi-initiates-phase-2-clinical-trial-evaluate,,,,,,,,,,,,,,,,,,,,,,
christian.buning@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,7,{first}.{last},Christian,Buning,,,,,,http://worldwidescience.org/topicpages/c/crystal+deposition+disease.html,http://worldwidescience.org/topicpages/n/nanoparticles+alter+cathepsin.html,http://uni-heidelberg.de/fakultaeten/chemgeo/aci/comba/former_members.html,http://worldwidescience.org/topicpages/m/multiple+nucleopolyhedrovirus+cathepsin.html,http://worldwidescience.org/topicpages/r/requires+microglial+cathepsin.html,http://worldwidescience.org/topicpages/b/bradykinin.html,http://osti.gov/scitech/biblio/22416308-crystal-structure-cathepsin-novel-target-treatment-cardiovascular-diseases,,,,,,,,,,,,,,,,,,,,,,
ellyn.schindler@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,7,{first}.{last},Ellyn,Schindler,Education,Research And Development,"","",+1 570 957 2689,http://3blmedia.com/news/eighth-annual-community-fundraiser-presented-vaxserve-and-sanofi-pasteur-awards-record-230000,http://3blmedia.com/news/vaxserve-sanofi-pasteur-signature-corporate-citizenship-program-continues-support-struggling,http://3blmedia.com/news/sanofi-pasteurs-12th-annual-pocono-mountains-community-fundraiser-awards-more-200000-record,http://3blmedia.com/news/sanofi-pasteurs-adopt-family-drive-20-years-strong,http://seleucidian66.rssing.com/chan-61547736/all_p111.html,http://3blmedia.com/news/sanofi-pasteurs-pocono-mountains-community-fundraiser-continues-its-legacy-millions-raised,http://responsibility460.rssing.com/chan-4249445/all_p451.html,,,,,,,,,,,,,,,,,,,,,,
matthias.schaefer@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,5,{first}.{last},Matthias,Schäfer,,,,,,http://worldwidescience.org/topicpages/c/calcium+signaling+induces.html,http://worldwidescience.org/topicpages/i/increased+calcium+influx.html,http://worldwidescience.org/topicpages/a/azd2171+inhibits+endothelial.html,http://worldwidescience.org/topicpages/l/lithium+rechargeable+cells.html,http://worldwidescience.org/topicpages/g/glycolytically+produced+nadh.html,,,,,,,,,,,,,,,,,,,,,,,,
ruchita.mehra@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,9,{first}.{last},Ruchita,Mehra,Writing & communication,Senior Director Communications,"","","",http://sanofi.in/dam/jcr:0778ba02-f96f-4625-b71c-9ba3db4548f3/diabetic%20teen%20from%20pune%20achieves%20unique%20feat.pdf,http://sanofi.in/dam/jcr:0bdfec1d-bbd7-484a-8acf-4200f83b4034/bhaichung%20bhutia%20in%20kolkata%20to%20share%20his%20own%20experience%20on%20how%20to%20manage%20knee-osteoarthritis.pdf,http://sanofi.in/dam/jcr:1355627d-b239-4bd7-9f38-4b6517d0ac2e/sanofi%20and%20rssdis%20mega%20walkathon%20triggers%20zest%20for%20diabetes%20control%20in%20lucknow%20city.pdf,http://sanofi.in/dam/jcr:59da2000-f680-4e04-a025-4f8266775a53/20year%20old%20indian%20woman%20with%20type%201%20diabetes%20conquers%20white%20mountains%20in%20crete%20greece.pdf,http://sanofi.in/dam/jcr:7131a7ab-43a9-4f27-a3e1-26eecfea1bbc/bhaichung%20bhutia%20in%20kochi%20to%20share%20his%20experience%20on%20managing%20kneeosteoarthritis.pdf,http://sagarmediainc.blogspot.com/2012/10/sanofi-launches-specially-designed-made.html,http://prfeed.blogspot.com/2014/09/bwi-apollo-hospitals-and-sanofi.html,http://prfeed.blogspot.com/2014/09,http://prfeed.blogspot.com/2014_09_01_archive.html,,,,,,,,,,,,,,,,,,,,
rachel.ferrand@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,4,{first}.{last},Rachel,Ferrand,,Specialist,"","",+1 908 981 6673,http://globalbrandsmagazine.com/new-gold-bond-no-mess-powder-spray-introduced-by-sanofis-chattem,http://nigeriantimes.blogspot.com/2013_05_01_archive.html,http://nigeriantimes.blogspot.com/2013/05,http://nigeriantimes.blogspot.com/2013/05/sanofi-us-and-actress-elizabeth-perkins.html,,,,,,,,,,,,,,,,,,,,,,,,,
kimberly.fox@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,8,{first}.{last},Kimberly,Fox,,,,,,http://biospace.com/article/releases/agamatrix-inc-clears-ibgstar-blood-glucose-monitoring-system-,http://biospace.com/article/releases/sanofi-aventis-massachusetts-release-allegra-r-and-survivor-winner-b-danni-boatwright-b-want-to-hear-about-your-allergy-adventures-,http://bio-medicine.org/medicine-technology-1/sanofi-announces-court-ruling-granting-preliminary-injunction-against-synvisc-one-ae-competitor-product-23295-1,http://bio-medicine.org/medicine-technology-1/allegra-ae-and-survivor-winner-danni-boatwright-want-to-hear-about-your--26quot-3ballergy-adventures-26quot-3b-19478-1,http://prnewswire.com/news-releases/allegra-and-survivor-winner-danni-boatwright-want-to-hear-about-your-allergy-adventures-127447298.html,http://biospace.com/News/sanofi-aventis-massachusetts-release-allegrar-and/229886,http://biospace.com/news/sanofi-aventis-massachusetts-release-allegrar-and/229886,http://biospace.com/news/agamatrix-inc-clears-ibgstar-blood-glucose/243096,,,,,,,,,,,,,,,,,,,,,
caroline.martel@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,2,{first}.{last},Caroline,Martel,Writing & communication,Communications Consultant,"","",+1 514 956 6120,http://newswire.ca/fr/news-releases/declaration-de-sanofi-canada-en-reponse-a-la-decision-de-linesss-ayant-une-incidence-pour-les-patients-du-cancer-de-la-prostate-au-quebec-512152021.html,http://newswire.ca/fr/news-releases/c-o-r-r-e-c-t-i-o-n----sanofi-canada-512151761.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
pamela.silva@sanofi.com,sanofi.com,Sanofi,,,,,,94,personal,4,{first}.{last},Pamela,Silva,,"",diariomentalorg,"","",http://conteudopublicacoes.com.br/baristar,http://agencia.fiocruz.br/museu-da-vida-leva-exposicao-vias-do-coracao-para-minas-gerais,http://conass.org.br/estao-abertas-as-inscricoes-para-o-7o-premio-inovacao-medical-services-da-sanofi,http://sobrac.org.br/portal_medical_services_da_sanofi.html,,,,,,,,,,,,,,,,,,,,,,,,,
william.pang@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},William,Pang,,,,,,http://yixuefuwu.com/news/489.html,http://yixuefuwu.com/news/543.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
annette.jardine@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Annette,Jardine,,,,,,http://sjaeldnesygdomme.dk/laesestof/om-sjaeldne-sygdomme/samtale-med-din-laege,http://sjaeldnesygdomme.dk/laesestof/om-sjaeldne-sygdomme/sjaelden-ordliste,http://sjaeldnesygdomme.dk/laesestof/om-sjaeldne-sygdomme/sjaelden-quiz,,,,,,,,,,,,,,,,,,,,,,,,,,
radhika.shah@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Radhika,Shah,,,,,,http://sanofiindialtd.com/dam/jcr:f3e4e6df-68cd-449f-8f8b-0f011f7d6478/draft%20annual%20return%202022.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
luisa.restrepo@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Luisa,Restrepo,,,,,,http://sanofi.com.co/dam/jcr:c58c50ae-bffe-4e53-a5b1-589bb1c05d26/comunicacion%20directa%20para%20el%20profesional%20de%20la%20salud.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sylvia.schulz@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Sylvia,Schulz,,,,,,http://tgds.org/media/einladung_21_04_2021.pdf,http://tgds.org/media/einladung_26_04_23.pdf,http://tgds.org/media/einladung_28_09_2022.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
miriam.gifre@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,5,{first}.{last},Miriam,Gifre,,,,,,http://sanofi.es/dam/jcr:4d3fdd20-9545-461e-b410-400fab276713/np_sgz_2edicion_proyectoembarcate_castilla.pdf,http://sanofi.es/dam/jcr:7ea28d03-d83b-4bb3-9def-53657dd28b26/np_d%c3%ada%20internacional%20pompe_partido%20laliga%20c%c3%a1diz-valencia.pdf,http://sanofi.es/dam/jcr:8fedc55e-d5bc-4f29-b0d6-8c231a9cfaaf/np_sgz_premiados_2edicion_proyectoembarcate.pdf,http://sanofi.es/dam/jcr:9f9667a3-c2ee-43fc-a642-ff6835c1867e/np_foundations%20sant%20joan%20de%20d%c3%a9u_def.pdf,http://sanofi.es/dam/jcr:d8913ec1-acc4-4446-abce-bb26fb1eb6ad/np_sgz_2edicion_proyectoembarcate_aragon.pdf,,,,,,,,,,,,,,,,,,,,,,,,
ralph.hug@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,6,{first}.{last},Ralph,Hug,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pharmaforum12_sanofi.pdf,http://sanofi.de/dam/jcr:543e72ad-eb8d-4439-bab8-5f6ff7ae2987/newsletter-standort-gesundheit_februar-2022.pdf,http://sanofi.de/dam/jcr:6886a46f-e99f-401c-be64-e866f3d9cfbe/newsletter-standort-gesundheit_oktober-2022.pdf,http://sanofi.de/dam/jcr:775d521d-7fe0-40b0-a175-772947ef7ff0/newsletter-standort-gesundheit_maerz-2023_en.pdf,http://sanofi.de/dam/jcr:91ed78d9-432b-4ea9-9b8f-7de12f2e2bee/newsletter-standort-gesundheit_maerz-2023.pdf,http://sanofi.de/dam/jcr:c8c1f756-08ee-4da7-90de-62b1481f5a51/newsletter-standort-gesundheit_maerz-2021.pdf,,,,,,,,,,,,,,,,,,,,,,,
contas.pagar@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Contas,Pagar,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
terri.pedone@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Terri,Pedone,,,,,,http://amga.org/amga/media/pdfs/about%20amga%20family/family/foundation/ccr/past%20meetings/20150629.pdf,http://amga.org/amga/media/pdfs/about%20amga%20family/family/foundation/ccr/past%20meetings/sumrpt.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
erin.hodges@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Erin,Hodges,,,,,,http://kyha.memberclicks.net/sponsors,http://kyha.com/sponsors,,,,,,,,,,,,,,,,,,,,,,,,,,,
ahmed.othman@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Ahmed,Othman,,,,,,http://entsaudi.org/ar/calendarofevents/approach-to-diagnosis-and-management-of-nasal-polyps-in-the-biologic-era,http://entsaudi.org/en/calendarofevents/approach-to-diagnosis-and-management-of-nasal-polyps-in-the-biologic-era,,,,,,,,,,,,,,,,,,,,,,,,,,,
jane.doe@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Jane,Doe,,,,,,http://linkstock.net/sanofi,http://dfkcompany.com/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,
juan.vargas@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Juan,Vargas,,,,,,http://uzbrussel.be/documents/36102/0/eupert2022_programme-def.pdf/9082f016-5743-15e1-1a23-06d345643229,http://ijidonline.com/article/s1201-9712(22)00053-4/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,
jill.callejas@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Jill,Callejas,,"","","","",http://vsronline.org/2022-exhibit-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shai.benno@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Shai,Benno,,,,,,http://vaccines.sanofi.co.il/accessibility,,,,,,,,,,,,,,,,,,,,,,,,,,,,
judit.linares@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Judit,Linares,,"","","","",http://aedem.org/la-comunidad-de-esclerosis-multiple-en-espana-se-moviliza-en-la-campana-de-sanofi-genzyme-exige-mas-a-tu-vida-con-em,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laszlo.takacs@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Laszlo,Takacs,,"","","","",http://ch.bme.hu/hirek/1001-bsc-vagy-msc-diplomamunka-lehetoseg-a-chinoinban,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nathalie.mantel@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Nathalie,Mantel,,"","","","",http://unboundmedicine.com/medline/citation/33685778/next_generation_live_attenuated_yellow_fever_vaccine_candidate:_safety_and_immuno_efficacy_in_small_animal_models_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andreas.henrichs@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Andreas,Henrichs,,"","","","",http://gqma.de/en/working-groups/analytic,http://gqma.de/vorstand,http://gqma.de/arbeitsgruppen/analytik,,,,,,,,,,,,,,,,,,,,,,,,,,
ronald.schmidt@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Ronald,Schmidt,,,,,,http://gqma.de/arbeitsgruppen/edv,http://gqma.de/en/working-groups/it,http://gqma.de/en/arbeitsgruppen/edv,,,,,,,,,,,,,,,,,,,,,,,,,,
andres.castillo@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Andres,Castillo,,"","","","",http://vcccolombia.com/courses/16-encuentro-latinoamericano-de-cirujanos-de-cadera-y-de-rodilla/lessons/muestra-comercial-elccr/topic/stand-sanofi-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,
deisy.castano@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Deisy,Castano,,"","","","",http://vcccolombia.com/courses/9-encuentro-de-artroscopia-rodilla-y-traumatologia-deportiva-socartd/lessons/muestra-comercial-5/topic/stand-sanofi-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,
juan.lopez2@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Juan,Lopez,,"","","","",http://vcccolombia.com/courses/17-encuentro-latinoamericano-de-cirujanos-de-cadera-y-de-rodilla/lessons/muestra-comercial-11/topic/stand-sanofi-6,http://vcccolombia.com/courses/66o-congreso-nacional-sccot/lessons/muestra-comercial-10/topic/stand-sanofi-6,,,,,,,,,,,,,,,,,,,,,,,,,,,
wanessa.scala@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Wanessa,Scala,,"","","","",http://ensaiosclinicos.gov.br/rg/rbr-5mfy5tx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
robert.lee@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Robert,Lee,,,,,,http://ssac.hockey/contacts-2019-20,http://ssac.hockey/board-2017-18,http://ssac.hockey/board-2016-17,,,,,,,,,,,,,,,,,,,,,,,,,,
janet.derrico@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Janet,Derrico,Education,Specialist Research,"","","",http://h1bdata.com/page/2,http://h1bdata.com,,,,,,,,,,,,,,,,,,,,,,,,,,,
marion.breyer@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,4,{first}.{last},Marion,Breyer,,"","","",+1 732 532 5318,http://sanofi.com/en/media-room/press-releases/2020/2020-12-09-06-00-00-2141881,http://dndi.org/press-releases/2020/innovative-single-dose-oral-sleeping-sickness-treatment-to-be-co-developed-by-sanofi-and-dndi,http://dndi.org/press-releases-translations/2020/sanofi-dndi-vont-developper-medicament-unidose-innovant-par-voie-orale-pour-traitement-maladie-du-sommeil,http://biotech-365.com/category/globenewswire,,,,,,,,,,,,,,,,,,,,,,,,,
frederic.vacher@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Frederic,Vacher,,"","","","",http://journal.pda.org/content/early/2020/03/16/pdajpst.2019.010389,http://journal.pda.org/content/early/2020/03/16/pdajpst.2019.010389/tab-article-info,http://journal.pda.org/content/early/2020/03/16/pdajpst.2019.010389/tab-references,,,,,,,,,,,,,,,,,,,,,,,,,,
charlotte.downs@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Charlotte,Downs,,"","","",+1 501 944 8391,http://anpassociation.enpnetwork.com/nurse-practitioner-news/207162-district-3-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurence.bollack@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Laurence,Bollack,,"","","","",http://news.europawire.eu/dr-jean-christophe-rufin-to-succeed-xavier-darcos-as-president-of-sanofi-espoir-corporate-foundation/eu-press-release/2020/09/18/14/15/19/81781,http://prnewswire.co.uk/news-releases/european-medicines-agency-recommends-approval-of-hexyonhexacima-6-in-1-pediatric-vaccine-192480901.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
xuan.lin@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Xuan,Lin,,"","","","",http://dirk.eddelbuettel.com/cranberries/2019/03/15,,,,,,,,,,,,,,,,,,,,,,,,,,,,
giovanna.miranda@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,4,{first}.{last},Giovanna,Miranda,Writing & communication,Chief Editor,"","","",http://old.eahil.eu/journal/47/assocnws.htm,http://old.eahil.eu/journal/48/subgroups.htm,http://old.eahil.eu/journal/47/index47.htm,http://old.eahil.eu/journal/48/contents.htm,,,,,,,,,,,,,,,,,,,,,,,,,
regis.verdier2@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Regis,Verdier,,"","","","",http://geres.org/geres/partenariats,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sebastian.larsson@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Sebastian,Larsson,,"","","","",http://mercell.com/en/95828282/vaccin-enligt-det-nationella-barnvaccinationsprogrammet-2017.aspx,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sergio.marco@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Sergio,Marco,,"","",http://fr.linkedin.com/pub/sergio-marco-garrido/83/164/3a/,"",http://masternanobio.es/image-analysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marianne.bredin@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Marianne,Bredin,,"","","","",http://mynewsdesk.com/se/sanofi/pressreleases/lyxumia-r-lixisenatid-faar-europeiskt-godkaennande-foer-behandling-av-typ-2-diabetes-833685,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jean-charles.gautier@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,5,{first}.{last},Jean,Gautier,,,,,,http://worldwidescience.org/topicpages/h/higher+serum+osteopontin.html,http://worldwidescience.org/topicpages/u/urinary+biomarker+3-phenoxybenzoic.html,http://worldwidescience.org/topicpages/l/links+potential+biomarkers.html,http://worldwidescience.org/topicpages/t/therapy+monkey+business.html,http://worldwidescience.org/topicpages/c/cynomolgus+macaca+fascicularis.html,,,,,,,,,,,,,,,,,,,,,,,,
adele.fang@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,5,{first}.{last},Adele,Fang,,,,,,http://28830368.b2b.11467.com/about.asp,http://28830368.b2b.11467.com/contact.asp,http://28830368.b2b.11467.com/job.asp,http://m.11467.com/b2b/co/28830368.htm,http://28830368.b2b.11467.com,,,,,,,,,,,,,,,,,,,,,,,,
pierre.colin@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,4,{first}.{last},Pierre,Colin,,"","","","",http://efspi.org/documents/annual%20reports/efspi%20annual%20report%202018%20final.pdf,http://openscience.fr/assessing-dunnett-and-mcp-mod-based-approaches-in-two-stage-dose-finding-trials,http://openscience.fr/evaluation-des-approches-basees-sur-le-test-de-dunnett-et-mcp-mod-dans-des,http://efspi.org/efspi/special_interest_groups/decision_making_sig.aspx,,,,,,,,,,,,,,,,,,,,,,,,,
hiroaki.tasaka@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Hiroaki,Tasaka,,,,,,http://jaden1996.com/workshop/application_2012.html,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.lapointe@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Thomas,Lapointe,,"","","","",http://pediatrielyon.fr/2017/04/25/invitation-r%c3%a9union-sur-les-maladies-de-surcharge,,,,,,,,,,,,,,,,,,,,,,,,,,,,
erin.pascal@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Erin,Pascal,Writing & communication,"","","",+1 617 685 5068,http://businesswire.com/news/home/20180419005771/en/25-data-presentations-sanofi-genzyme%e2%80%99s-multiple-sclerosis,http://businesswire.com/news/home/20180423005766/en/treatment-effects-maintained-years-patients-relapsing-remitting,http://businesswire.com/news/home/20180423005784/en/relapsing-ms-patients-switched-aubagio%c2%ae-teriflunomide-reported,,,,,,,,,,,,,,,,,,,,,,,,,,
shay.zukowski@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Shay,Zukowski,,"","","",+1 617 768 4477,http://businesswire.com/news/home/20170228005993/en/sanofi-genzyme-recognizes-rare-disease-day-2017,,,,,,,,,,,,,,,,,,,,,,,,,,,,
matthew.reaney@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,4,{first}.{last},Matthew,Reaney,Education,Quantitative Research,"","","",http://jrheum.org/content/early/2019/06/07/jrheum.180904.tab-article-info,http://jrheum.org/content/early/2019/06/07/jrheum.180904.tab-e-letters,http://jrheum.org/content/early/2019/06/07/jrheum.180904,http://jrheum.org/content/early/2019/06/07/jrheum.180904.tab-references,,,,,,,,,,,,,,,,,,,,,,,,,
melissa.davenport@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Melissa,Davenport,,Nurse Practitioner,"","",+1 256 684 2749,http://northalabamanpa.enpnetwork.com/nurse-practitioner-events/88491-sanofi-us-cordially-invites-you,,,,,,,,,,,,,,,,,,,,,,,,,,,,
britta.boehnisch@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,5,{first}.{last},Britta,Boehnisch,,,,,,http://worldwidescience.org/topicpages/c/crystal+deposition+disease.html,http://worldwidescience.org/topicpages/n/nanoparticles+alter+cathepsin.html,http://worldwidescience.org/topicpages/m/multiple+nucleopolyhedrovirus+cathepsin.html,http://worldwidescience.org/topicpages/r/requires+microglial+cathepsin.html,http://worldwidescience.org/topicpages/b/bradykinin.html,,,,,,,,,,,,,,,,,,,,,,,,
martina.john@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Martina,John,,"","","","",http://vfa.de/de/arzneimittel-forschung/datenbanken-zu-arzneimitteln/nisdb/nis-details/_902,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kyra.obolensky@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,2,{first}.{last},Kyra,Obolensky,,"","","","",http://epressi.com/tiedotteet/terveys/johtavat-laakeyhtiot-julkaisevat-teollisuudenalan-yhteisen-suunnitelman-mikrobilaakeresistenssin-vastaiseen-taisteluun.html,http://julkaise1.rssing.com/chan-52173986/all_p284.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
makoto.sakurai@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,4,{first}.{last},Makoto,Sakurai,,,,,,http://jaden1996.com/workshop/application/application_2019_kanto.html,http://jaden1996.com/workshop/application_2016.html,http://jaden1996.com/workshop/application/application_2018_kanto.html,http://jaden1996.com/workshop/application/application_2017_kanto.html,,,,,,,,,,,,,,,,,,,,,,,,,
karim.azer@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,1,{first}.{last},Karim,Azer,,Modeling Scientist,"","",+1 212 410 6777,http://netlib.org/na-digest-html/16/v16n30.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mai.tran@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,11,{first}.{last},Mai,Tran,Writing & communication,Corporate Communications,"","",+33 1 53 77 49 86,http://sanofi.com/en/media-room/press-releases/2016/2016-06-12-21-45-00,http://sanofi.com/fr/media-room/communiques-de-presse/2016/2016-09-13-11-59-00,http://boursorama.com/actualites/sanofi-annonce-les-resultats-positifs-de-phase-3-de-l-association-experimentale-a-dose-fixe-d-insuline-glargine-et-de-lixisenatide-88fff96e4e8c3556e08f5fe369968953,http://presseportal.ch/de/pm/100007059/100789294,http://health-ua.com/news/4134-kompanya-sanof-predstavlya-povn-rezultati-fkfd-dosldzhennya-z-porvnyannya-p,http://presseportal.ch/de/pm/100007059/100792860,http://presseportal.ch/de/pm/100007059/100795521,http://presseportal.ch/de/pm/100007059/100792702,http://presseportal.ch/de/pm/100061233/100800157,http://itiko.de/artikel/1467544/sanofi-und-voluntis-verkuenden-globale-partnerschaft-zur-vermarktung-digitaler-insulintitrationsloesungen-fuer-patienten-mit-typ-2-diabetes.html,http://spain412.rssing.com/chan-13731551/all_p633.html,,,,,,,,,,,,,,,,,,
cornelia.schaeffer@sanofi.com,sanofi.com,Sanofi,,,,,,93,personal,3,{first}.{last},Cornelia,Schäffer,Writing & communication,Head Of Global Communications,"","",+33 1 53 77 45 02,http://mynewsdesk.com/se/sanofi/pressreleases/lyxumia-r-lixisenatide-in-combination-with-basal-insulin-plus-oral-anti-diabetics-significantly-improved-glycemic-control-799401,http://biospace.com/article/releases/sanofi-france-release-lyxumia-lixisenatide-in-combination-with-basal-insulin-plus-oral-anti-diabetics-significantly-reduced-hba1c-and-post-prand,http://prnewswire.com/news-releases/lyxumia-lixisenatide-in-combination-with-basal-insulin-plus-oral-anti-diabetics-significantly-reduced-hba1c-and-post-prandial-glucose-158297075.html,,,,,,,,,,,,,,,,,,,,,,,,,,
gwen.chan@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,5,{first}.{last},Gwen,Chan,,,,,,http://haematology.org.my/2013/09,http://haematology.org.my/2014/09,http://haematology.org.my/2014/09/2014-art-of-haematology-meeting,http://haematology.org.my/author/shikin,http://haematology.org.my/author/shikin/page/2,,,,,,,,,,,,,,,,,,,,,,,,
michael.radetzky@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Michael,Radetzky,,,,,,http://krankenhaus-grimmen.de/gallery/news/news_156/fortbildung_diabetes_und_lipide_grevesmuehlen_14_06_2023.pdf,http://drk-kh-gvm.de/gallery/news/news_156/fortbildung_diabetes_und_lipide_grevesmuehlen_14_06_2023.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
monica.raigosa@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Monica,Raigosa,,,,,,http://campus.sanofi/co/ciencia/dermatitis-atopica/carga-de-la-enfermedad-que-siente-un-paciente-con-dermatitis-atopica,http://campus.sanofi/co/ciencia/diabetes/conoce-aplicaciones-moviles-para-el-control-glicemico,,,,,,,,,,,,,,,,,,,,,,,,,,,
wafa.tambe@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Wafa,Tambe,,,,,,http://pharmanaukri.in/index.php/2023/03/09/sanofi-hiring-expert-scientific-writer,,,,,,,,,,,,,,,,,,,,,,,,,,,,
karyn.mcintosh@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Karyn,Mcintosh,,,,,,http://sanofi.com.au/en/news/press-releases,http://sanofi.com.au/en/news,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicoletta.bertelli@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Nicoletta,Bertelli,,,,,,http://clusterspring.it/files/47/08-02-programma-preliminare-ebw-2018.pdf,http://biopharmanetwork.it/wp-content/uploads/2018/09/08-02-programma-preliminare-ebw-2018.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
emily.rogers@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Emily,Rogers,,,,,,http://spnp.enpnetwork.com/nurse-practitioner-news/219181-spnpa-thursday-may-18th-meeting,http://spnp.enpnetwork.com/nurse-practitioner-news/219182-spnpa-thursday-may-18th-meeting-reminder,,,,,,,,,,,,,,,,,,,,,,,,,,,
mariam.bishara@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,3,{first}.{last},Mariam,Bishara,,,,,,http://sanofi.com.eg/dam/jcr:068b0800-cb6c-434a-8906-2c8be5046269/kids%20educational%20program%20to%20fight%20diabetes%20in%20children%20already%20reached%20out%2012%20schools.pdf,http://sanofi.com.eg/dam/jcr:0f4771ea-ac4a-44bc-ae12-875bb32c57cf/sanofi-selected-10-start-ups-to-elaborate-innovative-.pdf,http://sanofi.com.eg/dam/jcr:1bb49b49-dfb2-44ec-baa6-cfc6092b8652/sanofi%20selected%2010%20start-ups%20to%20elaborate%20innovative.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
benjamin.albus@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Benjamin,Albus,,,,,,http://sanofi.de/dam/jcr:5d1e73d8-9462-4b8e-87a4-9b0ce530f3ac/newsletter-standort-gesundheit_januar-2019.pdf,http://sanofi.de/dam/jcr:90660112-73d6-43bf-aa6b-1de5e3925f20/newsletter-standort-gesundheit_oktober-2019.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
filippo.cipriani@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,5,{first}.{last},Filippo,Cipriani,,,,,,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,http://assobiotec.federchimica.it/docs/default-source/default-document-library/il-programma-dell'edizione-20194bae49e5e0534ac888773e0fa7970465.pdf,,,,,,,,,,,,,,,,,,,,,,,,
nikita.merchant@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,5,{first}.{last},Nikita,Merchant,,,,,,http://sanofi.in/dam/jcr:0778ba02-f96f-4625-b71c-9ba3db4548f3/diabetic%20teen%20from%20pune%20achieves%20unique%20feat.pdf,http://sanofi.in/dam/jcr:2c91a1f9-8213-436d-b24b-b4d0949c173c/slide%204%20press%20release%20shantha%20biotechnics%20inactivated%20polio%20vaccine%20%20shanipv.pdf,http://sanofi.in/dam/jcr:8993d907-5cfd-40fe-b162-9e7ee371e837/slide%204%20press%20release%20shantha%20biotechnics%20inactivated%20polio%20vaccine%20%20shanipv.pdf,http://sanofi.in/dam/jcr:d5297513-cce0-4952-92fc-2afbccc56975/sanofi%20pasteur%20launches%20indias%20first%206-in-1%20pediatric%20vaccine%20%20hexaxim.pdf,http://sanofi.in/dam/jcr:d96d4d87-b016-4205-ba07-0354dcc1e61e/sanofi%20pasteur%20launches%20indias%20first%206-in-1%20pediatric%20vaccine%20%20hexaxim.pdf,,,,,,,,,,,,,,,,,,,,,,,,
sabine.sommer@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,6,{first}.{last},Sabine,Sommer,,,,,,http://sanofi.at/dam/jcr:0a164b1d-0131-4476-b6cc-3d24d789c7de/181109.pdf,http://sanofi.at/dam/jcr:1b0c4e3d-c2bd-4b18-9e4e-25c887084756/181203.pdf,http://sanofi.at/dam/jcr:35b4e50d-2b9d-4479-8ade-6b4c042fd367/180115.pdf,http://sanofi.at/dam/jcr:6337ac7a-d09f-4fdb-8e2c-7048cfeea15a/181115.pdf,http://sanofi.at/dam/jcr:dc0c92ca-3803-402c-bdae-55a6a6e3b183/181114.pdf,http://concordia.at/sanofi-journalistenakademie-klinische-studien-mit-biomarkern,,,,,,,,,,,,,,,,,,,,,,,
shannon.smith@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Shannon,Smith,,,,,,http://eventually.com/speakers/shannon-lee-smith-associate-director-attp-rare-blood-disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicola.salvi@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Nicola,Salvi,,"",_nicola_salvi_,"","",http://magnetic-resonance-ampere.net/editorial_board.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
federico.rotolo@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,4,{first}.{last},Federico,Rotolo,,"","","","",http://rdrr.io/cran/parfm,http://dirk.eddelbuettel.com/cranberries/cran/new,http://dirk.eddelbuettel.com/cranberries/cran/new/index.html,http://dirk.eddelbuettel.com/cranberries/index.html,,,,,,,,,,,,,,,,,,,,,,,,,
leticia.platero@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Leticia,Platero,,"","","","",http://neumoped.org/evento/light-on-vax-vrs-360,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fanni.markus@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Fanni,Markus,,"","","","",http://sanofi.hu/hu/adatvedelem-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bill.giannakopoulos@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,3,{first}.{last},Bill,Giannakopoulos,,,,,,http://efsm.online/be_nl/article-overview/101/2022/self-healing-concept-for-musculoskeletal-pain-management-an-evidence-based-review,http://efsm.online/de_de/article-overview/101/2022/self-healing-concept-for-musculoskeletal-pain-management-an-evidence-based-review,http://efsm.online/int_en/article-overview/101/2022/self-healing-concept-for-musculoskeletal-pain-management-an-evidence-based-review,,,,,,,,,,,,,,,,,,,,,,,,,,
med.sams@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,9,{first}.{last},Med,Sams,,,,,,http://hsa.gov.sg/docs/default-source/hprg-vcb/pem-pmg-pac/lemtrada_pem_mat-sg-2300002(012023)_29112022.pdf,http://campus.sanofi/my/science,http://campus.sanofi/my/science/cutting-edge-science/cardiovascular,http://campus.sanofi/my/science/cutting-edge-science/central-nervous-system,http://campus.sanofi/my,http://campus.sanofi/sg,http://sanofi.com.my/en/terms-of-use,http://sanofi.com.sg/en/newsroom/important-note,http://sanofi.com.sg/en/terms-of-use,,,,,,,,,,,,,,,,,,,,
nancy.fitzgibbons@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Nancy,Fitzgibbons,,"","","","",http://horseandman.com/horse-stories/the-red-horse-diary-10-he-yawns-therefore-i-step-back/06/09/2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tania.barreto@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Tania,Barreto,,"","","","",http://dmsjournal.biomedcentral.com/counter/pdf/10.1186/1758-5996-7-s1-a31.pdf,http://dmsjournal.biomedcentral.com/articles/10.1186/1758-5996-7-s1-a31,,,,,,,,,,,,,,,,,,,,,,,,,,,
john.martinez@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},John,Martinez,Writing & communication,Community Relations,"","","",http://koala-bassoon-k5f7.squarespace.com/contactsanofi,http://nohf.org/sponsors,,,,,,,,,,,,,,,,,,,,,,,,,,,
jorge.echeverri@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Jorge,Echeverri,,"","","","",http://vcccolombia.com/courses/9-encuentro-de-artroscopia-rodilla-y-traumatologia-deportiva-socartd/lessons/muestra-comercial-5/topic/stand-sanofi-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yuliet.cano@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Yulieth,Cano,,"","","","",http://vcccolombia.com/courses/17-encuentro-latinoamericano-de-cirujanos-de-cadera-y-de-rodilla/lessons/muestra-comercial-11/topic/stand-sanofi-6,http://vcccolombia.com/courses/66o-congreso-nacional-sccot/lessons/muestra-comercial-10/topic/stand-sanofi-6,,,,,,,,,,,,,,,,,,,,,,,,,,,
marie-france.langis@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Marie,Langis,,,,,,http://armrs.com/nos-membres,http://armrs.com/recherche-avancee,,,,,,,,,,,,,,,,,,,,,,,,,,,
marcel.kulich@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Marcel,Kulich,,,,,,http://ssvpl.sk/brozura-pompeho-choroba,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mahsa.hadidi@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Mahsa,Hadidi,Education,Assistant Professor,udchbe,"","",http://cbe.udel.edu/about/oppindex,http://cbe.udel.edu/oppindex,,,,,,,,,,,,,,,,,,,,,,,,,,,
adriana.valdes@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,7,{first}.{last},Adriana,Valdes,,"","","","",http://sanofi.com.mx/es/centrodeinformacion/sanofi-y-translate-bio-colaboracion-vacunas-de-arnm,http://diariojudio.com/opinion/salud-cardio-metabolica-que-acciones-tomar-este-2023-para-mejorarla/422156,http://sanofi.com.mx/es/contacto,http://elmundodigital.mx/aprende-estos-8-pasos-para-controlar-tu-diabetes,http://sanofi.com.mx/es/centrodeinformacion/el-amor-te-deja-sin-aire-el-asma-tambien,http://sanofi.com.mx/es/centrodeinformacion/jovenes-construyendo-el-futuro,http://sanofi.com.mx/es/centrodeinformacion/pacientes-con-dermatitis-atopica,,,,,,,,,,,,,,,,,,,,,,
kelly.burke@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,3,{first}.{last},Kelly,Burke,,,,,,http://aanntriangle.nursingnetwork.com/nursing-news,http://aanntriangle.nursingnetwork.com/nursing-news/168771-fabry-disease-session-at-18-seaboard-on-june-20th,http://aanntriangle.nursingnetwork.com/nursing-news/169531-aann-event-at-18-seaboard-at-6-30pm-this-thursday-rsvp-by-tuesday-6-18-,,,,,,,,,,,,,,,,,,,,,,,,,,
zineb.belkacemi@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Zineb,Belkacemi,Education,Phd Student,"","","",http://cermics-lab.enpc.fr/zineb-belkacemi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dorothee.wellmann@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,5,{first}.{last},Dorothee,Wellmann,,"","","","",http://genshagenerkreis.de/team_member/wellmann-dorothee,http://genshagenerkreis.de/alle-teilnehmer-2019,http://genshagenerkreis.de/alle-teilnehmer-aus-wirtschaft,http://genshagenerkreis.de/uebersicht-der-teilnehmer/page/4,http://genshagenerkreis.de/uebersicht-der-mitglieder/page/4,,,,,,,,,,,,,,,,,,,,,,,,
bonnie.mills@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Bonnie,Mills,,,,,,http://thedigitel.com/s/charleston/property-0/week-around-walkers-woods-111103-101403,http://thedigitel.com/s/charleston/property-0/week-around-walkers-woods-111113-101412,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.vanderburg@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Thomas,Vanderburg,,,,,,http://slideshare.net/lkce/lkce18-thomas-van-der-burg-visual-workmanagement-at-sanofi-a-journey-towards-organizational-effectiveness,,,,,,,,,,,,,,,,,,,,,,,,,,,,
larry.mclean@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,5,{first}.{last},Larry,Mclean,,,,,,http://rcsb.org/structure/3v8w,http://rcsb.org/structure/3v5j,http://rcsb.org/structure/3v8t,http://rcsb.org/structure/3vf9,http://rcsb.org/structure/3vf8,,,,,,,,,,,,,,,,,,,,,,,,
nicolas.kressman@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,6,{first}.{last},Nicolas,Kressman,,"","","",+1 732 532 5318,http://sanofi.com/en/media-room/press-releases/2020/2020-06-16-14-00-00,http://sanofi.com/fr/media-room/communiques-de-presse/2020/2020-06-16-14-00-00,http://sanofi.com/en/media-room/press-statements/statement-regarding-dusseldorf-regional-court-decision-in-ongoing-praluent-alirocumab-patent-litigation-in-germany,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-la-fda-approuve-vaxelistm-le-vaccin-combine-hexavalent-pediatrique-de-sanofi-et-msd,http://sanofi.com/fr/media-room/declarations/declaration-au-sujet-de-la-decision-rendue-dans-le-litige-relatif-a-praluent-alirocumab-en-allemagne,http://sanofi.com/fr/media-room/communiques-de-presse/2018/2018-12-26-20-30-00,,,,,,,,,,,,,,,,,,,,,,,
rocio.reyes@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Rocio,Reyes,,"","","","",http://fmd.org.mx/llaman-asociaciones-medicas-a-sumarse-a-la-campana-bajomipielda-a-favor-de-los-pacientes-con-dermatitis-atopica,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ida.strutt@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Ida,Strutt,,"","","","",http://mynewsdesk.com/se/sanofi/pressreleases/sanofi-sverige-foerstaerker-ledningen-med-ny-kommunikationschef-1208481,,,,,,,,,,,,,,,,,,,,,,,,,,,,
barry.richards@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Barry,Richards,,Team Captain,"","","",http://worldslargestgolfouting.com/wlgo-team/royce-brook-golf-club/6089025656374493184,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sabine.lang@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,6,{first}.{last},Sabine,Lang,,,,,,http://sanofi.at/dam/jcr:2730dd10-631f-4e33-9a0f-663745ae1422/pi%20sanofi_11%20jahrbuch%20fr%20gesundheit.pdf,http://sanofi.at/dam/jcr:44b21898-e430-4733-be38-3a1800fb644e/pi%20sanofi_journalistenakademie%20digitale%20biomarker.pdf,http://sanofi.at/dam/jcr:74e26e94-3386-4e9d-b36f-f90865a14f6a/190909_presseinformation_innovationnetworktalk.pdf,http://sanofi.at/dam/jcr:7714aa22-ee1a-414b-97de-d6e659335954/191204_pm%20sanofi_%20influenza-impfung%20gerade%20mit%2050plus%20wichtig.pdf,http://sanofi.at/dam/jcr:cffe0a80-649b-42a4-a613-7e9c5e64c4a4/pi%20sanofi_influenza-impfung%20als%20beitrag%20zur%20entlastung%20der%20spitalskapazitten.pdf,http://ktn.mycity24.at/2019/10/sanofi-oesterreich-und-die-wirtschaftskammer-oesterreich-feierten-zehnjaehriges-kooperationsjubilaeum,,,,,,,,,,,,,,,,,,,,,,,
ulf.ludwigs@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Ulf,Ludwigs,,"","","","",http://mynewsdesk.com/se/sanofi/pressreleases/sanofi-presenterar-positiva-resultat-foer-kolesterolsaenkaren-alirocumab-1047019,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yves.leone@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Yves,Leone,,"","","","",http://04.force-ouvriere.org/coordonnees-de-nos-syndicats,,,,,,,,,,,,,,,,,,,,,,,,,,,,
luciana.miranda@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Luciana,Miranda,,"","","","",http://agencia.fiocruz.br/museu-da-vida-leva-exposicao-vias-do-coracao-para-minas-gerais,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.bertrand@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,5,{first}.{last},Thomas,Bertrand,,,,,,http://rcsb.org/structure/4f0i,http://rcsb.org/structure/4at5,http://rcsb.org/structure/4at4,http://rcsb.org/structure/4at3,http://rcsb.org/structure/4asz,,,,,,,,,,,,,,,,,,,,,,,,
christine.delsol@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,1,{first}.{last},Christine,Delsol,,"","","","",http://sites.google.com/site/fmc31200/idees-pour-2013-2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dominika.gorska@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,3,{first}.{last},Dominika,Gorska,,,,,,"http://centrumpr.pl/artykul/5-mitow-na-temat-watroby,95575.html","http://centrumpr.pl/artykul/czy-wiesz-jak-wazna-jest-twoja-watroba,96659.html","http://kafito.pl/artykul/czy-wiesz-jak-wazna-jest-twoja-watroba,96659.html",,,,,,,,,,,,,,,,,,,,,,,,,,
philipmcnamara@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,13,{first}.{last},Philip,Mcnamara,,"","","",+1 908 981 5497,http://sanofi.com/fr/media-room/communiques-de-presse/2016/2016-09-13-11-59-00,http://sanofi.com/fr/media-room/communiques-de-presse/2016/2016-08-19-23-01-00,http://sanofi.com/fr/media-room/communiques-de-presse/2016/2016-05-26-00-21-16,http://sanofi.com/fr/media-room/communiques-de-presse/2016/2016-07-28-01-44-08,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-approbation-de-suliquatm-dans-lunion-europeenne-pour-le-traitement-du-diabete-de-type-2-de-ladulte,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/le-chmp-recommande-lapprobation-du-suliquatm-de-sanofi-dans-lunion-europeenne,http://lookmedica.ro/blog/suliquatm-a-fost-aprobat-in-ue-pentru-tratamentul-pacientilor-adulti-cu-diabet-zaharat-tip-2/6367,http://prnewswire.com/news-releases/fda-advisory-committee-recommends-approval-of-sanofi-treatment-for-adults-with-type-2-diabetes-300275241.html,http://boursorama.com/actualites/sanofi-le-comite-consultatif-de-la-fda-recommande-l-approbation-de-d-un-traitement-du-diabete-de-type-2-de-l-adulte-de-sanofi-71344dd2b9dd1054870860cfded0f20d,http://boursorama.com/actualites/le-chmp-recommande-l-approbation-du-suliquatm-de-sanofi-dans-l-union-europeenne-ce866fb7cc6882facb97d206f041652e,http://boursorama.com/actualites/sanofi-annonce-l-approbation-par-la-fda-d-adlyxintm-dans-le-traitement-du-diabete-de-type-2-chez-l-adulte-d80371261c07412893ac4d57c1d8bf47,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-annonce-lapprobation-par-la-fda-dadlyxintm-dans-le-traitement-du-diabete-de-type-2-chez-ladulte,http://spain412.rssing.com/chan-13731551/all_p633.html,,,,,,,,,,,,,,,,
ines.windisch@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Ines,Windisch,Writing & communication,Head Communications,"","","",http://presseportal.ch/de/pm/100061233/100800157,http://itiko.de/artikel/1467544/sanofi-und-voluntis-verkuenden-globale-partnerschaft-zur-vermarktung-digitaler-insulintitrationsloesungen-fuer-patienten-mit-typ-2-diabetes.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
patricia.waghorn@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,7,{first}.{last},Patricia,Waghorn,Writing & communication,"","","",+61 2 8666 2726,http://businesswire.com/news/home/20121121005881/en/genzyme%e2%80%99s-once-daily-oral-aubagio%c2%ae-approved-australia-treatment,http://qlifepro.com/press/20121122-06-2065/ma-genzyme-1-2,http://biospace.com/News/sanofi-frances-genzyme-corporations-once-daily/280459/Source=TopBreaking,http://businesswire.com/news/home/20121121005881/en/Genzyme%E2%80%99s-Once-Daily-Oral-AUBAGIO%C2%AE-Approved-Australia-Treatment,http://businesswire.com/news/genzyme/20121121005881/en,http://biospace.com/news/sanofi-frances-genzyme-corporations-once-daily/280459/source=topbreaking,http://biospace.com/news/sanofi-frances-genzyme-corporations-once-daily/280459,,,,,,,,,,,,,,,,,,,,,,
jean-marc.podvin@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,9,{first}.{last},Jean,Podvin,,"",,,,http://worldbank.org/ja/news/press-release/2012/01/30/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020,http://newswire.ca/news-releases/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020-509504941.html,http://dndi.org/2012/media-centre/press-releases/london-ntd,http://newswire.ca/fr/news-releases/des-partenaires-prives-et-publics-sunissent-pour-combattre-dix-maladies-tropicales-negligees-dici-2020-509505541.html,http://hobart-everett.blogspot.com/2012/06/7-pharmaceutical-companies-join.html,http://newswire.ca/fr/news-releases/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020-509504941.html,http://tass.ru/arhiv/556707,http://tass.com/press-releases/668944,http://eurekalert.org/pub_releases/2012-06/ghs-spc062512.php,,,,,,,,,,,,,,,,,,,,
weiliang.shi@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,2,{first}.{last},Weiliang,Shi,,"","","","",http://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-13-98,http://biomedcentral.com/1471-2105/13/98/comments,,,,,,,,,,,,,,,,,,,,,,,,,,,
frederic.lemonde@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,9,{first}.{last},Frederic,Lemonde,,,,,,http://sanofi.ma/dam/jcr:6f62356d-8bc0-4525-a709-b2cba1b45df6/pdf%20k3.pdf,http://dndi.org/press-releases/2013/sanofi-dndi-distributed-20-million-treatments-asaq,http://path.org/media-center/sanofi-and-path-announce-the-launch-of-large-scale-production-of-semisynthetic-artemisinin-against-malaria,http://mynewsdesk.com/se/sanofi/pressreleases/curie-cancer-and-sanofi-cooperate-in-research-on-ovarian-cancer-878186,http://biospace.com/article/releases/sanofi-france-and-transgene-ink-immunotherapy-pact-,http://dndi.org/2013/media-centre/press-releases/sanofi-dndi-distributed-20-million-treatments-asaq,http://biospace.com/News/sanofi-france-and-transgene-ink-immunotherapy-pact/291401,http://biospace.com/news/sanofi-france-and-transgene-ink-immunotherapy-pact/291401/source=morenews,http://biospace.com/news/sanofi-france-and-transgene-ink-immunotherapy-pact/291401,,,,,,,,,,,,,,,,,,,,
jack.cox@sanofi.com,sanofi.com,Sanofi,,,,,,92,personal,22,{first}.{last},Jack,Cox,Writing & communication,Journalist,,,,http://rezasta.net/wp-content/uploads/2016/01/sarilumab2.pdf,http://presseportal.ch/de/pm/100053495/100744455,http://globenewswire.com/news-release/2014/06/14/644127/10085774/en/sanofi-reports-positive-phase-3-results-for-toujeo-r.html,http://globenewswire.com/news-release/2014/08/11/657435/10094006/en/sanofi-and-mannkind-announce-global-licensing-agreement-for-afrezza-r-insulin-human-rapid-acting-inhaled-insulin.html,http://globenewswire.com/news-release/2014/05/28/639728/10083425/en/sanofi-and-lilly-announce-licensing-agreement-for-cialis-r-tadalafil-otc.html,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/la-fda-approuve-toujeo-l-insuline-basale-de-sanofi-en-une-prise-par-jour,http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc-to/328248,http://news.europawire.eu/sanofi-and-medtronic-partner-to-improve-patient-experience-and-outcomes-for-people-with-diabetes-around-the-world-98765432123456789/eu-press-release/2014/06/16,http://news.europawire.eu/sanofis-investigational-therapy-toujeo-consistently-showed-significantly-fewer-low-blood-sugar-events-compared-with-lantus-097654321234567890/eu-press-release/2014/06/16,http://globenewswire.com/news-release/2014/06/14/644123/10085771/en/sanofi-and-medtronic-to-form-strategic-alliance-in-diabetes-to-improve-patient-experience-and-outcomes.html,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-sanofi-et-mannkind-annoncent-la-mise-disposition-d-afrezza-la-seule-insuline-inhaler-aux-tats-unis,http://biospace.com/news/data-show-sanofi-francenbspsan-pas-lyxumia0174/309482/source=topbreaking,http://jurmed.ro/medici/sanofi-romania-continuam-sa-ne-desfasuram-activitatea-la-fel-ca-si-pana-acum-respectandu-ne-angajamentele-asumate-fata-de-pacientii-si-partenerii-din-romania,http://markets.financialcontent.com/prnews/news/read/23136897/sanofi's_chattem_acquires_over,http://lerevenu.com/breves/la-fda-accepte-lexamen-du-dossier-de-linsuline-basale-toujeor-de-sanofi,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-annonce-les-premiers-r-sultats-positifs-de-la-deuxi-me-tude-pivot-de-phase-iii-consacr-e-lixilan,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/la-fda-accepte-l-examen-de-la-demande-d-approbation-du-lixis-natide-de-sanofi,http://biospace.com/news/fda-approves-sanofi-frances-nasacort0174-allergy/311602,http://biospace.com/article/releases/fda-approves-sanofi-france-s-nasacort-and-0174-allergy-24hr-for-over-the-counter-use-,http://mif-ua.com/archive/article/36957,http://crweworld.com/article/press-releases/9111/sanofi-and-lexicon-pharmaceuticals-to-collaborate-on-sotagliflozin-an-investigational-new-oral-medicine-for-people-with-diabetes,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-annonce-les-premi-res-donn-es-d-une-tude-sur-les-r-sultats-cardiovasculaires-de-lyxumia-lixis-natide,,,,,,,
song.sun@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Song,Sun,,,,,,http://iabs.org/documents/2022-meetings-and-webinars/3rd-next-generation-sequencing/ebook-iabs-3rd-ngs-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andy.haberlandt@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Andy,Haberlandt,,,,,,http://krankenhaus-grimmen.de/gallery/news/news_156/fortbildung_diabetes_und_lipide_grevesmuehlen_14_06_2023.pdf,http://drk-kh-gvm.de/gallery/news/news_156/fortbildung_diabetes_und_lipide_grevesmuehlen_14_06_2023.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
saad.usman@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Saad,Usman,,,,,,http://sanofi.com.pk/dam/jcr:8152ff61-63b3-44cc-8bca-d7c8a71234cc/q4-2015.pdf,http://sanofi.com.pk/dam/jcr:a35f9a7f-c36b-4f1f-aca5-88283d904d01/q4-2016.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
filip.hruby@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,5,{first}.{last},Filip,Hruby,,,,,,http://sanofi.cz/dam/jcr:05198a68-20fe-48cb-87a7-471e722377f9/pharma_talk_6_2017.pdf,http://sanofi.cz/dam/jcr:078ab87f-8ce8-4903-8cf9-5ad1ccc77c0f/oceneni_za_vyzkum_2017.pdf,http://sanofi.cz/dam/jcr:0c201963-3e5e-4c0c-aab3-fd948394a44e/pharma_talk_7_2017.pdf,http://sanofi.cz/dam/jcr:1fddcb12-d13c-4287-9ffc-f399f522f5ba/sanofizentiva_top_zamestnavatele_2017.pdf,http://sanofi.cz/dam/jcr:87747833-657b-4d71-be21-51da5c1485de/prace_v_zentive_2017.pdf,,,,,,,,,,,,,,,,,,,,,,,,
neha.shah@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,4,{first}.{last},Neha,Shah,,,,,,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,
gemma.llop@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Gemma,Llop,,,,,,http://sanofi.es/dam/jcr:98342bbf-1a0c-4733-931b-71090a179d62/ndp-cablivi.pdf,http://sanofi.es/dam/jcr:be71b18b-7e8b-404b-ad05-67df61aa16cc/ndp_proyecto_embarcate%203a_edicion.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
sofia.prim@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,5,{first}.{last},Sofia,Prim,,,,,,http://sanofi.es/dam/jcr:0c53a4c8-6480-4203-9741-c5007e7ebd2d/np_sanofi_webinar%20gestin%20enfermedades%20nocov.pdf,http://sanofi.es/dam/jcr:3b6fc609-a5ce-4474-9020-cb08a7b6d66f/np_toujeo%20junior.pdf,http://sanofi.es/dam/jcr:7975afc5-b3c6-41c6-8ec5-5b3cce7ccbfd/np_sanofi_dia%20mundial%20diabetes%202020_1.pdf,http://sanofi.es/dam/jcr:cceef486-6c5c-4298-ae84-92331a39a76e/np_sanofi_cruzroja_navidad.pdf,http://sanofi.es/dam/jcr:d5500a1c-556c-4451-9b6c-ca39e3cb52dc/np_da%20mundial%20corazn_calculadora.pdf,,,,,,,,,,,,,,,,,,,,,,,,
natalia.nicolas@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,5,{first}.{last},Natalia,Nicolas,,,,,,http://sanofi.es/dam/jcr:27ed4b6b-1c5a-42aa-b6e8-1b572971e863/np_sp_menquadfi%20ema%20approval_es.pdf,http://sanofi.es/dam/jcr:4bf1be5f-9f4e-49cb-9482-8a5ef2c0e840/np_sp_gripometro_baleares.pdf,http://sanofi.es/dam/jcr:b1c79cfa-2394-4b1c-bc11-4752f20db114/espid%202023_harmonie%20press%20release_castellano_def_120523.pdf,http://sanofi.es/dam/jcr:bc6211cd-5491-4d03-83c7-609dbb113fd3/np_gripmetro_noviembre_sp_1.pdf,http://sanofi.es/dam/jcr:c420e5bf-a06d-482d-8fe3-713029e9b1ad/np_sp_gripometro_aumento%20vacunacion%20gripe.pdf,,,,,,,,,,,,,,,,,,,,,,,,
maite.sanz@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Maite,Sanz,,,,,,http://emsevilla.es/dos-de-cada-diez-espanoles-cree-tener-em,http://emsevilla.es/la-comision-europea-aprueba-lemtrada-para-em,,,,,,,,,,,,,,,,,,,,,,,,,,,
nancy.kennedy@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Nancy,Kennedy,,,,,,http://astmh.org/blog/instructions-for-acquiring-glucantime-(meglumine-a,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emily.wyer@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Emily,Wyer,,"","","",+44 77 4041 0878,http://vaxbeforetravel.com/sanofi-trivalent-influenza-vaccine-high-dose-granted-uk-marketing-authorization,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.flis@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Anna,Flis,,"","","","",http://sanofi.pl/pl/media/dzial-komunikacji-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yumiko.kawabata@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Yumiko,Kawabata,,"","","","",http://wiki.cdisc.org/display/j3c/japan+academic+workshop+speaker+information,,,,,,,,,,,,,,,,,,,,,,,,,,,,
xuan.chen@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Xuan,Chen,,,,,,http://file.scirp.org/html/1-1240394_50488.htm,http://scirp.org/html/1-1240394_50488.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,
ruth.franken@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Ruth,Franken,,,,,,http://vfenr.nl/agenda/15-jaar-geneesmiddelenwet-tijd-voor-een-feestlift,,,,,,,,,,,,,,,,,,,,,,,,,,,,
franck.raynal@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Franck,Raynal,,"","","","",http://unboundmedicine.com/medline/citation/33685778/next_generation_live_attenuated_yellow_fever_vaccine_candidate:_safety_and_immuno_efficacy_in_small_animal_models_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dinesh.kumar3@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Dinesh,Kumar,,"","","","",http://biorxiv.org/content/10.1101/2021.05.06.442967v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
antoine.barbier@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Antoine,Barbier,,"","","","",http://findrugbynow.com/london/rugby-clubs/mens/london-french-rfc,,,,,,,,,,,,,,,,,,,,,,,,,,,,
brenda.bird@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Brenda,Bird,,,,,,http://ce.mayo.edu/content/exhibitor-sanofi-genzyme-virtual-exhibit-hall-hematology-review-2021,http://cme.advocateaurorahealth.org/content/sanofi-genzyme-rare-blood-disorders,,,,,,,,,,,,,,,,,,,,,,,,,,,
felix.lauscher@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,24,{first}.{last},Felix,Lauscher,,"","","",+1 908 612 7239,http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220203,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220428,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20221028,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203,http://forextv.com/top-news/dupixent-dupilumab-approved-by-european-commission-as-the-first-and-only-targeted-medicine-indicated-for-eosinophilic-esophagitis,http://sanofi.com/en/media-room/press-releases/2023/2023-01-05-07-00-00-2583365,http://sanofi.com/en/media-room/press-releases/2023/2023-01-27-06-00-00-2596599,http://sanofi.com/en/media-room/press-releases/2022/2022-04-14-05-00-00-2422388,http://inpda.org/chmp-recommends-approval-xenpozyme-olipudase-alfa-first-treatment-asmd,http://inpda.org/press-release-xenpozyme-olipudase-alfa-approved-european-commission-first-treatment-asmd,http://inpda.org/xenpozyme-olipudase-alfa-approved-japan-first-approved-therapy-indicated-treat-acid-sphingomyelinase-deficiency,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://scceu.org/fda-approves-dupixent-dupilumab-as-first,http://itbusinessnet.com/2022/05/press-release-update-on-cialis-rx-to-otc-switch-actual-use-trial,http://english.bashable.tech/2022/02/10/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199","http://biznes.newseria.pl/biuro-prasowe/sanofi-przedstawia-nowa,b577308199",http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/author/biotech365/page/3,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/category/globenewswire,,,,,
alain.boyer2@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Alain,Boyer,,"","","","",http://experts-univers.com/voulez-vous-m-aider.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
klara.kaempfer@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,6,{first}.{last},Klara,Kaempfer,,,,,,http://mynewsdesk.com/se/sanofi/pressreleases/u-s-fda-approves-zaltrap-r-ziv-aflibercept-after-priority-review-for-previously-treated-metastatic-colorectal-cancer-782871,http://mynewsdesk.com/se/sanofi/pressreleases/genzyme-provides-update-on-u-s-lemtrada-filing-787869,http://mynewsdesk.com/se/sanofi/pressreleases/jevtana-improves-survival-in-advanced-prostate-cancer-patients-487400,http://mynewsdesk.com/se/sanofi/pressreleases/suliqua-eu-godkaend-foer-behandling-av-vuxna-med-diabetes-typ-2-1755482,http://mynewsdesk.com/se/sanofi/pressreleases/origin-results-on-lantus-r-cardiovascular-safety-integrated-into-european-union-product-label-874651,http://sanofi.se/sv/om-oss/kontakt,,,,,,,,,,,,,,,,,,,,,,,
silvia.knoll@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Silvia,Knoll,,"","","","",http://oegknvirtuell.at/2021-02-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,
corinne.hardy2@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,3,{first}.{last},Corinne,Hardy,,"","","","",http://global.genderscan.org,http://2gap.fr/en/collectif/founding-members,http://2gap.fr/collectif/membres-fondateurs,,,,,,,,,,,,,,,,,,,,,,,,,,
burcu.bayraktar@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Burcu,Bayraktar,,"","","","",http://biyoloji.trakya.edu.tr/pages/mezun-gorusleri-2,http://biyoloji.trakya.edu.tr/pages/mezunlarimiz,,,,,,,,,,,,,,,,,,,,,,,,,,,
valerie.hatfield@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Valerie,Hatfield,,"","","","",http://capa-acam.ca/event/matching-the-agent-to-the-patient-getting-your-patients-a1c-to-target-safely,http://capa-acam.ca/fr/event/matching-the-agent-to-the-patient-getting-your-patients-a1c-to-target-safely,,,,,,,,,,,,,,,,,,,,,,,,,,,
elizabeth.poole@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Elizabeth,Poole,,"","","","",http://ijgc.bmj.com/content/27/s5/s20.info,http://ijgc.bmj.com/content/27/s5/s20,,,,,,,,,,,,,,,,,,,,,,,,,,,
arnaud.delepine@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,28,{first}.{last},Arnaud,Delepine,,"","","","",http://corporatemedianews.com/2023/06/press-release-vaccines-rd-pipeline-raises-the-bar-in-rsv-influenza-meningitis-and-pneumococcal-disease,http://sanofi.com/en/media-room/press-releases/2022/2022-05-30-05-30-00-2452303,http://magazine-pr.com/fda-aprueba-tratamiento-para-la-esofagitis-eosinofilica,http://sanofi.com/fr/media-room/communiques-de-presse/2022/2022-03-30-05-30-00-2412460,http://itbusinessnet.com/2023/03/dupixent-dupilumab-application-for-treatment-of-chronic-spontaneous-urticaria-csu-in-adults-and-adolescents-aged-12-years-and-older-accepted-for-fda-review,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220203,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20220428,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20221028,http://sanofi.de/de/media-center/pressemitteilungen-archiv/20230203,http://forextv.com/top-news/dupixent-dupilumab-approved-by-european-commission-as-the-first-and-only-targeted-medicine-indicated-for-eosinophilic-esophagitis,http://sanofi.com/en/media-room/press-releases/2023/2023-01-11-16-30-00-2587330,http://sanofi.com/en/media-room/press-releases/2023/2023-01-27-06-00-00-2596599,http://healthtechnologynet.com/2022/07/28/press-release-online-availability-of-sanofis-half-year-financial-report-for-2022,http://healthtechnologynet.com/2022/07/14/press-release-dupixent-dupilumab-phase-3-trial-shows-positive-results-in-children-1-to-11-years-of-age-with-eosinophilic-esophagitis,http://coldagglutinindisease.org/enjaymo-news,http://inpda.org/chmp-recommends-approval-xenpozyme-olipudase-alfa-first-treatment-asmd,http://inpda.org/press-release-xenpozyme-olipudase-alfa-approved-european-commission-first-treatment-asmd,http://inpda.org/xenpozyme-olipudase-alfa-approved-japan-first-approved-therapy-indicated-treat-acid-sphingomyelinase-deficiency,http://npuk.org/press-release-xenpozyme-olipudase-alfa-approved-by-european-commission-as-first-and-only-treatment-for-asmd,http://scceu.org/fda-approves-dupixent-dupilumab-as-first,http://itbusinessnet.com/2022/05/press-release-update-on-cialis-rx-to-otc-switch-actual-use-trial,http://english.bashable.tech/2022/02/10/sanofi-unveils-new-corporate-brand-and-logo-unites-the-company-under-one-purpose-and-a-single-identity,"http://biznes.newseria.pl/biuro-prasowe/farmacja/sanofi-przedstawia-nowa,b577308199","http://biznes.newseria.pl/biuro-prasowe/sanofi-przedstawia-nowa,b577308199",http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/category/globenewswire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/category/globenewswire,
joe.wildy@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Joe,Wildy,,"","","","",http://eczema.org/how-you-can-help/partnership-and-philanthropy/company-partnerships,,,,,,,,,,,,,,,,,,,,,,,,,,,,
robert.jeske@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,3,{first}.{last},Robert,Jeske,,,,,,http://lowerislandsoccer.com/directory/juan-de-fuca-allen-u18bg,http://lowerislandsoccer.com/staff/rob-jeske,http://lowerislandsoccer.com/team/juan-de-fuca-allen-u18bg,,,,,,,,,,,,,,,,,,,,,,,,,,
adam.belanger@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Adam,Belanger,,"","","","",http://insight.jci.org/articles/view/121762,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nelson.yew@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Nelson,Yew,,"","","","",http://insight.jci.org/articles/view/121762,,,,,,,,,,,,,,,,,,,,,,,,,,,,
praveen.khullar@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Praveen,Khullar,,,,,,http://gpma-assn.org/committee.php,,,,,,,,,,,,,,,,,,,,,,,,,,,,
claire.pichon@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Claire,Pichon,,"","","","",http://aipbl.com/fili%c3%a8re-internat/d-e-s-de-pharmacie-hospitali%c3%a8re/offres-de-stages-hors-r%c3%a9gion,http://aipbl.com/d-e-s-de-pharmacie-hospitali%c3%a8re/offres-de-stage,,,,,,,,,,,,,,,,,,,,,,,,,,,
mark.sheehe@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Mark,Sheehe,,Registered Nurses,"","",+1 260 705 9807,http://capni.enpnetwork.com/nurse-practitioner-events/119031-region-10-september-program,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sebastien.blache@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Sebastien,Blache,,"","","","",http://elementhumain-france.fr/les-nouveaux-certifies,,,,,,,,,,,,,,,,,,,,,,,,,,,,
george.qian@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},George,Qian,Education,Research And Development,"","","",http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
celso.cruz@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Celso,Cruz,,,,,,http://crossclustering.talkb2b.net/en/members/details/275/sanofi+spa,http://crossclustering.talkb2b.net/es/members/details/275/sanofi+spa,,,,,,,,,,,,,,,,,,,,,,,,,,,
marian.verhoeven@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,5,{first}.{last},Marian,Verhoeven,,,,,,http://medischescholing.nl/41023/huisarts/nascholing/nieuwe-middelen-diabetes-mellitus-type-2-toepassing-in-de-huisartsenpraktijk,http://medischescholing.nl/38337/huisarts/nascholing/masterclass-complexe-diabetescasuistiek,http://medischescholing.nl/36611/huisarts/nascholing/transmurale-afspraken-glp-1-inzet,http://medischescholing.nl/33612/huisarts/nascholing/insulinediploma-2019-starten-met-insuline,http://medischescholing.nl/32273/huisarts/nascholing/update-nhg-standaard-diabetes-mellitus-2018,,,,,,,,,,,,,,,,,,,,,,,,
denis.prat@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,5,{first}.{last},Denis,Prat,Education,Research Development,"","","",http://pubs.rsc.org/en/content/articlehtml/2016/gc/c5gc01008j,http://pubs.rsc.org/en/content/articlelanding/2014/gc/c4gc01149j/unauth,http://pubs.rsc.org/en/content/articlelanding/2016/gc/c5gc01008j,http://pubs.rsc.org/en/content/articlelanding/gc/2014/c4gc01149j,http://pubs.rsc.org/en/content/articlelanding/2014/gc/c4gc01149j,,,,,,,,,,,,,,,,,,,,,,,,
anastasia.makarova@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Anastasia,Makarova,,,,,,http://vidal.ru/novosti/kompaniya-dzhenzajm-zolotoj-sponsor-bio-international-convention-2012-2416,http://vidal.ru/novosti/2416,,,,,,,,,,,,,,,,,,,,,,,,,,,
sherif.fadl@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Sherif,Fadl,,,,,,http://nefsyashtaghal.blogspot.com/2012/10/21-22_8193.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
stefanie.holman@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,13,{first}.{last},Stefanie,Holman,Writing & communication,Communications Lead,"","","",http://npuk.org/sanofi-genzyme-pivotal-phase,http://prnewswire.co.uk/news-releases/sanofi-and-regeneron-announce-ema-acceptance-for-review-of-marketing-authorisation-application-for-sarilumab-588804771.html,http://prnewswire.co.uk/news-releases/sanofi-announces-licensing-of-kevzara-sarilumab-to-treat-adult-patients-with-moderately-to-severely-631002323.html,http://prnewswire.co.uk/news-releases/sanofi-announces-approval-of-kevzara-sarilumab-to-treat-adult-patients-with-moderately-to-severely-631003213.html,http://prnewswire.co.uk/news-releases/sanofi-receives-chmp-positive-opinion-for-dupixent-dupilumab-to-treat-adult-patients-with-moderate-to-635808573.html,http://prnewswire.co.uk/news-releases/it-affects-over-15-million-people-in-the-uk-12-in-a-survey-80-report-that-it-impacts-their-mood-mental-682627031.html,http://medindia.net/health-press-release/pivotal-phase-23-trial-of-olipudase-alfa-for-adult-patients-with-acid-sphingomyelinase-deficiency-niemann-pick-disease-type-b--305888-1.htm,http://biospace.com/article/releases/sanofi-genzyme-release-pivotal-phase-3-trial-of-b-neogaa-b-investigational-second-generation-therapy-for-pompe-disease-to-begin-in-the-uk-,http://prnewswire.com/news-releases/pivotal-phase-23-trial-of-olipudase-alfa-for-adult-patients-with-acid-sphingomyelinase-deficiency-niemann-pick-disease-type-b-to-begin-in-the-uk-599812921.html,http://prnewswire.com/news-releases/pivotal-phase-3-trial-of-neogaa-investigational-second-generation-therapy-for-pompe-disease-to-begin-in-the-uk-601634945.html,http://biospace.com/news/sanofi-genzyme-release-pivotal-phase-3-trial-of/439604,http://medindia.net/health-press-release/pivotal-phase-3-trial-of-neogaa-investigational-second-generation-therapy-for-pompe-disease-to-begin-in-the-uk-307678-1.htm,http://inpda.org/sanofi-genzyme-pivotal-phase,,,,,,,,,,,,,,,,
raphaelle.minne@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Raphaelle,Minne,,"","","","",http://wpm2011.org/58blil/imrab-3-ingredients-e0a15d,http://retrieverpro.com/dog-health-vaccines,,,,,,,,,,,,,,,,,,,,,,,,,,,
megan.thomas@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,2,{first}.{last},Megan,Thomas,,"","","",+1 617 768 8078,http://view.pagetiger.com/cc2013/issue1/page22.htm,http://cancercontrol.info/cc2013/towards-a-global-approach-for-access-to-oncology-care,,,,,,,,,,,,,,,,,,,,,,,,,,,
gabriel.valentini@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,1,{first}.{last},Gabriel,Valentini,,"","","","",http://sobrac.org.br/portal_medical_services_da_sanofi.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kyle.blankenship@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,4,{first}.{last},Kyle,Blankenship,,"","","","",http://associationdatabase.com/aws/oapa/pt/sd/calendar/26848/_parent/layout_details/false,http://associationdatabase.com/aws/OAPA/pt/sd/calendar/26848/_PARENT/layout_details/false,http://associationdatabase.com/aws/OAPA/pt/sd/calendar/26848/_PARENT/layout_details/true,http://associationdatabase.com/aws/oapa/pt/sd/calendar/26848/_parent/layout_details/true,,,,,,,,,,,,,,,,,,,,,,,,,
nadia.rahman@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,18,{first}.{last},Nadia,Rahman,Writing & communication,Senior Director Communications,"","",+1 514 856 8754,http://cqdm.org/fr/le-cqdm-et-sanofi-canada-sassocient-pour-accelerer-la-decouverte-de-medicaments,http://cqdm.org/le-cqdm-et-sanofi-canada-sassocient-pour-accelerer-la-decouverte-de-medicaments,http://melanomanetwork.ca/fr/forums/topic/carcinome-epidermoide-cutane-cec-2,http://newswire.ca/news-releases/sanofi-announces-25-million-contribution-to-dementia-research-515514651.html,http://newswire.ca/news-releases/skin-care-brand-neostrata-canada-joins-forces-with-canadian-activewear-brand-lole-517386011.html,http://internationalentertainmentnews.blogspot.com/2015/07/neostrata-and-viff-celebrate-canadian.html,http://melanomanetwork.ca/uncategorized/csccnewws,http://melanomanetwork.ca/forums/topic/24905,http://melanomanetwork.ca/fr/uncategorized/carcinome-epidermoide-cutane,http://cqdm.org/fr/news-and-events/le-cqdm-et-sanofi-canada-sassocient-pour-accelerer-la-decouverte-de-medicaments,http://newswire.ca/news-releases/neostrata-and-viff-celebrate-canadian-talent-on-the-big-screen-518067641.html,http://sanoficanada.fr.mediaroom.com/sanofi-canada-annonce-le-lancement-de-renassistplus,http://sanoficanada.fr.mediaroom.com/sanofi-canada-apporte-son-soutien-a-la-lutte-contre-la-tuberculose-au-canada,http://sanoficanada.mediaroom.com/sanofi-canada-lends-support-in-the-fight-to-eradicat-tuberculosis,http://sanoficanada.fr.mediaroom.com/partenariat-cqdm,http://newswire.ca/news-releases/kids-at-risk-of-severe-allergies-attend-soccer-clinic-hosted-by-the-montreal-impact-and-allerject-514571941.html,http://sanoficanada.fr.mediaroom.com/starsystem-collecte-de-fonds,http://sanoficanada.mediaroom.com/sanofi-canada-announces-launch-of-renassistplus,,,,,,,,,,,
lindsey.schedler@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,4,{first}.{last},Lindsey,Schedler,,"","","",+1 908 981 6754,http://biospace.com/article/releases/-b-nba-family-b-american-diabetes-association-and-b-sanofi-us-b-tip-off-2013-dribble-to-stop-diabetes-awareness-campaign-,http://markets.financialcontent.com/prnews/news/read/23191510/nba_family,http://biospace.com/news/nba-family-american-diabetes-association-and/284693,http://biospace.com/news/nba-family-american-diabetes-association-and/284693/source=morenews,,,,,,,,,,,,,,,,,,,,,,,,,
susan.brooks@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,18,{first}.{last},Susan,Brooks,Writing & communication,HR,"","",+1 908 981 6566,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-sanofi-et-mannkind-annoncent-la-mise-disposition-d-afrezza-la-seule-insuline-inhaler-aux-tats-unis,http://news.europawire.eu/sanofi-and-medtronic-partner-to-improve-patient-experience-and-outcomes-for-people-with-diabetes-around-the-world-98765432123456789/eu-press-release/2014/06/16,http://news.europawire.eu/sanofis-investigational-therapy-toujeo-consistently-showed-significantly-fewer-low-blood-sugar-events-compared-with-lantus-097654321234567890/eu-press-release/2014/06/16,http://mif-ua.com/archive/article/36957,http://boursorama.com/actualites/sanofi-annonce-les-resultats-positifs-de-phase-3-de-l-association-experimentale-a-dose-fixe-d-insuline-glargine-et-de-lixisenatide-88fff96e4e8c3556e08f5fe369968953,http://prnewswire.com/news-releases/data-show-sanofis-lyxumia-added-to-basal-insulin-lowered-blood-sugar-especially-when-fasting-plasma-glucose-was-controlled-224996252.html,http://globenewswire.com/news-release/2014/06/14/644127/10085774/en/sanofi-reports-positive-phase-3-results-for-toujeo-r.html,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/la-fda-approuve-toujeo-l-insuline-basale-de-sanofi-en-une-prise-par-jour,http://prnewswire.com/news-releases/new-epidemiological-data-provide-additional-safety-evidence-for-lantus-158480825.html,http://boursorama.com/actualites/sanofi-annonce-l-approbation-par-la-fda-d-adlyxintm-dans-le-traitement-du-diabete-de-type-2-chez-l-adulte-d80371261c07412893ac4d57c1d8bf47,http://presseportal.ch/de/pm/100007059/100789294,http://biospace.com/news/sanofi-france-announces-positive-phase-3-results/300896,http://news.europawire.eu/sanofis-soliqua-10033-now-available-by-prescription-in-u-s-for-the-treatment-of-adults-with-type-2-diabetes-6523134567890/eu-press-release/2017/01/04,http://biospace.com/news/sanofi-france-and-t1d-exchange-to-launch-worldwide/279801/source=morenews,http://globenewswire.com/news-release/2014/06/14/644123/10085771/en/sanofi-and-medtronic-to-form-strategic-alliance-in-diabetes-to-improve-patient-experience-and-outcomes.html,http://biospace.com/news/data-show-sanofi-francenbspsan-pas-lyxumia0174/309482/source=topbreaking,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-annonce-lapprobation-par-la-fda-dadlyxintm-dans-le-traitement-du-diabete-de-type-2-chez-ladulte,http://bio-medicine.org/medicine-technology-1/initiation-of-lantus-ae-leads-to-better-glycemic-control-at-similar-weight-gain-versus-other-comparators-in-patients-with-type-2-diabetes-20165-1,,,,,,,,,,,
lori.lukus@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,7,{first}.{last},Lori,Lukus,Writing & communication,Media Contact,"","",+1 908 981 3876,http://finanznachrichten.de/nachrichten-2013-07/27578918-fda-advisory-committee-recommends-approval-of-sanofi-s-nasacort-aq-nasal-spray-for-over-the-counter-use-008.htm,http://biospace.com/article/releases/fda-approves-sanofi-france-s-nasacort-and-0174-allergy-24hr-for-over-the-counter-use-,http://biospace.com/news/fda-panel-says-sanofi-frances-nasacort0174-can-go/304444,http://pm360online.com/pm360-presents-novel-patient-centric-strategies,http://prnewswire.com/news-releases/fda-advisory-committee-recommends-approval-of-sanofis-nasacort-aq-nasal-spray-for-over-the-counter-use-217824561.html,http://prnewswire.com/news-releases/fda-approves-sanofis-nasacort-allergy-24hr-for-over-the-counter-use-227413981.html,http://biospace.com/news/fda-approves-sanofi-frances-nasacort0174-allergy/311602,,,,,,,,,,,,,,,,,,,,,,
elizabeth.baxter@sanofi.com,sanofi.com,Sanofi,,,,,,91,personal,7,{first}.{last},Elizabeth,Baxter,Writing & communication,Global Communications,"","",+1 908 981 5360,http://biospace.com/article/releases/collaboration-between-sanofi-france-and-joslin-diabetes-center-to-focus-on-new-drugs-for-diabetes-,http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc-to/328248,http://eurekalert.org/pub_releases/2012-09/bc-sat091812.php,http://biospace.com/article/releases/regeneron-pharmaceuticals-inc-sanofi-france-shows-off-positive-phase-2-alirocumab-data-,http://biospace.com/news/regeneron-pharmaceuticals-inc-sanofi-france-shows/328669,http://bio-medicine.org/biology-technology-1/regeneron-and-sanofi-announce-plan-to-use-priority-review-voucher-for-alirocumab-u-s--fda-submission-29759-1,http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-the-american-college-of-cardiologys-63rd-annual-scientific-session-252586521.html,,,,,,,,,,,,,,,,,,,,,,
ahmet.celtikci@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,5,{first}.{last},,,,,,,,http://sanofi.com.tr/dam/jcr:1a5076bf-7e1c-4728-a5cd-a541152ba050/odp-egitim-platformu-hayata-geciyor-091122.pdf,http://sanofi.com.tr/dam/jcr:4b291cb4-2ccc-4ab0-bc2a-035326bccf58/sanofi-surdurulebilirlik-raporu-2021.pdf,http://sanofi.com.tr/dam/jcr:6dabfe88-eb98-4116-9ee1-379c00d64cc8/enterogermina-den-gnin-maceralari-kitap-lansmani-021122.pdf,http://sanofi.com.tr/dam/jcr:b3acacf5-6109-41f6-92a2-8c611f3bc281/pharmup-hub-tt-ventures-isbirligi.pdf,http://sanofi.com.tr/dam/jcr:bbee46c5-156a-4883-89b9-70626a8e1ac9/sanofi-turkiye-hedefler-icin-is-dunyasi-platformunun-kurumsal-destekcisi-oldu.pdf,,,,,,,,,,,,,,,,,,,,,,,,
rym.fettouche@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,5,{first}.{last},,,,,,,,http://sanofi.dz/dam/jcr:1626ba8c-3058-4dfd-8628-e59d75d43bbd/sanofi%20accueille%2011%20startup%20africaines%20dont%2001%20startup%20algrienne%20version%20arabe.pdf,http://sanofi.dz/dam/jcr:18a4e5fd-f3fb-4d82-a2b8-b13e18b96497/sanofi%20accueille%2011%20startup%20africaines%20dont%2001%20startup%20algrienne%20version%20franaise.pdf,http://sanofi.dz/dam/jcr:53867337-a7df-4816-9dba-6d6b94e20c5e/20190121_fr.pdf,http://sanofi.dz/dam/jcr:60604b18-f330-4c3a-963a-7c9bd2621a43/journ%c3%a9e%20mondiale%20de%20lutte%20contre%20les%20maladies%20rares%20maladies%20lysosomales.pdf,http://sanofi.dz/dam/jcr:65b2035b-4657-44cc-b83c-3602a0f43e7c/convention%20sanofi%20et%20la%20facult%c3%a9%20de%20pharmacie.pdf,,,,,,,,,,,,,,,,,,,,,,,,
matthias.suermondt@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,5,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:5d1e73d8-9462-4b8e-87a4-9b0ce530f3ac/newsletter-standort-gesundheit_januar-2019.pdf,http://sanofi.de/dam/jcr:b9377a45-6f7d-4337-b490-f7fce94fdb73/newsletter-standort-gesundheit_dezember-2020.pdf,http://sanofi.de/dam/jcr:c713dc6c-6cc0-49ec-8c92-be56b6d4b740/newsletter-standort-gesundheit_januar-2020.pdf,http://sanofi.de/dam/jcr:c8c1f756-08ee-4da7-90de-62b1481f5a51/newsletter-standort-gesundheit_maerz-2021.pdf,http://sanofi.de/dam/jcr:c8d16319-7a8b-47e2-a978-1d4cd6c1e8fd/newsletter-standort-gesundheit_mai-2020.pdf,,,,,,,,,,,,,,,,,,,,,,,,
renata.olejowska@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,9,{first}.{last},,,,,,,,http://kurier-warszawski.pl/prowadz-sie-zdrowo-i-zrob-przeglad-watroby,http://media.mslgroup.pl/3995/pr/802996/badaj-watrobe-i-prowadz-sie-zdrowo-podsumowanie-kampanii,http://sanofi.pl/dam/jcr:44b5e234-642d-420f-a207-6174ddc104d4/znow%20czujesz%20sie%20niewyspany%20jak%20zadbac%20o%20zdrowy%20sen_informacja%20prasowa.pdf,http://sanofi.pl/dam/jcr:712de07a-5cdd-4059-b186-8dc5448aa251/wspczesny%20styl%20ycia%20a%20stan%20naszej%20skry%20za%2020%20lat.pdf,http://sanofi.pl/dam/jcr:b39faa26-60e6-4404-a327-a4bce4191aec/i%20ty%20mozesz%20byc%20stresozaradny_informacja%20prasowa.pdf,http://sanofi.pl/dam/jcr:ed9d760c-280b-4237-8c52-386d81be8482/zdrowie%20w%20jelitach%20-%20zadbaj%20o%20centrum%20dowodzenia.pdf,http://sanofi.pl/dam/jcr:fc74dbd0-8423-4b4d-aa66-5485a2889233/zdrowotne%20konsekwencje%20smogu%20-%20teraz%20i%20w%20przyszoci.pdf,http://infowire.pl/company/3995,http://infowire.pl/generic/release/787739/przygonski-sprawdza-sie-nie-tylko-w-rajdach,,,,,,,,,,,,,,,,,,,,
lucia.depradogomez@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,3,{first}.{last},,,,,,,,http://openres.ersjournals.com/content/9/2/00417-2022,http://openres.ersjournals.com/content/9/2/00417-2022.article-info,http://openres.ersjournals.com/content/9/2/00417-2022.figures-only,,,,,,,,,,,,,,,,,,,,,,,,,,
nadav.cohen-keidar@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,2,{first}.{last},,,,,,,,http://campus.sanofi/il/accessibility-statement,http://sanofi.co.il/iw-il/accessibility,,,,,,,,,,,,,,,,,,,,,,,,,,,
priya.chandramohan@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,4,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:1b27d1b9-e045-4d31-b0ba-0284ed6a81d5/preetifutnaniannouncement.pdf,http://sanofi.in/dam/jcr:99fe8eed-7c35-46d7-ba04-2177d4021835/sanofi%20and%20gsk%20receive%20approval%20for%20phase%203%20efficacy%20trial%20of%20their%20covid19%20vaccine%20candidate%20in%20ind.pdf,http://sanofi.in/dam/jcr:c7dd91d8-d5ad-4e6e-9e71-6b7c6661ae37/sanofi_pasteur_launches_tetraxim.pdf,http://healthissuesindia.com/2020/10/01/sanofi-pasteur-launches-tetraxim-the-first-full-dose-dtap-booster-vaccine-in-india-for-preschoolers,,,,,,,,,,,,,,,,,,,,,,,,,
kamran.avini@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,3,{first}.{last},,,,,,,,http://ccysoccer.org/index.php/contacts,http://ccysoccer.org/node/76,http://ccysoccer.org/contacts,,,,,,,,,,,,,,,,,,,,,,,,,,
dorothea.greifenberg@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,3,{first}.{last},,,,,,,,http://efsm.online/be_nl/article-overview/101/2022/zinc-and-bacillus-clausii-a-promising-combination-to-improve-immunity-in-children,http://efsm.online/de_de/article-overview/101/2022/zinc-and-bacillus-clausii-a-promising-combination-to-improve-immunity-in-children,http://efsm.online/int_en/article-overview/101/2022/zinc-and-bacillus-clausii-a-promising-combination-to-improve-immunity-in-children,,,,,,,,,,,,,,,,,,,,,,,,,,
elton.rexhepaj@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,2,{first}.{last},,,,,,,,http://gdr-isis.fr/index.php/annonce/8146,http://ibisc.univ-evry.fr/cdd-post-doctorat-equipe-siam-ibisc-sanofi-computational-spatial-pathology-and-multimodal-data-integration,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.ukraine@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,10,{first}.{last},,,,,,,,http://sanofi.cz/dam/jcr:cb2bd0ef-36cf-44b9-9aab-64ba7e0dc7ed/reakce%20sanofi%20na%20situaci%20na%20ukrajin%c4%9b.pdf,http://sanofi.com/fr/media-room/notre-reponse-a-la-situation-en-ukraine,http://emsp.org/information-for-people-with-ms-affected-by-the-war-in-ukraine,http://sanofi.com/en/media-room/our-response-to-the-situation-in-ukraine,http://apteka.ua/article/518082,http://apteka.ua/article/574947,http://apteka.ua/article/592392,http://sanofi.ua/uk/contacts,http://sanofi.de/de/sanofi-in-deutschland/news-storys/ukraine-statement,http://sanofi.hu/hu/sajtoszoba/a-sanofi-valaszintezkedesei-az-ukrajnaban-kialakult-helyzetre,,,,,,,,,,,,,,,,,,,
farmacovigilancia.colombia@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,13,{first}.{last},,,,,,,,http://campus.sanofi/co/ciencia,http://campus.sanofi/co/ciencia/asma-grave,http://campus.sanofi/co/ciencia/dermatologia,http://campus.sanofi/co/ciencia/enfermedades-raras,http://sanofi-pacientes.com/campanasanofi/micrositios/homemonitoringbloodglucose.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/patientstartingguide.pdf,http://sanofi.com.co/dam/jcr:3033a9ae-7301-40ff-9622-6fb058ec6fac/tercer%20comunicado%20plaquinol%20y%20covid-19.pdf,http://sanofi.com.co/dam/jcr:3debbb33-412a-43cd-ac01-4b4d99f89e4d/quinolones%20and%20fluoroquinolones%20art%2031%20phv%20-%20dhpc_%20comunicacin%20a%20hcps.pdf,http://sanofi.com.co/dam/jcr:c58c50ae-bffe-4e53-a5b1-589bb1c05d26/comunicacion%20directa%20para%20el%20profesional%20de%20la%20salud.pdf,http://campus.sanofi/co,http://genfar.com/atencion-genfar,http://sanofi.com.co/es/contacto-reportes,http://allegra.com.ec/aviso-de-farmacovigilancia,,,,,,,,,,,,,,,,
marie.pouyet@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,3,{first}.{last},,,,,,,,http://instruct-eric.org/jobs/post-doctoral-fellowship-at-sanofi-58,http://instruct-ultra.eu/jobs/post-doctoral-fellowship-at-sanofi-58,http://inext-discovery.eu/jobs/post-doctoral-fellowship-at-sanofi-58,,,,,,,,,,,,,,,,,,,,,,,,,,
drugs.camwi@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,14,{first}.{last},,,,,,,,http://campus.sanofi/co/ciencia,http://campus.sanofi/co/ciencia/asma-grave,http://campus.sanofi/co/ciencia/dermatologia,http://campus.sanofi/co/ciencia/enfermedades-raras,http://sanofi-pacifico-caribe.com/dam/jcr:2a81f449-3fe0-4bce-9c29-a9c91c942e1e/fluoroquinolones%20and%20quinolones-letter%20for%20physicians-english-spanis.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:5fafb8a6-8fd1-4e3e-ad3b-f1a197cbe6e2/tarjeta%20de%20la%20paciente%20valproato%202022.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:7d5c96c6-118d-4e7f-9272-e05634d92a3a/tarjeta%20para%20medico%20pac%202020.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:da01b2c4-9cbf-466c-9c0b-5b85ec631368/educational%20material%20for%20physicians-leflunomide-%20english-spanish.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/homemonitoringbloodglucose.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/patientstartingguide.pdf,http://sanofi-pacientes.com/materiales/pompe-que-debo-vigilar-en-respuesta-al-tratamiento.pdf,http://campus.sanofi/co,http://genfar.com/atencion-genfar,http://sanofi-pacifico-caribe.com/es/contacto-reportes,,,,,,,,,,,,,,,
thomas.huebschle@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,4,{first}.{last},,,,,,,,http://jpet.aspetjournals.org/content/suppl/2020/11/17/jpet.120.000285.dc1,http://jpet.aspetjournals.org/content/early/2020/11/20/jpet.120.000285/tab-e-letters,http://jpet.aspetjournals.org/content/early/2020/11/20/jpet.120.000285/tab-article-info,http://jpet.aspetjournals.org/content/early/2020/11/20/jpet.120.000285,,,,,,,,,,,,,,,,,,,,,,,,,
pt-farmacovigilanciachc@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,9,{first}.{last},,,,,,,,http://mucosolvan.pt/contacte-nos,http://sanofi.pt/pt,http://bisolvon.pt/contacto,http://sanofi.pt,http://antistax.pt/contacto,http://stilnoite.pt/contactos,http://buscopan.pt/contacto,http://telfast.pt/contactos,http://pharmaton.pt/contactos,,,,,,,,,,,,,,,,,,,,
investor.relations@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,30,{first}.{last},,,Writing & communication,,,,,http://ml-eu.globenewswire.com/resource/download/fd6119ed-c8d4-414f-aeb7-413ce2a73371,http://kymab.com/contact,http://proventionbio.com/contact-us,http://ml-eu.globenewswire.com/resource/download/13d27ec6-5488-4976-8628-cc543fde688a,http://stada.de/news/pressemitteilung-stada-baut-europaeisches-consumer-healthcare-portfolio-durch-uebernahme-von-16-etablierten-marken-von-sanofi-aus,http://stada.com/blog/posts/2021/june/stada-further-grows-european-consumer-healthcare-portfolio-by-acquiring-16-well-established-brands-from-sanofi,http://stada.com/de/blog/posts/2021/juni/stada-baut-europaeisches-consumer-healthcare-portfolio-durch-%c3%bcbernahme-von-16-etablierten-marken-von-sanofi-aus,http://stada.com/media/6674/20210628_press-release_sanofi-portfolio.pdf,http://stada.com/media/6675/20210628_pressemitteilung_sanofi-portfolio.pdf,http://burberry.com.pl/2022/03/25/release-agreement-translate,http://healthtechhotspot.com/exscientia-and-sanofi-establish-strategic-research-collaboration-to-develop-ai-driven-pipeline-of-precision-engineered-medicines,http://yakuji.jp/entry120026.html,http://pharmiweb.com/press-release/2021-02-23/sanofi-and-gsk-initiate-new-phase-2-study-of-their-adjuvanted-recombinant-protein-based-covid-19-vaccine-candidate,http://pharmiweb.com/press-release/2021-07-29/dupixent-dupilumab-significantly-improved-itch-and-hives-in-patients-with-chronic-spontaneous-urticaria-a-step-forward-in-demonstrating-the-role-o,http://qlifepro.com/press/20220110-17-92708/exscientia-17,http://michbio.org/sanofi-to-help-manufacture-moderna-covid-19-vaccine-supporting-global-supply-demands,http://sanofi.com/en/media-room/press-releases/2021/2021-12-13-06-00-00-2350402,http://itbusinessnet.com/2022/01/chmp-recommends-approval-of-dupixent-dupilumab-for-children-aged-6-to-11-years-with-severe-asthma-with-type-2-inflammation,http://frazierhealthcare.com/system/uploads/fae/file/asset/462/translate.pdf,http://wallstreet-online.de/nachricht/13535202-fda-approves-libtayo-cemiplimab-rwlc-monotherapy-for-patients-with-first-line-advanced-non-small-cell-lung-cancer-with-pd-l1-expression-of-50,http://itbusinessnet.com/2022/04/press-release-euroapi-listing-on-euronext-paris-expected-on-may-6-2022,http://bigagainstbreastcancer.org/ameera-6,http://bigagainstbreastcancer.org/fr/ameera-6,http://qlifepro.com/press/20220112-19-92744/exscientia-18,http://coldagglutinindisease.org/fda-complete-response,http://proventionbio.squarespace.com/contact-us,http://pharmabarometer.de/innovation/exscientia-und-sanofi-begruenden-strategische-forschungskooperation-zur-entwicklung-einer-ki-gesteuerten-pipeline-fuer-personalisierte-medikamente,http://sanofi.es/dam/jcr:878cf689-7175-45b6-97fb-c42a4db2686f/ndp_positiva_chmp_isatuximab.pdf,http://sanofi.pl/dam/jcr:bf24c184-97f7-4852-b49a-9b3dfd458b1a/sanofi_and_gsk_initiate_global_phase_3_clinical_efficacy_study_of_covid%20(2).pdf,http://sanofi.pl/dam/jcr:f5b6b6a6-b893-4eb2-8f00-e95741157085/sanofi_and_gsk_initiate_global_phase_3_clinical_efficacy_study_of_covid.pdf
pharmacovigilance-by@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,15,{first}.{last},,,,,,,,http://apteka.103.by/15485-magne-v6-forte-instruktsiya,http://apteka.103.by/guttalaks-instruktsiya,http://apteka.103.by/magne-b62-instruktsiya,http://vseopilah.ru/lobziki/10-oshibok-kotorye-sovershayut-lyudi-pri-prieme-vitaminov-mikroelementov-i-badov,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-rastvor-dlja-ingaljacij-sirop-opisanie-sostav-ftg-mnn,http://apteka.103.by/plaviks-instruktsiya,http://cocktailshake.ru/raznoe/kak-pit-essenciale-forte-kurs-lecheniya.html,http://cocktailshake.ru/raznoe/kak-pit-lazolvan-rastvor-dlya-priema-vnutr-i-ingalyacij.html,http://cocktailshake.ru/raznoe/kak-pravilno-pit-essenciale-forte-v-kapsulah.html,http://cocktailshake.ru/raznoe/magnij-v6-v-ampulah-dlya-detej-kak-pravilno-pit.html,http://cocktailshake.ru/raznoe/essenciale-forte-kak-pit.html,http://gkpd.by/instrukcii/avaksim-80-suspenziya-25.html,http://gkpd.by/instrukcii/lazolvan-rastvor-dlya-ingalyaciy-sirop-2282.html,http://apteka.103.by/essentciale-forte-n-instruktsiya,http://erzdrav.ru/preparaty/analogi-akt-hib-vaktsina-dlya-profilaktiki-infektsii-vyzyvaemoj-haemophilus-influenzae-tip-b-konyugirovanna-po-tsene-ot-150-00-rub-instruktsiya-otzyvy.html,,,,,,,,,,,,,,
materesa.garcia@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,26,{first}.{last},,,,,,,,http://alfaronoticias.com.mx/salud-verifica-alerta-por-falsificacion-del-medicamento-plaquenil,http://horizontetunero.com/nacional-internacional/alerta-cofepris-sobre-falsificacion-de-medicamento-plaquenilhidroxicloroquina,http://masnoticiasbcs.com/la-cofepris-alerta-sobre-la-falsificacion-del-medicamento-plaquenil,http://medicinedepot.com.mx/2020/06/29/cofepris-alerta-sobre-falsificacion-de-plaquenil,http://epocanuevomilenio.com.mx/la-ss-de-veracruz-informa-sobre-falsificacion-de-medicamento-plaquenil,http://anafarmex.com.mx/alerta-sanitaria,http://614noticias.com/alerta-cofepris-por-falsificacion-del-medicamento-hidroxicloroquina,http://noticieroaltavoz.com/la-coepriss-alerta-sobre-la-falsificacion-del-medicamento-plaquenil,http://buzonxalapa.com/noticias/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo-51480.html,http://acropolismultimedios.mx/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo,http://reportenaranja.com/2020/06/28/la-coepriss-alerta-sobre-la-falsificacion-del-medicamento-plaquenil,http://calornoticias.mx/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo,http://elautonomo.mx/noticias/21-nacionales/908-alerta-cofepris-por-falsificacion-del-medicamento-hidroxicloroquina,http://radiohit.com.mx/2020/06/30/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo,http://numerocero.com.mx/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo,http://imagendelgolfo.mx/estado/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil/50025471,http://lostubos.com/2020/06/29/alerta-cofepris-por-distribucion-de-hidroxicloroquina-falsificada,http://imagendeveracruz.mx/estado/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil/50025471,http://tvnoticiasveracruz.com/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo,http://grupoacontecer.com/2020/06/30/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo,http://mundoxalapa.com/2020/06/30/advierten-sobre-falsificacion-del-medicamento-plaquenil-piden-evitar-venta-y-consumo,http://diariodexalapa.com.mx/local/alertan-autoridades-de-salud-sobre-falsificacion-de-medicamento-plaquenil-coronavirus-tratamiento-hidroxicloroquina-5434702.html,http://cxnoticias.com/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil-y-recomienda-evitar-su-venta-y-consumo,http://diarioacayucan.com/alertan-sobre-falsificacion-de-antiparasitario-y-antirreumatico-piden-evitar-su-consumo,http://diariodelistmo.com/estatal/advierte-secretaria-de-salud-sobre-falsificacion-del-medicamento-plaquenil/50025471,http://rrazones.com/la-coepriss-alerta-sobre-la-falsificacion-del-medicamento-plaquenil,,,
informazioni.medicoscientifiche@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,16,{first}.{last},,,Support,,,,,http://ordinefarmacistipz.it/images/fofi/14267.pdf,http://sofarmamorra.it/aggiornamento-tecnico-20-23-gennaio-2023,http://sofarmamorra.it/category/agg_tecnico/page/3,http://ordfarmbo.it/multimedia/allegati/14215.pdf,http://ordfarmbo.it/multimedia/allegati/14267.pdf,http://farmaciavirtuale.it/carenza-farmaco-frisium-le-istruzioni-operative-di-sanofi,http://aziendeinformano.it/2020/04/15/idrossiclorochina-coronavirus-no-fa-da-te,http://apmarr.it/news-dal-web/sanofi-aggiornamento-sulla-disponibilita-di-idrossiclorochina-plaquenil,http://migateway.eu/en/it/136/sanofi,http://farmacista33.it/idrossiclorochina-appello-dellazienda-non-e-carente-evitare-faidate-accaparramenti-e-scorte-familiari/politica-e-sanita/news--52717.html,http://apmarr.it/2020/04/06/sanofi-aggiornamento-sulla-disponibilita-di-idrossiclorochina-plaquenil,http://kofam.ch/de/studienportal/studie/44583,http://kofam.ch/de/studienportal/suche/0/studie/44583,http://sclerosistemica.info/plaquenil-richiesta-di-aggiornamenti-carenza-disponibilita-sui-territori,http://centrocaltagirone.it/2020/04/06/coronavirus-boom-di-richieste-per-farmaco-antimalarico,http://prontuariointegratori.com/azienda/2173,,,,,,,,,,,,,
infomed.pac@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,14,{first}.{last},,,Support,,,,,http://campus.sanofi/co/ciencia,http://campus.sanofi/co/ciencia/asma-grave,http://campus.sanofi/co/ciencia/dermatologia,http://campus.sanofi/co/ciencia/enfermedades-raras,http://sanofi-pacifico-caribe.com/dam/jcr:5fafb8a6-8fd1-4e3e-ad3b-f1a197cbe6e2/tarjeta%20de%20la%20paciente%20valproato%202022.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:632ddf0d-307d-4b0a-ad96-71275ed000af/gu%c3%ada%20de%20la%20paciente%20valproato%202022.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:846c1d3e-2f88-4617-98a9-e803a34d808d/gu%c3%ada%20para%20los%20profesionales%20de%20la%20salud%20valproato%202022.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:a593bb96-a933-48d0-a291-c47c7b4aefcc/formulario%20reconocimiento%20riesgo%20anual%20valproato%202022.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/homemonitoringbloodglucose.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/patientstartingguide.pdf,http://sanofi-pacientes.com/materiales/pompe-que-debo-vigilar-en-respuesta-al-tratamiento.pdf,http://campus.sanofi/co,http://genfar.com/atencion-genfar,http://sanofi-pacifico-caribe.com/es/contacto-reportes,,,,,,,,,,,,,,,
pharmacovigilance.finland@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,18,{first}.{last},,,,,,,,http://fimea.fi/documents/160140/12924879/fasturtec+dhpc+fi+15.2.2023.pdf/9c980f4b-d082-cfa7-28ed-5682db8e5454,http://fimea.fi/documents/160140/12924879/sabrilex+dhcp+fi+15.9.2022.pdf/7a9bc3ba-a882-147d-715f-2fbe33d820b8,http://fimea.fi/documents/160140/5248301/aubagio_potilaskortti_versio5_fi_v1_lowres.pdf/d60b1e9f-42b0-6a45-6e98-c7e34a96b58a,http://fimea.fi/documents/160140/3649702/lemtrada_patient_guide_a5_fi_v2_lowres.pdf/d0268e7c-2c18-c500-0bda-88d25bdbc9a6,http://pharmacafennica.fi/supportmaterial/download/105926784/fi,http://pharmacafennica.fi/supportmaterial/download/105926788/fi,http://pharmacafennica.fi/supportmaterial/download/105926788/sv,http://sanofi.fi/dam/jcr:71475ddf-ee15-437f-b82f-53621623f184/potilasopas.pdf,http://sanofi.fi/dam/jcr:7c0eec9a-ae79-4733-98cf-b03c56913fe2/terveydenhuollon%20ammattilaisen%20opas.pdf,http://sanofi.fi/dam/jcr:a1d81cc8-9259-4221-a516-71d2b2664c89/tiedotteet-terveydenhuollon-ammattilaisille.pdf,http://tevapharm.fi/globalassets/finland-files---global/news/fi-fluoroquinolone-dhpc_10-2020-fi-071020.pdf,http://tevapharm.fi/globalassets/finland-files---global/news/fi-fluoroquinolone-dhpc_10-2020-sv-071020-.pdf,http://tevapharm.fi/globalassets/finland-files---global/news/fluoroquinolones--dhpc-fise-final-17.10.2018.pdf,http://tevapharm.fi/globalassets/finland-files---global/news/quinolones_fluoroquinolones-dhpc.pdf,http://fimea.fi/documents/160140/5248301/hcp_koulutusopas_versio5_fi_v3_lowres.pdf/e2f23ffc-e4c0-dd54-cc08-2f31924efc77,http://sanofi.fi/fi/tietoa-meista/yhteystiedot,http://pharmacafennica.fi/safetynotice/51458878,http://pharmacafennica.fi/safetynotice/52335563,,,,,,,,,,,
farmacovigilancia.peru@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,12,{first}.{last},,,,,,,,http://campus.sanofi/co/ciencia,http://campus.sanofi/co/ciencia/asma-grave,http://campus.sanofi/co/ciencia/dermatologia,http://campus.sanofi/co/ciencia/enfermedades-raras,http://sanofi-pacifico-caribe.com/dam/jcr:5fafb8a6-8fd1-4e3e-ad3b-f1a197cbe6e2/tarjeta%20de%20la%20paciente%20valproato%202022.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/patientstartingguide.pdf,http://campus.sanofi/co,http://genfar.com/atencion-genfar,http://sanofi.com.pe/es/contacto-reportes,http://sanofi.com.pe/terminos-y-condiciones-sf,http://sanofi.com.pe/es/terminos-y-condiciones-gz,http://sanofi.com.pe/es/terminos-y-condiciones-sf,,,,,,,,,,,,,,,,,
recepcia@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,11,{first}.{last},,,,,,,,http://liek.beautywoman.sk/clanok/6775,http://vysetrenie.zoznam.sk/cl/1000663/2495073/starajte-sa-o-svoju-pecen--odvdaci-sa-vam-vitalitou,http://omdvsr.sk/downloads/new/ozvena/ozvena_2016_02.pdf,http://omdvsr.sk/images/2017_01_web.pdf,http://omdvsr.sk/images/2017_02_web.pdf,http://vysetrenie.zoznam.sk/cl/1000663/2286927/bolest-hlavy-si-rocne-obdobie-nevybera--zaskoci-aj-za-pekneho-pocasia,http://ibalgin.sk/kontakt.html,http://mucosolvan.sk/kontakt.html,http://vysetrenie.zoznam.sk/cl/1000663/2222361/vitalny-jezisko--tip-na-darcek-nielen-pre-aktivnych-rodicov,http://vysetrenie.zoznam.sk/cl/1000663/2245293/bolest-dnes-uz-nikoho-brzdit-nemusi,http://vysetrenie.zoznam.sk/cl/1000663/2146499/hrdinovia-modernej-doby-nemaju-cas-na-bolest,,,,,,,,,,,,,,,,,,
proteccion.dedatos@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,19,{first}.{last},,,,,,,,http://campus.sanofi/co/ciencia,http://campus.sanofi/co/ciencia/asma-grave,http://campus.sanofi/co/ciencia/dermatologia,http://campus.sanofi/co/ciencia/enfermedades-raras,http://sanofi-pacifico-caribe.com/dam/jcr:686bba19-6c44-4d13-8644-5fc11f0cc169/privacy%20notification.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:c2147179-d1c4-46d9-8f14-871beeb728f6/procedimiento%20de%20manejo%20de%20privacidad%20y%20pdp%20pac%2027072021.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:fdad603f-80b1-4bf7-9f2c-c1f1aa1c0bb5/privacy%20and%20personal%20data%20protection%20management%20procedure%20pdp%20pac%2027072021.pdf,http://sanofi-pacientes.com/pol%c3%adticasprivacidad,http://sanofi-pacientes.com/politicas,http://campus.sanofi/co,http://sanofi-pacientes.com/inscripciontvco,http://sanofi-pacientes.com/politicastvco,http://sanofi.com.co/es/avisodatospersonales,http://sanofi.com.co/es/avisolegal,http://sanofi-pacifico-caribe.com/es/aviso-de-privacidad,http://sanofi-pacifico-caribe.com/es/aviso-legal,http://sanofi-pacientes.com/consentimientoinformado,http://sanofi.com.pe/es/aviso-proteccion-datos-personales,http://buscapina.com.co/terminos-condiciones,,,,,,,,,,
beata.kujanova@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,12,{first}.{last},,,,,,,,http://nusch.sk/files/novinky/2013/ts-2013-06-04-mdd.pdf,http://nusch.sk/files/novinky/tlacova-sprava-mikulas-2011.pdf,http://nusch.sk/files/press/sds-klucove-odkazy.pdf,http://nusch.sk/files/press/sds-pozvanka.pdf,http://nusch.sk/files/press/sds-tlacova-sprava.pdf,http://spolumozeme.sk/aktuality/108/neskryvaj-sa-vystup-z-radu-zivot-so-sklerozou-multiplex,http://prservis.sk/tim-spolocnosti-sanofi-posilnili-nadseni-studenti,http://hlavnespravy.sk/ots-den-deti-medzi-srdieckami-uz-siestykrat-v-detskom-kardiocentre-v-bratislave/1601,http://hlavnespravy.sk/ots-falosne-lieky-skutocna-hrozba-pre-zdravie/7877,http://maxivyber.sk/slovensko/tim-spolocnosti-sanofi-posilnili-nadseni-studenti,http://tasr.sk/ots/ots-edukacne-granty-nadacie-zentiva/17426-clanok.html,http://spolumozeme.sk/aktuality/36/neskryvaj-sa-odhod-predsudky-moj-zivot-so-sklerozou-multiplex,,,,,,,,,,,,,,,,,
iod@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,19,{first}.{last},,,,,,,,http://campus.sanofi/pl/prawny/polityka-prywatnosci,http://kardiologiawieczorowapora.pl/files/informacja_sanofi.pdf,http://czwartkichirurgiczne.pl/files/polityka-prywatno%c5%9bci-2021.pdf,http://zakrzepica24.pl/dam/jcr:02971219-fdf6-481f-80c0-1f3933cb7552/polityka%20prywatno%c5%9aci%20dla%20zakrzepica24_ensi.09.08.pdf,http://sanofidlaaptek.pl/files/attachments/owsum_opella_2022.pdf,http://sanofidlaaptek.pl/files/pp_sanofi_2022.pdf,http://dulcobis.pl/dam/jcr:2175cf84-c9cf-4629-8cf2-343e972e4dc8/polityka%20prywatno%c5%9bci%20opella%20healthcare%20poland%20dulcobis.pdf,http://sanofi.pl/dam/jcr:4c2f8ab3-1021-45b6-a7a3-34ea6fcad6fc/pp_sanofi%202022.pdf,http://sanofi.pl/pl/nasze-produkty/zglos-dzialanie-niepozadane-leku-bez-recepty-wyrobu-medycznego-suplementu-diety,http://sanofi.pl/pl/kontakt,http://szczepieniadlapodrozujacych.pl/polityka-cookies,http://sanofi.pl/nasze-produkty/zglos-dzialanie-niepozadane-leku,http://choroba-gauchera.pl/pl/polityka-prywatnosci,http://szczepieniaprzeciwgrypie.pl/polityka-prywatnosci,http://szczepieniadlapodrozujacych.pl/polityka-prywatnosci,http://msonetoone.pl/node/28,http://szczepieniadlapodrozujacych.pl/informacja-o-przetwarzaniu-danych-osobowych,http://sanofi.pl/pl/nasze-produkty/zglos-dzialanie-niepozadane-leku,http://pharmaton.pl/polityka-prywatnosci,,,,,,,,,,
geral.pt@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,15,{first}.{last},,,,,,,,http://sanofi.pt/dam/jcr:7f94b9a6-da61-4ab8-aa0e-be8d32c10a44/brochura2017.pdf,http://sanofi.pt/pt/sobre-nos,http://sanofi.pt/pt/termos-de-utilizacao,http://campus.sanofi/pt/termos-de-utilizacao,http://pjp.spp.pt/media/00mkkw1b/app-vol_54_n_2.pdf,http://pjp.spp.pt/media/c5vmbc3b/app-vol_53_n_4_completa.pdf,http://pjp.spp.pt/media/eatcmxbr/app-vol_53_n_3_completa.pdf,http://emprego.pt/companies/sanofi,http://atlasdasaude.pt/lista-de-farmaceuticas-search/s,http://atlasdasaude.pt/publico/content/sanofi-produtos-farmaceuticos-lda,http://apdis.pt/recursos/rbas/sanofi-aventis-produtos-farmaceuticos-lda,http://indice.eu/pt/medicamentos/laboratorios/sanofi-produtos-farmaceuticos-lda/informacao-geral,http://indice.eu/pt/medicamentos/laboratorios/sanofi-pasteur/informacao-geral,http://sanofi.pt,http://sanofi.pt/pt,,,,,,,,,,,,,,
datos.personales@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,13,{first}.{last},,,,,,,,http://spark225.com/aviso-de-privacidad-spark225,http://sanofi.com.mx/dam/jcr:35f553c4-7b6d-49bd-b9d1-419977463c3b/aviso%20de%20privacidad%20programa%20de%20acceso%20al%20tratamiento%20enero%202022.pdf,http://sanofi.com.mx/dam/jcr:f935961e-10b3-494a-9a2b-4958a8740281/aviso%20de%20privacidad%20entregando%20salud%20pacientes%20mieloma%20m%c3%baltiple.pdf,http://lactacyd.mx/challenge04,http://lactacyd.mx/challenge05,http://lactacyd.mx/challenge06,http://lactacyd.mx/challenge07,http://buscapina.com/es-mx/avisoprivacidad,http://medicoconsentido.com.mx/aviso-de-privacidad,http://pharmaton.com.mx/aviso-privacidad,http://lactacyd.mx,http://aderogyl.com.mx,http://histiacil.com.mx/aviso-de-privacidad,,,,,,,,,,,,,,,,
mirka.rinkinen@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,9,{first}.{last},,,,"",,,,http://sanofi.fi/dam/jcr:36a79fd3-6fb9-4fc6-b0b1-edab5897306f/methodological%20note_finland_eng_2021.pdf,http://sanofi.fi/dam/jcr:91b37a58-7fdf-48ab-ab44-0fe30aee9477/methodological%20note_finland_fin_2021.pdf,http://sanofi.fi/fi/tietoa-meista/yhteystiedot,http://epressi.com/tiedotteet/terveys/tunnistatko-okasolusyovan-yli-puolet-suomalaisista-ei-tieda-mika-se-on.html,http://mynewsdesk.com/fi/tamrofinland/pressreleases/tamro-ja-sanofi-jatkavat-monivuotista-yhteistyoetaeaen-1672768,http://mynewsdesk.com/fi/pressreleases/sanofi-pasteurin-ja-msd-n-rokoteyhteistyoe-euroopassa-paeaettyy-vuodenvaihteessa-1672478,http://mynewsdesk.com/fi/pressreleases/diabeteksen-hoidon-kipupiste-vihdoin-hallintaan-aterianjaelkeinen-verensokeri-925439,http://epressi.com/tiedotteet/terveys/tuore-kysely-kertoo-influenssarokotteen-ottamisella-halutaan-suojata-myos-lahimmaisia.html,http://mynewsdesk.com/fi/pressreleases/diabetes-liksisenatidi-sai-myyntiluvan-euroopassa-ensimmaeinen-kerran-paeivaessae-annosteltava-glp-1-agonisti-joka-on-kehitetty-aterianjaelkeisten-833880,,,,,,,,,,,,,,,,,,,,
esprotecciondedatos@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,24,{first}.{last},,,,,,,,http://sanofi.es/dam/jcr:58507646-fd7d-4b60-95a5-4fac563b05eb/nota-metodologica-pacientes-2020.pdf,http://sanofi.es/dam/jcr:c1ee0674-adec-4947-83f1-b91dba3c2217/nota%20metodologica%202019.pdf,http://sanofi.es/dam/jcr:ec7a750a-da4d-4aa6-bb8c-8b416874de2f/nota-metodologica-transparencia-2020.pdf,http://vacunas.sanofipasteur.es/politica-de-privacidad,http://emonetoone.es/politica-de-privacidad,http://conatencionprimaria.es/politica-de-privacidad,http://sanoficonladiabetes.es/privacy-policy,http://tcoach.es/cookies,http://tcoach.es/legal,http://tcoach.es/privacy,http://tcoach.es/register,http://digimed.es/politica-privacidad,http://rarasperoreales.es/politica-privacidad,http://emonetoone.es/terminos-y-condiciones-de-uso,http://diguan.es/politica-de-privacidad,http://sanofi.es/politica-de-privacidad,http://bajarelcolesterol.es/politica-privacidad,http://sanofi.es/es/politica-de-privacidad,http://trombosisvenosa.es/public/contactusform,http://diguan.es/contacto,http://vigimed.es/profesional/l/aviso-legal,http://ak9demia.es/contacto,http://ak9demia.es/politica-privacidad,http://vigimed.es/particular/l/aviso-legal,,,,,
uzbekistan.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,19,{first}.{last},,,,,,,,http://apteka.103.by/guttalaks-instruktsiya,http://cocktailshake.ru/raznoe/magnij-v6-kak-pit.html,http://apteka.103.by/15485-magne-v6-forte-instruktsiya,http://uzpharm-control.uz/en/news/view/2020-08-14-the-use-of-hydroxychloroquine-in-the-context-of-covid-19,http://uzpharm-control.uz/ru/news/view/2020-08-14-the-use-of-hydroxychloroquine-in-the-context-of-covid-19,http://uzpharm-control.uz/uz/news/view/2020-08-14-the-use-of-hydroxychloroquine-in-the-context-of-covid-19,http://vseopilah.ru/lobziki/10-oshibok-kotorye-sovershayut-lyudi-pri-prieme-vitaminov-mikroelementov-i-badov,http://detisakh.ru/pitanie/magne-b6-v-ampulah-dlya-detey-instruktsiya-po-primeneniyu,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-rastvor-dlja-ingaljacij-sirop-opisanie-sostav-ftg-mnn,http://apteka.103.by/plaviks-instruktsiya,http://cocktailshake.ru/raznoe/kak-pit-essenciale-forte-kurs-lecheniya.html,http://cocktailshake.ru/raznoe/kak-pit-magnij-b6-v-tabletkah.html,http://cocktailshake.ru/raznoe/kak-pravilno-pit-essenciale-forte-v-kapsulah.html,http://cocktailshake.ru/raznoe/essenciale-forte-kak-pit.html,http://gkpd.by/instrukcii/lazolvan-rastvor-dlya-ingalyaciy-sirop-2282.html,http://apteka.103.by/essentciale-forte-n-instruktsiya,http://uzpharm-control.uz/news/view/2020-08-14-the-use-of-hydroxychloroquine-in-the-context-of-covid-19,http://uzpharm-control.uz/news/view/2020-12-16-fluoroquinolone-sanofi,http://letsearch.ru/host/uz,,,,,,,,,,
kazakhstan.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,30,{first}.{last},,,,,,,,http://europharma.kz/kz/lazolvan-15-mg2-ml-100ml-rastvor-dlya-priyema-vnutr-i-ingalyatsiy,http://apteka.103.by/15485-magne-v6-forte-instruktsiya,http://apteka.103.by/essentciale-forte-n-instruktsiya,http://apteka.103.by/magne-b62-instruktsiya,http://apteka.103.by/plaviks-instruktsiya,http://diabetiki.kz/product/%d0%b4%d1%83%d0%bb%d1%8c%d0%ba%d0%be%d0%bb%d0%b0%d0%ba%d1%81-%d0%bf%d0%b8%d0%ba%d0%be-75%d0%bc%d0%b3-15%d0%bc%d0%bb-%d0%ba%d0%b0%d0%bf%d0%bb%d0%b8,http://diabetiki.kz/product/%d0%bb%d0%b0%d0%b7%d0%be%d0%bb%d0%b2%d0%b0%d0%bd-%d0%bc%d0%b0%d0%ba%d1%81-75%d0%bc%d0%b3-%e2%84%96-10-%d0%ba%d0%b0%d0%bf%d1%81,http://diabetiki.kz/product/%d0%bd%d0%be-%d1%88%d0%bf%d0%b0-%d1%84%d0%be%d1%80%d1%82%d0%b5-40%d0%bc%d0%b3-%e2%84%9624-%d1%82%d0%b0%d0%b1,http://diabetiki.kz/product/%d0%bd%d0%be-%d1%88%d0%bf%d0%b0-%d1%84%d0%be%d1%80%d1%82%d0%b5-80%d0%bc%d0%b3-%e2%84%9624-%d1%82%d0%b0%d0%b1,http://newniva.ru/effektivnye-tabletki-ot-diarei-bystrodeystvuyushchie-top-15.html,http://diabetiki.kz/product/%d1%8d%d0%bd%d1%82%d0%b5%d1%80%d0%be%d0%b6%d0%b5%d1%80%d0%bc%d0%b8%d0%bd%d0%b0-%e2%84%9612-%d0%ba%d0%b0%d0%bf%d1%81,http://europharma.kz/kz/magne-v6-premium-no-60-tabl-pokrytyye-obolochkoy,http://europharma.kz/magne-v6-premium-no-60-tabl-pokrytyye-obolochkoy,http://europharma.kz/dulkolaks-piko-15-ml-kapli,http://europharma.kz/kz/dulkolaks-piko-15-ml-kapli,http://aptk.kz/lekarstvennye-sredstva-i-bad/vitaminy-mineraly/vitamin-e/vitamin-e-400-mg-30,http://apteka.103.by/guttalaks-instruktsiya,http://saryagash.europharma.kz/dulkolaks-piko-15-ml-kapli,http://dobraya-apteka.kz/product/33931670/lazolvan-15mg-2ml-100ml-d-priema-vnutry-r-r_33931670,http://dobraya-apteka.kz/product/33935637/enterozhermina-forte-4-mlrd-5ml-5-ml-10-susp--dlya-priema-vnutry_33935637,http://dobraya-apteka.kz/product/490882/bronhikum-s-sirop-100ml,http://oskemen.europharma.kz/dulkolaks-piko-15-ml-kapli,http://oskemen.europharma.kz/lazolvan-15-mg2-ml-100ml-rastvor-dlya-priyema-vnutr-i-ingalyatsiy,http://turkestan.europharma.kz/dulkolaks-piko-15-ml-kapli,http://gkpd.by/instrukcii/lazolvan-rastvor-dlya-ingalyaciy-sirop-2282.html,http://cocktailshake.ru/raznoe/essenciale-forte-kak-pit.html,http://cocktailshake.ru/raznoe/kak-pit-essenciale-forte-kurs-lecheniya.html,http://cocktailshake.ru/raznoe/kak-pit-magnij-b6-v-tabletkah.html,http://cocktailshake.ru/raznoe/kak-pravilno-pit-essenciale-forte-v-kapsulah.html,http://cocktailshake.ru/raznoe/magnij-v6-kak-pit.html
aziz.yousfimalki@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,19,{first}.{last},,,,,,,,http://sanofi.ci/dam/jcr:05e0b1ee-2c0c-4900-ab15-e6d538c45908/media%20release%20ghana%20mou%2014%20april%202023%20fr.pdf,http://sanofi.ci/dam/jcr:6f62f285-fd8e-4180-a6d5-1fc30bb2cd74/press%20release.pdf,http://sanofi.ci/fr/presse,http://tn.sanofi.com/dam/jcr:06a868ba-033c-4152-9164-719e42f1e3d6/cp2.pdf,http://tn.sanofi.com/dam/jcr:52ea3648-98ef-4a86-ab7b-38280d3dc27e/cp1.pdf,http://tn.sanofi.com/dam/jcr:7e8626c8-2eaa-43ec-84c3-66aaba344543/cp3.pdf,http://tn.sanofi.com/dam/jcr:c6a1b6a7-8016-4ce6-a3fb-8f2c6e2ea10f/cp4.pdf,http://sanofi.ma/dam/jcr:2222106b-5270-40c7-b6ba-f0ff0c0981e6/press%20release.pdf,http://sanofi.ma/dam/jcr:6ad61de9-eea0-4837-a768-93139d0f2953/press%20release.pdf,http://sanofi.ma/dam/jcr:9f9f95b8-fd6a-4674-8f96-73139c921fe7/press%20release.pdf,http://sanofi.ma/dam/jcr:c8e30026-c9e8-4db5-8923-fc2c8fba766e/press%20release%20(1).pdf,http://sanofi.ma/dam/jcr:d0167517-fdb2-476a-b59b-bac886494725/pr%20rdd%202023%20(1).pdf,http://sanofi.ci/fr/nous-connaitre/sanofi-cameroun-cote-ivoire-senegal,http://fichier-pdf.fr/2018/11/04/liste-entreprise-labellisees-cgem,http://fichier-pdf.fr/2019/04/26/fichier-pdf-sans-nom,http://slideshare.net/khadijamoussayer/journe-des-maladies-rares-le-28-fvrier-communiqu-alliance-des-maladies-rares-amrm-sanofi,http://fichier-pdf.fr/2019/03/22/fichier-pdf-sans-nom-3,http://tn.sanofi.com/fr/mentions-legales,http://docplayer.fr/2615758-liste-et-contacts-des-entreprises-labellisees.html,,,,,,,,,,
medinfo.india@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,12,{first}.{last},,,,,,,,http://campus.sanofi/in/footer-links/contact-us,http://sanofi.in/en/science-and-innovation/specialty-care-product,http://sanofi.in/en,http://sanofi.in,http://rxindia.com/pharmacy-and-health/medical-devices/insulin-pens-and-injectors/allstar-reusable-insulin-pen,http://weekenddad.ca/blog/89f45f-sanofi-uk-head-office-address-vasotec,http://sanofi.in/en/science-and-innovation/pharmaceutical-products,http://sanofi.in/en/science-and-innovation/vaccine-products,http://intolife.in/contact,http://enterogermina.in/contacts,http://sanofiindialtd.com,http://sanofiindialtd.com/en,,,,,,,,,,,,,,,,,
iepharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,17,{first}.{last},,,,,,,,http://campus.sanofi/ie/events,http://campus.sanofi/ie/events/dyslipidaemia/dr-paddy-barrett-are-irish-patients-achieving-ldl-c-goals,http://campus.sanofi/ie/events/dyslipidaemia/ruth-agar-assessment-and-management-of-lipid-disorders,http://campus.sanofi/ie/patient-support,http://campus.sanofi/ie,http://sanofi.ie/en/contact,http://dupixent.co.uk/1/real-world-experience/southampton,http://dupixent.co.uk/1/dupixent,http://dupixent.co.uk/1/reimbursement,http://dupixent.co.uk/1/expert-hub,http://vtematters.ie/hcp/clexane-resources,http://migateway.eu/en/ie/434/sanofi,http://weekenddad.ca/blog/89f45f-sanofi-uk-head-office-address-vasotec,http://qr.epilimandme.ie/sitemap,http://vtematters.ie/sitemaintenance,http://sanofi.ie/en,http://sanofi.ie,,,,,,,,,,,,
communication.vn@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,15,{first}.{last},,,,,,,,http://nhathuocngocanh.com/thuong-hieu/sanofi,http://thanhnien.vn/phu-nu-sau-30-tuoi-lieu-co-qua-som-de-bo-sung-canxi-185230327175353449.htm,http://dvdn247.net/gioi-thieu-cong-ty-co-phan-sanofi-viet-nam,http://myhanoi.com.vn/hang-duoc-pham-sanofi,http://toptenvietnam.vn/thong-tin-doanh-nghiep/cong-ty-tnhh-sanofi-aventis-viet-nam-chart--1585-2021.html,http://itppharma.com/thuong-hieu/sanofi,http://profit500.vn/thong-tin-doanh-nghiep/cong-ty-cp-duoc-pham-sanofi-synthelabo-viet-nam-chart--1272-2021.html,http://hanimexchem.com/gioi-thieu-cong-ty-co-phan-sanofi-viet-nam,http://sanofi.com.vn/thong-tin-va-su-kien/tin-tuc-va-su-kien/thong-tin-quan-trong-ve-thuoc-plaquenil-va-dich-covid19,http://sanofi.com.vn/vi/thong-tin-va-su-kien/tin-tuc-va-su-kien/thong-tin-quan-trong-ve-thuoc-plaquenil-va-dich-covid19,http://2bacsi.webflow.io/bai-viet/alpha-choay,http://incontinet.com/alpha-choay,http://toptenvietnam.vn/thong-tin-doanh-nghiep/cong-ty-tnhh-sanofi-aventis-viet-nam-chart--1585-2019.html,http://sanofi.com.vn/vi/contact,http://baove24h.vn/danh-ba/list-danh-sach-cac-cong-ty-tai-quan-4.html,,,,,,,,,,,,,,
kapcsolat@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,23,{first}.{last},,,,,,,,http://elefantpatika.hu/category/blog/page/5,http://sanofi.hu/dam/jcr:8dfa4d1c-f6fb-4780-aac9-cef8eca4f8d9/sajt%c3%b3k%c3%b6zlem%c3%a9ny_civil%20szervezetk%c3%a9nt%20%c3%b6nk%c3%a9nteseket%20keresel_seg%c3%adt%20a%20sanofi_0316%20(1).pdf,http://sanofi.hu/dam/jcr:d429173a-923e-4a19-971c-2e1f2429845f/sanofi_vallalati_brossura_a4_final.pdf,http://contactmksz.hu/author/contactmunkatars/page/12,http://techworld.hu/2023/03/17/fizetett-szabadnapokon-onkenteskedhetnek-a-sanofi-dolgozoi,http://bilagit.hu/jogi-es-felhasznalasi-feltetelek,http://nospa.hu/jogi-es-felhasznalasi-feltetelek,http://orrdugulas.hu,http://magneb6.hu/kapcsolat.html,http://sanofi.hu/hu/fogyasztovedelem,http://sanofi.hu/hu/kapcsolat,http://sanofi.hu/hu/magunkrol/a-sanofi-magyarorszagon/elerhetoseg,http://elefantpatika.hu/2020/03/28/ibuprofen-alkalmassaga-a-covid-19-koronavirus-jarvany-tuneteinek-enyhiteseben,http://elefantpatika.hu/category/egyeb/page/2,http://elefantpatika.hu/ibuprofen-alkalmassaga-a-covid-19-koronavirus-jarvany-tuneteinek-enyhiteseben,http://smutitars.hu/kapcsolat,http://nospa.hu/kapcsolat,http://normaflore.hu/kapcsolat,http://hirarena.com/nemzetbiztonsagi-panasz-a-titkosszolgalatok-fele_1714,http://allegra.hu/jog-adatvedelem,http://allegra.hu/kapcsolat,http://algoflex.hu/kapcsolat,http://bilagit.hu/kapcsolat,,,,,,
pt-dados-pessoais@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,13,{first}.{last},,,,"",,,,http://campus.sanofi/pt/politica-privacidade,http://sanofi.pt/politica-de-privacidade-global-da-sanofi,http://buscopan.pt/politica-de-privacidade,http://sanofi.pt/pt/politica-de-privacidade-global-da-sanofi,http://telfast.pt/privacidade,http://prevenirtev.pt/politica-privacidade,http://stilnoite.pt/politica-de-privacidade,http://emonetooneportugal.pt/politica-de-privacidade,http://prevenirtev.pt/politica-de-cookies,http://mucosolvan.pt/politica-de-privacidade,http://bisolvon.pt/politica-de-privacidade,http://antistax.pt/politica-de-privacidade,http://pharmaton.pt/politica-de-privacidade,,,,,,,,,,,,,,,,
pv.india@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,10,{first}.{last},,,,,,,,http://campus.sanofi/in/footer-links/contact-us,http://vesect.com/article/all-you-need-to-know-about-combiflam-sanofi-india,http://sanofi.in/en,http://sanofi.in/en/science-and-innovation/specialty-care-product,http://sanofi.in/en/science-and-innovation/vaccine-products,http://weekenddad.ca/blog/89f45f-sanofi-uk-head-office-address-vasotec,http://sanofi.in/en/science-and-innovation/pharmaceutical-products,http://sanofiindialtd.com,http://sanofi.in,http://sanofiindialtd.com/en,,,,,,,,,,,,,,,,,,,
sanofi.russia@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,17,{first}.{last},,,,,,,,http://ru.sanofi.com/dam/jcr:3721d674-5cc4-4655-995b-64277dcae641/sanofi%20unveils%20new%20brand%2004022022_rus.pdf,http://ru.sanofi.com/dam/jcr:8ebd9b63-7e5d-4329-9431-26278f830ac0/pr_heart_is_essential.pdf,http://ru.sanofi.com/dam/jcr:d5b3ca97-5ecd-40a4-9666-ad13f7e74ff6/pr_kindred_blood.pdf,http://ru.sanofi.com/dam/jcr:f74c46f8-8674-4dc0-aff9-06c1e410a401/anzhela%20simakova%20appointed%20chairman%20of%20the%20sanofi%20management%20committee%20in%20the%20eurasian%20region.pdf,http://ru.sanofi.com/dam/jcr:f8a54e6c-7814-4b30-930f-1bf17c6899aa/topemployers0802rus.pdf,http://onco-conference.ru/congress2021,http://onco-conference.ru/congress2022,http://labazina.ru/press/p114807.html,http://sk.ru/news/zdoroveru-i-sanofi-pomogut-pacientam-s-atopicheskim-dermatitom-i-bronhialnoy-astmoy,http://labazina.ru/press/p115352.html,http://philanthropy.ru/novosti-organizatsij/2021/12/10/109854,http://bloodjournal.ru/press-reliz-kompanii-sanofi,http://labazina.ru/press/p113656.html,http://labazina.ru/press/p114914.html,http://labazina.ru/press/p115185.html,http://inthepress.ru/press/p345383.html,http://ztema.ru/soobshestvo/blogs/9564-beregite-svoe-serdce,,,,,,,,,,,,
agnes.gougeon-chamayou@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,5,{first}.{last},,,,,,,,http://cdurable.info/special-reporting-rse.html,http://cdurable.info/rapports-developpement-durable-2014-de-campus-collectivites-et-entreprises.html,http://cdurable.info/special-financement-innovation-et-developpement-durable.html,http://cdurable.info/special-reporting-des-entreprises,http://cdurable.info/special-dialogue-avec-les-parties-prenantes.html,,,,,,,,,,,,,,,,,,,,,,,,
quality.info@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,30,{first}.{last},,,Support,,,,,http://alcojet.ru/total/hlorprotiksen-instrukciya-po-primeneniyu-moshchnyi-neiroleptik-hlorprotiksen.html,http://nomens.ru/hu/lekarstvennyi-preparat-baralgin-baralgin-moshchnyi-udar-po-boli-ili-pochemu-my,http://nomens.ru/lekarstvennyi-preparat-baralgin-baralgin-moshchnyi-udar-po-boli-ili-pochemu-my,http://nomens.ru/lt/lekarstvennyi-preparat-baralgin-baralgin-moshchnyi-udar-po-boli-ili-pochemu-my,http://nomens.ru/sl/lekarstvennyi-preparat-baralgin-baralgin-moshchnyi-udar-po-boli-ili-pochemu-my,http://apteka.103.by/15485-magne-v6-forte-instruktsiya,http://apteka.103.by/essentciale-forte-n-instruktsiya,http://apteka.103.by/magne-b62-instruktsiya,http://apteka.103.by/plaviks-instruktsiya,http://esspro.ru/instrukciya-po-primeneniyu-immunoglobulina-antirabicheskogo,http://astronko.ru/psychology/sutochnaya-doza-baralgina-v-tabletkah-baralgin-instrukciya-po-primeneniyu-cena.html,http://diabetiki.kz/product/%d0%b2%d0%b8%d1%82%d0%b0%d0%bc%d0%b8%d0%bd-%d0%b5-400%d0%bc%d0%b3-%e2%84%9630,http://divemby.ru/about-about-chickenpox/eglonil-200-mg-eglonil---instrukciya-po-primeneniyu-opisanie.html,http://diabetiki.kz/product/%d0%b0%d0%bd%d1%82%d0%b8-%d0%b1%d0%b8%d1%82-%d1%88%d0%b0%d0%bc%d0%bf%d1%83%d0%bd%d1%8c-150-%d0%bc%d0%bb,http://diabetiki.kz/product/%d0%b1%d0%b0%d1%80%d0%b0%d0%bb%d0%b3%d0%b8%d0%bd-%d0%bc-%e2%84%9620,http://diabetiki.kz/product/%d1%8d%d0%bd%d1%82%d0%b5%d1%80%d0%be%d0%b6%d0%b5%d1%80%d0%bc%d0%b8%d0%bd%d0%b0-%e2%84%9612-%d0%ba%d0%b0%d0%bf%d1%81,http://diabetiki.kz/product/%d1%8d%d1%81%d1%81%d0%b5%d0%bd%d1%86%d0%b8%d0%b0%d0%bb%d0%b5-%d0%bd-5%d0%bc%d0%bb-%e2%84%965-%d0%b0%d0%bc%d0%bf,http://2s5.ru/ar/drugs/eglonil-50-v-kapsulah-instrukciya-po-primeneniyu-instrukciya-po,http://2s5.ru/hy/mums/insuman-rapid-gt---instrukciya-po-primeneniyu-insuman-rapid-gt,http://aptk.kz/lekarstvennye-sredstva-i-bad/pishchevarenie-i-pechen/preparaty-pri-gastrite-i-yazve/gastrosidin-40-mg-30-tabletki,http://aptk.kz/lekarstvennye-sredstva-i-bad/vitaminy-mineraly/vitamin-e/vitamin-e-400-mg-30,http://tuta24.ru/product/13032,http://tuta24.ru/product/8949,http://arkansasfoodies.com/article/gebruiksaanwijzing-indicaties-andere-namen-furosemide-46567,http://apteka.103.by/guttalaks-instruktsiya,http://rxeli.com/p/15-ml-of-maalox-30s-oral-suspension-dosage,http://dobraya-apteka.kz/product/11218/lozap-plyus-50mg-12-5mg-30_11218,http://dobraya-apteka.kz/product/33931670/lazolvan-15mg-2ml-100ml-d-priema-vnutry-r-r_33931670,http://dobraya-apteka.kz/product/33935637/enterozhermina-forte-4-mlrd-5ml-5-ml-10-susp--dlya-priema-vnutry_33935637,http://dobraya-apteka.kz/product/490882/bronhikum-s-sirop-100ml
uk-drugsafety@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,25,{first}.{last},,,,,,,,http://campus.sanofi/dam/jcr:e850a465-f5b0-4275-97ec-27a46126aa54/myozyme.pdf,http://campus.sanofi/uk/coming-soon,http://epilepsysociety.org.uk/news/medication-updates,http://medicines.org.uk/emc/rmm/293/document,http://sps.nhs.uk/articles/reporting-suspected-covid-19-vaccine-side-effects-product-defects-and-counterfeit-products,http://sanofi.co.uk/dam/jcr:d9692153-06ca-44fe-95db-2e43d13421c3/valproate%20rmms%202021%20uk%20distribution%20hcp%20booklet.pdf,http://sanofi.co.uk/en/contact,http://sanofipasteur.co.uk/flu/docs/087_revaxis_price_increase_01_2018_uk.pdf,http://sanofipasteur.co.uk/flu/docs/093_typhim_price_increase_01_2018_uk.pdf,http://sanofipasteur.co.uk/flu/docs/105_stamaril_mah_address_update_12_2017_uk.pdf,http://sanofipasteur.co.uk/flu/docs/139_avaxim_breastfeeding_update_05_2018_uk.pdf,http://sanofipasteur.co.uk/flu/docs/150_viatim_price_increase_01_2018_uk.pdf,http://sanofi.co.uk/en/about-us/sanofi-in-the-uk/contact-us,http://dupixent.co.uk/1/real-world-experience/southampton,http://dupixent.co.uk/1/dupixent,http://dupixent.co.uk/1/reimbursement,http://dupixent.co.uk/1/expert-hub,http://diabetesmatters.co.uk/sanoficares,http://domainc.co.uk/site/sanofi.co.uk,http://campus.sanofi/uk,http://clexanepatientsupport.co.uk,http://vtematters.co.uk/hcp,http://migateway.eu/en/gb/21/sanofi,http://sanofi.co.uk/en/other-legal-notices/direct-to-pharmacy-terms-conditions-of-sale,http://sanofi.co.uk/en/other-legal-notices/terms-conditions-of-sale,,,,
gb-customerservices@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,14,{first}.{last},,,Support,,,,,http://cpe.org.uk/dispensing-and-supply/supply-chain/manufacturer-contingency-arrangements,http://care4quality.co.uk/class-2-medicines-recall-aventis-pharma-limited-t-a-sanofi-stemetil-5mg-5ml-syrup-el22a-41,http://psnc.org.uk/dispensing-and-supply/supply-chain/manufacturer-contingency-arrangements,http://dispensingdoctor.org/news/stemetil-syrup-recall-and-supply-stoppage,http://dispex.net/class-2-medicines-recall-aventis-pharma-limited-t-a-sanofi-stemetil-5mg-5ml-syrup-el22a-41,http://dispex.net/class-2-medicines-recall-various-marketing-authorisation-holders-and-parallel-distributor-companies-irbesartan-containing-products-el21a-34,http://dispex.net/class-2-medicines-recall-various-marketing-authorisation-holders-and-parallel-distributor-companies-irbesartan-containing-products-el21a-34-2,http://dispex.net/class-2-medicines-recallvarious-marketing-authorisation-holders-and-parallel-distributor-companies-irbesartan-containing-products-el-21a-19,http://dispensingdoctor.org/news/three-recalls,http://gov.uk/drug-device-alerts/class-2-medicines-recall-mollipaxin-100-mg-capsules-one-batch,http://gov.uk/drug-device-alerts/drug-alert-brochlor-1-w-w-eye-ointment-issue-with-seal-integrity-and-compromised-sterility-assurance,http://uhcw.nhs.uk/bam/drug-treatments-in-bam,http://psnc.org.uk/dispensing-supply/supply-chain/manufacturer-contingency-arrangements,http://psnc.org.uk/dispensing-supply/supply-chain/manufacturer-contingency-arrangements/,,,,,,,,,,,,,,,
cz-info@sanofi.com,sanofi.com,Sanofi,,,,,,90,generic,30,{first}.{last},,,Support,,,,,http://dermatologiepropraxi.cz/incpdfs/act-000320-0001_10_001.pdf,http://urologiepropraxi.cz/incpdfs/act-000320-0001_10_001.pdf,http://solen.cz/incpdfs/act-000320-0001_10_001.pdf,http://civilky.cz/aktuality/2016/09/sukl-upozornuje-na-zavadnou-jakost-nekterych-leku,http://asklepionkamyk.cz/masaze/casto-nemirime-k-lekari-ale-rovnou-do-lekarny-delame-chybu.html,http://asklepionkamyk.cz/masaze/koronavirus-k-podpurne-lecbe-covid-19-se-vyuzivaji-i-volne-dostupne-leky.html,http://campus.sanofi/cz,http://campus.sanofi/cz/login,http://campus.sanofi/cz/podpora-pacienta,http://campus.sanofi/cz/products,http://campus.sanofi/cz/science,http://sanofi.cz/cs/produktove-informace,http://csnn.eu/casopisy/ceska-slovenska-neurologie/2017/dokumenty/31-cesky-a-slovensky-neurologicky-sjezd-29-cesko-slovensky-epileptologicky-sjezd-brno-22-25-11-2017-33,http://csnn.eu/en/journals/czech-and-slovak-neurology-and-neurosurgery/2017/documents/31-cesky-a-slovensky-neurologicky-sjezd-29-cesko-slovensky-epileptologicky-sjezd-brno-22-25-11-2017-33,http://ibalgin.cz/kontakt.html,http://psychiatriepropraxi.cz/incpdfs/act-000320-0001_10_001.pdf,http://internimedicina.cz/incpdfs/act-000320-0001_10_001.pdf,http://casopisendoskopie.cz/incpdfs/act-000320-0001_10_001.pdf,http://nonstop-lekarna.cz/adenocor-165/pribalovy-letak,http://nonstop-lekarna.cz/adenocor-165/souhrn-udaju,http://nonstop-lekarna.cz/deniban-1748/pribalovy-letak,http://nonstop-lekarna.cz/muxoangin-med-a-citron-4486/pribalovy-letak,http://nonstop-lekarna.cz/muxoangin-med-a-citron-4486/souhrn-udaju,http://sanofi.cz/cs/o-nas/kde-nas-najdete,http://zdravotnickydenik.cz/2016/09/zentiva-stahuje-z-ceskeho-trhu-110-tisic-krabicek-leku-chtel-ji-nekdo-poskodit,http://sanofi.cz/cs/o-nas/sanofi-pasteur,http://sanofi.cz/o-nas/sanofi-pasteur/sanofi-pasteur-v-cr,http://medipool.cz/2016/09/stahuji-se-bezne-leky-z-urovne-pacientu-atram-125-neurol-025-neurol-05-oxazepam-a-prednison-20-jejich-baleni-mohou-obsahovat-jiny-lek,http://vozejkov.cz/cz/aktuality/zdravi-2/avizo-sukl-na-jakost-leku,http://sanofi.cz/cs/o-nas/sanofi-pasteur/sanofi-pasteur-v-cr
sac.brasil@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,30,{first}.{last},,,,,,,,http://suppliers.sanofi.com/statics/pdfs/tc_sanofi_brazil.pdf,http://precomedicamentos.com.br/medicamentos/dupixent-175mg-ml-caixa-com-2-seringas-preenchidas-com-114ml-de-solucao-de-uso-subcutaneo-sistema-seguranca,http://precomedicamentos.com.br/medicamentos/dupixent-300mg-caixa-com-2-seringas-preenchidas-com-2ml-de-solucao-de-uso-subcutaneo-sistema-de-seguranca,http://precomedicamentos.com.br/medicamentos/praluent-150mg-ml-1-seringa-preenchida-1ml-solucao-subcutaneo-1-caneta-aplicadora,http://precomedicamentos.com.br/medicamentos/praluent-75mg-ml-2-seringas-preenchidas-1ml-solucao-subcutaneo-2-canetas-aplicadoras,http://consultaremedios.com.br/dupilumabe/pa,http://farmadelivery.com.br/analgesico-dorflex-sanofi-36-comprimidos-25827/p,http://farmadelivery.com.br/analgesico-dorflex-uno-1g-enxaqueca-20-comprimidos-27973793/p,http://farmadelivery.com.br/antialergico-allegra-120mg-sanofi-10-comprimidos-2530/p,http://farmadelivery.com.br/multivitaminico-pharmaton-complex-imunidade-e-energia-60caps-28070/p,http://farmadelivery.com.br/pharmaton-50--c--60-capsulas-27966980/p,http://sanofi.com.br/pt/fale-conosco,http://sanofi.com.br/pt/mencoes-legais,http://sanofi.com.br/pt/quem-somos/noticias/informacoes-de-produto/2020-02-06-valpakine,http://sanofi.com.br/pt/quem-somos/noticias/releases/2021-12-15-sistemas-seguranca-clexane,http://sanofi.com.br/pt/quem-somos/noticias/releases/2022-01-12--descontinuacao-produto-clexane,http://precomedicamentos.com.br/public/medicamentos/praluent-150mg-ml-1-seringa-preenchida-1ml-solucao-subcutaneo-1-caneta-aplicadora,http://oncomg.com.br/dupixent-175mgml-dupilumabe-114ml-200mg,http://nuonhealth.com.br/anvisa-alerta-sobre-medicamento-falsificado,http://m2farma.com/blog/anvisa-alerta-sobre-medicamento-falsificado,http://saudeemtela.com/anvisa-alerta-sobre-falsificacao-de-medicamento-para-esclerose-multipla,http://paraibaempauta.com.br/noticia/68587/anvisa-alerta-para-venda-de-remedio-falso-para-esclerose-multipla.html,http://seusfolhetos.com.br/farmacias-descontao-ofertas/folheto-644994-13,http://diviweb.com.br/anvisa-alerta-sobre-falsificacao-de-medicamento-para-esclerose-multipla,http://programaviva.com.br/contato/fale-conosco,http://cvpvacinas.com.br/descubra-a-atualizacao-da-indicacao-da-vacina-contra-dengue-dengvaxiar,http://panoramafarmaceutico.com.br/anvisa-alerta-sobre-medicamento-falsificado,http://buladeremedio.net/sanofi_aventis_farmaceutica_ltda/0/actonel,"http://salvadornoticias.com.br/noticias/11/105086,anvisa-suspende-lote-de-medicamento-para-esclerose-multipla-falsificado.html",http://jovemnamidia.com.br/2023/04/03/anvisa-suspende-lote-de-medicamento-para-esclerose-multipla-falsificado
tilmann.kiessling@sanofi.com,sanofi.com,Sanofi,,,,,,90,personal,25,{first}.{last},,,Writing & communication,Journalist,,,,http://cardiobrief.org/2012/06/11/basal-insulin-and-omega-3-fatty-acids-fail-to-improve-outcomes-in-diabetics-and-prediabetics,http://mif-ua.com/archive/article/34886,http://en.prnasia.com/releases/global/more_patients_with_type_2_diabetes_reach_hba_1c_target_with_apidra_r_on_top_of_lantus_r_than_with_twice_daily_aspart_premixed_insulin_-50869.shtml,http://en.antaranews.com/news/75633/more-patients-with-type-2-diabetes-reach-hba1c-target-with-apidrar-on-top-of-lantusr,http://en.antaranews.com/news/78214/impact-of-early-insulin-initiation-on-glycemic-control-in-asian-people-with-type-2-diabetes,http://newswire.ca/news-releases/sanofi-announces-positive-phase-3-results-for-toujeo-insulin-glargine-rdna-origin-injection-300-uml-in-japanese-people-with-uncontrolled-diabetes-514455631.html,http://sanofi.com/en/media-room/press-releases/2015/2015-06-06-21-01-00,http://lerevenu.com/breves/la-fda-accepte-lexamen-du-dossier-de-linsuline-basale-toujeor-de-sanofi,http://news.europawire.eu/sanofis-investigational-therapy-toujeo-consistently-showed-significantly-fewer-low-blood-sugar-events-compared-with-lantus-097654321234567890/eu-press-release/2014/06/16,http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/la-fda-approuve-toujeo-l-insuline-basale-de-sanofi-en-une-prise-par-jour,http://europapress.es/comunicados/empresas-00908/noticia-comunicado-impact-of-early-insulin-initiation-on-glycemic-control-in-asian-people-with-type-diabetes-20111205141254.html,http://mynewsdesk.com/se/sanofi/pressreleases/origin-results-on-lantus-r-cardiovascular-safety-integrated-into-european-union-product-label-874651,http://mynewsdesk.com/se/sanofi/pressreleases/sanofi-announces-positive-phase-3-results-for-investigational-new-insulin-u300-879640,http://presseportal.ch/de/pm/100053495/100757392,http://presseportal.ch/de/pm/100053495/100744455,http://presseportal.ch/de/pm/100007059/100703709,http://presseportal.ch/de/pm/100053495/100757678,http://presseportal.ch/de/pm/100007059/100709467,http://bio-medicine.org/biology-technology-1/new-epidemiological-data-provide-additional-safety-evidence-for-lantus-ae-22365-1,http://prnewswire.com/news-releases/new-epidemiological-data-provide-additional-safety-evidence-for-lantus-158480825.html,http://bio-medicine.org/medicine-technology-1/sanofi-announces-positive-phase-3-results-for-investigational-new-insulin-u300-34049-1,http://prnewswire.com/news-releases/lantus-initiation-after-metformin-achieved-superior-glycemic-control-versus-sitagliptin-in-type-2-diabetes-158293685.html,http://prnewswire.com/news-releases/sanofi-reports-positive-phase-3-results-for-toujeo-insulin-glargine-rdna-origin-injection-300-uml-263155011.html,http://biospace.com/news/sanofi-france-announces-positive-phase-3-results/300896,http://globenewswire.com/news-release/2014/06/14/644127/10085774/en/sanofi-reports-positive-phase-3-results-for-toujeo-r.html,,,,
chris.rucker@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Chris,Rucker,,,,,,http://greencroftclub.com/documents/20124/49188/april+2023+newsletter.pdf/741be2fb-fa69-b21e-6cab-1fe0fd701e67,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kin.wong@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Kin,Wong,,,,,,http://wcacc.org/exhibitorshowcase/sanofi_06.03.23.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dongil.shin@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Shin,Dongil,,,,,,http://superookie.com/jobs/649976628b129f04785ea1fe,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sophie.pallardy@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Sophie,Pallardy,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.18-0534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
matthias.gossel@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Matthias,Gossel,,,,,,http://immuniverse.eu/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ana.casares@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Ana,Casares,,,,,,http://sanofi.com.co/dam/jcr:c58c50ae-bffe-4e53-a5b1-589bb1c05d26/comunicacion%20directa%20para%20el%20profesional%20de%20la%20salud.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.vega@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Alexandra,Vega,,,,,,http://sanofi.com.co/dam/jcr:c58c50ae-bffe-4e53-a5b1-589bb1c05d26/comunicacion%20directa%20para%20el%20profesional%20de%20la%20salud.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
naouel.tamazight@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Naouel,Tamazight,,,,,,http://sanofi.dz/dam/jcr:3156d5a5-b06d-492b-9af3-9b3765f30133/cp17.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pascal.fremont@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Pascal,Fremont,,,,,,http://cftc-cmte.fr/app/download/11285842/la+comete+n%c2%b055.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
naoki.kobayashi@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Naoki,Kobayashi,,,,,,http://dm-net.co.jp/event/2023/037282.php,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lars.meese@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Lars,Meese,,,,,,http://sanofi.de/dam/jcr:c713dc6c-6cc0-49ec-8c92-be56b6d4b740/newsletter-standort-gesundheit_januar-2020.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
helene.bricout@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Helene,Bricout,,,,,,http://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-13433-0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
giuseppe.secchi@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Giuseppe,Secchi,,,,,,http://assobiotec.federchimica.it/docs/default-source/default-document-library/0930-programma-ebw-2020finaleaa78676265c4fec80167667934aa40e.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marius.bosman@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Marius,Bosman,,,,,,http://irenerunner.co.za/uploads/7/9/8/1/7981210/irene_news__21_oct_13_____no_42_2013.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lucile.plourde@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Lucile,Plourde,,,,,,http://a3p.org/it/enumeration-viable-microorganisms,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cathy.marquez@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Cathy,Marquez,,,,,,http://eloctate.com/resources/spanish,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alexandra.abreu@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Alexandra,Abreu,,,,,,http://eloctate.com/resources/spanish,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michelangelo.canzoneri@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Michelangelo,Canzoneri,,,,,,http://ispe.org/pharmaceutical-engineering/july-august-2017/ispe-europes-biotech-portfolio,,,,,,,,,,,,,,,,,,,,,,,,,,,,
melissa.jiles@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Melissa,Jiles,,,,,,http://nccalliance.org/ncca-practices/ncca-practices-table-copy,,,,,,,,,,,,,,,,,,,,,,,,,,,,
angel.guess@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Angel,Guess,,,,,,http://hfmich.org/resources-pharmaceuticals-and-homecare,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pascal.billot@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Pascal,Billot,,,,,,http://allfordrugs.com/cocrystals,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sri-china@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,2,{first}.{last},Sri,China,,,,,,http://sanofi.com/en/science-and-innovation/collaboration-and-awards/china,http://sanofi.com/fr/science-et-innovation/collaboration-et-awards/chine,,,,,,,,,,,,,,,,,,,,,,,,,,,
maurice.auguste@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Maurice,Auguste,,,,,,http://a4ws.org/training/professional-credentialing-directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
liz.xiang@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Liz,Xiang,,,,,,http://isjtu.cn/thread-132084-1-196.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joseluis.garcia@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Joseluis,Garcia,,,,,,http://sanofi.com.mx/es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,,,
terence.sharpe@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Terence,Sharpe,,,,,,http://corcareeducation.com,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.langer@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Thomas,Langer,,,,,,http://academic.oup.com/peds/article-abstract/doi/10.1093/protein/gzaa026/5959880,,,,,,,,,,,,,,,,,,,,,,,,,,,,
annick.moureau@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Annick,Moureau,,,,,,http://mymedr.afpm.org.my/publications/66953,,,,,,,,,,,,,,,,,,,,,,,,,,,,
werner.kramer@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Werner,Kramer,,,,,,http://imi.europa.eu/projects-results/catalogue-project-tools,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shawn.holland@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Shawn,Holland,,,,,,http://christthesavior.org/connect/join-a-group,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joseph.devaney@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Joseph,Devaney,,,,,,http://housecleaningday.blogspot.com/2013/03/total-house-cleaning-sanofi-aventis-u-s.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
corey.robertson@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Corey,Robertson,,,,,,"http://journals.lww.com/pidj/fulltext/2019/03000/safety_and_immunogenicity_of_a_full_dose,.26.aspx",,,,,,,,,,,,,,,,,,,,,,,,,,,,
veronica.cunningham@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Veronica,Cunningham,,,,,,http://cdestudycourse.com/video-presentations,,,,,,,,,,,,,,,,,,,,,,,,,,,,
takayuki.kimura@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Takayuki,Kimura,,,,,,http://jaden1996.com/workshop/application_2014.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joachim.heppner@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Joachim,Heppner,,,,,,http://worldslargestgolfouting.com/wlgo-team/royce-brook-golf-club/6089025585237721088,,,,,,,,,,,,,,,,,,,,,,,,,,,,
takeshi.morita@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Takeshi,Morita,,,,,,http://jaden1996.com/workshop/application_2012.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zsuzsanna.kardos@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Zsuzsanna,Kardos,,,,,,http://ch.bme.hu/hirek/645-hermecz-istvan-emlekdelutan,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yasuko.hashi@sanofi.com,sanofi.com,Sanofi,,,,,,89,personal,1,{first}.{last},Yasuko,Hashi,,,,,,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sylvie.uhlrich@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Sylvie,Uhlrich,,,,,,http://iabs.org/documents/2023-meetings-and-webinars/reference-standards-ottawa/e-book-reference-standards-meeting-ottawa-2023,,,,,,,,,,,,,,,,,,,,,,,,,,,,
liliana.gomez@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Liliana,Gomez,,,,,,http://eloctate.com/resources/spanish,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christian.viskov@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Christian,Viskov,,,,,,http://portlandpress.com/biochemj/article/449/2/343/46590/an-unusual-antithrombin-binding-heparin,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thomas.kehl@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Thomas,Kehl,,,,,,http://healthpolicy-online.de/archiv/2012-und-aelter/ma-hp-06-13/at_download/file,,,,,,,,,,,,,,,,,,,,,,,,,,,,
carina.frago@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Carina,Frago,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.18-0534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
iga.jablonka@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Iga,Jablonka,,,,,,http://campus.sanofi/pl/prawny/nota-prawna,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eva.lin@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Eva,Lin,,,,,,http://news.galengrowth.com/sanofi-partners-with-health2sync-to-deliver-an-innovative-digital-solution-to-patients-and-healthcare-providers-paving-the-way-for-digital-therapeutics-in-diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fernando.noriega@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Fernando,Noriega,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.18-0534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
angus.thomson@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Angus,Thomson,,,,,,http://profgaelle.com/files/thomson2018.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
silvina.fotia@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Silvina,Fotia,,,,,,http://notedescuides.com.ar/alergias-de-piel,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hege.hagen@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,2,{first}.{last},Hagen,Hege,,,,,,http://nyemetoder.no/documents/bestillerforum%20rhf%20-%20%28%20innkallinger%20og%20referater%29/bestillerforum%20rhf.%20offentlig%20utgave%20av%20sakspapirene.pdf,http://nyemetoder.no/documents/bestillerforum%20rhf%20-%20%28%20innkallinger%20og%20referater%29/offentlig%20sakspapirer%20bestillerforum%20rhf%2023.09.2019_redigert%20bort%20bunntekst.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
clara.tarrero@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Clara,Tarrero,,,,,,http://sanofi.es/dam/jcr:6770a9a3-4c3e-4755-bcc4-cfaf3b63e05f/ndp_hub_barcelona_100_nuevas_incorporaciones_2022.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
carrie.koenig@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Carrie,König,,,,,,http://hfmonline.org/product-manufacturers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
benoit.lemelin@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Benoit,Lemelin,,,,,,http://ispecanada.org/product/benoit-lemelin,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wendy.banh@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Wendy,Banh,,,,,,http://ispecanada.org/product/wendy-banh,,,,,,,,,,,,,,,,,,,,,,,,,,,,
volker.schellenberger@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Volker,Schellenberger,,,,,,http://acir.org/journal-articles/not%20available%20in%20pubmed,,,,,,,,,,,,,,,,,,,,,,,,,,,,
freddie.henriksson@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Freddie,Henriksson,,,,,,http://isl-forum.se/2021/06/07/kommissionen-vara-fyra-viktigaste-forslag-for-god-tillgang-sallsynta-lakemedel,,,,,,,,,,,,,,,,,,,,,,,,,,,,
peter.hecht@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Peter,Hecht,,,,,,http://biomap-imi.eu/network/industry-partners/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
andre.deister@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Andre,Deister,,,,,,http://gmp-publishing.com/content/en/gmp-news/gmp-newsletter/gmp-logfile-lead-article/d/1552/gmp-logfile-39-packaging-materials-testing-role-of-your-suppliers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sabine.froehlich@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Sabine,Fröhlich,,,,,,http://emsp.org/ukrainian-residents-with-ms-relocating-to-germany-country-specific-information,,,,,,,,,,,,,,,,,,,,,,,,,,,,
attila.tar@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Attila,Tar,,,,,,http://docplayer.fr/2790963-liste-des-medecins-francophones.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ashley.koss@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Ashley,Koß,,,,,,http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-new-data-on-dupixent-dupilumab-for-moderate-to-severe-atopic-dermatitis-at-upcoming-medical-congresses-300413658.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
edu.moura@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Edu,Moura,,,,,,http://peeplookup.com/email-search,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rana.rukab@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Rana,Rukab,,,,,,http://ce.mayo.edu/content/exhibitor-sanofi-genzyme-virtual-exhibit-hall-hematology-review-2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,
linda.lie@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Linda,Lie,,,,,,http://legeforeningen.no/foreningsledd/fagmed/norsk-forening-for-dermatologi-og-venerologi/aktuelt/2020/webinar-i-easi-skaring,,,,,,,,,,,,,,,,,,,,,,,,,,,,
astrid.villa@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Astrid,Villa,,,,,,http://vcccolombia.com/courses/16-encuentro-latinoamericano-de-cirujanos-de-cadera-y-de-rodilla/lessons/muestra-comercial-elccr/topic/stand-sanofi-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,
micheal.stager@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Micheal,Stager,,,,,,http://worldslargestgolfouting.com/wlgo-team/royce-brook-golf-club/6089025656374493184,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mathew.chamberlain@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Mathew,Chamberlain,,,,,,http://dirk.eddelbuettel.com/cranberries/cran/new,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anne.moeller@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Anne,Möller,,,,,,http://legeforeningen.no/foreningsledd/fagmed/norsk-forening-for-dermatologi-og-venerologi/aktuelt/2020/sanofi-inviterer-til-tverrfaglig-symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,
agnes.caillaud@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Agnes,Caillaud,,,,,,http://pharmandcie.fr/2019/07/16/alternant-charge-de-validation-sanofi-le-trait-normandie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
caroline.petit@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Caroline,Petit,,,,,,http://sfds.asso.fr/newsletter-1308-a8835742b7dfa2344509ceeea273964f,,,,,,,,,,,,,,,,,,,,,,,,,,,,
faizan.khan@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Faizan,Khan,,,,,,http://ojobo.blogspot.com/2013/09/internees-required-at-hse-dept-at-sanofi.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chami.moon@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Moon,Chami,,,,,,http://sanofi.co.kr/ko/newsroom/notice/20150605,,,,,,,,,,,,,,,,,,,,,,,,,,,,
patricia.clare@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Patricia,Clare,,,,,,http://frugalbits.com/how-to-do-your-own-microdermabrasion-treatments-using-neostrata-skin-resurfacing-du,,,,,,,,,,,,,,,,,,,,,,,,,,,,
annick.josse@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Annick,Josse,,,,,,http://echosciences-sud.fr/communautes/fete-de-la-science-occitanie/articles/fete-de-la-science-en-occitanie-ouverture-de-laboratoires,,,,,,,,,,,,,,,,,,,,,,,,,,,,
satoshi.nagaoka@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Satoshi,Nagaoka,,,,,,http://jaden1996.com/workshop/application_2014.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joseph.duffy@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Joseph,Duffy,,,,,,http://worldslargestgolfouting.com/wlgo-team/royce-brook-golf-club/6089025585237721088,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ryo.arakawa@sanofi.com,sanofi.com,Sanofi,,,,,,88,personal,1,{first}.{last},Ryo,Arakawa,,,,,,http://jaden1996.com/workshop/application/application_2017_chugoku.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
guy.houillon@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Guy,Houillon,,,,,,http://iabs.org/documents/2019-meetings-and-webinars/towards-rabies-elimination-in-asia-pacific/ebook-rabies-2019-v15,,,,,,,,,,,,,,,,,,,,,,,,,,,,
beth.koch@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Beth,Koch,,,,,,http://actoonline.org/membership-account/directory,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jonathan.josephs@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Jonathan,Josephs,,,,,,http://asms.org/docs/default-source/workshop-reports/2019-dmpk-report.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.kramer@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Daniel,Kramer,,,,,,http://e-i-p.eu/media/pages/symposiums/2019-lisbon/a65d460df2-1640619054/veerle-snoeck.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pauline.bros@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Pauline,Bros,,,,,,http://e-i-p.eu/media/pages/symposiums/2017-lisbon/7156d0617b-1644227750/gilles-miscoria.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicolas.schwarz@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Nicolas,Schwarz,,,,,,http://sanofi.no/dam/jcr:a4e407c5-9354-44c5-9915-96584e754b92/mat-no-2200322%20v0.1-07.2022_metodenotat%202021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nicholas.jackson@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Nicholas,Jackson,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.18-0534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
heiner.gertzen@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Heiner,Gertzen,,,,,,http://therqamgt.com/uploads/2/9/2/2/29228847/membership_satisfaction_survey_full_2015.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julian.gonzalez@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Julian,Gonzalez,,,,,,http://amcham.com.ar/2023/04/24/evitemos-que-la-gripe-nos-sorprenda-este-ano/12467,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pinar.kaya@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Pinar,Kaya,,,,,,http://sanofi.com.tr/dam/jcr:4b291cb4-2ccc-4ab0-bc2a-035326bccf58/sanofi-surdurulebilirlik-raporu-2021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
irene.chou@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Irene,Chou,,,,,,http://sanofi.com.tw/dam/jcr:683ff479-147b-46b4-bd4c-6de8fa9aa6b9/20220209_.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
frances.mauro@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Frances,Mauro,,,,,,http://izsummitpartners.org/content/uploads/2018/04/sanofi-program-flyer-18-04-25.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chaim.vandenberghe@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Chaim,Vandenberghe,,,,,,http://mysanofi.be/nl-be/diabetes-time-in-range-up,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rita.vicente@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Rita,Vicente,,,,,,http://femmesetsciences.fr/_files/ugd/5836fc_c7aa860334c94f0faa52528548669f21.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kiyoko.uno@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Kiyoko,Uno,,,,,,http://atherosclerosis-journal.com/article/s0021-9150(18)31168-7/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rosemary.thompson@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Rosemary,Thompson,,,,,,http://thenortherngroup.co.uk/colne-horticultural-society,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maureen.baker@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Maureen,Baker,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dariusz.figura@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Dariusz,Figura,,,,,,http://sanofidlaaptek.pl/zmiana-modelu-kana%c5%82u-interwencyjnego-us%c5%82ugi-zaopatrzenia-detalicznego-i-czasowe-wstrzymanie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marta.labena@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Marta,Labena,,,,,,http://sadar.org/evento/dupilumab-la-nueva-diana-terapeutica-para-el-asma-grave-papel-de-la-il-4-y-il-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marine.bonne@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Marine,Bonne,,,,,,http://ambertlivradoisforez.fr/actualites/semaine-de-lindustrie-des-rendez-vous-pour-promouvoir-le-tissu-industriel-local,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christina.bailey@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Christina,Bailey,,,,,,http://journal.pda.org/content/early/2022/02/15/pdajpst.2021.012722,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ross.martin@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Ross,Martin,,,,,,http://nnpdf.org/2021/03,,,,,,,,,,,,,,,,,,,,,,,,,,,,
martina.ochs@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Martina,Ochs,,,,,,http://umcgresearch.org/w/griac-will-participate-in-inno4vac-a-new-european-public-private-partnership-to-innovate-vaccine-development,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dolores.barrero@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Dolores,Barrero,,,,,,http://ivoox.com/diabetes-tiempos-del-covid-19-audios-mp3_rf_49933874_1.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joshua.nealon@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Joshua,Nealon,,,,,,http://mymedr.afpm.org.my/publications/66953,,,,,,,,,,,,,,,,,,,,,,,,,,,,
heinz.haenel@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Heinz,Hänel,,,,,,http://uni-giessen.de/faculties/f09/institutes/nutrition/biochemistry/druid/organization/scientific-advisory-board,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thais.azevedo@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Thais,Azevedo,,,,,,http://conass.org.br/estao-abertas-as-inscricoes-para-o-7o-premio-inovacao-medical-services-da-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jean-marc.herbert@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Jean,Herbert,,,,,,http://thieme-connect.de/products/ejournals/abstract/10.1055/s-0037-1615196,,,,,,,,,,,,,,,,,,,,,,,,,,,,
monica.garcia@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Monica,Garcia,,,,,,http://carreraprofesional.org/2011/12/becarios-y-la-confusion-por-la.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jean-luc@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Jean,Luc,,,,,,http://cooperationsante.fr/colloques-et-sante,,,,,,,,,,,,,,,,,,,,,,,,,,,,
helene.ferrand@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Helene,Ferrand,,,,,,http://sfds.asso.fr/newsletter-1245-bfdb6ee657e6d40bbd7b6a463cbdbb9d,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.tomczak@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Anna,Tomczak,,,,,,http://msonetoone.pl/node/27,,,,,,,,,,,,,,,,,,,,,,,,,,,,
takao.oda@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,2,{first}.{last},Oda,Takao,,,,,,http://jaden1996.com/workshop/application_2015.html,http://jaden1996.com/workshop/application_2016.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
hiroyuki.sugimoto@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Hiroyuki,Sugimoto,,,,,,http://jaden1996.com/workshop/application/application_2018_kanto.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
masahiro.sugawara@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Masahiro,Sugawara,,,,,,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
erwan.david@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Erwan,David,,,,,,http://slideshare.net/mongodb/sanofi-mongodbworld20140625final,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joseph.kim@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,1,{first}.{last},Joseph,Kim,,,,,,http://zarbi.chem.yale.edu/alumni.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ingrid.goerg-armbrecht@sanofi.com,sanofi.com,Sanofi,,,,,,87,personal,8,{first}.{last},Ingrid,Armbrecht,,,,,,http://oncowikia.blogspot.com/2011/07,http://oncowikia.blogspot.com/2011/07/sarilumab-succeeds-in-treating.html,http://oncowikia.blogspot.com/search/label/rheumatoid%20arthritis,http://oncowikia.blogspot.com/search/label/sarilumab,http://oncowikia.blogspot.com/search/label/ankylosing%20spondylitis,http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-report-positive-phase-2b-trial-results-with-sarilumab-in-rheumatoid-arthritis-18731-1,http://biospace.com/News/sanofi-france-regeneron-pharmaceuticals-inc-s/226743,http://biospace.com/news/sanofi-france-regeneron-pharmaceuticals-inc-s/226743,,,,,,,,,,,,,,,,,,,,,
allena.ji@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,2,{first}.{last},,,,,,,,http://gavinpublishers.com/article/view/a-novel-and-sensitive-lc-ms-ms-method-for-quantitation-of-pyochelin-in-human-sputum-samples-from-cystic-fibrosis-patients,http://gavinpublishers.com/assets/articles_pdf/1564644819article_pdf1275355627.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
farmacovigilancia.ve@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,10,{first}.{last},,,,,,,,http://campus.sanofi/co/calendario-eventos/17-endocongress-cali-2023,http://campus.sanofi/co/ciencia/cardiologia/calculadora-precise-dapt,http://campus.sanofi/co/ciencia/cardiologia/calculadora_crusade,http://campus.sanofi/co/ciencia/neurologia/calculadora_nihss,http://campus.sanofi/co/productos/soliqua/soliqua-terapia-costo-ahorradora,http://sanofi-pacifico-caribe.com/dam/jcr:9e38703a-596a-45b7-b143-75ede65bdb62/sanofi%20pasteur%20proteccion%20a%20lo%20largo%20de%20la%20vida.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:db93f0e6-86ef-436f-945f-4aeeb1086e76/protegete%20contra%20la%20tosferina%20en%20cada%20embarazo-sanofi%20pasteur.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/homemonitoringbloodglucose.pdf,http://sanofi-pacientes.com/campanasanofi/micrositios/patientstartingguide.pdf,http://sanofi-pacientes.com/materiales/pompe-que-debo-vigilar-en-respuesta-al-tratamiento.pdf,,,,,,,,,,,,,,,,,,,
natasa.grulovic@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://infoaboutdiabetes.net.au/2022/10/15/prevalence-and-predictors-of-diabetes-related-distress-in-adults-with-type-1-diabetes-scientific-reports-nature-com,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lgoutni@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,10,{first}.{last},,,,,,,,http://startup365.fr/author/862global,http://startup365.fr/author/862global/page/2,http://startup365.fr/author/862global/page/4,http://biotech-365.com/author/biotech365,http://biotech-365.com/author/biotech365/page/2,http://biotech-365.com/author/biotech365/page/5,http://biotech-365.com/category/globenewswire,http://biotech-365.com/category/globenewswire/page/2,http://wireassociation.eu/newsroom/sanofi/releases/en/media-update-positive-data-from-two-phase-3-dupixent-dupilumab-trials-in-prurigo-nodularis-published-in-nature-medicine-1117,http://sanofi.com/fr/media-room/communiques-de-presse/2023/2023-04-11-06-00-00-2644042,,,,,,,,,,,,,,,,,,,
lori.bogdanis@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://lifesciencesbc.ca/members/notice-of-compliance-issued-regarding-rezurocktm-belumosudil-tablets,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cn@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
holger.vonfircks@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://apotekarsocieteten.se/sektioner-kretsar/kretsar-2/stockholmskretsen/styrelse-och-valberedning,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jenni.vuola@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://fimea.fi/documents/160140/1454401/myyntiluvan+haltijan+kommentit_isatuksimabi_.pdf/36bce3f5-ad00-05c0-c383-82869b160bde,,,,,,,,,,,,,,,,,,,,,,,,,,,,
angela.li2@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://bioprocessintl.com/downstream-processing/chromatography/mechanistic-modeling-for-a-hydrophobic-interaction-chromatography-process-use-in-vaccine-antigen-purification,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gsa_sbs_p2p@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
sylvain.huille@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://etp-nanomedicine.eu/sfnano-phd-award22,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pankaj.durgapal@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
informacionmedica@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,8,{first}.{last},,,Support,,,,,http://campus.sanofi/co/calendario-eventos/17-endocongress-cali-2023,http://campus.sanofi/co/ciencia/enfermedades-raras/que-es-la-enfermedad-de-fabry,http://sanofi-pacifico-caribe.com/dam/jcr:5fafb8a6-8fd1-4e3e-ad3b-f1a197cbe6e2/tarjeta%20de%20la%20paciente%20valproato%202022.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:632ddf0d-307d-4b0a-ad96-71275ed000af/gu%c3%ada%20de%20la%20paciente%20valproato%202022.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:846c1d3e-2f88-4617-98a9-e803a34d808d/gu%c3%ada%20para%20los%20profesionales%20de%20la%20salud%20valproato%202022.pdf,http://sanofi-pacifico-caribe.com/dam/jcr:a593bb96-a933-48d0-a291-c47c7b4aefcc/formulario%20reconocimiento%20riesgo%20anual%20valproato%202022.pdf,http://genfar.com/atencion-genfar,http://sanofi.com.pe/es/contacto-reportes,,,,,,,,,,,,,,,,,,,,,
jeeyong.lee@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://ssiemvirtual.org/partners/sa_ssiem2020,,,,,,,,,,,,,,,,,,,,,,,,,,,,
quality.greatergulf@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,9,{first}.{last},,,,,,,,http://campus.sanofi/bh/science/multiple-sclerosis/cutting-edge-science/2022/a-promising-biomarker-in-ms-neurofilament-light-chain,http://campus.sanofi/bh/science/vaccines/influenza/cutting-edge-science/2022/influenza-focus-on-elderly,http://campus.sanofi/sa,http://campus.sanofi/ae/events/diabetes/2022/innovation-of-iglarlexi-in-intensification,http://campus.sanofi/bh/science/prurigo-nodularis/cutting-edge-science/2022/mechanism-of-prurigo-nodularis-disease,http://enterogermina.sa/ar-sa/sitemap,http://sanofi.com.sa,http://sanofi.com.sa/ar,http://sanofi.com.sa/en,,,,,,,,,,,,,,,,,,,,
igrc.sil@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,11,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:6b667806-9e22-448d-a45a-b5ce3e81e163/sanofi%20india%20iar%202022_brsr.pdf,http://sanofiindialtd.com/dam/jcr:9cc49302-774c-4c1e-a217-1b7650309f3f/auditor&%23039;s%20certificate%20for%20non-applicability%20of%20para%20(a)(10).pdf,http://sanofiindialtd.com/dam/jcr:b4368b92-36cf-4417-aaac-c6af361b171c/unaudited_financial_results_march_2023.pdf,http://sanofiindialtd.com/dam/jcr:b72fc7a8-56b7-4418-8741-1901eecbbede/sanofi%20india%20iar%202022.pdf,http://economictimes.indiatimes.com/sanofi-india-ltd/stocks/companyid-13607.cms,http://skicapital.net/corporateinfo/company-snapshot/-/4163,http://skicapital.net/corporateinfo/company-snapshot/-/500674,http://ifinltd.in/equity/companyprofile/company-snapshot/sanofi-india-ltd/256,http://ifinltd.in/equity/companyprofile/company-snapshot/sanofi-india/256,http://skicapital.net/corporateinfo/company-snapshot/sanofi-india-ltd/500674,http://sanofiindialtd.com/en/investors/contact-us,,,,,,,,,,,,,,,,,,
infomedpac@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,10,{first}.{last},,,Support,,,,,http://pharmaton-cam.com/aviso-de-farmacovigilancia,http://pharmaton-cam.com/tu-pharmaton-ideal,http://pharmaton-cam.com/inicio-old,http://pharmaton-cam.com/por-que-es-importante-la-nutricion-en-los-ninos,http://pharmaton-cam.com/conoces-la-importancia-de-una-alimentacion-balanceada,http://enterogermina.com.do/proposito,http://enterogermina.com.do/aviso-de-farmacovigilancia,http://enterogermina.com.do/mapa-sitio,http://enterogermina.com.do/preguntas-frecuentes,http://enterogermina.com.do/flora-intestinal/flora-intestinal-en-desequilibrio,,,,,,,,,,,,,,,,,,,
info.medica@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,9,{first}.{last},,,Support,,,,,http://lactacyd.mx/challenge04,http://lactacyd.mx/challenge05,http://lactacyd.mx/challenge06,http://lactacyd.mx/challenge07,http://histiacil.com.mx/aviso-de-farmacovigilancia,http://lactacyd.mx,http://aderogyl.com.mx,http://mercadolibre.com.mx/a/store/sanofi-,http://sanofi.com.mx/es/contacto,,,,,,,,,,,,,,,,,,,,
communications.mco@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,6,{first}.{last},,,,,,,,http://hklrh.rlswire.com/medicament-herpes-maroc/36816277,http://idealmedhealth.com/pharmaceutical-companies-in-morocco,http://tn.sanofi.com,http://sanofi.ma,http://sanofi.ma/fr,http://tn.sanofi.com/fr,,,,,,,,,,,,,,,,,,,,,,,
pascal.houlmann@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,2,{first}.{last},,,,,,,,http://cineman.ch/fr/film/1985/outofafrica,http://cineman.ch/movie/2008/bodyoflies,,,,,,,,,,,,,,,,,,,,,,,,,,,
laura.kolodjeski@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,2,{first}.{last},,,,,,,,http://de.slideshare.net/socialmediaorg/bw26-bos-presentationsanofius,http://slideshare.net/socialmediaorg/bw26-bos-presentationsanofius,,,,,,,,,,,,,,,,,,,,,,,,,,,
sohil.bahamania@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,9,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:46f35873-bf90-438c-b5e3-9bc1c85f11ac/23%20young%20people%20with%20type%201%20diabetes%20scaled%20maharashtras%20highest%20peak%20in%20indias%20first%20t1d%20challenge.pdf,http://sanofi.in/dam/jcr:6b386065-aba3-4c80-9d5f-1827bb5bd592/sanofi%20genzyme%20reaffirms%20its%20commitment%20to%20support%20patients%20with%20rare%20diseases%20in%20india.pdf,http://sanofi.in/dam/jcr:e5e925cf-ec79-4089-af69-e7edfe70e8c2/press%20release%20%20aubagio%20launch%20final%20july%2019.pdf,http://sanofiindialtd.com/dam/jcr:41b22ad5-edfa-4b74-8595-a996892d394d/young-people-with-type-1-diabetes.pdf,http://sanofiindialtd.com/dam/jcr:6f096ba0-790c-45c6-8eac-c1af60f5fb89/press-release---combiflam.pdf,http://sanofiindialtd.com/dam/jcr:7e8dccb8-1d39-487c-8b09-800006673b98/annoucement-20190121.pdf,http://sanofi.in/dam/jcr:972ff6e5-bc84-4a65-9ad4-231432aa6e48/press%20release%20-fluquadri_india_press%20release.pdf,http://sanofi.in/dam/jcr:a424b0a8-e14a-4647-9b1c-b8e22e00cbf2/press%20release%20-%20combiflam%20range%20of%20pain%20relief%20solutions%20launches%20pain%20education%20campaign.pdf,http://medindia.net/health-press-release/sanofi-launches-once-daily-oral-teriflunomide-14-mg-tablet-aubagio-for-treatment-of-multiple-sclerosis-in-india-395758-1.htm,,,,,,,,,,,,,,,,,,,,
info.finland@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,7,{first}.{last},,,Support,,,,,http://pharmacafennica.fi/supportmaterial/download/74020620/fi,http://pharmacafennica.fi/supportmaterial/download/74020650/fi,http://pharmchoices.com/full-list-of-pharmaceutical-companies-in-finland/2,http://fimea.fi/documents/160140/5106901/cerezyme-kotihoito_vv-pv-0396496_lr.pdf/b0b24498-75d7-34f6-78ab-a3a1b09a8767,http://fimea.fi/documents/160140/5106901/gaucher_potilasopas_a4_2020_vv-pv-0396497_lr.pdf/30a4388f-75fd-eab7-b0cd-c9f146e05fef,http://sanofi.fi/fi/tietoa-meista/yhteystiedot,http://msopas.fi/user/lot-login,,,,,,,,,,,,,,,,,,,,,,
gb-patientaccess@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,11,{first}.{last},,,,,,,,http://qualitytradeframes.com/nodular-prurigo-nice-cks/17182928,http://sanofi.co.uk/dam/jcr:222a4458-719b-4022-aadf-eea417ac240a/dudley~1.pdf,http://sanofi.co.uk/dam/jcr:33fd2774-6883-4112-9890-56f5480b243a/exexcu~1.pdf,http://sanofi.co.uk/dam/jcr:1dfc0dc5-98bb-46ca-8e1f-a1d797067882/cwpuhd~1.pdf,http://sanofi.co.uk/dam/jcr:8d746253-bc29-4019-9a40-cd37bac125e5/mapping%20of%20front-end%20skin%20pathway%20across%20lancashire%20&%20south%20cumbria%20icb.pdf,http://sanofi.co.uk/dam/jcr:99cb1f9e-5c82-4f35-a6cb-ca601b81ed66/mrcc%20executive%20summary%20finalcertified%20no%20vevva.pdf,http://nice.org.uk/guidance/ta667,http://nice.org.uk/guidance/indevelopment/gid-ta10361,http://nice.org.uk/guidance/ta534,http://nice.org.uk/guidance/ta485/chapter/4-implementation,http://nice.org.uk/guidance/ta391,,,,,,,,,,,,,,,,,,
servicio.cliente@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,11,{first}.{last},,,,,,,,http://sanofi-pacientes.com,http://sanofi-pacientes.com/inicio,http://sanofi-pacientes.com/pol%c3%adticasprivacidad,http://sanofi-pacientes.com/sitemap,http://sanofi-pacientes.com/sobreprogramasanofi,http://sanofi.com.co/es/sobre-nosotros/nuestra-responsabilidad,http://genfar.com/atencion-genfar,http://sanofi.com.co/es/nuestras-areas-terapeuticas,http://sanofi.com.co/es,http://sanofi.com.co,http://sanofi.com.co/es/sobre-nosotros,,,,,,,,,,,,,,,,,,
philippe.waghemacker@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,1,{first}.{last},,,,,,,,http://liguegolfnormandie.fr/2019/pages/commissions/actus/entreprise.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
indonesia.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,8,{first}.{last},,,,,,,,http://nulis.in/2017/10/lactacyd-romantic-journey-alfamart-berhadiah-trip-ke-maldives.html,http://infokuisberhadiah.com/gratis-paket-bulan-madu-ke-dubai-voucher-belanja-hampers-dari-lactacyd-romantic-journey,http://bursakuis.com/2017/09/promo-lactacyd-romantic-journey.html,http://bursakuis.com/2017/09/lomba-menulis-lactacy-baby-berhadiah.html,http://infolombanulis.com/2017/05/lomba-menulis-blog-hadiah-macbook-air.html,http://bursakuis.com/2017/07/promo-kuis-lactacyd-herbal-berbagi.html,http://satyawinnie.com/2016/04/lactacyd-white-intimate-rahasia-pede-traveling.html,http://nulis.in/2017/05/kulit-sehat-tidur-lelap-bersama-lactacyd-baby-berhadiah-voucher-belanja.html,,,,,,,,,,,,,,,,,,,,,
communication.russia@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,12,{first}.{last},,,,,,,,http://vidal.ru/drugs/danol__4462,http://vidal.ru/drugs/rulid__738,http://tuta24.ru/product/13032,http://tuta24.ru/product/8949,http://prostatitmd.ru/narkologiya/bronhikum-sirop-effektivnoe-sredstvo-protiv-kashlya,http://vidal.ru/drugs/abraxane__38394,http://vidal.ru/drugs/company/36,http://vidal.ru/drugs/dalfaz_sr__2395,http://tuta24.ru/product/15887,http://tuta24.ru/product/3071,http://tuta24.ru/product/6083,http://dr-denisov.ru/forum/29-7353-3,,,,,,,,,,,,,,,,,
medinfo.australia@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,12,{first}.{last},,,,,,,,http://mydr.com.au/medicines/telfast,http://mydr.com.au/medicines/panadeine-forte,http://news-medical.net/drugs/adacel.aspx,http://news-medical.net/drugs/aldurazyme.aspx,http://news-medical.net/drugs/alprolix.aspx,http://news-medical.net/drugs/amisulpride-winthrop.aspx,http://news-medical.net/drugs/arabloc.aspx,http://nps.org.au/medical-info/medicine-finder/aldurazyme-concentrate-for-infusion,http://nps.org.au/medical-info/medicine-finder/cerezyme-powder-for-injection,http://nps.org.au/medical-info/medicine-finder/thyrogen-powder-for-injection,http://nps.org.au/medical-info/medicine-finder/fabrazyme-powder-for-infusion,http://nps.org.au/medical-info/medicine-finder/mozobil-solution-for-injection,,,,,,,,,,,,,,,,,
pharmacovigilance.vietnam@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,9,{first}.{last},,,,,,,,http://helpbmt.com/san-pham/calcium-corbiere-extra-kids-5-ml-hop,http://helpbmt.com/san-pham/calcium-corbiere-extra-kids-5-ml-ong,http://nhathuocbachmai.vn/thuoc/calcium-corbiere-extra-10ml-bo-sung-calci,http://vivita.vn/thuoc-calcium-corbiere-extra-kids-sanofi,http://vivita.vn/thuoc-calcium-corbiere-extra-sanofi,http://medigoapp.com/product/dung-dich-uong-giup-chac-xuong-calcium-corbiere-extra-kids-hop-30-ong-x-5ml.html,http://nhathuocankhang.com/thuoc-bo-va-vitamin/calcium-corbiere-extra-10ml-h-30-ong,http://nhathuocankhang.com/thuoc-bo-va-vitamin/calcium-corbiere-kids-extra-5ml-h-30-ong,http://medigoapp.com/product/dung-dich-uong-giup-chac-xuong-calcium-corbiere-extra-hop-30-ong-x-10ml.html,,,,,,,,,,,,,,,,,,,,
domain.names@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,7,{first}.{last},,,,,,,,http://statduck.com/domain-analysis/cdehelpteam.com,http://stats.rankiing.net/domain/sanofi.fr,http://ec.websitelibrary.com/sanofi.com.ec,http://whois.alexa.cn/reverse_mail,http://webstatsdomain.org/d/www.mmbb.org,http://ec.websitelibrary.com/sanofi-aventis.com.ec,http://travelvacs.ca.clearwebstats.com,,,,,,,,,,,,,,,,,,,,,,
cainternet@sanofi.com,sanofi.com,Sanofi,,,,,,86,generic,11,{first}.{last},,,,,,,,http://drugshortagescanada.ca/shortage/165914,http://drugshortagescanada.ca/shortage/179335,http://lifesciencesbc.ca/member/sanoficanada,http://drugshortagescanada.ca/shortage/80353,http://drugshortagescanada.ca/shortage/71284,http://drugshortagescanada.ca/shortage/134199,http://sanofi.ca/fr/accessibilite,http://sanofi.ca/en/accessibility,http://sanofi.ca/en/econsent,http://sanofi.ca/fr/consentement-electronique,http://sanofi.ca/fr/econsent,,,,,,,,,,,,,,,,,,
george.grofik@sanofi.com,sanofi.com,Sanofi,,,,,,86,personal,13,{first}.{last},,,Writing & communication,Journalist,,,,http://finanznachrichten.de/nachrichten-2013-07/27578918-fda-advisory-committee-recommends-approval-of-sanofi-s-nasacort-aq-nasal-spray-for-over-the-counter-use-008.htm,http://mynewsdesk.com/se/sanofi/pressreleases/u-s-fda-approves-zaltrap-r-ziv-aflibercept-after-priority-review-for-previously-treated-metastatic-colorectal-cancer-782871,http://biospace.com/news/fda-approves-sanofi-frances-nasacort0174-allergy/311602,http://biospace.com/article/releases/regeneron-pharmaceuticals-inc-sanofi-france-shows-off-positive-phase-2-alirocumab-data-,http://biospace.com/article/releases/fda-approves-sanofi-france-s-nasacort-and-0174-allergy-24hr-for-over-the-counter-use-,http://biospace.com/news/sanofi-france-to-pay-109-million-for-fine-dining/282876,http://prnewswire.com/news-releases/fda-advisory-committee-recommends-approval-of-sanofis-nasacort-aq-nasal-spray-for-over-the-counter-use-217824561.html,http://biospace.com/news/regeneron-pharmaceuticals-inc-sanofi-france-shows/328669,http://markets.financialcontent.com/prnews/news/read/23136897/sanofi's_chattem_acquires_over,http://prnewswire.com/news-releases/fda-approves-sanofis-nasacort-allergy-24hr-for-over-the-counter-use-227413981.html,http://prnewswire.com/news-releases/sanofi-us-reaches-settlement-agreement-on-hyalgan-184163451.html,http://prnewswire.com/news-releases/sanofi-and-regeneron-report-positive-results-with-alirocumab-from-phase-2-japanese-study-253351361.html,http://prnewswire.com/news-releases/sanofis-chattem-acquires-over-the-counter-antacid-rolaids-185862082.html,,,,,,,,,,,,,,,,
olga.proskuryakova@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,1,{first}.{last},,,,,,,,http://ru.sanofi.com/dam/jcr:6ac2ef78-78bd-4e27-98e4-9474e4347436/pr_new_appointment_oproskuryakova.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ondrej.krizalkovic@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,1,{first}.{last},,,,,,,,http://sanofi.cz/dam/jcr:2e666b80-441b-4c1a-8c91-c5f243d46ddf/myozyme_zdravotnicke_pracovniky.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
piril.kavasoglu@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,2,{first}.{last},,,,,,,,http://sanofi.com.tr/dam/jcr:066f2133-b2a5-480e-9784-78a4ef5508cf/nadir-hastaliklar-merkezi.pdf,http://sanofi.com.tr/dam/jcr:5fe995b1-ecf0-4f0e-9c86-e9770f1d1f8e/pharmup-yeni-donem-basvuru-bas%c4%b1nbulteni.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
rbdpatientsolutions@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,9,{first}.{last},,,Marketing,,,,,http://eloctate.com/content/pdf/patient%20services%20hem%20enrollment%20form.pdf,http://eloctate.com/content/pdf/patient-services-hem-enrollment-form-bilingual.pdf,http://cablivi.com/attp/stay-connected,http://cablivi.com/content/assets/pdf-assets/cablivi%20patient%20enrollment%20form.pdf,http://alprolix.com/_assets/pdf/patient-enrollment-form-bilingual.pdf,http://alprolix.com/_assets/pdf/patient-enrollment-form.pdf,http://alprolixpro.com/content/pdfs/patient_services_hem-enrollment-form-11-15-2021.pdf,http://alprolixpro.com/content/pdfs/patient_services_hem-enrollment-form-bilingual.pdf,http://alprolixpro.com/content/pdfs/patient_services_hem-enrollment-form-spanish.pdf,,,,,,,,,,,,,,,,,,,,
sagar.narvekar@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,1,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:7355766b-ef55-4a80-9656-e261f7031f86/biomedical-waste-annual-report-2018-dated-2018.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zuzanna.grzeskiewicz@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,3,{first}.{last},,,,,,,,http://biotech-365.com/category/business-wire/page/2,http://biotech-365.com/author/biotech365,http://biotech-365.com/category/business-wire,,,,,,,,,,,,,,,,,,,,,,,,,,
chc.calidad@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,8,{first}.{last},,,,,,,,http://histiacil.com.mx/aviso-de-farmacovigilancia,http://aderogyl.com.mx,http://mercadolibre.com.mx/a/store/sanofi-,http://lactacyd.mx/challenge04,http://lactacyd.mx/challenge05,http://lactacyd.mx/challenge06,http://lactacyd.mx/challenge07,http://lactacyd.mx,,,,,,,,,,,,,,,,,,,,,
hu_adatvedelem@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,9,{first}.{last},,,,,,,,http://sanofi.hu/dam/jcr:350c1257-bfea-4613-b854-3e14f9704f07/014sa_ceg_tisztsegviselok_egyseges_szerkezetu_tajekoztato_legal002.pdf,http://sanofi.hu/dam/jcr:63ce8af2-9c14-4ab9-beda-463098a5e13c/sa_hatosagi_megkeresesek_egyseges_szerkezetu_tajekoztato_legal001.pdf,http://sanofi.hu/dam/jcr:95997d5e-f1c9-43a9-84a5-9a480545717a/altalanosadatvedelmitajekoztato.pdf,http://sanofi.hu/dam/jcr:be7aafc2-6651-41f6-ab1a-7e685d26f55a/sa_cegkapu_regisztracio_egyseges_szerkezetu_tajekoztato_legal004.pdf,http://sanofi.hu/dam/jcr:fd6dc5bc-1f66-4780-882c-f8137dd1e383/sa_meghatalmazasok_keszitese_egyseges_szerkezetu_tajekoztato_legal003.pdf,http://normaflore.hu/adatvedelem,http://bilagit.hu/adatvedelmi-tajekoztato,http://nospa.hu/adatvedelmi-tajekoztato,http://allegra.hu/adatvedelmi-tajekoztato,,,,,,,,,,,,,,,,,,,,
jenna.dickinson2@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,2,{first}.{last},,,,,,,,http://nergg.org/2021/10/diagnosing-gaucher-disease-were-you-expecting-leukemia-whats-behind-your-patients-hematologic-abnormalities-october-20-2021,http://nergg.org/2020/11/sanofi-genzyme-presents-its-not-what-you-think-diagnosing-acid-sphingomyelinase-deficiency-asmd-june-30-2021,,,,,,,,,,,,,,,,,,,,,,,,,,,
bashir.ullah2@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
emanuele.derinaldis@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,2,{first}.{last},,,,,,,,http://biomap-imi.eu/network/industry-partners/sanofi,http://dirk.eddelbuettel.com/cranberries/cran/new,,,,,,,,,,,,,,,,,,,,,,,,,,,
carl.weitzmann@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,2,{first}.{last},,,,,,,,http://journal.pda.org/content/74/5/524,http://journal.pda.org/content/early/2020/05/28/pdajpst.2019.011387,,,,,,,,,,,,,,,,,,,,,,,,,,,
consent-tr@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,11,{first}.{last},,,,,,,,http://farkyarataneller.com/nadir-hastaliklar-nedir.html,http://campus.sanofi/tr,http://campus.sanofi/tr/bilimsel/diyabet,http://campus.sanofi/tr/bilimsel/norology/multipl-skleroz/makaleler/objektif-ilac-tedavisi-uyumu-ve-persistansi,http://campus.sanofi/tr/urunlerimiz/soliqua/soliqua-doz-karti,http://farkyarataneller.com/hangi-durumlarda-anne-adaylari-ve-yeni-dogan-bebeklerde-genetik-testi-yapilir.html,http://farkyarataneller.com/nadir-hastaliklar-ile-yasamak.html,http://pharmaton.com.tr/dahafazlasenchallengeduyuru,http://farkyarataneller.com/genler-cocuklara-kimden-geciyor.html,http://farkyarataneller.com/mps-tip-1-hastaligini-taniyalim.html,http://sanofi.com.tr/tr/cerez-politikasi,,,,,,,,,,,,,,,,,,
info.de@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,10,{first}.{last},,,Support,,,,,http://diabetiki.kz/product/%d0%b4%d1%83%d0%bb%d1%8c%d0%ba%d0%be%d0%bb%d0%b0%d0%ba%d1%81-%d0%bf%d0%b8%d0%ba%d0%be-75%d0%bc%d0%b3-15%d0%bc%d0%bb-%d0%ba%d0%b0%d0%bf%d0%bb%d0%b8,http://turkestan.europharma.kz/dulkolaks-piko-15-ml-kapli,http://oskemen.europharma.kz/dulkolaks-piko-15-ml-kapli,http://oskemen.europharma.kz/lazolvan-15-mg2-ml-100ml-rastvor-dlya-priyema-vnutr-i-ingalyatsiy,http://europharma.kz/kz/lazolvan-15-mg2-ml-100ml-rastvor-dlya-priyema-vnutr-i-ingalyatsiy,http://saryagash.europharma.kz/dulkolaks-piko-15-ml-kapli,http://europharma.kz/dulkolaks-piko-15-ml-kapli,http://europharma.kz/dulkolaks-piko-30-ml-kapli,http://europharma.kz/kz/dulkolaks-piko-15-ml-kapli,http://europharma.kz/lazolvan-15-mg2-ml-100ml-rastvor-dlya-priyema-vnutr-i-ingalyatsiy,,,,,,,,,,,,,,,,,,,
ptcindia@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,9,{first}.{last},,,,,,,,http://campus.sanofi/in/footer-links/contact-us,http://sanofi.in,http://sanofi.in/en,http://sanofi.in/en/science-and-innovation/specialty-care-product,http://weekenddad.ca/blog/89f45f-sanofi-uk-head-office-address-vasotec,http://sanofi.in/en/science-and-innovation/pharmaceutical-products,http://sanofi.in/en/science-and-innovation/vaccine-products,http://sanofiindialtd.com,http://sanofiindialtd.com/en,,,,,,,,,,,,,,,,,,,,
quejas.ptc@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,10,{first}.{last},,,,,,,,http://sanofi-pacientes.com,http://sanofi-pacientes.com/inicio,http://sanofi-pacientes.com/pol%c3%adticasprivacidad,http://sanofi-pacientes.com/sitemap,http://sanofi-pacientes.com/sobreprogramasanofi,http://genfar.com/atencion-genfar,http://sanofi.com.pe/es/contacto-reportes,http://sanofi.com.pe/terminos-y-condiciones-sf,http://sanofi.com.pe/es/terminos-y-condiciones-gz,http://sanofi.com.pe/es/terminos-y-condiciones-sf,,,,,,,,,,,,,,,,,,,
safety.austria@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,7,{first}.{last},,,Legal,,,,,http://campus.sanofi/at/services/risikomanagementplaene,http://migateway.eu/en/at/380/sanofi--sterreich,http://sanofi.at/kontakt,http://ganzemedizin.at/update-hydroxychloroquin-jetzt-endlich-f,http://sanofi.at,http://sanofi.at/de,http://sanofi.at/de/kontakt,,,,,,,,,,,,,,,,,,,,,,
info.greece@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,11,{first}.{last},,,Support,,,,,http://campus.sanofi/gr/footer-links/legal-notice,http://sanofi.gr/dam/jcr:52dbd22c-5ffa-44ab-8c30-a88d95478475/_sanofi_%20valentina%20belcheva%20%20%20%20%20%20%20_112.pdf,http://cap.com.cy/en/expansion-of-the-strategic-cooperation-between-sanofi-and-c-a-papaellinas-for-the-distribution-of-sanofi-vaccines-in-cyprus,http://cap.com.cy/dieyrynsi-stratigikis-synergasias-sanofi-ch-a-papaellinas-gia-ti-diathesi-ton-emvolion-tis-etaireias-stin-kypro,http://bisolvon.gr/epikoinonia,http://bisolvon.gr/oroi-chrisis,http://amcham.gr/amchamgr-members/sanofi-aventis,http://sanofi.gr/el/oroi-xrisis,http://sanofi.gr/el/forma-epikinonias,http://sanofi.gr/el,http://sanofi.gr,,,,,,,,,,,,,,,,,,
alexia.letierce@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,2,{first}.{last},,,,,,,,http://sfds.asso.fr/ddoc-5096-7a2b6a633bf9a5cf486b2a0729d5a68a-2019_affiche_prix_marx.pdf,http://sfds.asso.fr/newsletter-1181-9725cd944da0512853010e98bfcc6700,,,,,,,,,,,,,,,,,,,,,,,,,,,
gb-dataprotection@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,11,{first}.{last},,,,,,,,http://sanofi.co.uk/dam/jcr:87e6914b-0da5-4189-aa61-68c3cceabcd9/method~1.pdf,http://sanofi.ie/dam/jcr:957d96fd-7e5c-49b6-9eb1-bb696a9a9517/methodological-note-for-ireland-organisation-disclosure-2021.pdf,http://sanofi.co.uk/dam/jcr:e4d719d3-869d-4aef-aa88-3265d30bae16/methodological%20note%20for%20uk%20patient%20organisation%20disclosure%202021.pdf,http://sanofi.ie/en/staying-in-touch/privacy-notice,http://sanofi.ie/en/webinar-privacy-notice,http://msonetoone.co.uk/terms-use,http://smarter-traveller.co.uk/terms-of-use,http://sanofi.co.uk/en/webinar-privacy-notice,http://sanofi.co.uk/privacy-policy,http://vtematters.co.uk/patient/terms-of-use-and-conditions,http://sanofi.co.uk/en/privacy-policy,,,,,,,,,,,,,,,,,,
ksa_pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,10,{first}.{last},,,,,,,,http://campus.sanofi/dam/jcr:0d6c80a4-d2c2-4782-af9a-4a2ce9be8117/gulf%20sarclisa%20api%20&%20med%20info%20(1).pdf,http://campus.sanofi/sa/science,http://campus.sanofi/sa/science/atopic-dermatitis,http://campus.sanofi/sa/science/eosinophilic-esophagitis,http://campus.sanofi/sa,http://telfast-arabia.com/ar-sa/contact,http://sanofi.com.sa/ar,http://sanofi.com.sa/en,http://mucosolvan-arabia.com/contact,http://sanofi.com.sa,,,,,,,,,,,,,,,,,,,
sirimas.sudsakorn@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,1,{first}.{last},,,,,,,,http://nedmdg.org/privacy-policy,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo-norge@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,11,{first}.{last},,,,,,,,http://felleskatalogen.no/medisin/dokument/enjaymo-pasientveiledning.pdf,http://felleskatalogen.no/medisin/dokument/enjaymo-physicians-guide.pdf,http://felleskatalogen.no/medisin/firmaer/a;jsessionid=jhq9ra4fayh03ejwjff1n5hh3hbl7g5ubghcceza.fkweb-live-web-fkweb-live-2,http://felleskatalogen.no/medisin/firmaer/a;jsessionid=ttio7moefsz6jcryg8p6cfoxtzkedz7fqbrod0iw.fkweb-live-web-cluster-fkweb-live-4,http://felleskatalogen.no/medisin/firmaer/sanofi-725786-sanofi-563739,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2017/klexane%20dhcp_no%20-%20ge%20juli%202017_il-korr1.pdf,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2018/fluorokinoloner.pdf,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2019/2018-03-26%20quinolones%20and%20fluoroquinolones_langtidae__legemiddelverket_%20final.pdf,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2019/2019-04-16_dhcp_ema_final_12april2019_lemtrada-no_translation_clean_esignlth.pdf,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2020/hcq-dhcp%20no.pdf,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,
communication-france@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,9,{first}.{last},,,,,,,,http://association-cavernome-cerebral.e-monsite.com/medias/files/cp-jimr-2021-vf.pdf,http://capgemini.com/gb-en/news/press-releases/sanofi-capgemini-generali-and-orange-announce-the-creation-of-a-digital-ecosystem-dedicated-to-e-health-a-first-in-europe,http://sogeti.com/explore/newsroom/sanofi-capgemini-group-generali-and-orange-announce-the-creation-of-a-digital-ecosystem-dedicated-to-e-health-a-first-in-europe,http://toute-la.veille-acteurs-sante.fr/107147/le-chu-de-nantes-et-sanofi-partenaires-dans-la-recherche-clinique-et-scientifique-communique,http://businesswire.com/news/home/20170628005059/fr,http://businesswire.com/news/home/20161005006020/fr,http://businesswire.com/news/home/20171207005996/fr,http://businesswire.com/news/home/20170223005592/fr,http://businesswire.com/news/home/20170608005590/fr,,,,,,,,,,,,,,,,,,,,
info.nl@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,8,{first}.{last},,,Support,,,,,http://zorgen.nl/bedrijven/sanofi-nederland,http://amsterdamlifesciencesdistrict.nl/company/sanofi,http://roosgoesgreen.nl/voeding/van-mond-tot-kont-wat-je-ontlasting-je-kan-vertellen-over-je-gezondheid,http://jdrf.nl/leven-met-t1d/hulp-en-ondersteuning-bij-t1d,http://migateway.eu/en/nl/254/sanofi,http://awe24.com/89524,http://sanofi.nl,http://sanofi.nl/nl,,,,,,,,,,,,,,,,,,,,,
premiozanibelli@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,6,{first}.{last},,,,,,,,http://ordinefarmacisti.torino.it/5608,http://leggeretutti.eu/al-via-la-seconda-edizione-del-premio-letterario-leggi-in-salute-angelo-zanibelli,http://uniroma1.jobsoul.it/sala-stampa/premio-il-valore-della-ricerca-clinica,http://ilpiacerediscrivere.it/premio-per-opere-edite-e-inedite-sanofi-aventis-leggi-in-salute-angelo-zanibelli,http://cremonaoggi.it/2014/05/12/premio-zanibelli-presentata-la-seconda-edizione-a-roma,http://ingegneriameccanica.uniroma2.it/2016/06/17/stage-sanofi-s-p-a,,,,,,,,,,,,,,,,,,,,,,,
medinfo.russia@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,8,{first}.{last},,,,,,,,http://congress.raaci.ru/sanofigenzyme,http://congress.raaci.ru/sanofi,http://vidal.ru/novosti/novye-dannye-po-bezopasnosti-lekarstvennyh-preparatov-soderzhashhih-valproat-natriya-valproevuyu-kislotu-valproat-seminatriya-i-valpromid-5614,http://vidalru.blogspot.com/2015,http://white-medicine.com/manufacturers/view/7,http://vidalru.blogspot.com/2015/10,http://vidalru.blogspot.com/2015/10/blog-post.html,http://vidal.ru/novosti/5614,,,,,,,,,,,,,,,,,,,,,
anisya.ekasetiawati@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,9,{first}.{last},,,,,,,,http://joxzank.blogspot.com/2014/08/daftar-alamat-email-perusahaan-di_25.html,http://karir-halal.blogspot.com/2013/02/sanofi-group-indonesia.html,http://karir-halal.blogspot.com/2013/02/sanofi-group-indonesia_10.html,http://kerja-an.blogspot.com/2012/09/lowongan-kerja-migas-sanofi-group.html,http://lowongan-ini.blogspot.com/2012/09/sanofi-group-indonesia-export-import.html,http://lowongankerjaoperator1.blogspot.com/2013/03/lowongan-kerja-operator-produksi-sanofi.html,http://lowongankerjaoperator1.blogspot.com/2013/02/lowongan-kerja-operator-produksi-sanofi.html,http://lowongankerjaoperator1.blogspot.com/2012/08/lowongan-kerja-operator-produksi-sanofi.html,http://lowongankerjaoperator1.blogspot.com/2013_02_01_archive.html,,,,,,,,,,,,,,,,,,,,
farmacovigilanza.italia@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,9,{first}.{last},,,,,,,,http://migateway.eu/en/it/136/sanofi,http://maketocare.it/contatti/@sc_lang=en,http://maketocare.it/contatti/@sc_lang=it-it,http://mystarsanofi.it/assistenza/contatti,http://sclerosistemica.info/plaquenil-richiesta-di-aggiornamenti-carenza-disponibilita-sui-territori,http://fexallegra.it/contatti,http://synvisc.it/contatti,http://maketocare.it/contatti,http://maalox.it/contatti,,,,,,,,,,,,,,,,,,,,
contact.ch@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,10,{first}.{last},,,Support,,,,,http://swisshepa.org/en/about-us/financing-of-the-association/sponsors,http://swisshepa.org/fr/a-propos-de-nous/financement-de-lassociation/parrains,http://swisshepa.org/it/chi-siamo/finanziamento-dellassociazione/sponsor,http://swisshepa.org/ueber-uns/finanzierung-des-vereins/sponsoren,http://kofam.ch/de/studienportal/studie/44583,http://kofam.ch/de/studienportal/suche/0/studie/44583,http://sanofi.ch/fr,http://sanofi.ch/de,http://sanofi.ch/fr/mentions-legales,http://sanofi.ch,,,,,,,,,,,,,,,,,,,
ambra.zaltieri@sanofi.com,sanofi.com,Sanofi,,,,,,85,personal,1,{first}.{last},,,,,,,,http://venicearrhythmias.org/exhibitors-and-sponsors-list-va2015,,,,,,,,,,,,,,,,,,,,,,,,,,,,
iemedinfo@sanofi.com,sanofi.com,Sanofi,,,,,,85,generic,10,{first}.{last},,,Support,,,,,http://campus.sanofi/ie/science/dyslipidaemia/dyslipidaemia-guidelines-interactive-tool,http://campus.sanofi/ie/science/dyslipidaemia/dyslipidaemia-guidelines-interactive-tool-1-hour,http://campus.sanofi/ie/science/dyslipidaemia/dyslipidaemia-guidelines-interactive-tool-20-minutes,http://sanofi.ie/dam/jcr:082edfb3-c892-452a-a683-8926c412e12c/epilim%20valproate%20hcp%20booklet_3.0.pdf,http://sanofi.ie/dam/jcr:f76ed516-f848-4c55-8722-2780ab545819/epilim%20ire%20-%20valproate%20patient%20guide%20ie.pdf,http://weekenddad.ca/blog/89f45f-leflunomide-washout-procedure-amoxil,http://medicines.ie/companies/sanofi-genzyme-5075,http://imedi.co.uk/nasacort-55-mcg-dose-nasal-spray-suspension,http://imedi.co.uk/telfast-120-mg-film-coated-tablets,http://imedi.co.uk/telfast-180-mg-film-coated-tablets,,,,,,,,,,,,,,,,,,,
anne-celine.le-fevre@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,1,{first}.{last},Anne,Fevre,,,,,,http://xiahepublishing.com/2310-8819/jcth-2020-00015,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ane.ducos-anglade@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,1,{first}.{last},Ane,Anglade,,,,,,http://francebiotechnologies.fr/evenement/doc/cv-assistante-ingenieur-cv-estelle-2019-pdf.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gabriella.szilagyine-kiss@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,1,{first}.{last},Gabriella,Kiss,,,,,,http://mfk.uni-miskolc.hu/files/17528/du%c3%a1lis+kapcsolattart%c3%b3k+2022+0502.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jacques-henri.weidmann@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,2,{first}.{last},Jacques,Weidmann,,,,,,http://sanofi.ch/dam/jcr:a577927a-2641-4003-8da9-f469aacce307/medienmitteilung_sanofi_umzug%20rotkreuz_20200909%20(1).pdf,http://sanofi.ch/dam/jcr:ed7ba29c-9475-4ed0-ba26-1e7a54e40262/medienmitteilung_sanofi_umzug%20rotkreuz_20200909.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
mindy.robinson-paquette@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,1,{first}.{last},Mindy,Paquette,,,,,,http://cahslachronicle.blogspot.com/2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anne-catherine.marka@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,5,{first}.{last},Anne,Marka,,,,,,http://encotentin.fr/sejour/hebergements/hebergements-meubles-tourisme/irisit/conforts/cuisiniere,http://encotentin.fr/sejour/hebergements/hebergements-meubles-tourisme/irisit/equipements/jeux-pour-enfants,http://encotentin.fr/sejour/hebergements/hebergements-meubles-tourisme/irisit/descriptif-habitation/sanitaire-prive,http://encotentin.fr/sejour/hebergements/hebergements-meubles-tourisme/irisit/langues-parlees/allemand,http://encotentin.fr/chambres-hotes-et-gites/meuble-de-tourisme-letoile-bleue,,,,,,,,,,,,,,,,,,,,,,,,
franck.da-silva@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,1,{first}.{last},Franck,Silva,,,,,,http://irmb-montpellier.fr/contacts,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kerstin.traub-hoffmann@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,2,{first}.{last},Kerstin,Hoffmann,,,,,,http://journal.pda.org/content/early/2021/11/15/pdajpst.2021.012633/tab-article-info,http://journal.pda.org/content/early/2021/11/15/pdajpst.2021.012633,,,,,,,,,,,,,,,,,,,,,,,,,,,
rogerio-ext.martins@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,1,{first}.{last},Rogerio,Martins,,,,,,http://wiki.transmartfoundation.org/display/tsmtgpl/testing+volunteers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
susanna.del-signore@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,5,{first}.{last},Susanna,Signore,,,,,,http://mysprintt.eu/fr/communiqu-de-presse,http://mysprintt.eu/it/comunicato-stampa,http://mysprintt.eu/en/press-release,http://mysprintt.eu/es/comunicado-de-prensa,http://mysprintt.eu/de/pressever-ffentlichung,,,,,,,,,,,,,,,,,,,,,,,,
brigitte.pouletty-lefebvre@sanofi.com,sanofi.com,Sanofi,,,,,,84,personal,2,{first}.{last},Brigitte,Lefebvre,,,,,,http://journal-therapie.org/articles/therapie/abs/2015/01/therapie140032/therapie140032.html,http://journal-therapie.org/articles/therapie/abs/2015/01/therapie150007/therapie150007.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
eumedicalservices@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,6,{first}.{last},,,Support,,,,,http://sanofi.cz/dam/jcr:2e666b80-441b-4c1a-8c91-c5f243d46ddf/myozyme_zdravotnicke_pracovniky.pdf,http://pharmacafennica.fi/supportmaterial/download/109033436/fi,http://pharmacafennica.fi/supportmaterial/download/109033436/sv,http://pharmacafennica.fi/supportmaterial/download/109911784/en,http://sanofi.dk/dam/jcr:e973bbe1-2a80-466e-a0c1-5e417fe53ccf/nexviadyme%20-%20immunotest%20serviceguide%20til%20l%c3%a6ger%20og%20sundhedspersonale.pdf,http://sanofi.dk/dam/jcr:fc4292d4-e86a-466c-9573-12f631322cee/myozyme---safety-information-packet.pdf,,,,,,,,,,,,,,,,,,,,,,,
infomed.mco@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,7,{first}.{last},,,Support,,,,,http://campus.sanofi/ma,http://sanofi.ma/fr/science-innovation/information-medicale,http://tn.sanofi.com,http://tn.sanofi.com/fr,http://sanofi.ma,http://sanofi.ma/science-innovation/information-medicale,http://sanofi.ma/fr,,,,,,,,,,,,,,,,,,,,,,
drugsafety.finland@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,7,{first}.{last},,,,,,,,http://pharmacafennica.fi/supportmaterial/download/109911758/fi,http://pharmacafennica.fi/supportmaterial/download/109911758/sv,http://pharmacafennica.fi/supportmaterial/download/109911771/fi,http://pharmacafennica.fi/supportmaterial/download/109911771/sv,http://sanofi.fi/dam/jcr:a1d81cc8-9259-4221-a516-71d2b2664c89/tiedotteet-terveydenhuollon-ammattilaisille.pdf,http://fimea.fi/documents/160140/4855839/potilaskortti.pdf/5bfe37dc-9a97-336a-3100-7a0482cad620,http://fimea.fi/documents/160140/4855839/terveydenhuollon+ammattilaisen+koulutusmateriaali.pdf/fd6e4dd5-4c13-b2e0-b77a-340d5fc1ee58,,,,,,,,,,,,,,,,,,,,,,
isolde.pfeuffer-ext@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,8,{first}.{last},,,,,,,,http://campus.sanofi/de/unterstuetzende-materialien/diabetes/infografik-1-diagnose,http://campus.sanofi/de/unterstuetzende-materialien/diabetes/infografik-2-insulintitration,http://campus.sanofi/de/unterstuetzende-materialien/diabetes/infografik-3-dosiserhoehung,http://sanofi.de/de/innovationen/digitalisierung,http://sanofi.de/de/innovationen/digitalisierung/health-x-tomorrow,http://sanofi.de/de/sanofi-in-deutschland/news-storys/sanofi-gesundheitstrend-selbstfuersorge-selfcare,http://sanofi.de/de/innovationen/forschung-entwicklung/technologieplattformen,http://sanofi.de/de/sanofi-in-deutschland/news-storys/podcast-gesundheit-innovation,,,,,,,,,,,,,,,,,,,,,
es-chc-atencion-web@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,4,{first}.{last},,,,,,,,http://lizipaina.es/contacto,http://bisolherbal.es/aviso-legal,http://bisolherbal.es/contacta-con-nosotros,http://pharmaton.es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,
kazakhstan.pharmacoviqilance@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,7,{first}.{last},,,,,,,,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-15-mg-sirop-opisanie-sostav-ftg-mnn,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-30-mg-sirop-opisanie-sostav-ftg-mnn,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-tabletki-sirop-opisanie-sostav-ftg-mnn,http://gkpd.by/instrukcii/lazolvan-15-mg-sirop-2280.html,http://gkpd.by/instrukcii/lazolvan-30-mg-sirop-2281.html,http://gkpd.by/instrukcii/lazolvan-rastvor-dlya-ingalyaciy-sirop-2282.html,http://gkpd.by/instrukcii/lazolvan-tabletki-sirop-2283.html,,,,,,,,,,,,,,,,,,,,,,
qualitv.info@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,6,{first}.{last},,,Support,,,,,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-15-mg-sirop-opisanie-sostav-ftg-mnn,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-30-mg-sirop-opisanie-sostav-ftg-mnn,http://maminmayak.ru/instrukcija-po-primeneniju-lazolvan-tabletki-sirop-opisanie-sostav-ftg-mnn,http://gkpd.by/instrukcii/lazolvan-15-mg-sirop-2280.html,http://gkpd.by/instrukcii/lazolvan-30-mg-sirop-2281.html,http://gkpd.by/instrukcii/lazolvan-tabletki-sirop-2283.html,,,,,,,,,,,,,,,,,,,,,,,
proteccion.dedatospac@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,6,{first}.{last},,,,,,,,http://sanofi-pacifico-caribe.com/dam/jcr:28ee31f2-eced-40c0-b011-b35894b771ca/legal-notice.pdf,http://enterogermina.com/es-ec/terminos-de-uso,http://sanofi-pacifico-caribe.com/es/aviso-de-privacidad,http://sanofi-pacifico-caribe.com/es/aviso-legal,http://allegra.com.ec/privacy,http://allegra.com.ec/terminos-y-condiciones,,,,,,,,,,,,,,,,,,,,,,,
nacompliance@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,4,{first}.{last},,,,,,,,http://ru.sanofi.com/dam/jcr:60569675-29fa-4968-83ff-264dfc147b14/sanofi_code_of_ethics.pdf,http://sanofi.cz/dam/jcr:90f37744-a0ae-4d61-baca-f3e3e950d651/cz-code-of-ethics.pdf,http://sanofi.cz/dam/jcr:d462d8f0-938c-4267-9ec9-6bac06591aca/en-code-of-ethics.pdf,http://sanofi.com.uy/dam/jcr:05370114-612f-4cf0-9ac5-26accdd88a7a/code-of-ethics.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
jean-michel.clerget2@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,1,{first}.{last},,,,,,,,http://jqheducation.ca/sponsors/05,,,,,,,,,,,,,,,,,,,,,,,,,,,,
infochc.ch@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,6,{first}.{last},,,Support,,,,,http://dulcolax.ch/de/nutzer-bedingungen,http://dulcolax.ch/mentions_legales,http://buscopan.ch/nutzungsbedingungen,http://drogistenverband.ch/de/beruf/fort_und_weiterbildung/validierungsantraege,http://bisolvon.ch/nutzungsbedingungen,http://bisolvon.ch/fr/mentions-legales,,,,,,,,,,,,,,,,,,,,,,,
pt-medinfo@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,4,{first}.{last},,,Support,,,,,http://campus.sanofi/pt/recursos/servico-de-informacao-cientifica,http://migateway.eu/en/pt/203/sanofi,http://sanofi.pt,http://sanofi.pt/pt,,,,,,,,,,,,,,,,,,,,,,,,,
zavaccine.queries@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,5,{first}.{last},,,,,,,,http://medinformer.co.za/health_subjects/vaccines-back-to-school,http://medinformer.co.za/health_subjects/world-immunization,http://campus.sanofi/za,http://sanofi.co.za/en/contact-us,http://sanofi.co.za/contact-us,,,,,,,,,,,,,,,,,,,,,,,,
levant.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,6,{first}.{last},,,,,,,,http://campus.sanofi/le/science,http://campus.sanofi/le/science/cardiovascular,http://campus.sanofi/le/science/cardiovascular/dyslipidemia,http://campus.sanofi/le/science/cardiovascular/hypertension,http://campus.sanofi/le,http://lb.sanofi.com/en/media/information-on-plaquenil-and-covid-19,,,,,,,,,,,,,,,,,,,,,,,
reklamationen.austria@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,5,{first}.{last},,,,,,,,http://migateway.eu/en/at/380/sanofi--sterreich,http://sanofi.at/kontakt,http://sanofi.at,http://sanofi.at/de,http://sanofi.at/de/kontakt,,,,,,,,,,,,,,,,,,,,,,,,
medicalinformation.greece@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,6,{first}.{last},,,,,,,,http://campus.sanofi/gr/footer-links/legal-notice,http://campus.sanofi/gr/login,http://campus.sanofi/gr/registration,http://campus.sanofi/gr/science/cardiovascular/hypertension,http://campus.sanofi/gr,http://sanofi.gr/el/forma-epikinonias,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.maroc@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,6,{first}.{last},,,,,,,,http://campus.sanofi/ma,http://sanofi.ma/dam/jcr:9c07de98-5fc4-4d7a-95c4-1780722e43da/guide%20patient%20%20version%20arabe.pdf,http://sanofi.ma/dam/jcr:ad40fe42-4227-4d30-b574-f40bf29419cd/guide%20patient%20%20version%20francaise.pdf,http://sanofi.ma,http://sanofi.ma/fr,http://sanofi.ma/fr/science-innovation/pharmacovigilance,,,,,,,,,,,,,,,,,,,,,,,
katarina.podhorova@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,4,{first}.{last},,,,,,,,http://aosl.sk/statny-ustav-pre-kontrolu-lieciv-informuje-o-stiahnuti-vybranych-sarzi-liekov,http://aosl.sk/spravy/statny-ustav-pre-kontrolu-lieciv-informuje-o-stiahnuti-vybranych-sarzi-liekov,http://liekinfo.sk/spravy/statny-ustav-pre-kontrolu-lieciv-informuje-o-stiahnuti-vybranych-sarzi-liekov,http://primarnykontakt.sk/spravy/mimoriadne-upozornenie-sukl-u,,,,,,,,,,,,,,,,,,,,,,,,,
es-comunicacion@sanofi.com,sanofi.com,Sanofi,,,,,,83,personal,6,{first}.{last},,,,,,,,http://sanofi.es/dam/jcr:c1ee0674-adec-4947-83f1-b91dba3c2217/nota%20metodologica%202019.pdf,http://sanofi.es/dam/jcr:ec7a750a-da4d-4aa6-bb8c-8b416874de2f/nota-metodologica-transparencia-2020.pdf,http://sanofi.es/es/prensa/notas-prensa,http://numerodeinformacion.com/telefono-sanofi,http://sanofi.es/prensa/notas-prensa,http://sanofi.es/es/prensa,,,,,,,,,,,,,,,,,,,,,,,
kontakt.de@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,5,{first}.{last},,,,,,,,http://pharmaforum-sw.de/sites/default/files/2019-10/pf2019_tagungsband_web_0.pdf,http://pharmaforum-sw.de/sites/default/files/2019-10/pf_tagungsband_2018_web.pdf,http://hessenchemie.de/mitgliedsunternehmen,http://tab.103.kz/tavanik-infuzii-instruktsiya,http://laxoberal.de/service/kontakt,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.belgium@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,9,{first}.{last},,,,,,,,http://sanofi.be/dam/jcr:5a20b843-8746-4f0a-9a52-90d7811ca07c/2022%20-%20hcp%20guide%20lu%20fr.pdf,http://sanofi.be/dam/jcr:6809ed07-5e92-4884-a5af-48cab75c6a62/2022%20-%20hcp%20guide%20be%20fr.pdf,http://sanofi.be/dam/jcr:69147261-0705-44c9-a9f0-17d3950d583d/2022%20-%20cover%20letter%20be%20fr.pdf,http://sanofi.be/fr/nous-connaitre/contact-form,http://sanofi.be/nl/over-ons/contact-form,http://migateway.eu/en/be/370/sanofi,http://reference.medscape.com/viewarticle/928210,http://fichier-pdf.fr/2017/12/04/sanofi-charte-de-bonne-conduite-nl-fr,http://thrombosiscare.be/contactusform,,,,,,,,,,,,,,,,,,,,
infomed.maroc@sanofi.com,sanofi.com,Sanofi,,,,,,83,generic,6,{first}.{last},,,Support,,,,,http://sanofi.ma/dam/jcr:09a57a52-971a-4059-9a16-d024f6237c84/valproate%20carte%20patiente_mat-ma-2200520.pdf,http://sanofi.ma/dam/jcr:4029afc2-ef85-4613-828c-d59c57773829/formulaire%20accord%20de%20soins%20(version%20arabe).pdf,http://sanofi.ma/dam/jcr:8576bc2a-829a-4cee-8a9d-1cf1fff5c0ae/guide%20patiente%20(version%20arabe).pdf,http://sanofi.ma/dam/jcr:b1cdba4c-e519-4073-acd0-bc1d4dd587aa/guide%20patiente%20(version%20fran%c3%a7aise).pdf,http://sanofi.ma/dam/jcr:f62c522e-fbf0-419d-b32c-872e1c9a1dd7/note%20dinformation%20destine%20aux%20professionnels%20de%20sant.pdf,http://santeplus.ma/actus/smartpacks-plus-quune-application-une-vraie-solution,,,,,,,,,,,,,,,,,,,,,,,
ptc.nl@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,5,{first}.{last},,,,,,,,http://sanofi.nl/nl/contact,http://sanofi.nl/nl/over-ons/contactinformatie,http://migateway.eu/en/nl/254/sanofi,http://sanofi.nl/contact,http://sanofi-academy.nl/site/contact,,,,,,,,,,,,,,,,,,,,,,,,
chcpvmexico@sanofi.com,sanofi.com,Sanofi,,,,,,82,personal,7,{first}.{last},,,,,,,,http://mercadolibre.com.mx/a/store/sanofi-,http://theinsidersnet.com/es-mx/campaigns/blog/63250/sanofipharmatonsenior2301.htm,http://theinsidersnet.com/es-mx/campaigns/blog/63253/sanofigelicartaction2301.htm,http://theinsidersnet.com/es-mx/campaigns/info/62824/info.htm,http://theinsidersnet.com/es-mx/campaigns/info/63247/info.htm,http://theinsidersnet.com/es-mx/campaigns/info/63256/info.htm,http://lactacyd.mx,,,,,,,,,,,,,,,,,,,,,,
gb-marketaccess@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,6,{first}.{last},,,,,,,,http://sanofi.co.uk/dam/jcr:33cb1e0c-a57c-4fc7-abdb-31ad2c886e85/cwp%20cardiff%20and%20vale%20university%20health%20board.pdf,http://sanofi.co.uk/dam/jcr:535b4c9a-d4e6-4eab-8256-84b2a4623356/the%20christie%20exec%20summary%20v2.0%20%2019may23%20%7bveeva%20approved%7d.pdf,http://sanofi.co.uk/dam/jcr:c632b764-b195-4b2f-ad72-69e91954790f/nee%20collaborative%20working%20diabetes%20project%20-%20executive%20summary%20(4).pdf,http://nice.org.uk:443/guidance/ta802,http://sanofi.co.uk/en/our-responsibility/sanofi-partnerships/collaborative-working,http://sanofi.co.uk/en/our-responsibility/working-in-partnership/collaborative-working,,,,,,,,,,,,,,,,,,,,,,,
bhavesh.patel3@sanofi.com,sanofi.com,Sanofi,,,,,,82,personal,1,{first}.{last},,,,,,,,http://constructiononline.com/profile/sanofiprojects,,,,,,,,,,,,,,,,,,,,,,,,,,,,
opellaprotecciondedatos@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,4,{first}.{last},,,,,,,,http://proxfarma.com/registro,http://lizipaina.es/contacto,http://bisolherbal.es/contacta-con-nosotros,http://pharmaton.es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,
za.chcdrugsafety@sanofi.com,sanofi.com,Sanofi,,,,,,82,personal,4,{first}.{last},,,,,,,,http://dulcolax.co.za/contact-us,http://campus.sanofi/za,http://sanofi.co.za/en/contact-us,http://sanofi.co.za/contact-us,,,,,,,,,,,,,,,,,,,,,,,,,
pacquality@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,7,{first}.{last},,,,,,,,http://sanofi-pacientes.com,http://sanofi-pacientes.com/inicio,http://sanofi-pacientes.com/pol%c3%adticasprivacidad,http://sanofi-pacientes.com/sitemap,http://sanofi-pacientes.com/sobreprogramasanofi,http://genfar.com/atencion-genfar,http://sanofi-pacifico-caribe.com/es/contacto-reportes,,,,,,,,,,,,,,,,,,,,,,
alicja.krzywy@sanofi.com,sanofi.com,Sanofi,,,,,,82,personal,7,{first}.{last},,,,,,,,http://sanofi.pl/dam/jcr:44b5e234-642d-420f-a207-6174ddc104d4/znow%20czujesz%20sie%20niewyspany%20jak%20zadbac%20o%20zdrowy%20sen_informacja%20prasowa.pdf,http://sanofi.pl/dam/jcr:4fc78f26-88e0-466b-9d81-1bf817fd969c/swiadomosc_nafdl_w_populacji_polskiej_ii_edycja_informacja_prasowa.pdf,http://sanofi.pl/dam/jcr:712de07a-5cdd-4059-b186-8dc5448aa251/wspczesny%20styl%20ycia%20a%20stan%20naszej%20skry%20za%2020%20lat.pdf,http://sanofi.pl/dam/jcr:983e0b8b-1d95-4a76-a610-4e02943b914e/mucodual_2w1_action_spray_dossier_prasowe.pdf,http://sanofi.pl/dam/jcr:b4c027e0-5939-41f2-b700-c6f55053f721/novanoc_naturalny_sen_dossier_prasowe.pdf,http://kopd.pl/aktualnosci/atopowi-bohaterowie-czuja-wiecej,http://kopd.pl/aktualnosci/smiech-to-zdrowie-ostatni-odcinek-bajki-atopowi-bohaterowie,,,,,,,,,,,,,,,,,,,,,,
iletisim@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,6,{first}.{last},,,,,,,,http://wazifalab.com/employer/sanofi,http://sanofi.com.tr/dam/jcr:0e05d020-87ab-45d7-afef-841e22576520/srdrlebilirlik%20raporu%20final.pdf,http://sanofi.com.tr/dam/jcr:4b291cb4-2ccc-4ab0-bc2a-035326bccf58/sanofi-surdurulebilirlik-raporu-2021.pdf,http://sanofi.com.tr/dam/jcr:880b7756-1ab0-474d-acff-714cf6ae8ed5/sanofi-surdurulebilirlik-raporu-2018-tr.pdf,http://sanofi.com.tr/medya,http://sanofi.com.tr/tr/medya,,,,,,,,,,,,,,,,,,,,,,,
levant.medinfo@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,6,{first}.{last},,,Support,,,,,http://campus.sanofi/le/science,http://campus.sanofi/le/science/cardiovascular,http://campus.sanofi/le/science/cardiovascular/dyslipidemia,http://campus.sanofi/le/science/cardiovascular/hypertension,http://campus.sanofi/le,http://lb.sanofi.com/en/media/information-on-plaquenil-and-covid-19,,,,,,,,,,,,,,,,,,,,,,,
fabrice.hurbin@sanofi.com,sanofi.com,Sanofi,,,,,,82,personal,6,{first}.{last},,,,,,,,http://gmp.asso.fr/students,http://gmp.asso.fr/wp-content/uploads/2022/08/program-integrated-in-vitro-in-silico-transporter-workshop-6-july-2022.pdf,http://gmp.asso.fr/wp-content/uploads/2022/09/workshop-pbpk_8-9-decembre-2022_final-version.pdf,http://gmp.asso.fr/wp-content/uploads/2023/04/2023_bourse-etudiante_version-finale-espace-centenaire.pdf,http://gmp.asso.fr/about-us/board-members,http://medrxiv.org/content/10.1101/2020.05.15.20103101v1,,,,,,,,,,,,,,,,,,,,,,,
za.medinfo@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,6,{first}.{last},,,Support,,,,,http://nxtgovtjobs.com/sanofi-vacancies,http://sanofi.co.za/dam/jcr:1802be8e-2b34-49eb-bb7f-2eec70b40383/insomnia_severity_index_form.pdf,http://sanofi.co.za/dam/jcr:b56e782b-7600-4924-8369-b42710ff084a/tips_to_overcome_insomnia_booklet_sanofi.pdf,http://campus.sanofi/za,http://sanofi.co.za/contact-us,http://sanofi.co.za/en/contact-us,,,,,,,,,,,,,,,,,,,,,,,
valentin.kiselevich@sanofi.com,sanofi.com,Sanofi,,,,,,82,personal,5,{first}.{last},,,,,,,,http://katrenstyle.ru/news/vnimanie_pokhishcheno_11_seriy_preparatov_sanofi,http://bazanpa.ru/fts-rossii-pismo-n14-4004033-ot02022015-h3217239,http://katrenstyle.ru/articles/journal/news/vnimanie_pokhishcheno_11_seriy_preparatov_sanofi,http://alta.ru/rois/0102500589001%d0%a2%d0%97170308,http://alta.ru/tamdoc/15p04033,,,,,,,,,,,,,,,,,,,,,,,,
customer.care@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,4,{first}.{last},,,Support,,,,,http://gesundheit.lu.ch/-/media/gesundheit/dokumente/humanmedizin/schulgesundheit/schulimpfungen/bestellformular_schulimpfungen_sanofi_pasteur.pdf,http://saez.ch/article/doi/saez.2018.06963,http://bullmed.ch/article/doi/bms.2018.06963,http://bullmed.ch/fr/article/doi/bms.2018.06963,,,,,,,,,,,,,,,,,,,,,,,,,
ro.medical_info@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,5,{first}.{last},,,Support,,,,,http://campus.sanofi/ro,http://svnews.ro/informatii-utile-pentru-cei-care-cauta-medicamentul-plaquenil/207567,http://newsbucovina.ro/social/280787/update-precizari-sanofi-pentru-pacientii-care-au-nevoie-de-plaquenil-si-nu-l-gasesc-in-farmacii,http://sanofi.ro/ro/angajamentul-nostru/etica-si-transparenta,http://sanofi.ro/ro/contact,,,,,,,,,,,,,,,,,,,,,,,,
info.nigeria@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,8,{first}.{last},,,Support,,,,,http://techpoint.africa/2019/02/11/africa-tech-2019-sanofi-launches-3-health-innovation-challenges-for-startups-in-africa,http://sanofi.com.ng/en,http://sanofi.com.ng/en/legal-notice,http://techcabal.com/2019/02/04/africtech-sanofi-launches-3-health-innovation-challenges-for-startups-in-africa,http://techcabal.com/2019/02/05/techcabal-daily-709-facebook-has-partnered-with-dubawa-in-the-fight-against-fake-information-in-nigeria,http://techcabal.com/2019/02/07/techcabal-daily-711-theres-a-vulnerability-in-eskoms-information-systems-that-is-leaking-customer-data,http://techcabal.com/2019/02/11/techcabal-daily-713-telkom-kenya-and-airtel-kenya-plan-merger,http://sanofi.com.ng,,,,,,,,,,,,,,,,,,,,,
farmacovigilancia.argentina@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,4,{first}.{last},,,,,,,,http://campus.sanofi/cs/aviso-de-farmacovigilancia,http://sanofi.com.uy/es/contacto,http://sanofi.com.uy/es/nuestro-compromiso,http://sanofi.com.ar/es/nuestro-compromiso,,,,,,,,,,,,,,,,,,,,,,,,,
n.dedatos@sanofi.com,sanofi.com,Sanofi,,,,,,82,personal,6,{first}.{last},,,,,,,,http://campus.sanofi/co/aviso-privacidad,http://sanofi.com.co/es/avisodatospersonales,http://buscapina.com.co/terminos-condiciones,http://gelicart.com.co/aviso-de-privacidad,http://gelicart.com.co/aviso-legal-y-terminos-y-condiciones,http://gelicart.com.co/politica-de-proteccion-y-datos-personales,,,,,,,,,,,,,,,,,,,,,,,
office.ro@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,6,{first}.{last},,,,,,,,http://campus.sanofi/ro,http://srmi.ro/cnmi2022.php,http://sanofi.ro/ro/centru-media,http://sanofi.ro/ro/notificare-legala,http://sanofi.ro,http://sanofi.ro/ro,,,,,,,,,,,,,,,,,,,,,,,
eventi@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,4,{first}.{last},,,,,,,,http://sociale.it/2016/07/12/boom-health-la-rivoluzione-della-mobile-health,http://dottorsalute.info/2014/11/10/giornata-mondiale-diabete-5azioni-i-volti-in-mostra-chiostro-bramante-roma,http://digitalmarketingfarmaceutico.it/sanofi-viva-technology,http://gabrielecaramellino.nova100.ilsole24ore.com/2016/03/22/internet-of-things-e-futuro-della-salute,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.ru@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,5,{first}.{last},,,,,,,,http://vidal.ru/novosti/novye-dannye-po-bezopasnosti-lekarstvennyh-preparatov-soderzhashhih-valproat-natriya-valproevuyu-kislotu-valproat-seminatriya-i-valpromid-5614,http://vidalru.blogspot.com/2015,http://vidalru.blogspot.com/2015/10,http://vidalru.blogspot.com/2015/10/blog-post.html,http://vidal.ru/novosti/5614,,,,,,,,,,,,,,,,,,,,,,,,
fondationsanofiespoir@sanofi.com,sanofi.com,Sanofi,,,,,,82,generic,4,{first}.{last},,,,,,,,http://accessobservatory.org/_files/ugd/37a51e_3284e642b5d94040aa024ec6d342597b.pdf,http://ideas4development.org/auteur/caty-forget,http://ideas4development.org/en/auteur/caty-forget-2,http://admical.org/actualit%c3%a9s/rdv-le-19-juin-pour-la-journee-vulnerabilites-et-parcours-de-vie-en-france-organisee-par,,,,,,,,,,,,,,,,,,,,,,,,,
k.subramani@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,5,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:346fa521-7f82-48b0-9e97-d72653911464/annual%20report%202012.pdf,http://sanofiindialtd.com/dam/jcr:57d74c15-f4e1-4a7c-88dc-d98ca3ffdc39/annual%20report%202013.pdf,http://sanofiindialtd.com/dam/jcr:744a69c1-9204-4571-a8e9-19104c431c28/annual%20report%202015.pdf,http://sanofiindialtd.com/dam/jcr:a8c09ad0-76bc-40c4-b01b-8fb5cb770938/annual%20report%202011.pdf,http://sanofiindialtd.com/dam/jcr:c3bc6fc0-afb1-4cad-a71f-07c6b092218d/annual%20report%202014.pdf,,,,,,,,,,,,,,,,,,,,,,,,
myhr@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,2,{first}.{last},,,,,,,,http://sanofi.ca/dam/jcr:f106eb4f-7f31-4046-b582-39eb29a1a173/aoda_sanofi-multi-year-accessibility-plan_french.pdf,http://sanofi.ca/dam/jcr:fdb11cf1-a9c2-4379-ab00-71de2740d920/aoda_sanofi-multi-year-accessibility-plan.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
consumer.affairs@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,5,{first}.{last},,,,,,,,http://custservice.org/es/servicio-al-cliente-gold-bond,http://custservice.org/es/servicio-al-cliente-nasacort,http://custservice.org/gold-bond-customer-service,http://custservice.org/nasacort-customer-service,http://custservice.org/rolaids-customer-service,,,,,,,,,,,,,,,,,,,,,,,,
druginfo.finland@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,6,{first}.{last},,,,,,,,http://pharmacafennica.fi/supportmaterial/download/109911765/fi,http://pharmacafennica.fi/supportmaterial/download/109911765/sv,http://pharmacafennica.fi/supportmaterial/download/109911771/fi,http://pharmacafennica.fi/supportmaterial/download/109911771/sv,http://fimea.fi/documents/160140/4855839/potilaan+ja+huoltajan+opas.pdf/98478415-f617-f701-c430-81ab87a188dd,http://fimea.fi/documents/160140/4855839/terveydenhuollon+ammattilaisen+koulutusmateriaali.pdf/fd6e4dd5-4c13-b2e0-b77a-340d5fc1ee58,,,,,,,,,,,,,,,,,,,,,,,
t.anhthu.nguyen@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,1,{first}.{last},,,,,,,,http://congnghemay.info/2013/10/portable-lectra-modaris-diamino-justprint-tich-hop-viet-hoa/comment-page-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chinabd@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/china-and-emerging-markets,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pt-encomendas@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,6,{first}.{last},,,,,,,,http://scmscdao.pt/index.php/documentos/covid-19/119-plano-de-contingencia-covid-19-versao-12-27-05-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/120-plano-de-contingencia-covid-19-versao-13-23-07-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/121-plano-de-contingencia-covid-19-versao-14-10-08-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/122-plano-de-contingencia-covid-19-versao-15-07-09-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/123-plano-de-contingencia-covid-19-versao-16-12-09-2020/file,http://sanofi.pt/pt/areacliente,,,,,,,,,,,,,,,,,,,,,,,
medinfo.pasteur.ph@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,6,{first}.{last},,,,,,,,http://campus.sanofi/ph/data-privacy-notice-and-personal-data-consent-form,http://campus.sanofi/ph/login,http://campus.sanofi/ph/registration,http://campus.sanofi/ph/search,http://sanofi.ph/contact,http://campus.sanofi/ph,,,,,,,,,,,,,,,,,,,,,,,
infomedica.colombia@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,6,{first}.{last},,,Support,,,,,http://campus.sanofi/co/calendario-eventos/17-endocongress-cali-2023,http://campus.sanofi/co/ciencia/enfermedades-raras/que-es-la-enfermedad-de-fabry,http://sanofi.com.co/dam/jcr:3033a9ae-7301-40ff-9622-6fb058ec6fac/tercer%20comunicado%20plaquinol%20y%20covid-19.pdf,http://sanofi.com.co/dam/jcr:c58c50ae-bffe-4e53-a5b1-589bb1c05d26/comunicacion%20directa%20para%20el%20profesional%20de%20la%20salud.pdf,http://genfar.com/atencion-genfar,http://sanofi.com.co/es/contacto-reportes,,,,,,,,,,,,,,,,,,,,,,,
goldenticket@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,4,{first}.{last},,,,,,,,http://healthcapital.de/service/wettbewerbe-preise/artikel/golden-ticket-competition,http://comunitafaces.it/en/us-finals-golden-ticket-winners.html,http://kendallsquare.org/event/sanofi-golden-ticket-competition-for-free-lab-space-at-tufts-launchpad-biolabs,http://viceprovost.tufts.edu/announcements/sanofi-golden-ticket-competition,,,,,,,,,,,,,,,,,,,,,,,,,
meldpunt.nl@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,6,{first}.{last},,,,,,,,http://sanofi.nl/contact,http://sanofi-academy.nl/site/contact,http://jdrf.nl/leven-met-t1d/hulp-en-ondersteuning-bij-t1d,http://migateway.eu/en/nl/254/sanofi,http://sanofi.nl/nl/contact,http://sanofi.nl/nl/over-ons/contactinformatie,,,,,,,,,,,,,,,,,,,,,,,
gb-transparency@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,6,{first}.{last},,,,,,,,http://sanofi.co.uk/dam/jcr:87e6914b-0da5-4189-aa61-68c3cceabcd9/method~1.pdf,http://sanofi.ie/dam/jcr:957d96fd-7e5c-49b6-9eb1-bb696a9a9517/methodological-note-for-ireland-organisation-disclosure-2021.pdf,http://sanofi.ie/en/our-responsibility/transparency-in-our-interactions,http://sanofi.co.uk/dam/jcr:e4d719d3-869d-4aef-aa88-3265d30bae16/methodological%20note%20for%20uk%20patient%20organisation%20disclosure%202021.pdf,http://sanofi.co.uk/en/our-responsibility/transfers-of-value,http://sanofi.ie/en/transparency-in-our-interactions,,,,,,,,,,,,,,,,,,,,,,,
pt-clientes@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,8,{first}.{last},,,,,,,,http://scmscdao.pt/index.php/documentos/covid-19/119-plano-de-contingencia-covid-19-versao-12-27-05-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/120-plano-de-contingencia-covid-19-versao-13-23-07-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/121-plano-de-contingencia-covid-19-versao-14-10-08-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/122-plano-de-contingencia-covid-19-versao-15-07-09-2020/file,http://scmscdao.pt/index.php/documentos/covid-19/123-plano-de-contingencia-covid-19-versao-16-12-09-2020/file,http://sanofi.pt/pt/areacliente,http://sanofi.pt,http://sanofi.pt/pt,,,,,,,,,,,,,,,,,,,,,
loic.darchy@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,3,{first}.{last},,,,,,,,http://sfds.asso.fr/newsletter-1404-7498e47d907bfb3642d4b61f90936592,http://openscience.fr/assessing-dunnett-and-mcp-mod-based-approaches-in-two-stage-dose-finding-trials,http://openscience.fr/evaluation-des-approches-basees-sur-le-test-de-dunnett-et-mcp-mod-dans-des,,,,,,,,,,,,,,,,,,,,,,,,,,
za.drugsafety@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,7,{first}.{last},,,,,,,,http://saraa.co.za/wp-content/uploads/2020/05/letter-for-ha-hydroxychloroquinecovid-19.pdf,http://essentiale.co.za/contact-purchase,http://campus.sanofi/za,http://sanofi.co.za/contact-us,http://sanofi.co.za/healthcare-solution/vaccines,http://sanofi.co.za/en/contact-us,http://sanofi.co.za/en/healthcare-solution/vaccines,,,,,,,,,,,,,,,,,,,,,,
za.productqualitycomplaints@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,4,{first}.{last},,,Support,,,,,http://essentiale.co.za/contact-purchase,http://campus.sanofi/za,http://sanofi.co.za/contact-us,http://sanofi.co.za/en/contact-us,,,,,,,,,,,,,,,,,,,,,,,,,
ie-medicalinformation@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,4,{first}.{last},,,,,,,,http://migateway.eu/en/ie/434/sanofi,http://vtematters.ie/sitemaintenance,http://sanofi.ie/en,http://sanofi.ie,,,,,,,,,,,,,,,,,,,,,,,,,
ideen2@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,2,{first}.{last},,,,,,,,http://sanofi.de/sanofi-in-deutschland/kooperationen-partnering,http://sanofi.de/de/sanofi-in-deutschland/kooperationen-partnering,,,,,,,,,,,,,,,,,,,,,,,,,,,
tetote@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,5,{first}.{last},,,,,,,,http://sanofi.co.jp/dam/jcr:11dd3b37-f59c-4326-8b02-e4eda408cfaa/20180730.pdf,http://fabry-next.com/wp2/wp-content/uploads/0bf8af096d7b5d587117d336382268dd.pdf,http://digitalpr.jp/r/28263,http://lysolife.jp/tetote,http://lysolife.jp/tetote/index.html,,,,,,,,,,,,,,,,,,,,,,,,
senthilnathan.mohanasundaram@sanofi.com,sanofi.com,Sanofi,,,,,,81,personal,3,{first}.{last},,,,,,,,http://openrheumatologyjournal.com/volume/8/page/54,http://openrheumatologyjournal.com/volume/8/page/54/abstract,http://openrheumatologyjournal.com/volume/8/page/54/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,
datenschutz.de@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,5,{first}.{last},,,,,,,,http://antistax.de/datenschutz,http://infoline-schilddruese.de/datenschutzhinweise,http://laxoberal.de/datenschutz,http://selfmedic.de/datenschutz,http://sanofi.de/de/datenschutz,,,,,,,,,,,,,,,,,,,,,,,,
us@sanofi.com,sanofi.com,Sanofi,,,,,,81,generic,8,{first}.{last},,,,,,,,http://realtalkms.com/past-podcast-episodes-2/page/66,http://realtalkms.com/past-podcast-episodes-2/page/65,http://vasculitisfoundation.org/study-enrolling-patients-to-evaluate-efficacy-and-safety-of-sarilumab-in-patients-with-giant-cell-arteritis,http://realtalkms.com/episode-173-creating-the-covid-vaccine-guidance-for-people-with-ms-with-dr-nancy-sicotte,http://clinicaltrials.gov/ct2/show/results/nct01644175,http://clinicaltrials.gov/ct2/show/results/nct02389452,http://clinicaltrials.gov/ct2/show/results/nct01597596,http://clinicaltrials.gov/ct2/show/results/nct01617655,,,,,,,,,,,,,,,,,,,,,
sansen@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,4,{first}.{last},,,,,,,,http://screen4care.eu/de/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/fr/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/it/meet-the-partners/partners-of-screen4care/sanofi,http://screen4care.eu/meet-the-partners/partners-of-screen4care/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,
margarita.murrieta-aguttes@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,3,{first}.{last},,,,,,,,http://efsm.online/be_nl/article-overview/101/2023/efficacy-and-safety-of-fexofenadine-in-children-with-allergic-rhinitis,http://efsm.online/de_de/article-overview/101/2023/efficacy-and-safety-of-fexofenadine-in-children-with-allergic-rhinitis,http://efsm.online/int_en/article-overview/101/2023/efficacy-and-safety-of-fexofenadine-in-children-with-allergic-rhinitis,,,,,,,,,,,,,,,,,,,,,,,,,,
prg.cz_phv@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,6,{first}.{last},,,Writing & communication,,,,,http://campus.sanofi/cz/hlaseni-podezieni-na-nezadouci-ucinky,http://sanofi.cz/dam/jcr:2013d857-4154-4602-85c1-8b03019912f0/tz%20hydroxychlorochin_1152020_cz%20verze.pdf,http://sanofi.cz/dam/jcr:2767402d-a2d6-4d79-875a-305e365274bd/vseobecne_dodaci_podminky_sanofi_cz.pdf,http://sanofi.cz/dam/jcr:3f8cba54-fb4e-4b87-9f4c-4ada31f97682/general_terms_of_delivery_sanofi_cz.pdf,http://sanofi.cz/cs/o-nas/sanofi-pasteur,http://sanofi.cz/cs/produkty-vpois,,,,,,,,,,,,,,,,,,,,,,,
hanane.katerji@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,6,{first}.{last},,,,,,,,http://lb.sanofi.com/dam/jcr:41f45681-739d-4465-b035-5ad7d9ad2571/en_%20wiw%202017%20final.pdf,http://lb.sanofi.com/dam/jcr:b1b4d902-8731-4af7-b88f-3bc3c8d667d3/eng_press%20release%20wkd.pdf,http://lb.sanofi.com/dam/jcr:b68f4599-9662-4bdd-b692-02b40339d3c3/en-press%20release%20wkd%202018%20final.pdf,http://lb.sanofi.com/dam/jcr:ba950bc4-d314-4753-9d17-68657e0ca2a4/en-%20sanofi%20diabetes%20forum.pdf,http://lb.sanofi.com/dam/jcr:d1b4d7c3-fda1-43ee-b36a-bc9c5f019e49/en-2017%20waw%20urticaria%20final-.pdf,http://radar-news.net/archives/165468,,,,,,,,,,,,,,,,,,,,,,,
reception.russia@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,4,{first}.{last},,,Writing & communication,,,,,http://gipertonik.ru/files/conference/kongress-20-mart-22-mart-2013/tesis.pdf,http://cardioweb.ru/files/conference_28-29_nov_2013/tesis.pdf,http://cardioweb.ru/files/conference_5-6_jun_2013/tesis.pdf,http://ru.sanofi.com/ru/legal-notice,,,,,,,,,,,,,,,,,,,,,,,,,
pv-greece@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,6,{first}.{last},,,,,,,,http://campus.sanofi/gr/footer-links/legal-notice,http://campus.sanofi/gr/login,http://campus.sanofi/gr/registration,http://campus.sanofi/gr/science/cardiovascular/hypertension,http://campus.sanofi/gr,http://sanofi.gr/el/forma-epikinonias,,,,,,,,,,,,,,,,,,,,,,,
qa.greece@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,6,{first}.{last},,,,,,,,http://campus.sanofi/gr/footer-links/legal-notice,http://campus.sanofi/gr/login,http://campus.sanofi/gr/registration,http://campus.sanofi/gr/science/cardiovascular/hypertension,http://campus.sanofi/gr,http://sanofi.gr/el/forma-epikinonias,,,,,,,,,,,,,,,,,,,,,,,
srinivasan.r@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,1,{first}.{last},,,,,,,,http://nicci.org/membership,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.opellabelgium@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,7,{first}.{last},,,,,,,,http://omnivit.be/fr/contactez-nous,http://omnivit.be/fr/produit/omnivit-daily-protect-effervescent,http://omnivit.be/fr/blog/product_category/energie,http://omnivit.be/fr/revendeurs,http://omnivit.be/fr/blog/category/stress,http://allegra-allergie.be/nl/privacy,http://allegra-allergie.be/fr/contact,,,,,,,,,,,,,,,,,,,,,,
info.opellabelgium@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,6,{first}.{last},,,Support,,,,,http://omnivit.be/fr/contactez-nous,http://omnivit.be/fr/produit/omnivit-daily-protect-effervescent,http://omnivit.be/fr/blog/product_category/energie,http://omnivit.be/fr/revendeurs,http://omnivit.be/fr/blog/category/stress,http://allegra-allergie.be/fr/contact,,,,,,,,,,,,,,,,,,,,,,,
pv-malaysia@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,7,{first}.{last},,,,,,,,http://campus.sanofi/my/science,http://campus.sanofi/my/science/cutting-edge-science/cardiovascular,http://campus.sanofi/my/science/cutting-edge-science/central-nervous-system,http://campus.sanofi/my/science/cutting-edge-science/chronic-kidney-disease,http://campus.sanofi/my,http://sanofi.com.my/en/contactus,http://sanofi.com.my/en/terms-of-use,,,,,,,,,,,,,,,,,,,,,,
farmakovijilans.turkiye@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,7,{first}.{last},,,,,,,,http://sanofi.com.tr/dam/jcr:136159aa-c9ea-4fa2-88b0-ea5e1706efe9/hidroksiklorokin-basin-bulteni-16042020.pdf,http://sanofi.com.tr/dam/jcr:4b291cb4-2ccc-4ab0-bc2a-035326bccf58/sanofi-surdurulebilirlik-raporu-2021.pdf,http://sanofi.com.tr/dam/jcr:70df7d14-c02d-4e87-9575-7b401db015b8/raporu-2017.pdf,http://sanofi.com.tr/dam/jcr:880b7756-1ab0-474d-acff-714cf6ae8ed5/sanofi-surdurulebilirlik-raporu-2018-tr.pdf,http://sanofi.com.tr/tr/surdurulebilirlik/etik-seffaflik/hasta-sagliginin-korunmasi,http://tasimapostasi.com/2020/04/18/sanofiden-t-c-saglik-bakanligina-covid-19-mucadelesinde-destek,http://iyiklinikuygulamalar.com/sanofiden-t-c-saglik-bakanligina-covid-19-mucadelesinde-destek,,,,,,,,,,,,,,,,,,,,,,
question@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,5,{first}.{last},,,Support,,,,,http://ahfmc.fr/hydroxychloroquine,http://migateway.eu/en/fr/138/sanofi,http://ema.europa.eu/en/medicines/human/orphan-designations/eu3192150,http://lemoniteurdespharmacies.fr/actu/actualites/actus-socio-professionnelles/hydroxychloroquine-un-depannage-des-patients-chroniques.html,http://dermato-info.fr/fr/actualit%c3%a9s-en-dermatologie/covid-19_malades-trait%c3%a9s-en-dermatologie,,,,,,,,,,,,,,,,,,,,,,,,
iedataprotection@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,5,{first}.{last},,,,,,,,http://campus.sanofi/ie/terms-of-use,http://sanofi.ie/en/staying-in-touch/privacy-notice,http://sanofi.ie/en/webinar-privacy-notice,http://sanofi.co.uk/en/webinar-privacy-notice,http://sanofi.ie/en/privacy-policy,,,,,,,,,,,,,,,,,,,,,,,,
za.chcenquiries@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,7,{first}.{last},,,Writing & communication,,,,,http://essentiale.co.za/contact-purchase,http://campus.sanofi/za,http://dulcolax.co.za/contact-us,http://dulcolax.co.za/terms-of-use,http://sanofi.co.za/en/contact-us,http://sanofi.co.za/contact-us,http://essentiale.co.za/terms-of-use,,,,,,,,,,,,,,,,,,,,,,
tashif.ayaz@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,5,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:863d7e04-02ee-4318-a294-affa18dd05cb/shanthas%20pentavalent%20pediatric%20vaccine%20launched%20in%20india.pdf,http://sanofi.in/dam/jcr:bcb811b9-77e9-451a-adb0-c995c5ef47e9/indias%20infants%20to%20receive%20shantha%20biotechnics%20_made%20in%20india_%20shanipv%20for%20polio%20eradication.pdf,http://sanofi.in/dam/jcr:bcfb2df5-91a1-4156-8f24-7d044cf55aad/shanthas%20pentavalent%20pediatric%20vaccine%20prequalified%20by%20world%20health%20organization.pdf,http://sanofi.in/dam/jcr:ce0bd841-09cb-402e-b32e-e3b568c6e04a/telangana%20chief%20minister%20lays%20foundation%20for%20shantha%20biotechnicss%20460%20crore%20insulin%20manufacturing%20fa.pdf,http://lerevenu.com/breves/sanofi-le-candidat-vaccin-anti-rotavirus-de-shantha-entre-en-recherche-clinique-de-phase-iii,,,,,,,,,,,,,,,,,,,,,,,,
ksa.medicalinformation@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,8,{first}.{last},,,,,,,,http://campus.sanofi/dam/jcr:0d6c80a4-d2c2-4782-af9a-4a2ce9be8117/gulf%20sarclisa%20api%20&%20med%20info%20(1).pdf,http://campus.sanofi/sa/science,http://campus.sanofi/sa/science/atopic-dermatitis,http://campus.sanofi/sa/science/eosinophilic-esophagitis,http://campus.sanofi/sa,http://sanofi.com.sa/ar,http://sanofi.com.sa/en,http://sanofi.com.sa,,,,,,,,,,,,,,,,,,,,,
ngoctuyen.lam@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,6,{first}.{last},,,,,,,,http://pharmaworks.vn/trinh-duoc-vien-benh-vien-dong-nai-j1861.html,http://pharmaworks.vn/trinh-duoc-vien-benh-vien-hcm-j1617.html,http://slapaka.com/company/sanofi%20vietnam/206/controlling%20manager,http://cra.com.kh/job-detail/sale-representative-0326038a,http://cra.com.kh/job-detail/0325038a,http://cra.com.kh/job-detail/accounting-manager-03240384,,,,,,,,,,,,,,,,,,,,,,,
maggie.wangmaric@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,5,{first}.{last},,,,"",,,,http://melanomanetwork.ca/fr/forums/topic/carcinome-epidermoide-cutane-cec-2,http://melanomanetwork.ca/uncategorized/csccnewws,http://melanomanetwork.ca/forums/topic/24905,http://melanomanetwork.ca/fr/uncategorized/carcinome-epidermoide-cutane,http://newswire.ca/news-releases/sanofi-genzyme-announces-approval-of-cerdelga-eliglustat-capsules-by-health-canada-for-rare-genetic-condition-620879883.html,,,,,,,,,,,,,,,,,,,,,,,,
pt-farmacovigilancia@sanofi.com,sanofi.com,Sanofi,,,,,,80,personal,5,{first}.{last},,,,,,,,http://migateway.eu/en/pt/203/sanofi,http://sanofi.pt/pt,http://sanofi.pt,http://antistax.pt/sobre/informacao-allestax-gel,http://antistax.pt/sobre/informacao-antistax-comprimidos,,,,,,,,,,,,,,,,,,,,,,,,
usmediarelations@sanofi.com,sanofi.com,Sanofi,,,,,,80,generic,6,{first}.{last},,,Writing & communication,,,,,http://stopmediabiasnow.com/x008,http://prnewswire.com/news-releases/sanofi-us-collaborates-with-duke-university-and-massachusetts-general-hospital-on-big-data-and-type-2-diabetes-300258508.html,http://sanofi.com/en/media-room/press-releases/2015/2015-09-28-15-29-38,http://prnewswire.com/news-releases/sanofi-us-launches-second-innovation-challenge-collaborate--innovate-235058651.html,http://sanofi.com/en/media-room/press-releases/2015/2015-08-31-15-06-00,http://foodallergyawareness.org/alerts/sanofi-us-issues-voluntary-nationwide-recall-of-auvi-q-due-to-potential-inaccurate-dosage-delivery,,,,,,,,,,,,,,,,,,,,,,,
lynn.laws-ricker@sanofi.com,sanofi.com,Sanofi,,,,,,79,personal,1,{first}.{last},Lynn,Ricker,,,,,,http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chris.hunter-ward@sanofi.com,sanofi.com,Sanofi,,,,,,79,personal,1,{first}.{last},Chris,Ward,,,,,,http://presseportal.ch/de/pm/100007059/100701964,,,,,,,,,,,,,,,,,,,,,,,,,,,,
customerservice.za@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,Support,,,,,http://saraa.co.za/wp-content/uploads/2020/05/nivaquine-200-mg-tabs-100.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofimedinfoca@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/21-003.pdf,http://hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/21-005.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanoficares@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://bjd-abcd.com/index.php/bjd/article/download/751/999/6283,,,,,,,,,,,,,,,,,,,,,,,,,,,,
diabetescare.ch@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://diabetes.sanofi.de/dam/jcr:bb7c9fa8-b12b-4731-8756-35a990061244/gi_allstarpro.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alain.bouckenooghe@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.18-0534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
levantdigital@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://campus.sanofi/le/legal-notice,http://campus.sanofi/le/privacy-policy,,,,,,,,,,,,,,,,,,,,,,,,,,,
pvthai@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://campus.sanofi/th,,,,,,,,,,,,,,,,,,,,,,,,,,,,
global@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofi.cz/dam/jcr:d462d8f0-938c-4267-9ec9-6bac06591aca/en-code-of-ethics.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christian.schoenau@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://realhope.se/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
priyanka.sugath@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://pharmanaukri.in/index.php/2023/02/13/sanofi-hiring-senior-and-principal-sr-biostatistician,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lauren.sekhuthe2@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://portal.ptcma.org.za,http://portal.ptcma.org.za/welcome,,,,,,,,,,,,,,,,,,,,,,,,,,,
dzial.sprzedazy@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://archiwum.mz.gov.pl/leki/produkty-lecznicze/braki-lekow/komunikat-w-sprawie-plaquenil-hydroxychloroquine,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1grc.sll@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:9ac8f4af-fe98-406d-bf88-b3cf1615eb24/publication-of-board-meeting-notice.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lgrc.sil@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:bd311f41-58a5-48fc-beaf-22fb846b91dc/postal%20ballot%20voting%20results%20-%20appointment%20of%20managing%20director.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lgrc.sll@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:55a6327f-6672-41ef-ba65-6f076f57ed84/unaudited-financial-results-for-the-quarter-ended-september-30-2018--october-31-2018.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
igrc.sll@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:cc4e7993-8c50-4bf4-99e5-dc3330bc2e23/20190226-audited-financial-results-for-the-year-ended-december-31-2018.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lahcen.bouchaouir@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://sanofi.ma/dam/jcr:3eee2dd6-fa74-494a-a956-6d6bd02f4165/pdf%20p3.pdf,http://sanofi.ma/dam/jcr:a3e80b94-c1d6-4840-8bd2-92ada1d0f132/pdf%20h4.pdf,http://sanofi.ma/dam/jcr:da9fb577-5966-4221-804d-483856e2fab4/pdf%20p3.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
anticounterfeit.coordination@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://toujeopro.com/dam/jcr:eead5438-dffb-45a2-8dac-45f27e4f4b33/us_cor_14_05_008_counterfeit_brochure.pdf,http://sanofi.ma/dam/jcr:394fc6c4-ee28-4f4c-88cf-a5f0dd7c97d6/pdf%20m.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
filippos.mouhelis@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://kefea.org.cy/el/board,,,,,,,,,,,,,,,,,,,,,,,,,,,,
protecciondatosgenfar@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,Writing & communication,,,,,http://genfar.com/politica-de-privacidad,http://genfar.com/terminos-y-condiciones,,,,,,,,,,,,,,,,,,,,,,,,,,,
kazuo.matsubara@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://fukui-byoyaku.com/wp-content/uploads/2021/07/ac2977155a5e5c1733d19906d6819d34.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
masatsugu.arimoto@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://fukui-byoyaku.com/wp-content/uploads/2021/07/82d208a2aefa2889d963d0fbf96e8867.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chcpv@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofi.ph/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofidisclosure.greece@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,5,{first}.{last},,,,,,,,http://sanofi.gr/dam/jcr:37cc2f86-5f72-4d07-b5c5-179197213191/2%20-%20gr%20methodological%20note%20greek%202019.pdf,http://sanofi.gr/dam/jcr:442e9fa7-3f35-4999-8363-b2fc8fd6ecae/methodological%20note%202021%20greece%20-%20en.pdf,http://sanofi.gr/dam/jcr:4bbb06d5-2704-490b-8988-2bb83d98d38e/gr%20%20%202020%20sanofi.pdf,http://sanofi.gr/dam/jcr:faab953b-a013-41fd-a887-9aae504da319/3%20-%20gr%20methodological%20note%20english%202019.pdf,http://sanofi.gr/dam/jcr:fbb19371-5377-480a-a071-729d3567e2ce/greece%20methodological%20note%202020%20sanofi.pdf,,,,,,,,,,,,,,,,,,,,,,,,
haekyung.lee@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofi.co.kr/dam/jcr:8a3deebe-5594-4aa0-81ce-804766b6a1c4/press-2022-01-05.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rym.fettouhe@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,5,{first}.{last},,,,,,,,http://sanofi.dz/dam/jcr:023121c2-c61e-4bc1-a72f-9841b516bf16/communiqu_rencontre%20nationale%20cardiodiabte_ar.pdf,http://sanofi.dz/dam/jcr:05fa955d-6a16-4966-8f81-e5767213e2a3/communiqu%20journe%20internationale%20des%20maladies%20rares%20var.pdf,http://sanofi.dz/dam/jcr:1b0fbdde-3379-438d-ac5e-841d73bd4f0e/communique%20presse%20_diabetes%20your%20type.pdf,http://sanofi.dz/dam/jcr:3424ec52-09ac-4538-9d55-bd965432189a/communiqu%20presse_%20la%20caravane%20medicale%20un%20projet%20humain%20avant%20tout.pdf,http://sanofi.dz/dam/jcr:3b5c176d-3f70-4a0c-8b78-b891fa76e670/communiqu%20journee%20miondiale%20maladies%20rares%20-%20ar.pdf,,,,,,,,,,,,,,,,,,,,,,,,
kazuhiro.aoyagi@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,4,{first}.{last},,,,,,,,http://cad-net.jp/index.php/seminar/detail/1408,http://cad-net.jp/mano/uploads/248/bd50126c4b5a648c2a1cad66c77bd892.pdf,http://cad-net.jp/mano/uploads/249/28e8142eb3060e98587cef06d74daf59.pdf,http://cad-net.jp/seminar/uploads/1408/ff0d673faa557b1590c19110079e99bd.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
kristen.ondy@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://smira.org.uk/keyword-ranking/1917447/jessica+simpson+infertility,,,,,,,,,,,,,,,,,,,,,,,,,,,,
luc.kuykens@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://accessobservatory.org/_files/ugd/37a51e_b0de30097c4745caa81b2eb53244503a.pdf,http://accessobservatory.org/_files/ugd/37a51e_b4e7d54262114caab524e9b0ebc695f3.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
de-molin@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://economie.gouv.fr/files/files/directions_services/cge/bio-production.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
menschenrechtsbeauftragte@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:32c042c4-736c-453d-9e53-8a6c16e55fb0/07_sanofi-suppliers-code-of-conduct.pdf,http://sanofi.de/dam/jcr:75df4265-218a-4243-9132-22af37efc92a/23_sanofi-suppliers-code-of-conduct.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
kaufmaennischerkundenservice@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,Support,,,,,http://sanofi.de/dam/jcr:11c36cb7-ccaa-4314-8f74-0c07023622a8/sadg-retourenregelung-klinik_mai-2023.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kommunikation.fra@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:a6953b8b-bb2b-4b29-b4f8-96479cce1256/csr-broschuere-2011-2012.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
servicecenter-diabetes@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,4,{first}.{last},,,Support,,,,,http://diabetes.sanofi.de/dam/jcr:404ffb1a-d822-4849-ae5f-0ecc499cb014/allstarpro_penanleitung.pdf,http://diabetes.sanofi.de/dam/jcr:5ced0ddf-f7b7-489c-b9e7-6481896d9b75/kurzanleitung_tactipen.pdf,http://diabetes.sanofi.de/dam/jcr:c0e9c21b-4a21-4e9d-9483-dafb1c13a3ed/kurzbedienung_mystarextra_gi.pdf,http://sanofi.de/dam/jcr:d64cbcbb-43a2-432b-8db9-8e39cadbba31/csr-report-2019-sanofi-deutschland.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
planetmobilization@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://mein.sanofi.de/dam/jcr:d90adde7-43fd-4f39-82ff-50b6e0f929df/csr-report-2022-sanofi-deutschland.pdf,http://sanofi.de/dam/jcr:24f5e9e0-79b7-4c20-8207-c552c92ad50e/csr-report-2022-sanofi-deutschland.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
kozzetetel@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofi.hu/dam/jcr:59adb51f-8cb3-478c-b43b-7dc61709d857/transzaperencia%20riport_m%c3%b3dszertani_%c3%batmutato_2021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sven.tops@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://asse.be/verenigingen/detail/223/juve-mollem,,,,,,,,,,,,,,,,,,,,,,,,,,,,
wenquan.wang@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,4,{first}.{last},,,,,,,,http://efspi.org/documents/news/efspi%20newsletter%20august%202019.pdf,http://efspi.org/documents/news/efspi%20newsletter%20september%202019.pdf,http://psiweb.org/docs/default-source/default-document-library/vax-sig-news-2019-2.pdf,http://psiweb.org/docs/default-source/vaccines-newsletters/vaccines-sig-news-2020-1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
dzialprzetargow@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://zzpprzymz.pl/pliki/2018/05/og%c5%82oszenie-o-udzieleniu.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
klavdiya.karpacheva@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://neuromuscular.ru/wp-content/uploads/2019/05/1-2016.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
reklamationer.sto@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofi.se/sv/om-oss/kontakt,,,,,,,,,,,,,,,,,,,,,,,,,,,,
us.csr@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofifoundation-northamerica.org/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
blitzlicht-gesundheit@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,5,{first}.{last},,,,,,,,http://sanofi.at/dam/jcr:39e6a9a1-a300-461b-b06a-a44a10bb48ba/blitzlicht-gesundheit-4-2020.pdf,http://sanofi.at/dam/jcr:3f1e98bb-f206-426e-bce4-0391a9b5f7a6/blitzlicht-gesundheit-4-2019.pdf,http://sanofi.at/dam/jcr:4bc166c5-dcab-4b45-87a8-9b427f092ed3/blitzlicht-gesundheit-2-2020.pdf,http://sanofi.at/dam/jcr:985732da-1b84-4a43-bf19-de31822d08cf/blitzlicht-gesundheit-1-2020.pdf,http://sanofi.at/dam/jcr:b722db2a-af63-4989-ad4d-ae21f8f35d9c/blitzlicht-gesundheit-3-2020.pdf,,,,,,,,,,,,,,,,,,,,,,,,
copac_externals_services@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,Support,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
radicacionwinthrop.bogta@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
sc_externals_services_invoices@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,http://sanofi.cl/dam/jcr:380f4a6b-cdd2-4aff-a29b-3148808a1690/tc%20harmonization%20cl%20final.pdf,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,
ch.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
at.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
ukie-donations@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofi.co.uk/en/our-responsibility/sanofi-partnerships/local-communities-support,,,,,,,,,,,,,,,,,,,,,,,,,,,,
theresa.vonfugler@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://bvdak-kooperationsgipfel.de/rueckblick-2023/die-referenten,http://bvdak-kooperationsgipfel.de/der-gipfel/die-referenten,,,,,,,,,,,,,,,,,,,,,,,,,,,
sirine.ayari-ext@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://ce-crva.fr,http://ce-crva.fr/index.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
valentine.tetillon-ext@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://ce-crva.fr,http://ce-crva.fr/index.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
julie.david-ext@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,5,{first}.{last},,,,,,,,http://sanofi.com/en/investors/environmental-social-governance,http://sanofi.com/en/investors/environmental-social-governance/esg-newsletters,http://sanofi.com/en/investors/environmental-social-governance/our-double-materiality-assessment,http://sanofi.com/en/our-responsibility/equality-and-inclusiveness/a-million-conversations,http://sanofi.com/fr/investisseurs/environnement-societe-gouvernance,,,,,,,,,,,,,,,,,,,,,,,,
emea_iawards-europe@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/collaboration-and-awards/europe/iawards,http://sanofi.com/fr/science-et-innovation/collaboration-et-awards/europe/iawards,,,,,,,,,,,,,,,,,,,,,,,,,,,
marie.massou-ext@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,5,{first}.{last},,,,,,,,http://sanofi.com/en/our-responsibility/equality-and-inclusiveness/global-poll,http://sanofi.com/en/paris-2024-partnership,http://sanofi.com/en/science-and-innovation/clinical-trials-and-results/post-trial-access,http://sanofi.com/fr/science-et-innovation/essais-cliniques-et-resultats/post-trial-access,http://sanofi.com/en/your-health/patient-safety,,,,,,,,,,,,,,,,,,,,,,,,
laurine.hourdel@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://lagepp.univ-lyon1.fr/membre/hourdel-laurine,,,,,,,,,,,,,,,,,,,,,,,,,,,,
philippe.juvin@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://mondial-metiers.com/exposants/sanofi-pasteur.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marcosiii.perez@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://tdtmvjournal.biomedcentral.com/articles/10.1186/s40794-019-0089-5,http://tdtmvjournal.biomedcentral.com/articles/10.1186/s40794-022-00166-6,,,,,,,,,,,,,,,,,,,,,,,,,,,
departamentomedicofabry@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://ar.juntosporfabry.com/terminos-y-condiciones,http://ar.juntosporfabry.com/politica-privacidad,,,,,,,,,,,,,,,,,,,,,,,,,,,
benl_sbs_p2p@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
hktw-p2p-vendorcc@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
aucasian@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://tuta24.ru/product/13032,http://tuta24.ru/product/8949,http://apteka.103.by/guttalaks-instruktsiya,,,,,,,,,,,,,,,,,,,,,,,,,,
joicy.shocken@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://quimica.uchile.cl/noticias/167686/40-nuevos-diplomas-en-investigacion-clinica-y-7-nuevos-monitores-en-ensayos-clinicos,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc_sk-productsqualitycomplaints@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,Support,,,,,http://ibalgin.sk/kontakt.html,http://mucosolvan.sk/kontakt.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
bjorn-kristian.svendsrud@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://sanofi.no/no/nyheter/pressemelding-ny-daglig-leder,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,,,,,,,,,,
quality.partnermarketsafrica@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://sanofi.com.ng/en,http://sanofi.com.ng,,,,,,,,,,,,,,,,,,,,,,,,,,,
mcm@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,5,{first}.{last},,,,,,,,http://docsfera.ru/direction/cardiology/programm,http://docsfera.ru/directions/cardio-head,http://docsfera.ru/directions/cardio/esh2019,http://docsfera.ru/direction/cardiology/praluent,http://docsfera.ru/directions/gh,,,,,,,,,,,,,,,,,,,,,,,,
traineehu@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofi.hu/hu/karrier/gyakornok,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kivalasztas@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofi.hu/hu/karrier,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc.adr.pl@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,http://sanofidlaaptek.pl/files/attachments/owsum_opella_2022.pdf,http://sanofi.pl/dam/jcr:78dac636-0305-4bee-bfba-e3b919d886ba/pv_form_02_opella.pdf,http://sanofi.pl/pl/nasze-produkty/zglos-dzialanie-niepozadane-leku-bez-recepty-wyrobu-medycznego-suplementu-diety,,,,,,,,,,,,,,,,,,,,,,,,,,
belmary.silva@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://sanofi.com.pe/es/media/dia-mundial-sindrome-de-west,http://sanofi.com.co/es/dulcolax,http://sanofi.com.co/es/media/lanza-consejo-de-diversidad-equidad-e-inclusion,,,,,,,,,,,,,,,,,,,,,,,,,,
shunya.ebata@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2022_online.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
isabela.batsu@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,"http://archivesofmedicalscience.com/treatment-adherence-and-effect-of-concurrent-statin-intensity-on-the-efficacy-and,143476,0,2.html",,,,,,,,,,,,,,,,,,,,,,,,,,,,
nacsr@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://sanofifoundation-northamerica.org/docs/pdf/2014_sanofi_foundation_annual_review.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lumanoreply.russia@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://ru.sanofi.com/ru/about-us/sanofi-russia/to-our-suppliers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
massinissa.makri@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://azizdz.com/aziz-electromenager-134,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emea_itech-awards@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/collaboration-and-awards/europe/idea-itech,http://sanofi.com/fr/science-et-innovation/collaboration-et-awards/europe/idea-itech,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc.ukraine@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://no-spa.ua/faq,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc.qa.greece@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://sanofi.gr/dam/jcr:d401c82f-1a88-4f9e-a9a2-e41c7ab3cb29/gregeneraltermsandconditions2021-greece_opella.pdf,http://sanofi.gr/el/forma-epikinonias,,,,,,,,,,,,,,,,,,,,,,,,,,,
weronika.dessoulavy@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://achtedzieciaki.pl/artykul/specjalistyczna-pielegnacja-iwostin-solecrin,http://achtedzieciaki.pl/artykul/znajdz-spokoj-brzucha-1,,,,,,,,,,,,,,,,,,,,,,,,,,,
uzbekistan.pharmacoviqilance@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://gkpd.by/instrukcii/lazolvan-rastvor-dlya-ingalyaciy-sirop-2282.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
studentonboard@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://mojestypendium.pl/staz/staz-w-sanofi-program-student-on-board,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fr_vaccindt@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://medicament.ooreka.fr/astuce/voir/544421/dt-polio,,,,,,,,,,,,,,,,,,,,,,,,,,,,
plaquenil@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://rx.edu.pl/jak-prawidlowo-dokonac-zakupu-leku-plaquenil,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.denmark@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,5,{first}.{last},,,,,,,,http://sanofi.dk/dam/jcr:61da8254-6e31-47dd-9fc1-5833caa33676/cerdelga---patientkort.pdf,http://sanofi.dk/dam/jcr:9404436e-9d75-49f3-9310-fa495d5a0efc/nexviadyme%20-%20vejledning%20til%20l%c3%a6ger%20og%20sundhedspersonale%20-%20hjemmeinfusion.pdf,http://sanofi.dk/dam/jcr:f12a72c8-9ef9-48f8-9dde-f02e5aeac0e5/56074%20dk%20lemtrada%20hcp%20guide%20a5%2009.2022%202.kor.pdf,http://sanofi.dk/dam/jcr:fc4292d4-e86a-466c-9573-12f631322cee/myozyme---safety-information-packet.pdf,http://sanofi.dk/da/om-sanofi/kontakt,,,,,,,,,,,,,,,,,,,,,,,,
darya.petryaeva.ext@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://medpred.ru/companies/sanofi/reviews,http://medpred.ru/companies/sanofi/vacancies,http://medpred.ru/companies/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
beata.durczak@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://efsm.online/be_nl/article-overview/101/2022/real-world-data-support-the-use-of-essential-phospholipids-in-non-alcoholic-fatty-liver-disease,http://efsm.online/de_de/article-overview/101/2022/real-world-data-support-the-use-of-essential-phospholipids-in-non-alcoholic-fatty-liver-disease,http://efsm.online/int_en/article-overview/101/2022/real-world-data-support-the-use-of-essential-phospholipids-in-non-alcoholic-fatty-liver-disease,,,,,,,,,,,,,,,,,,,,,,,,,,
sbs_ee_hu@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofi.hu/hu/karrier/gyakornok,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nadeeka.jayathilaka@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://peakphotowp.com/f238724114,http://peakphotowp.com/p772538533,,,,,,,,,,,,,,,,,,,,,,,,,,,
comunicaciones.copac@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,Writing & communication,,,,,http://sanofi.com.pe/es/media,http://sanofi-pacifico-caribe.com/es/media,http://sanofi.com.co/es/media,,,,,,,,,,,,,,,,,,,,,,,,,,
productquality.belgium@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,Writing & communication,,,,,http://sanofi.be/fr/nous-connaitre/contact-form,http://sanofi.be/nl/over-ons/contact-form,http://migateway.eu/en/be/370/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
dbstest@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://mediafarm.inwise.net/rarediseases_sanofi_genzyme,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jorhie.alban@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://mepra.org/careers/greatergulf-mco-communicationslead-sanofi,http://uaemoments.com/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bsanofi-king-abdullah-medical-city-sign-agreement-to-establish-466492.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
es-chc-atencionclientes@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,http://proxfarma.com/registro,http://lizipaina.es/condiciones-de-uso,http://sanofi.es/es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,
candidature@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://oemaroc.weebly.com/offres-demploi-sanofi.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
juanguillermo.lopez@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.15-0280,http://ajtmh.org/content/journals/10.4269/ajtmh.14-0386,,,,,,,,,,,,,,,,,,,,,,,,,,,
annick.peleraux@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://wiki.transmartfoundation.org/display/tsmtgpl/testing+volunteers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christiane.mbimbe@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://letogolais.com/togo-fait-face-a-une-nette-recrudescence-de-la-meningite,http://medis.com.tn/fr/communique/reprise-de-winthrop-pharma-senegal-par-les-laboratoires-medis,http://info-communication.com/fr/2397981742-journee-mondiale-contre-la-meningite-une-journee-pour-intensifier-la-lutte-contre-cette-maladie-potentiellement-mortelle,,,,,,,,,,,,,,,,,,,,,,,,,,
napurchasetopay@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
accounting.cambodia@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,Finance,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
farmacogivilancia.argentina@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://pharmaton.com.ar/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,,,
comunicacao.portugal@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,Writing & communication,,,,,http://sanofi.pt/pt/media,,,,,,,,,,,,,,,,,,,,,,,,,,,,
karenlorena.meza@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://vcccolombia.com/courses/16-encuentro-latinoamericano-de-cirujanos-de-cadera-y-de-rodilla/lessons/muestra-comercial-elccr/topic/stand-sanofi-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sawsan.moukadam@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://enterogermina.sa/ar-sa/privacy,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ksa_ptc_reporting@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://enterogermina.sa/ar-sa/faq,http://enterogermina.sa/ar-sa/privacy,,,,,,,,,,,,,,,,,,,,,,,,,,,
bg-medical-info@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,Support,,,,,http://oldwww.namama.bg/article-vliyanieto-na-akari-i-hlebarki-v-doma-vurhu-alergii-i-astma/308,http://oldwww.namama.bg/card-marimer-s-grizha-za-vsyako-nosle/75,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilancemalta@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://qr.epilimandme.ie/sitemap,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ukie.genmed-contact@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,Support,,,,,http://vtematters.ie/sitemaintenance,,,,,,,,,,,,,,,,,,,,,,,,,,,,
comunicaciones@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,4,{first}.{last},,,Writing & communication,,,,,http://sanofi.com.ar/es/aviso-legal,http://sanofi.cl/es/aviso-legal,http://sanofi.com.py/es/aviso-legal,http://sanofi.com.py/aviso-legal,,,,,,,,,,,,,,,,,,,,,,,,,
zimnylancuch.sp@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://mgr.farm/aktualnosci/szczepionka-przeciw-grypie-bezpieczna-do-72-godzin-od-przerwania-zimnego-lancucha,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fv-imed@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://medicoconsentido.com.mx/farmacovigilancia,,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.pidault@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://m.annuaire-comite-entreprise.com/7301716+21800+quetigny+comite-entreprise+comite-ets-synthelabo-groupe.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofi.ro@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://doingbusiness.ro/companie/sanofi-romania-srl-11147490,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sophie.michaut@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://e-pediatrie.org/e-pediatrie/le-programme/comite-scientifique-scientifique,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pierre-aime.assemien@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://e-pediatrie.org/e-pediatrie/le-programme/comite-scientifique-scientifique,,,,,,,,,,,,,,,,,,,,,,,,,,,,
devoluciones.sanofi.peru@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,http://sanofi.com.pe/terminos-y-condiciones-sf,http://sanofi.com.pe/es/terminos-y-condiciones-gz,http://sanofi.com.pe/es/terminos-y-condiciones-sf,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.latvia@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://farmacija-mic.lv/sanofi-butiska-informacija-par-plaquenil-un-covid-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bio-scouting@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://medivizyon.com.tr/yasam-bilimlerinin-lider-projesi-araniyor,http://saglikteknoloji.com/sanofi-bio-scouting-projesi-ile-turkiyede-yasam-bilimlerinde-lider-projeleri-ariyor,http://aa.com.tr/tr/sirkethaberleri/saglik/sanofiden-bio-scouting-projesi-/654789,,,,,,,,,,,,,,,,,,,,,,,,,,
france-pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://atoopharm.fr/post/covid19-%3a-baisse-dactivite-comment-piloter-l-officine-au-quotidien,http://atoopharm.fr/post/covid19-:-baisse-dactivite-comment-piloter-l-officine-au-quotidien,http://conseil34.ordre.medecin.fr/content/regles-prescription-lhydroxychloroquine-plaquenilc-lassociation-lopinavirritonavir-kaletra,,,,,,,,,,,,,,,,,,,,,,,,,,
myalprolix@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,4,{first}.{last},,,,,,,,http://alprolix.com/resources/financial-assistance,http://alprolix.com/resources/financial-assistance.aspx,http://alprolix.com/resources/patient-services,http://alprolix.com/resources/patient-services.aspx,,,,,,,,,,,,,,,,,,,,,,,,,
contact.cepia-sales@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,Sales,,,,,http://pharmaceutical-suppliers.com/listing/sanofi-active-ingredient-solutions-api-supply-custom-synthesis-api-and-pharma-contract-manufacturing-solutions,,,,,,,,,,,,,,,,,,,,,,,,,,,,
trmdenmark@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://magasinetpleje.dk/procurement/view/102100/amgros_20201551a,http://magasinetpleje.dk/procurement/view/83302/amgros_20201441a,,,,,,,,,,,,,,,,,,,,,,,,,,,
piplan@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-002418-pip01-18-m01,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sunyung.moon@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://careerbrdg.tistory.com/590,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yann.tudal@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://a3p.org/exploiter-la-donnee-pour-optimiser-le-pilotage-dun-procede,,,,,,,,,,,,,,,,,,,,,,,,,,,,
televendas.brasil@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://vaxinlife.com.br/contato,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mathieu.nivoliez@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://gitlab.deep-nope.me/mnivoliez/deeply-universal-react-redux-boilerplate/blob/master/.babelrc,,,,,,,,,,,,,,,,,,,,,,,,,,,,
joerg.haberich@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://haberich.de/author/joerg,http://haberich.de/the-h-cap-on-sale,,,,,,,,,,,,,,,,,,,,,,,,,,,
eg_media@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,Writing & communication,,,,,http://sanofi.com.eg/en/press-room,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jungwoo.lee@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://campus.sanofi/kr/privacy-policy,http://dev.superookie.com/jobs/6305d6978b129f281774d5e6,,,,,,,,,,,,,,,,,,,,,,,,,,,
david.peyruc@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://slideshare.net/mongodb/sanofi-mongodbworld20140625final,,,,,,,,,,,,,,,,,,,,,,,,,,,,
agnieszka.baczkowska@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://sanofi.pl/o-nas/odpowiedzialnosc-spoleczna/infolinia-zgodnosci-sanofi,http://sanofi.pl/pl/o-nas/etyka-i-integralnosc-biznesu,http://sanofi.pl/pl/o-nas/odpowiedzialnosc-spoleczna/infolinia-zgodnosci-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
new.opportunity@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,http://sanofi.co.jp/ja/research-and-development/partners,http://sanofi.co.jp/ja/contact,http://sanofi.co.jp/ja/research-and-development/for-researcher/form,,,,,,,,,,,,,,,,,,,,,,,,,,
kenpo@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://neo-gift.net/11372,http://neo-gift.net/11373,http://neo-gift.net/11375,,,,,,,,,,,,,,,,,,,,,,,,,,
presse.ch@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,4,{first}.{last},,,Writing & communication,,,,,http://sanofi.ch/dam/jcr:0d42e2a4-5f2d-4416-974c-14a75d6d0581/communiqu%c3%a9_michael%20kubischik_country%20lead%20sanofi%20suisse_01112022.pdf,http://sanofi.ch/dam/jcr:31b783bc-dbcb-4588-bda7-9624acce7c38/pressemitteilung_michael%20kubischik_country%20lead%20sanofi%20schweiz_01112022.pdf,http://sanofi.ch/de/presse,http://sanofi.ch/fr/medias,,,,,,,,,,,,,,,,,,,,,,,,,
isabelle.gantier@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://atlanpolebiotherapies.com/agenda/reunion-de-lancement-de-laccelerateur-sante-pme,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hirokazu.kawano@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2015.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hazuki.watanabe@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2012.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hiroyoshi.akehi@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2012.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kenta.watanebe@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2012.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pv.philippines@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,5,{first}.{last},,,,,,,,http://campus.sanofi/ph/data-privacy-notice-and-personal-data-consent-form,http://campus.sanofi/ph/login,http://campus.sanofi/ph/registration,http://campus.sanofi/ph/search,http://campus.sanofi/ph,,,,,,,,,,,,,,,,,,,,,,,,
diabetescamps@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofifoundation-northamerica.org/programs,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chitose.orii@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2012.html,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
kazuhiro.araki@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kenta.watanabe@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
junichi.yamamoto@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2014.html,http://jaden1996.com/workshop/application_2012.html,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,
kariera.slovakia@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,http://prservis.sk/tim-spolocnosti-sanofi-posilnili-nadseni-studenti,http://mozaikazdravia.sk/zdravie/tim-spolocnosti-sanofi-posilnili-nadseni-studenti,http://maxivyber.sk/slovensko/tim-spolocnosti-sanofi-posilnili-nadseni-studenti,,,,,,,,,,,,,,,,,,,,,,,,,,
communication.afsub@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,2,{first}.{last},,,,,,,,http://sanofi.ci/dam/jcr:cc6e59bd-3a8c-40e7-a4c7-bdb8e42d54a4/cp_sanofi%20_africatech_2019%20-%20annonce_finalistes.pdf,http://info-communication.com/fr/1180160844-des-experts-afrique-subsaharienne-reunis-pour-une-meilleure-prise-en-charge-de-la-grippe,,,,,,,,,,,,,,,,,,,,,,,,,,,
shuhei.hashimoto@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2017_shikoku.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
diabetesforum@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,Writing & communication,,,,,http://delegia.com/app/netattm/attendee/page/48632,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.eg@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,"http://sanofi.com.eg/dam/jcr:001dcbdd-e126-48aa-86d8-19acc95692b4/tritace%201.25mg,2.5mg,5mg%20tablets%20and%20tritace%20protect%2010mg%20tablets%20leaflet.pdf",http://sanofi.com.eg/our-products,http://sanofi.com.eg/en/our-products,,,,,,,,,,,,,,,,,,,,,,,,,,
eunjin.bae@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,1,{first}.{last},,,,,,,,http://careerbrdg.tistory.com/787,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.bd@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://tradebangla.com.bd/business/sanofi-bangladesh-limited,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dzial.przetargow@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,4,{first}.{last},,,,,,,,http://zzpprzymz.pl/pliki/2018/01/udzielenie-zam%c3%b3wienia-20.18.pdf,http://zzpprzymz.pl/pliki/2018/02/og%c5%82oszenie-o-udzieleniu-1.pdf,http://zzpprzymz.pl/pliki/2018/09/og%c5%82.o.udzieleniu.zam_.pdf,http://bip.109szpital.pl/zamowienia-publiczne/od-30-000-euro/dostawy/przetarg-nieograniczony-na-dostawe-produktow-leczniczych-z-podzialem-na-4-zadania-1,,,,,,,,,,,,,,,,,,,,,,,,,
alexander.liesum@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,6,{first}.{last},,,,,,,,http://worldwidescience.org/topicpages/c/crystal+deposition+disease.html,http://worldwidescience.org/topicpages/n/nanoparticles+alter+cathepsin.html,http://worldwidescience.org/topicpages/m/multiple+nucleopolyhedrovirus+cathepsin.html,http://worldwidescience.org/topicpages/r/requires+microglial+cathepsin.html,http://worldwidescience.org/topicpages/b/bradykinin.html,http://science.gov/topicpages/a/abstract+crystal+structure.html,,,,,,,,,,,,,,,,,,,,,,,
recruitment.adriatic@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,3,{first}.{last},,,,,,,,http://mismozastvar.com/category/casopisni-clanki,http://mismozastvar.com/2016/09,http://mismozastvar.com/category/branje,,,,,,,,,,,,,,,,,,,,,,,,,,
mexico.calidadycumplimiento@sanofi.com,sanofi.com,Sanofi,,,,,,78,generic,1,{first}.{last},,,,,,,,http://sanofi.com.mx/es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marykathryn.steel@sanofi.com,sanofi.com,Sanofi,,,,,,78,personal,3,{first}.{last},,,,,,,,http://biospace.com/article/releases/regeneron-pharmaceuticals-inc-sanofi-france-shows-off-positive-phase-2-alirocumab-data-,http://prnewswire.com/news-releases/sanofi-and-regeneron-report-positive-results-with-alirocumab-from-phase-2-japanese-study-253351361.html,http://biospace.com/news/regeneron-pharmaceuticals-inc-sanofi-france-shows/328669,,,,,,,,,,,,,,,,,,,,,,,,,,
cadjp@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://e-mr.sanofi.co.jp/products/enjaymo,,,,,,,,,,,,,,,,,,,,,,,,,,,,
myeloctatecoordinator@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://hanj.org/pharmaceutical-resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,
infomed.tunisie@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://tn.sanofi.com/dam/jcr:b914b97b-1973-48e9-84c0-141bdfd4e33a/plaquenil%20update%20juin%202020.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
erzsebet.udvardi@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://docplayer.hu/2514761-fontos-gyogyszerbiztonsagi-informaciokrol-szolo-tajekoztato-level-dhpc.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.estonia@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,5,{first}.{last},,,,,,,,http://ravimiamet.ee/media/570/download,http://ravimiamet.ee/media/787/download,http://ravimiamet.ee/media/789/download,http://ravimiamet.ee/media/797/download,http://ravimiamet.ee/media/812/download,,,,,,,,,,,,,,,,,,,,,,,,
vijaybalakishore@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://pharmaudyog.com/2018/10/sanofi-shantha-biotech-opportunity-for.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
karin.benstein@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://e-i-p.eu/media/pages/symposiums/2023-lisbon/1a1393e85a-1684147772/2023-04-27-4-linlin-luo.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
guray.karacar@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sjd.org.tr/_files/ugd/a696ce_50347b941b9549569848f16536fc82c4.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chcpv.russia@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://no-spa.ru/faq/kakie-vozmozhny-pobochnye-yavleniya-pri-primenenii-tabletok-no-shpa,,,,,,,,,,,,,,,,,,,,,,,,,,,,
diversidade@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.com.br/dam/jcr:b762fedd-ccf5-4207-81f9-64b21937e39a/cartilha_doseujeito_diversidade%20%281%29.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
contactossanofiplus@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://campus.sanofi/pt/contactos,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc_pv_liaison.latam@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,5,{first}.{last},,,,,,,,http://campus.sanofi/co/ciencia,http://campus.sanofi/co/ciencia/asma-grave,http://campus.sanofi/co/ciencia/dermatologia,http://campus.sanofi/co/ciencia/enfermedades-raras,http://campus.sanofi/co,,,,,,,,,,,,,,,,,,,,,,,,
pv.israel@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,5,{first}.{last},,,,,,,,http://campus.sanofi/il/science/diabetes,http://campus.sanofi/il/science/nasal-polyps,http://campus.sanofi/il/science/type-2-inflammation,http://campus.sanofi/il/science/vaccines,http://campus.sanofi/il,,,,,,,,,,,,,,,,,,,,,,,,
irina.zarochintseva@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://vspru.ru/media/384106/katalog_viii-kongress.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ogrc.sil@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:5bbb754a-7f32-4222-a7e6-82a744daa4de/publication-of-board-meeting-notice-feb.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
igrc.s1l@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:998b33e5-b4ad-41ea-9bc0-b0c1bc954e30/meeting-of-board-of-directors-to-be-held-on-25th-july-2018.pdf,http://sanofiindialtd.com/dam/jcr:b2926cd9-b269-474e-8bfa-44215f595116/outcome-of-board-meeting-held-on-10th-september-2019.pdf,http://sanofiindialtd.com/dam/jcr:f3559115-d290-4db5-b9c1-ec7d8d56dcad/unaudited-financial-results-for-the-quarter-ended-30th-september-2019.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
grc.s1i@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:55a6327f-6672-41ef-ba65-6f076f57ed84/unaudited-financial-results-for-the-quarter-ended-september-30-2018--october-31-2018.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sapdataintegrity@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://synvisconehcp.com/dam/jcr:2f57857f-355d-4e40-b8ca-199cc0866567/credit-application-form.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julkaisu@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.fi/dam/jcr:36a79fd3-6fb9-4fc6-b0b1-edab5897306f/methodological%20note_finland_eng_2021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chcmedinfo.ph@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.ph/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vedrana.brataljenovic@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.gr/dam/jcr:3ebeee6f-fa83-48e1-b62f-3ce167d6e2cc/200918_gr_positive%20pivotal%20data%20for%20cemiplimab%20monotherapy%20in%20labcc-esmo_final.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
es-transparencia@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,5,{first}.{last},,,,,,,,http://sanofi.es/dam/jcr:58507646-fd7d-4b60-95a5-4fac563b05eb/nota-metodologica-pacientes-2020.pdf,http://sanofi.es/dam/jcr:9d8771b5-669b-4775-8fef-203069b7980f/nota%20metodologica-%20pacientes%202021.pdf,http://sanofi.es/dam/jcr:c1ee0674-adec-4947-83f1-b91dba3c2217/nota%20metodologica%202019.pdf,http://sanofi.es/dam/jcr:ec7a750a-da4d-4aa6-bb8c-8b416874de2f/nota-metodologica-transparencia-2020.pdf,http://sanofi.es/dam/jcr:ef62f158-51ad-4baa-8cd9-f47728c76053/nota%20metodologica%20hcp-hco%202021.pdf,,,,,,,,,,,,,,,,,,,,,,,,
francois.desbrandes@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://docplayer.fr/1275784-11-eme-reunion-du-groupe-de-travail-rbm-sur-la-gestion-des-achats-et-de-la-chaine-d-approvisionnement-psm-11.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anne.gagnepain-lacheteau@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,4,{first}.{last},,,,,,,,http://accessobservatory.org/_files/ugd/37a51e_230d9f1acf784b2a99a9dfbfde1644bb.pdf,http://accessobservatory.org/_files/ugd/37a51e_288e8543b3b34fb5b5ac3c444bb85409.pdf,http://accessobservatory.org/_files/ugd/37a51e_330f4e7465d04315adc411d75f93dd78.pdf,http://accessobservatory.org/_files/ugd/37a51e_4e709581603a4ef6873eca13924fffd8.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
hse.unfallmeldung@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:292298bf-65c0-4b00-aa0e-7c527b1852ab/08_fremdleistungs-und-montagebedingungen-sanofi-aventis-deutschland.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lebenundarbeiten@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:4a818ee9-96db-4a39-b42a-b857ca10b120/181_aktionsplan-un-behindertenrechtskonvention-sanofi.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marc.bianciotto@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://opensourcepharma.net/uploads/3/1/7/8/31787557/osp3_cri_brochure_march2019_1.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
frakkschc@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://pharmazeutische-zeitung.de/toiletten-fuer-alle-139652,,,,,,,,,,,,,,,,,,,,,,,,,,,,
responsibility@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,4,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:3cb4ee2a-6448-4ccd-86dd-94e20dcd701e/sanofi-india-iar-2022-brsr.pdf,http://sanofiindialtd.com/dam/jcr:6b667806-9e22-448d-a45a-b5ce3e81e163/sanofi%20india%20iar%202022_brsr.pdf,http://sanofiindialtd.com/dam/jcr:b72fc7a8-56b7-4418-8741-1901eecbbede/sanofi%20india%20iar%202022.pdf,http://sanofi.com/dam/jcr:8bbd0604-1fdf-43dc-87eb-2135f46bd479/gri-content-index.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
vaccins.belux@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://mysanofi.be/dam/jcr:17f34c9b-96f3-4e5a-83a2-dd32a5d6034d/efluelda%20-%20annexe%20a%20-%20nl.pdf,http://mysanofi.be/dam/jcr:4e7dd06f-ae57-4d4e-b362-a8290d1f2920/efluelda%20-%20leave-behind%20-%20nl.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
pompe.japan@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.co.jp/dam/jcr:4e34aeb6-6b82-4f01-8796-94505730b69f/20180413.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.shantha@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:540b024a-314a-4962-8542-77473c3b987e/shanchol_2015.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.shantha@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://sanofi.in/dam/jcr:540b024a-314a-4962-8542-77473c3b987e/shanchol_2015.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
digital.at@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.at/dam/jcr:a072e92d-d1e2-4116-b311-f253de09ddba/blitzlicht-gesundheit-2-2017.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
transp_mco_gsa@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:036f00a9-31b4-4f0c-bc82-0a396dc5a881/sadg-genzyme-methodisches-hinweise.pdf,http://sanofi.ch/dam/jcr:cc374e44-faab-46d1-a347-aefe45638a32/methodische%20hinweise%20sanofiaventis%20schweiz%20ag.pdf,http://sanofi.at/dam/jcr:14a7d9c4-9eda-4845-a737-f7cfaf8024b7/methodische%20hinweisesanofiaventis%20gmbh%20sterreich.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
chcmktintern.kr@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://careerbrdg.tistory.com/1571,http://careerbrdg.tistory.com/2168,,,,,,,,,,,,,,,,,,,,,,,,,,,
arproveedores@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://sanofi.com.uy/dam/jcr:0e03f860-8240-44ca-a4a6-97af79bde24a/tc%20harmonization%20uy%20final.pdf,http://suppliers.sanofi.com/statics/pdfs/chc_argentina.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
radicacionsanofi.bogta@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
copefacturasprov@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
radicacionpasteur.bogta@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
dz1_externals_services@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,Support,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
de.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
pa.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
co.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
marketaccess.finland@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,Sales,,,,,http://palveluvalikoima.fi/documents/1237350/107321684/palko+4.2.22+p%c3%b6yt%c3%a4kirja.pdf/9f7941ad-2dab-8a2b-453f-b0da484fc4ca/palko+4.2.22+p%c3%b6yt%c3%a4kirja.pdf,http://fimea.fi/documents/160140/1454401/kommentti_sanofi+oy_+fimean+ikd+arviointiraportti.pdf/639d5a6e-bbaa-dbc7-5bb8-d59b60580235,,,,,,,,,,,,,,,,,,,,,,,,,,,
infossa@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://sanofi.ci/fr/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanoficanadacommunications@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,3,{first}.{last},,,,,,,,http://sanoficanada.mediaroom.com/media-contacts,http://sanoficanada.fr.mediaroom.com/contacts-pour-les-medias,http://stage.mediaroom.com/sanoficanada2/media-contacts,,,,,,,,,,,,,,,,,,,,,,,,,,
stefan.guessregen@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://jcheminf.biomedcentral.com/counter/pdf/10.1186/s13321-016-0119-5.pdf,http://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0119-5,,,,,,,,,,,,,,,,,,,,,,,,,,,
communicationthai@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://eabc-thailand.org/member/101,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pakistan.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.com.pk/en/health-and-wellbeing,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ainara.rodriguezmarco@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://skinofcolorupdate.com/skin-of-color-update-2021-poster-session,,,,,,,,,,,,,,,,,,,,,,,,,,,,
josephine.kinyota@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://products.pharmacyboardkenya.org/ppb_admin/pages/public_view_ectd_red.php,,,,,,,,,,,,,,,,,,,,,,,,,,,,
clinical-trials-jp@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://fpcr-joho.jp/search_list/index/genre:57,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lola.millet-ext@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://ce-crva.fr,http://ce-crva.fr/index.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
guillaume.mondesert@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://scripps.edu/reed/alumni.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sri-eu@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/collaboration-and-awards/europe,http://sanofi.com/fr/science-et-innovation/collaboration-et-awards/europe,,,,,,,,,,,,,,,,,,,,,,,,,,,
immunologybd@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/immunology,,,,,,,,,,,,,,,,,,,,,,,,,,,,
neurologybd@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/neuroscience,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vaccinebd@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/vaccines,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cristina.bitou@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://pneumon.org/pdf-137286-65105,"http://pneumon.org/ambroxol-more-than-an-expectorant-the-benefit-of-using-ambroxol-in-chronic-respiratory,137286,0,2.html",,,,,,,,,,,,,,,,,,,,,,,,,,,
czsk_sbs_p2p@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
anz-p2p-vendorcc@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
noba_sbs_p2p@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
resepsjon@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.norway@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cv.russia@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://pmedpharm.ru/studentu_ochniku/graduate,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ng-gh.pv@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://sanofi.com.ng,http://sanofi.com.ng/en,,,,,,,,,,,,,,,,,,,,,,,,,,,
issaka.yougbare@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://nephrojournal.com/articles/alterations-of-campcgmp-signaling-pathways-in-lupus-nephritis.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.tr@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.com.tr/tr/hakkimizda/saglik-cozumleri/urunler,,,,,,,,,,,,,,,,,,,,,,,,,,,,
moning.liu@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.cn/zh/high-quality-products/prescription/multaq-material,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medical.israel@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,5,{first}.{last},,,,,,,,http://campus.sanofi/il/science/diabetes,http://campus.sanofi/il/science/nasal-polyps,http://campus.sanofi/il/science/type-2-inflammation,http://campus.sanofi/il/science/vaccines,http://campus.sanofi/il,,,,,,,,,,,,,,,,,,,,,,,,
girish.tekchandani@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:0db99a2f-f539-4887-9504-40d5a5f0f0a8/communication-of-deduction-of-tax-at-source-on-dividend.pdf,http://sanofiindialtd.com/dam/jcr:46a7f57c-9569-4de4-bf74-796e4015e6f3/communication%20of%20deduction%20of%20tax%20at%20source%20on%20dividend%20(1).pdf,http://indiancompany.info/company/sanofi-india-limited,,,,,,,,,,,,,,,,,,,,,,,,,,
vietnam.chcmedinfo@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://phosphalugel.com.vn/faqs,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ptpsharedservice.russia@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://ru.sanofi.com/ru/about-us/sanofi-russia/to-our-suppliers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
qa.dk@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.dk/da/om-sanofi/kontakt,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc.me.quality@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://telfast-arabia.com/ar-ae/contact,http://telfast-arabia.com/en-us/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,
naresh.konduri@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julkaisu.finland@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://sanofi.fi/dam/jcr:91b37a58-7fdf-48ab-ab44-0fe30aee9477/methodological%20note_finland_fin_2021.pdf,http://sanofi.fi/fi/uutisia/sanofi-ja-terveydenhuollon-ammattilaiset,,,,,,,,,,,,,,,,,,,,,,,,,,,
complaints.finland@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,Support,,,,,http://sanofi.fi/fi/tietoa-meista/yhteystiedot,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lyudmyla.babych@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,4,{first}.{last},,,,,,,,http://modern-pharmacy.com.ua/putem-otvetstvennogo-biznesa-sanofi-v-ukraine-podderzhala-provedenie-iv-farmakoe-konomicheskogo-foruma-po-diabetologii,http://modern-pharmacy.com.ua/sotsial-ny-j-proekt-po-diabetu-i-dva-preparata-sanofi-v-ukraine-poluchili-naivy-sshee-priznanie-v-konkurse-panatseya-2014,http://modern-pharmacy.com.ua/vmeste-radi-spaseniya-zhizni-sanofi-podderzhala-ryad-proektov-ko-vsemirnomu-dnyu-bor-by-protiv-raka-molochnoj-zhelezy-v-ukraine,http://modern-pharmacy.com.ua/vsemirny-j-den-bor-by-s-diabetom-v-ukraine-dejstvuya-radi-budushhego,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacoviqilance-by@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://gkpd.by/instrukcii/lazolvan-rastvor-dlya-ingalyaciy-sirop-2282.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anastasiya.zorina@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://ru.sanofi.com/dam/jcr:a1a2b2df-d4e0-41e6-8d02-66cf46cd708d/rusfinal.pdf,http://arfp.ru/uspeshnoe-zavershenie-pervogo-etapa-postavki-pyatikomponentnoj-pediatricheskoj-vakcziny-v-ramkah-dvuhletnego-kontrakta-novyj-etap-v-borbe-s-opasnymi-infekcziyami,,,,,,,,,,,,,,,,,,,,,,,,,,,
laith.elkurd@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://hfmonline.org/product-manufacturers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gtly-domtech@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://stats.rankiing.net/domain/sanofi.fr,,,,,,,,,,,,,,,,,,,,,,,,,,,,
paulina.buks@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.pl/pl/media/dzial-komunikacji-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chcmedical-information.me@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://telfast-arabia.com/en-us/contact,http://telfast-arabia.com/ar-ae/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,
yana.denisova.ext@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://medpred.ru/companies/sanofi/reviews,http://medpred.ru/companies/sanofi/vacancies,http://medpred.ru/companies/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofi.brasilfarmacovigilancia@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.com.br/pt/quem-somos/noticias/informacoes-de-produto/2020-03-26-nota-plaquinol,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gorka.ortizdezarate@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://aedem.org/la-comunidad-de-esclerosis-multiple-en-espana-se-moviliza-en-la-campana-de-sanofi-genzyme-exige-mas-a-tu-vida-con-em,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dkselvhjaelpsguide@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,4,{first}.{last},,,,,,,,http://sanofi.dk/da/vores-sociale-ansvar-som-virksomhed/selvhjaelpsguide,http://msguiden.dk/lev-med-ms/selvhjaelpsguide-til-teenagere-og-unge-voksne,http://msguiden.dk/lev-med-ms/guide-om-krisehaandtering,http://msguiden.dk/lev-med-ms/guide-om-krise-hos-boern,,,,,,,,,,,,,,,,,,,,,,,,,
winthropus@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://lantus.com/how-to-use/insulin-glargine-u100,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sylviane.gautheron@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://unboundmedicine.com/medline/citation/33685778/next_generation_live_attenuated_yellow_fever_vaccine_candidate:_safety_and_immuno_efficacy_in_small_animal_models_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
idrissa.tiene@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sanofi.ci/fr/nous-connaitre/sanofi-cameroun-cote-ivoire-senegal,,,,,,,,,,,,,,,,,,,,,,,,,,,,
medical_info.belgium@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,3,{first}.{last},,,,,,,,http://sanofi.be/fr/nous-connaitre/contact-form,http://sanofi.be/nl/over-ons/contact-form,http://migateway.eu/en/be/370/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
riadmamun.prodhani@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://addressbd.xyz/sanofi-bangladesh-ltd,http://addressbd.xyz/tag/bangladeshi-companies,http://addressbd.xyz/tag/pharmaceuticals-companies-of-bangladesh,,,,,,,,,,,,,,,,,,,,,,,,,,
es-atencion.clientes@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://proxfarma.com/registro,http://sanofi.es/es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.dk@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,5,{first}.{last},,,,,,,,http://sanofi.dk/dam/jcr:2bb73a99-0d90-4f66-a539-41e6c46a76ca/dk_enjaymo_physician_guide.pdf,http://sanofi.dk/dam/jcr:6786c393-9373-4f26-ad19-5d5f95e4ad93/fabrazyme_home-infusion-hcp-manual_2021.pdf,http://sanofi.dk/dam/jcr:795b1de1-b228-4790-b2ac-c19ef7d1996d/dk_enjaymo_patient_guide.pdf,http://sanofi.dk/dam/jcr:f12a72c8-9ef9-48f8-9dde-f02e5aeac0e5/56074%20dk%20lemtrada%20hcp%20guide%20a5%2009.2022%202.kor.pdf,http://sanofi.dk/da/om-sanofi/kontakt,,,,,,,,,,,,,,,,,,,,,,,,
researchtocare@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://researchtocare.it/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
charlotte.raillere@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://wiki.transmartfoundation.org/display/tsmtgpl/testing+volunteers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc.medicalinformation.greece@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://bisolvon.gr/epikoinonia,http://sanofi.gr/el/forma-epikinonias,,,,,,,,,,,,,,,,,,,,,,,,,,,
mohammad.giasuddin@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
samrathana.kong@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
richard.tazioli@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://ce.mayo.edu/node/114883,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hanan.katerji@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://lb.sanofi.com/media/sanofi-donates-health-emergency-kits,http://lb.sanofi.com/en/media/sanofi-donates-health-emergency-kits,,,,,,,,,,,,,,,,,,,,,,,,,,,
baoshi.wang@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://xyzp.haitou.cc/page-30,http://xyzp.haitou.cc/page-6,,,,,,,,,,,,,,,,,,,,,,,,,,,
jason.pelleetier@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://masoref.com/maso11.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
srinivas.tirunala@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://pharmajobs.co/sanofi-hiring-for-b-tech-m-tech-m-sc-candidates-production-specialist,http://pharmatutor.org/content/april-2020/job-for-mpharm-bpharm-as-packing-expert-at-sanofi,http://pharmatutor.org/content/march-2020/walk-in-interview-for-in-vaccine-production-at-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
creditos.cobranzas@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,3,{first}.{last},,,,,,,,http://sanofi.com.pe/terminos-y-condiciones-sf,http://sanofi.com.pe/es/terminos-y-condiciones-gz,http://sanofi.com.pe/es/terminos-y-condiciones-sf,,,,,,,,,,,,,,,,,,,,,,,,,,
dubravka.arandjelovic@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://apothekersnieuws.nl/recall-toujeo-solostar-300-e-ml-voorgevulde-pen-15-ml,,,,,,,,,,,,,,,,,,,,,,,,,,,,
christian.astrand@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://svenskalag.se/lindoff-p13/nyheter/1427821/uppdatering-p13-jan-mars,http://svenskalag.se/lindoff/nyheter/1389512/valberedningen-kickar-igang-pa-allvar,,,,,,,,,,,,,,,,,,,,,,,,,,,
valerie.lameyre@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://malariajournal.biomedcentral.com/articles/10.1186/s12936-019-2837-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,
francois.bompart@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://malariajournal.biomedcentral.com/articles/10.1186/s12936-019-2837-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pt-candidaturas@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://canalsuperior.pt/noticia/sanofi-portugal-recruta-jovens-recem-formados/1141,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mathabo.mashiane@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://sapraa.org.za/members.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jeanne.puelma@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://anpassociation.enpnetwork.com/nurse-practitioner-news/207374-district-3-news-update,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sadek.krouri@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://b.21-bal.com/doc/1748/index.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nitin.hiwase@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://pharmavacancy.co.in/2019/06/required-candidates-for-officersr.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mexico.calidadyservicio@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://medicoconsentido.com.mx/noticia/hematologia/infografia/importacion-autorizada-isatuximab,http://medicoconsentido.com.mx/farmacovigilancia,,,,,,,,,,,,,,,,,,,,,,,,,,,
yukihiro.tsurumi@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://cad-net.jp/index.php/seminar/detail/1103,,,,,,,,,,,,,,,,,,,,,,,,,,,,
prenom.nom@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,Writing & communication,,,,,http://growthhacking.fr/t/structure-mail-industrie-pharmaceutique/14489,,,,,,,,,,,,,,,,,,,,,,,,,,,,
myapplicationdata@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,3,{first}.{last},,,,,,,,http://sanofi.com/careers/global-terms-and-conditions,http://sanofi.com/fr/carrieres/termes-et-conditions-globales,http://sanofi.com/en/careers/global-terms-and-conditions,,,,,,,,,,,,,,,,,,,,,,,,,,
ewelina.slocinska@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://szczepieniaprzeciwgrypie.pl/nota-prawna,http://szczepieniadlapodrozujacych.pl/nota-prawna,,,,,,,,,,,,,,,,,,,,,,,,,,,
tielmann.kiessling@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://mif-ua.com/archive/article/30928,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ieinformation@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sanofi.ie/en/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
llningtilaus@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://pharmacafennica.fi/safetynotice/33797488,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofi.innovationawards@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://medicine-matters.blogs.hopkinsmedicine.org/2015/08/sanofi-innovation-awards-call-for-pre-proposals,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jean-geric.malville@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://mondedesgrandesecoles.fr/sanofi-vitry-le-lieu-de-tous-les-possibles,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marie-karelle.riviere@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,1,{first}.{last},,,,,,,,http://sfds.asso.fr/newsletter-1164-09ce470d9e8ac8e1ab630d058a49293f,,,,,,,,,,,,,,,,,,,,,,,,,,,,
amilia-sharni.arshad@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://ipohecho.com.my/2018/05/16/help-needed-for-rare-disease,http://ipohecho.com.my/v4/article/2018/05/16/help-needed-for-rare-disease,,,,,,,,,,,,,,,,,,,,,,,,,,,
ukraine.communications@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,2,{first}.{last},,,,,,,,http://sanofi.ua/uk/contacts,http://sanofi.ua/uk/media,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofipy@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://pharmchoices.com/full-list-of-pharmaceutical-companies-in-paraguay,,,,,,,,,,,,,,,,,,,,,,,,,,,,
viktoriia.eremina@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://rmj.ru/news/sanofi_predstavila_initsiativu_zdorovye_deti_schastlivye_deti_v_ramkakh_pediatricheskogo_kongressa,,,,,,,,,,,,,,,,,,,,,,,,,,,,
protecciondedatos@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,3,{first}.{last},,,Writing & communication,,,,,http://aeped.es/sites/default/files/formulario_becas_sanofi_67_congreso_aep-editable.pdf,http://vigimed.es/particular/l/aviso-legal,http://vigimed.es/profesional/l/aviso-legal,,,,,,,,,,,,,,,,,,,,,,,,,,
kohei.tsukuda@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2015.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hirofumi.miura@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2015.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
hidetada.kobayashi@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2014.html,http://jaden1996.com/workshop/application_2015.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
koike_hideyasu@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2014.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jarmo.kaukua@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://mynewsdesk.com/fi/pressreleases/diabeteksen-hoidon-kipupiste-vihdoin-hallintaan-aterianjaelkeinen-verensokeri-925439,http://epressi.com/tiedotteet/terveys/sanofi-aloittaa-uuden-aikakauden-diabeteksen-hoidossa.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
gertireisspreis@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,4,{first}.{last},,,,,,,,http://sanofi.at/dam/jcr:0451a311-6547-40d7-ae27-6fd0147331a4/pi%20sanofi_gerti%20reiss%20schulungspreis%20ausschreibung%202019.pdf,http://sanofi.at/dam/jcr:57240877-b1c3-4ed0-80b7-a37a42c2b262/pi%20sanofi%20gerti%20reiss%20schulungspreis%20ausschreibung%202020.pdf,http://sanofi.at/dam/jcr:e20765ca-388e-4ddf-8ffb-6839cc03f057/180530.pdf,http://brandaktuell.at/2020/05/26/politik/gerti-reiss-schulungspreis-wird-zum-10-mal-ausgeschrieben,,,,,,,,,,,,,,,,,,,,,,,,,
afoafc.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,5,{first}.{last},,,,,,,,http://sanofi.ci/fr/conditions-generales-utilisation-twitter-cameroun,http://sanofi.ci/fr/conditions-generales-utilisation-twitter-cote-ivoire,http://sanofi.ci/fr/conditions-generales-utilisation-twitter-senegal,http://sanofi.ci/fr/nos-programmes/accompagner-les-professionnels-de-sante/information-medicale/informations-sur-le-thiocolchicoside,http://sanofi.ci/fr/nos-programmes/accompagner-les-professionnels-de-sante/information-medicale/informations-sur-le-valproate-et-grossesse,,,,,,,,,,,,,,,,,,,,,,,,
jean-marc.dumaisnil@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,5,{first}.{last},,,,,,,,http://cpias-nouvelle-aquitaine.fr/wp-content/uploads/2017/06/programme-jia-sept-2017.pdf,http://cpias-nouvelle-aquitaine.fr/evenements/journee-dinfectiologie-en-aquitaine,http://cpias-nouvelle-aquitaine.fr/evenements/journee-regionale-referents-infectiologie,http://docplayer.fr/25561019-2-eme-congres-vendredi-9-apres-midi-et-samedi-10-matin-en-attente-d-agrement-fmc-par-la-sfo-durant-le-week-end-de-la-fete-des-lumieres.html,http://docplayer.fr/62317749-horaires-lieu-lieu-cours-besancon-faculte-de-medecine-les-hauts-de-chazal-lieu-cours-dijon.html,,,,,,,,,,,,,,,,,,,,,,,,
brasil.siv@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://alergovaccine.com.br/mundo-das-vacinas/dengue,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yohei.sugaya@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2023_online.html,http://cad-net.jp/index.php/seminar/detail/964,,,,,,,,,,,,,,,,,,,,,,,,,,,
takashi.higashiyama@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2018_kyushu.html,http://jaden1996.com/workshop/application/application_2017_kyushu.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna-kaija.gronblad@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://sanofi.se/sv/om-oss/kontakt,http://mynewsdesk.com/se/sanofi,http://mynewsdesk.com/se/sanofi/pressreleases/sanofi-faar-europeiskt-godkaennande-foer-zaltrap-aflibercept-foer-behandling-av-metastaserad-kolorektal-cancer-834136,,,,,,,,,,,,,,,,,,,,,,,,,,
janna.aksenova@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://myshared.ru/slide/1287305,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance-dz@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://sanofi.dz/science-innovation/information-medicale-et-pharmacovigilance,http://sanofi.dz/fr/contact,http://sanofi.dz/fr/science-innovation/information-medicale-et-pharmacovigilance,,,,,,,,,,,,,,,,,,,,,,,,,,
christine.zeindler@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,4,{first}.{last},,,,"",,,,http://newswire.ca/news-releases/prostate-cancer-what-you-need-to-know-510326901.html,http://newswire.ca/fr/news-releases/prostate-cancer-what-you-need-to-know-510326901.html,http://newswire.ca/fr/news-releases/le-cancer-de-la-prostate--ce-que-vous-devez-savoir-510326701.html,http://newswire.ca/fr/news-releases/le-cancer-de-la-prostate--ce-que-vous-devez-savoir-510328881.html,,,,,,,,,,,,,,,,,,,,,,,,,
recruitment.kr@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,4,{first}.{last},,,,,,,,http://careerbrdg.tistory.com/2547,http://careerbrdg.tistory.com/1285,http://careerbrdg.tistory.com/1559,http://careerbrdg.tistory.com/1722,,,,,,,,,,,,,,,,,,,,,,,,,
wenfei.zhang@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://bmcsystbiol.biomedcentral.com/counter/pdf/10.1186/s12918-017-0444-y.pdf,http://dirk.eddelbuettel.com/cranberries/2019/03/15,http://bmcsystbiol.biomedcentral.com/articles/10.1186/s12918-017-0444-y,,,,,,,,,,,,,,,,,,,,,,,,,,
corporate-responsibility@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,4,{first}.{last},,,Management,,,,,http://sanofi.de/dam/jcr:5110eb39-70ca-4648-a70f-af3e557e94b6/csr-broschuere-2014-2015.pdf,http://sanofi.de/dam/jcr:6dc7dac4-bdde-4c66-a611-c11aa63afd37/csr-broschuere-2013-2014.pdf,http://3blmedia.com/news/reportalertinfo-sanofi-epasan-publishes-2013-corporate-social-responsibility-csr-report,http://3blmedia.com/news/sanofi-publishes-its-first-integrated-report,,,,,,,,,,,,,,,,,,,,,,,,,
christine.luxemburger@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://clisp.fr/2017/02/22/stage-programme-vie-sanofi-epidemiologie-du-vrs-edimbourg,http://clisp.fr/2017/02/22/stage-programme-vie-sanofi-epidemiologie-du-vrs-edimbourg-2,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofi.bd@sanofi.com,sanofi.com,Sanofi,,,,,,77,generic,5,{first}.{last},,,,,,,,http://iccbangladesh.org.bd/member/index/national-companies/10,http://iccbangladesh.org.bd/member/index/national-companies,http://iccbangladesh.org.bd/national-companies,http://iccbangladesh.org.bd/member/index/national-companies/40,http://iccbangladesh.org.bd/member/index/national-companies/20,,,,,,,,,,,,,,,,,,,,,,,,
ernest.moussoki@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://madinin-art.net/agenda-des-actions-africaines-en-region-parisienne-de-fevrier-2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,
thavrath.rin@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://khmeronlinejobs.com/company/2795-sanofi-cambodia-co-ltd,http://kh.khmeronlinejobs.com/company/991-sanofi-cambodia,,,,,,,,,,,,,,,,,,,,,,,,,,,
katsuaki.yokomichi@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2016.html,http://jaden1996.com/workshop/application/application_2017_koshinetsu.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
anna.cywinska@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,1,{first}.{last},,,,,,,,http://masarnia.pl/branza-miesna/weterynaria/16-merial-rozpoczyna-dzialalnosc.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
juliane.zache@sanofi.com,sanofi.com,Sanofi,,,,,,77,personal,3,{first}.{last},,,,,,,,http://fapema.br/estao-abertas-as-inscricoes-para-o-7o-premio-inovacao-medical-services-da-sanofi,http://conass.org.br/estao-abertas-as-inscricoes-para-o-7o-premio-inovacao-medical-services-da-sanofi,http://sobrac.org.br/portal_medical_services_da_sanofi.html,,,,,,,,,,,,,,,,,,,,,,,,,,
transparency.ru@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,,,,,,http://ru.sanofi.com/dam/jcr:3740e015-a3fc-4350-92f9-2b7b3d3e0e47/methodological%20note%20for%20transparency%20disclosure%20report%202020.pdf,http://ru.sanofi.com/dam/jcr:9c604dbc-99ed-4199-a487-19d9c4b29693/methodological_note_for_transparency_disclosure_report%20_2019.pdf,http://ru.sanofi.com/dam/jcr:a95009a2-7d96-4ee8-8e94-de2c789b3d33/methodological%20note%20transparency%20report%2030.06.2022.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
emma1.wang@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://ingredientsnetwork.com/sanofi-comp272642.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vijaybalakishore.dodda@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://pharmaudyog.com/2018/10/shantha-biotech-sanofi-company-urgently.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shibani.mitra-kaushik@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://e-i-p.eu/media/pages/symposiums/2017-lisbon/26a6b15dfe-1644227750/vibha-jawa.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vie.diabetesportal@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://diabetes.sanofi.de/dam/jcr:bb7c9fa8-b12b-4731-8756-35a990061244/gi_allstarpro.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anjumnida.rahman@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,4,{first}.{last},,,,,,,,http://sanofi.com.pk/dam/jcr:20bfebe1-7572-498e-9f74-b1aff067041b/foundation%20s%20_donation%20_%20press%20release%20_nov10.pdf,http://sanofi.com.pk/dam/jcr:60937e72-ed0d-45cd-8987-1bcf84268bcb/launch%20of%20aisac%20guidelines%20for%20people%20with%20diabetes%20-20221022%20sanofi%20press%20release.pdf,http://sanofi.com.pk/dam/jcr:7c02fdcc-21b2-4734-8ca2-b326a7331a20/akhuwat%20kicks%20off%20global%20kids%20program%20.%209.12.22.pdf,http://sanofi.com.pk/dam/jcr:f40a1edb-d5d8-4501-82aa-7b9b7de96bc4/20221007%20pharmacovigilance%20press%20release%20final%20anr.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
compliance.pk@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://sanofi.com.pk/dam/jcr:0cf3c241-7e21-4fef-8fd1-09b20815b9af/q4-2013.pdf,http://sanofi.com.pk/dam/jcr:8152ff61-63b3-44cc-8bca-d7c8a71234cc/q4-2015.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurent.chambonneau@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.18-0534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
betzana.zambrano@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.18-0534,,,,,,,,,,,,,,,,,,,,,,,,,,,,
membership.administration@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,Writing & communication,,,,,http://ccpapp.org/assets/1/17/ccf_contract_commitment_form_membership_-_2021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chcpvcopac@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://campus.sanofi/co/ciencia,http://campus.sanofi/co/ciencia/asma-grave,http://campus.sanofi/co/ciencia/dermatologia,http://campus.sanofi/co/ciencia/enfermedades-raras,http://campus.sanofi/co,,,,,,,,,,,,,,,,,,,,,,,,
cz-transparency@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.cz/dam/jcr:ee6116e7-6592-45e2-938f-a93ec7194eca/cz_methodological%20note_2021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.hkg@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,Support,,,,,http://sanofi.hk/en/legal-notice,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1grc.s1l@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:52d82892-9001-4662-8f5d-134d53d4b365/appointmentreappointment-of-directors-reappointment-of-chairman.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1grc.sil@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,4,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:4ed79087-7d51-4044-80df-1fef5454306c/sanofi-india-limited-to-sell-ankleshwar-site-to-zentiva.pdf,http://sanofiindialtd.com/dam/jcr:84dc81c2-eb0f-4e27-9b8f-bab1524a6ea2/audited-financial-results-for-the-year-ended-december-31-2020.pdf,http://sanofiindialtd.com/dam/jcr:8be0a683-4ecf-49f6-a12c-860b1f7fbb5b/audited%20financial%20results%20for%20the%20year%20ended%20december%2031%202020.pdf,http://sanofiindialtd.com/dam/jcr:e0a91ff9-5dc0-4feb-adb7-ab8598b5b3f6/half-yearly-related-party-diclosure-as-on-30-june-2019.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
igrc.apl@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofiindialtd.com/dam/jcr:a8c09ad0-76bc-40c4-b01b-8fb5cb770938/annual%20report%202011.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
penniparasti.amalia@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://apotekers.com/2016/09/lowongan-kerja-sanofi-indonesia.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aziz.youfimalki@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.ma/dam/jcr:5048acb0-7445-476b-9815-b5817782b871/pdf%20l3.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
productstewardshipfrance@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,Writing & communication,,,,,http://somersetpharma.com/wp-content/uploads/2017/10/cyano-msds.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
irte.topaloglu@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.com.tr/dam/jcr:e624133b-a3fa-4f20-b0ec-6c3f137b29f7/sanofisurdurulebilirlik_tr.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ap.greece@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://sanofi.gr/dam/jcr:b17883a9-f8aa-43f1-8619-97a0e6ee532a/general%20purchasing%20terms_gr.pdf,http://sanofi.gr/dam/jcr:e5191473-9614-40b4-aec2-eb530d06c89a/_gr.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
nasiha.soofie@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://pntonline.co.za/index.php/pnt/article/download/1089/2026,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vaxihelpaustralia@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://vaxiplace.com.au/node/877,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gemma.llopgil2@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.es/dam/jcr:37d7e986-c805-4dd8-825b-2e72d55089f0/ndp_diabetes_programa_kids.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zadatarequests@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://sanofi.co.za/dam/jcr:d3059ccd-2119-4203-9650-5de91ae8d2e1/sanofi-manual-paia-manual.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
isabelle.thizon-degaulle@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://economie.gouv.fr/files/files/directions_services/cge/bio-production.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
seniorscelebration@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://carp.ca/2019/09/03/celebrate-seniors-day-photo-exhibit-fundraiser,http://ossco.org/share-photos-to-celebrate-national-seniors-day,,,,,,,,,,,,,,,,,,,,,,,,,,,
deugennet.fra@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://sanofi.de/dam/jcr:b52d78bf-9ea0-4397-9ea2-7cae7cba2b60/gender%20-balance-in-fuehrungspositionen-broschuere.pdf,http://sanofi.de/dam/jcr:f350578e-9096-4b5e-b3bd-0755e1cadc73/gender%20-balance-in-fuehrungspositionen-broschuere.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
pierre.bruand@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://accessobservatory.org/_files/ugd/37a51e_c7cda8d2537744fbbe720e10dc03531a.pdf,http://panafrican-med-journal.com/content/article/38/389/full,,,,,,,,,,,,,,,,,,,,,,,,,,,
careconnectpss@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://careconnectpss.com/dam/jcr:238d5760-9306-44e8-b798-cdfdaa58e17d/journey%20ahead%20brochure.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurence.regazzoni@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://sanofi.com/en/about-us/our-stories/protecting-heart-health-flu-vaccines-and-beyond,http://sanofi.com/en/about-us/our-stories/the-race-is-on-to-defeat-meningitis,,,,,,,,,,,,,,,,,,,,,,,,,,,
masahisa.shinohara@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://toyonaka-pa.net/sys/files/information/001/104/news.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
klaudia.dobosiewicz@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,4,{first}.{last},,,,,,,,http://sanofi.pl/dam/jcr:70030e50-d660-4a94-aa3c-b574f7d2094d/informacja%20prasowa%20-%20dobre%20praktyki%20csr%20w%202018%20roku%20w%20sanofi.pdf,http://sanofi.pl/dam/jcr:bcead1e8-fb61-4d73-9457-167b21d6a6c8/ip_zaangazowanie_sanofi_pck_final.pdf,http://sanofi.pl/dam/jcr:d0be3af3-fb86-4fde-b5f4-3d35154ba6db/kampania_edukacyjna_nie_sam_na_sm_informacja_prasowa.pdf,http://sanofi.pl/dam/jcr:efd5b663-e194-45db-a07b-10a5e757b2e0/11-sanofi-polska-efpia-nagroda.pdf,,,,,,,,,,,,,,,,,,,,,,,,,
li-hsing.wang@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://jcheminf.biomedcentral.com/articles/10.1186/1758-2946-4-s1-o20,http://jcheminf.biomedcentral.com/counter/pdf/10.1186/1758-2946-4-s1-o20.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
vigilance.ch@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,5,{first}.{last},,,,,,,,http://sanofi.ch/dam/jcr:32735122-987e-4408-8006-b9af759f89b8/mul_infokarte_aerzte_ch_de_20221118.pdf,http://sanofi.ch/dam/jcr:49edf96a-05e7-4d98-86e8-8a54fe07e2d0/plaquenil%20-%20fr%20-%20final%20statement.pdf,http://sanofi.ch/dam/jcr:ab6436cc-ca4b-4368-9d7c-7f5d7e2116a0/mul_infokarte_aerzte_ch_ita_20221118.pdf,http://sanofi.ch/dam/jcr:ce9c04c2-468b-4dfa-8caf-3ed6606e6a40/plaquenil%20-%20d%20-%20final%20statement.pdf,http://sanofi.ch/dam/jcr:d523ff8e-4db1-43b8-86c3-340b6071d076/mul_infokarte_aerzte_ch_frz_20221118.pdf,,,,,,,,,,,,,,,,,,,,,,,,
enterogermina.india@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:dfbc47b1-e65f-4d5c-bf4a-02fa0096f7b1/enterogermina__oral_suspension_pil.pdf,http://sanofi.in/dam/jcr:f8a38096-9b86-4c16-b7ea-d4ea0a14e31e/enterogermina%c2%ae%20oral%20suspension-pil.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
heeral.dcosta@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:0bdfec1d-bbd7-484a-8acf-4200f83b4034/bhaichung%20bhutia%20in%20kolkata%20to%20share%20his%20own%20experience%20on%20how%20to%20manage%20knee-osteoarthritis.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gyorgyi.major@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://ujpestmedia.hu/wp-content/uploads/ujpest_naplo/ujpesti_naplo_2014-28.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
posmaterial@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://diepta.de/news/ihre-medizin-ist-der-humor,,,,,,,,,,,,,,,,,,,,,,,,,,,,
dk-nordicmedical@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.dk/dam/jcr:fc4292d4-e86a-466c-9573-12f631322cee/myozyme---safety-information-packet.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
adr.dk@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,,,,,,http://sanofi.dk/dam/jcr:115e87ad-2364-48cc-a86e-53af34e644f6/multaq_ordinationskort.pdf,http://sanofi.dk/dam/jcr:22e3e987-d9fe-4301-bd7a-fd273f945f39/cerezyme_hcp%20guidance.pdf,http://sanofi.dk/dam/jcr:9e923316-5526-4dc7-bb57-b1b9b898c257/caprelsa_uddannelsesmateriale-til-sundhedspersonale.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
farmacovigilancia.brasil2@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://suppliers.sanofi.com/statics/pdfs/tc_sanofi_brazil.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cn-p2p-vendor@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofi.compatibilitefournisseur@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eg1_externals_services@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,Support,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
sc1_externals_services@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,Support,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
sc_externals_services_invoices_importations@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
nfe.sanofibrasil@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,http://suppliers.sanofi.com/statics/pdfs/tc_sanofi_brazil.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
eg_externals_services_invoices@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
nfs.sanofibrasil@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,http://suppliers.sanofi.com/statics/pdfs/tc_sanofi_brazil.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
mx.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
ar.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
kineskardal.kleven@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,,,,,,,,,,,
berrin.uyguner@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://amasyaeo.org.tr/p5753,,,,,,,,,,,,,,,,,,,,,,,,,,,,
infomedicale.afc@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,Support,,,,,http://doualazoom.com/web/fr/accueil/rubrique/pharmaceutiques%2c%20produits%2c%20laboratoires%2c%20industries/136,,,,,,,,,,,,,,,,,,,,,,,,,,,,
julianne.orsonneau-ext@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://ce-crva.fr,http://ce-crva.fr/index.php,,,,,,,,,,,,,,,,,,,,,,,,,,,
thefoundations@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://siop-online.org/news/my-child-matters-call-for-proposals,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rarebd@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/rare-diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,
outlicensingbd@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/out-licensing,,,,,,,,,,,,,,,,,,,,,,,,,,,,
genmedbd@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/general-medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,
celebrateseniors@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://thekoalamom.com/2019/09/senior-health,,,,,,,,,,,,,,,,,,,,,,,,,,,,
emilija.businskas@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://myerecords.info/2021/03/22/sanofi-canada-earns-gold-level-gender-parity-certification-for-the-second-straight-year-canada-newswire,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ans.vanbroekhoven@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://journal.pda.org/content/early/2022/07/15/pdajpst.2021.012726,http://journal.pda.org/content/early/2022/07/15/pdajpst.2021.012726/tab-article-info,http://journal.pda.org/content/early/2022/07/15/pdajpst.2021.012726/tab-references,,,,,,,,,,,,,,,,,,,,,,,,,,
gr_sbs_p2p@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
ventas@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://placestogodr.com/profile/consulado-de-la-republica-argentina/santo-domingo,,,,,,,,,,,,,,,,,,,,,,,,,,,,
aniko.karacsonyi@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,4,{first}.{last},,,,,,,,http://sanofi.hu/hu/felelossegvallalasunk/tarsadalmi-szerepvallalasunk/we-volunteer,http://sanofi.hu/hu/sutikre-vonatkozo-szabalyzat,http://sanofi.hu/hu/magunkrol/a-sanofi-magyarorszagon/vallalati-brosura,http://sanofi.hu/hu/sajtoszoba/a-sanofi-valaszintezkedesei-az-ukrajnaban-kialakult-helyzetre,,,,,,,,,,,,,,,,,,,,,,,,,
initiative.easi.paris.region@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://biopharmanalyses.fr/microfluidics-for-health-from-sciences-to-business,http://biopharmanalyses.fr/nobel-prize-for-the-discovery-of-the-first-immune-checkpoints,,,,,,,,,,,,,,,,,,,,,,,,,,,
medinfo.kazakhstan@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,4,{first}.{last},,,,,,,,http://tuta24.ru/product/13032,http://tuta24.ru/product/8949,http://apteka.103.by/guttalaks-instruktsiya,http://apteka.103.by/lantus-solostar-instruktsiya,,,,,,,,,,,,,,,,,,,,,,,,,
daniel.guzmangallardo@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.com.mx/es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc-zaqacomplaints@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://sanofi.co.za/en/contact-us,http://dulcolax.co.za/contact-us,http://campus.sanofi/za,,,,,,,,,,,,,,,,,,,,,,,,,,
kazuki.shiiyama@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2022_online.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yann.poulouin-ext@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,"http://archivesofmedicalscience.com/treatment-adherence-and-effect-of-concurrent-statin-intensity-on-the-efficacy-and,143476,0,2.html",,,,,,,,,,,,,,,,,,,,,,,,,,,,
moriyoshi.yamamoto@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2022_kanto.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.communicationafo@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,Support,,,,,http://connectuemoa.com/sellers/list/page/67,,,,,,,,,,,,,,,,,,,,,,,,,,,,
startups.russia@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://ru.sanofi.com/ru/startups,,,,,,,,,,,,,,,,,,,,,,,,,,,,
p2p.mdm.eurasia@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://ru.sanofi.com/ru/about-us/sanofi-russia/to-our-suppliers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
procurement.russia@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,Writing & communication,,,,,http://ru.sanofi.com/ru/about-us/sanofi-russia/to-our-suppliers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alumni@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://elobservatoriodeltrabajo.org/odt-el-observatorio-del-trabajo-programa-de-gestion-de-personas-octubre-21-top-employers-institute-30-aniversario-caso-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
engage.gulf@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,5,{first}.{last},,,,,,,,http://campus.sanofi/hcp-portal-kw/kw/registration,http://campus.sanofi/bh/registration,http://campus.sanofi/hcp-portal-bh/bh/registration,http://campus.sanofi/bh/footer-links/legal-notice,http://campus.sanofi/bh/footer-links/privacy-policy,,,,,,,,,,,,,,,,,,,,,,,,
sanofi_global_health@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://sanofi.com/fr/notre-responsabilite/acces-a-des-soins-de-qualite-sanofi-global-health,http://sanofi.com/en/our-responsibility/access-to-quality-healthcare-sanofi-global-health,,,,,,,,,,,,,,,,,,,,,,,,,,,
miariise.hansen@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://sanofi.dk/da/nyheder/pressemeddelelse,http://sanofi.dk/da/om-sanofi/kontakt,,,,,,,,,,,,,,,,,,,,,,,,,,,
gina.vechiarelli@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://ccexpo.site/2021-01-28-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc.pv.greece@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://sanofi.gr/dam/jcr:d401c82f-1a88-4f9e-a9a2-e41c7ab3cb29/gregeneraltermsandconditions2021-greece_opella.pdf,http://sanofi.gr/el/forma-epikinonias,,,,,,,,,,,,,,,,,,,,,,,,,,,
shoko.tsukube@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://file.scirp.org/html/4-4300240_50567.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
artur.suleimenov@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://dasaqmeba.ge/companies/load/2016,http://dasaqmeba.ge/about_company/company/4145,,,,,,,,,,,,,,,,,,,,,,,,,,,
arvindra.a-jaiswal@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.cambodia@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,Support,,,,,http://investireincambogia.com/sanofi-cambodia-co-ltd.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
job.dz@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://sanofi.dz,http://sanofi.dz/fr,,,,,,,,,,,,,,,,,,,,,,,,,,,
vira.chaplinska@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://noatero.ru/en/v-pomoshch-pacientu/consultatsii,http://noatero.ru/ru/comment/10779,http://noatero.ru/ru/v-pomoshch-pacientu/consultatsii/2018,http://noatero.ru/ru/v-pomoshch-pacientu/consultatsii/plaviks-dopolnitelnaya-informaciya,http://noatero.ru/ru/v-pomoshch-pacientu/consultatsii,,,,,,,,,,,,,,,,,,,,,,,,
sanofi.dk@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://sanofi.dk/da/om-sanofi/kontakt,,,,,,,,,,,,,,,,,,,,,,,,,,,,
es-lopd@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://bajarelcolesterol.es/aviso-legal,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anastasia.petryaeva.ext@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,,,,,,http://medpred.ru/companies/sanofi/reviews,http://medpred.ru/companies/sanofi/vacancies,http://medpred.ru/companies/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
natalya.makhmutkina@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://medpred.ru/companies/sanofi/reviews,http://medpred.ru/companies/sanofi/vacancies,http://medpred.ru/companies/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
valeriya.kutepova.ext@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,,,,,,http://medpred.ru/companies/sanofi/reviews,http://medpred.ru/companies/sanofi/vacancies,http://medpred.ru/companies/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
kazakhstan.pharmacovigiiance@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,,,,,,http://cocktailshake.ru/raznoe/kak-chasto-mozhno-pit-festal.html,http://cocktailshake.ru/raznoe/kak-pit-festal-do-edy-ili-posle.html,http://apteka.103.by/festal-instruktsiya,,,,,,,,,,,,,,,,,,,,,,,,,,
takayoshi.maruyama@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://kpshp.jp/events/event/%e4%bb%a4%e5%92%8c4%e5%b9%b42%e6%9c%88%e5%ba%a6-%e8%a5%bf%e9%83%a8%e5%9c%b0%e5%8c%ba%e5%ae%9a%e4%be%8b%e7%a0%94%e4%bf%ae%e4%bc%9a,,,,,,,,,,,,,,,,,,,,,,,,,,,,
famacovigilancia.argentina@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://sanofi.com.ar/es/aviso-legal,http://sanofi.com.uy/es/aviso-legal,,,,,,,,,,,,,,,,,,,,,,,,,,,
alix.raquin@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://unboundmedicine.com/medline/citation/33685778/next_generation_live_attenuated_yellow_fever_vaccine_candidate:_safety_and_immuno_efficacy_in_small_animal_models_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
erika.navarrosanchez@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://unboundmedicine.com/medline/citation/33685778/next_generation_live_attenuated_yellow_fever_vaccine_candidate:_safety_and_immuno_efficacy_in_small_animal_models_,,,,,,,,,,,,,,,,,,,,,,,,,,,,
uk-mr@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://sanofi.co.uk/en/contact,http://sanofi.co.uk/en/about-us,http://sanofi.co.uk/en/news,,,,,,,,,,,,,,,,,,,,,,,,,,
pv.ro@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://campus.sanofi/ro,,,,,,,,,,,,,,,,,,,,,,,,,,,,
farmacovigilancia.chile@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,,,,,,http://campus.sanofi/cs/aviso-de-farmacovigilancia,http://sanofi.cl/es/aviso-legal,http://sanofi.cl/es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,
customerservice.farmacie@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,Support,,,,,http://messinamedica.it/wp-content/uploads/2020/04/2020_169all1.pdf,http://messinamedica.it/2020/04/comunicato-su-farmaco-plaquenil,http://farmaiuto.it/2020/04/08/carenze-antimalarico-plaquenil-sanofi-rassicura-ma-invita-alluso-solo-se-considerato-essenziale,,,,,,,,,,,,,,,,,,,,,,,,,,
fra.frafrwapsupport@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,Support,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
dulce.garciaalcantara@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://sanofi.com.mx/es/contacto,http://ciudadanospormexico.org/pandemia-detuvo-la-deteccion-de-dermatitis-atopica-pero-la-comezon-sigue-en-los-adolescentes-mexicanos,,,,,,,,,,,,,,,,,,,,,,,,,,,
jubeom.lee@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://sanofi.co.kr/dam/jcr:969df88c-1e91-466a-9cee-9aedc2610727/sanofi-aventis_transfer_of_personal_information_f_0812.pdf,http://sanofi.co.kr/ko/privacy-statement,,,,,,,,,,,,,,,,,,,,,,,,,,,
natalia.arrubla@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://vcccolombia.com/courses/17-encuentro-latinoamericano-de-cirujanos-de-cadera-y-de-rodilla/lessons/muestra-comercial-11/topic/stand-sanofi-6,http://vcccolombia.com/courses/66o-congreso-nacional-sccot/lessons/muestra-comercial-10/topic/stand-sanofi-6,,,,,,,,,,,,,,,,,,,,,,,,,,,
kazuaki.chiba@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2021_online.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anzinvoices@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
akifumi.miura@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://daidohp.or.jp/study/post-10189,,,,,,,,,,,,,,,,,,,,,,,,,,,,
geunhye.cho@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://careerbrdg.tistory.com/400,,,,,,,,,,,,,,,,,,,,,,,,,,,,
irene.boulu@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://openfloor.org/teachers/irene-boulu,http://open-floor.fr/irene-boulu,,,,,,,,,,,,,,,,,,,,,,,,,,,
makis.bokaris@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://kefea.org.cy/board,,,,,,,,,,,,,,,,,,,,,,,,,,,,
mx-procurement@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://sanofi.com.mx/es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,,,
meltsje.dehoop@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://elmi.embl.org/home/elmi-members/elmi-members-in-germany,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cansu.abaci@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://kariyer.istanbul.edu.tr/tr/duyuru/sanofi-saglik-urunleri-sanofi-young-power-internship-programme-78004400470051006f0052004d0077003200780041003100,,,,,,,,,,,,,,,,,,,,,,,,,,,,
klaudia.lipinska@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://choroba-gauchera.pl/pl/nota-prawna,,,,,,,,,,,,,,,,,,,,,,,,,,,,
assembleegenerale@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://bourse24.be/corporate_news/406354-sanofi-informations-sur-l-assemblee-generale-des-actionnaires-du-mardi-28-avril-2020,http://pharmiweb.com/press-release/2020-04-01/sanofi-information-on-sanofi-s-shareholder-general-meeting-of-tuesday-april-28-2020,http://sanofi.com/en/media-room/press-releases/2020/2020-04-01-07-00-00,,,,,,,,,,,,,,,,,,,,,,,,,,
lethanhvan.tran@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://sanofi.com.vn/vi/thong-tin-va-su-kien/thongcaobaochi/sanofi-luminostic-hop-tac-phat-trien-giai-phap-tu-xet-nghiem-covid19-tren-dien-thoai-thong-minh,http://sanofi.com.vn/vi/thong-tin-va-su-kien/thongcaobaochi/kpmg-phoi-hop-sanofi-gioi-thieu-bao-cao-doc-quyen,http://sanofi.com.vn/vi/thong-tin-va-su-kien/thongcaobaochi/lua-gao-nguon-nang-luong-xanh-moi,http://sanofi.com.vn/vi/thong-tin-va-su-kien/thongcaobaochi/sanofi-va-gsk-ho-tro-200-trieu-lieu-vac-xin,http://sanofi.com.vn/vi/thong-tin-va-su-kien/thongcaobaochi/thu-nghiem-lam-sang-kevzara-tren-benh-nhan-nhiem-covid-19-nang-trien-khai-ben-ngoai-hoa-ky,,,,,,,,,,,,,,,,,,,,,,,,
medical-information.gulf@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,5,{first}.{last},,,,,,,,http://campus.sanofi/bh/science/multiple-sclerosis/cutting-edge-science/2022/a-promising-biomarker-in-ms-neurofilament-light-chain,http://campus.sanofi/bh/science/vaccines/influenza/cutting-edge-science/2022/influenza-focus-on-elderly,http://campus.sanofi/om/patient-support,http://campus.sanofi/ae/events/diabetes/2022/innovation-of-iglarlexi-in-intensification,http://campus.sanofi/bh/science/prurigo-nodularis/cutting-edge-science/2022/mechanism-of-prurigo-nodularis-disease,,,,,,,,,,,,,,,,,,,,,,,,
annelise.hestvik@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://portal.findresearcher.sdu.dk/da/publications/teri-life-an-observational-study-of-quality-of-life-in-patients-w,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kristine.ronka@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://farmacija-mic.lv/par-izmainam-depakine-un-depakine-chrono-iepakojuma,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurence.pagnon@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://flutrackers.com/forum/forum/welcome-to-the-scientific-library/vaccines/819788-why-we-need-more-collaboration-in-europe-to-enhance-post-marketing-surveillance-of-vaccines,,,,,,,,,,,,,,,,,,,,,,,,,,,,
jcastro_rodriguez@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://prensalibre.com/vida/los-cuidados-a-tener-ahora-que-es-temporada-de-ataques-de-asma,,,,,,,,,,,,,,,,,,,,,,,,,,,,
xianyi.sun@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://utrace.de/whois/168.124.241.48,http://utrace.de/whois/168.124.241.4,http://utrace.de/whois/168.124.241.84,http://utrace.de/whois/168.124.241.102,http://utrace.de/whois/168.124.241.69,,,,,,,,,,,,,,,,,,,,,,,,
registrycontactus@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://clinicaltrials.gov/ct2/show/results/nct01001988,,,,,,,,,,,,,,,,,,,,,,,,,,,,
infomed-dz@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,4,{first}.{last},,,Support,,,,,http://sanofi.dz/dam/jcr:45053992-141a-4f08-9d54-98b399463a0d/cp6.pdf,http://sanofi.dz/science-innovation/information-medicale-et-pharmacovigilance,http://sanofi.dz/fr/contact,http://sanofi.dz/fr/science-innovation/information-medicale-et-pharmacovigilance,,,,,,,,,,,,,,,,,,,,,,,,,
medicalinfo.eg@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://sanofi.com.eg/en/healthcare-solutions,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zahrrecruitment@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,,,,,,http://za.karier.co/job/back-and-front-end-web-developer-cape-town-hire-resolve-izz,http://sanofi.co.za/careers,http://sanofi.co.za/en/careers,,,,,,,,,,,,,,,,,,,,,,,,,,
slsa@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://slsa-asso.com/index.php,http://slsa-asso.com,,,,,,,,,,,,,,,,,,,,,,,,,,,
chheangorn.lorn@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://healthtime.tips/km/library/article/544,http://healthtime.tips/km/library/articles/544,,,,,,,,,,,,,,,,,,,,,,,,,,,
student.russia@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,,,,,,http://tabin.ru/prochee/stazhirovka-v-ispanii-dlya-studentov-i-spetsialistov-v-2020-godu-preimushhestva-trebovaniya-varianty-stoimost.html,http://selfmadetrip.com/stazhirovki-dlya-spetsialistov-i-studentov-inzhenernyih-i-biznes-spetsialnostey,,,,,,,,,,,,,,,,,,,,,,,,,,,
gb-vaccinecustomerservices@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,3,{first}.{last},,,Support,,,,,http://dispex.net/statement-of-amendments-to-annual-flu-letter-21-july-2022,http://middlesexlpcs.org.uk/flu-vac-50-64-year-old-cohort-goes-live,http://gov.uk/government/publications/pertussis-occupational-vaccination-of-healthcare-workers/pertussis-occupational-vaccination-of-healthcare-workers,,,,,,,,,,,,,,,,,,,,,,,,,,
kwame.amaning@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://rcsb.org/structure/3zm4,http://rcsb.org/structure/3zlw,http://rcsb.org/structure/3zlx,http://rcsb.org/structure/3zls,http://rcsb.org/structure/3zly,,,,,,,,,,,,,,,,,,,,,,,,
pompe-de@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://lysosolutions.de/infantiler-juveniler-morbus-pompe,,,,,,,,,,,,,,,,,,,,,,,,,,,,
heikeandrea.wieland@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://vfa.de/de/verband-mitglieder/biotech-partnering,,,,,,,,,,,,,,,,,,,,,,,,,,,,
irina.ostryakova@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://vidal.ru/novosti/sanofi-i-endokrinologicheskij-nauchnyj-tsentr-ents-zaklyuchili-memorandum-o-namereniyah-3222,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vertolaye.comiteentreprise@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://docplayer.fr/26983813-dossier-de-presentation-ateliers-radio.html,http://docplayer.fr/24863154-ardeche-vallon-pont-d-arc-ardeche-plusieurs-formules-pour-votre-sejour-plusieurs-formules.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
kazuaki.nakamura@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2015.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
yusuke.uemura@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2016.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
shuji.ogomori@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2014.html,http://jaden1996.com/workshop/application_2015.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
oncocarechallenge.nl@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,5,{first}.{last},,,,,,,,http://oncocarechallenge.nl/deelnemen,http://oncocarechallenge.nl/inspiratie/fit-to-fight-programma-bij-chirurgische-behandeling-van-blaascarcinoom,http://oncocarechallenge.nl/achtergrond,http://oncocarechallenge.nl/inspiratie,http://oncocarechallenge.nl,,,,,,,,,,,,,,,,,,,,,,,,
chinh.dao@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://medicine.uiowa.edu/research/future-biomedicine/past-programs/future-biomedicine%e2%84%a0-fellows-directory,http://medicine.uiowa.edu/node/1091,,,,,,,,,,,,,,,,,,,,,,,,,,,
ryuji.takaishi@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2012.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kiyomi.nakamura@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2012.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kanae.zaidan@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://kanae-zaidan.com/index.html,http://kanae-zaidan.com/outline/gaiyou.html,http://kanae-zaidan.com/aid/prize_documents.html,http://kanae-zaidan.com,http://kanae-zaidan.com/aid/question.html,,,,,,,,,,,,,,,,,,,,,,,,
florian.chuit@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://slideshare.net/mongodb/sanofi-mongodbworld20140625final,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.nordic@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,2,{first}.{last},,,Support,,,,,http://ms-guiden.no/personvernerklaering,http://ms-guiden.no/vilkar-betingelser,,,,,,,,,,,,,,,,,,,,,,,,,,,
diabetologia@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://laboratoria.net/aktualnosci/19907.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
didier.machard@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://exilerugby.tripod.com/index.htm,http://exilerugby.tripod.com/orig_backup/index.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,
agbolade@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,1,{first}.{last},,,,,,,,http://potrixnaija.blogspot.com/2014/11/world-pneumonia-day-sanofi-reinforces.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
estonia@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,1,{first}.{last},,,,,,,,http://ccfe.ee/our-members,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nobuki.takahashi@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,3,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2021_online.html,http://jaden1996.com/workshop/application/application_2018_kanto.html,http://jaden1996.com/workshop/application/application_2017_kanto.html,,,,,,,,,,,,,,,,,,,,,,,,,,
ordinionlinesynvisc@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,5,{first}.{last},,,,,,,,http://synvisc.it/contatti,http://synvisc.it/prodotti,http://synvisc.it/prodotti/synvisc,http://synvisc.it,http://synvisc.it/prodotti/synvisc-one,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilanceno@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,2,{first}.{last},,,,,,,,http://legemiddelverket.no/documents/bivirkninger%20og%20sikkerhet/kj%c3%a6re%20helsepersonell-brev/2015/dhcp_insuman%20final.pdf,http://docplayer.me/4634941-hjemmeinfusjon-av-cerezyme-veiledning-for-helsepersonell-som-behandler-pasienter-med-gaucher-sykdom.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
tunisie.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,76,generic,5,{first}.{last},,,,,,,,http://tn.sanofi.com/dam/jcr:b914b97b-1973-48e9-84c0-141bdfd4e33a/plaquenil%20update%20juin%202020.pdf,http://tn.sanofi.com,http://tn.sanofi.com/fr,http://tn.sanofi.com/contact,http://tn.sanofi.com/fr/contact,,,,,,,,,,,,,,,,,,,,,,,,
didier.terrolle@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://cdurable.info/special-reporting-rse.html,http://cdurable.info/rapports-developpement-durable-2014-de-campus-collectivites-et-entreprises.html,http://cdurable.info/special-assises-nationales-de-l-education-a-l-environnement-et-au-developpement-durable-eedd.html,http://cdurable.info/special-reporting-des-entreprises,http://cdurable.info/rapport-developpement-durable-2013-des-adherents-du-comite21.html,,,,,,,,,,,,,,,,,,,,,,,,
tilmannkiessling@sanofi.com,sanofi.com,Sanofi,,,,,,76,personal,5,{first}.{last},,,,,,,,http://biospace.com/news/sanofi-france-and-t1d-exchange-to-launch-worldwide/279801/source=morenews,http://biospace.com/article/releases/sanofi-france-and-b-t1d-exchange-b-to-launch-worldwide-study-to-investigate-factors-for-optimal-care-for-young-people-with-diabetes-,http://bio-medicine.org/medicine-technology-1/sanofi-and-t1d-exchange-to-launch-worldwide-study-to-investigate-factors-for-optimal-care-for-young-people-with-diabetes-28991-1,http://biospace.com/news/sanofi-france-and-t1d-exchange-to-launch-worldwide/279801,http://prnewswire.com/news-releases/sanofi-and-t1d-exchange-to-launch-worldwide-study-to-investigate-factors-for-optimal-care-for-young-people-with-diabetes-179281211.html,,,,,,,,,,,,,,,,,,,,,,,,
donations.russia@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,3,{first}.{last},,,,,,,,http://ru.sanofi.com/dam/jcr:609c8e0d-483a-4f3c-9a3d-7156bc18ac63/docs_requirements.pdf,http://ru.sanofi.com/dam/jcr:6e29d617-1367-485a-9269-92d33bcfecbd/general_terms.pdf,http://ru.sanofi.com/dam/jcr:c1f3be6d-f5a9-4446-b14b-66ca64b1fab0/list_of_docs.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
myalprolixcoordinator@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://hanj.org/pharmaceutical-resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ines.benhadjali@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://tn.sanofi.com/dam/jcr:6ad60e10-ef9c-4129-b23c-b3719faab607/cp10.pdf,http://tn.sanofi.com/dam/jcr:91a88a57-2e81-4db6-b3af-aa20eaab83d8/cp9.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
vie.bestellung@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://herba-chemosan.at/sonder-chefinfo-covid-19-aktuelles-vor-dem-wochenende,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pk.agm@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://sanofi.com.pk/dam/jcr:69231147-c7ba-43f2-b991-29b21fe5fc42/notice%20of%20extra-ordinary%20general%20meeting.pdf,http://sanofi.com.pk/dam/jcr:e69f6c4d-605c-45d3-b862-dc009c5506fc/annual-report-for-the-year-ended-december-31-2020.pdf,http://sanofi.com.pk/dam/jcr:f959cd62-bc1d-4869-bf7e-4f6eee5aba41/accounts%20for%20the%20year%20ended%20on%20dec%2031%202019.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,
contact.pk@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,5,{first}.{last},,,Support,,,,,"http://sanofi.com.pk/dam/jcr:0955e7ea-9fef-45ca-ab5c-12ce1f35a959/accounts%20for%20the%201st%20quarter%20ended%20on%20march%2031,%202022.pdf","http://sanofi.com.pk/dam/jcr:0f4367c7-0035-4dd5-a6b7-7fb56e00db8b/financial%20statements%20for%20the%20period%20ended%20september%2030,%202022.pdf",http://sanofi.com.pk/dam/jcr:1a217912-fa46-44f0-9203-8bd43192a8da/accounts-for-the-half-year-ended-june-30-2021.pdf,http://sanofi.com.pk/dam/jcr:74a59df4-8f0d-48b6-a8c8-083c7357591a/accounts-for-the-period-ended-on-30-september-2021.pdf,"http://sanofi.com.pk/dam/jcr:c32ad25c-55ea-4360-b503-1bca24e182a1/half-yearly%20report%20for%20the%20period%20ended%20june%2030,%202022.pdf",,,,,,,,,,,,,,,,,,,,,,,,
rana.jreich@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sfds.asso.fr/newsletter-1887-72b54bd42cee649de60105965023393e,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pt-frio@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://campus.sanofi/pt/recursos/servico-de-informacao-cientifica,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lovisa.fasth@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://mynewsdesk.com/se/sanofi/pressreleases/u-s-fda-approves-zaltrap-r-ziv-aflibercept-after-priority-review-for-previously-treated-metastatic-colorectal-cancer-782871,http://mynewsdesk.com/se/sanofi/pressreleases/genzyme-provides-update-on-u-s-lemtrada-filing-787869,,,,,,,,,,,,,,,,,,,,,,,,,,,
relations.actionnaires@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Writing & communication,,,,,http://sanofi.com/fr/investisseurs/actionnaires-individuels/bienvenue-chez-sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chairman.silauditcommittee@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Executive,,,,,http://sanofiindialtd.com/dam/jcr:63c7a2a3-528a-40a8-a48b-5c9d8183e26d/whistle%20blower%20policy.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vigilanzachc.ita@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://soldissimi.it/forum/forum/omaggi-coupon-sconti-anteprime-gratuite/omaggi-legati-agli-acquisti/20634585-enterogermina-active-age-rimborso-100-scade-31-07-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cl-cpv-receipt@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://pharmacafennica.fi/supportmaterial/download/109033436/fi,http://pharmacafennica.fi/supportmaterial/download/109033436/sv,http://pharmacafennica.fi/supportmaterial/download/109911784/en,,,,,,,,,,,,,,,,,,,,,,,,,,
asuka.nakao@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://fukui-byoyaku.com/wp-content/uploads/2021/06/2d8c08e7f11af9c0558ac4bf22a8ace9.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.croatia@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://cijepljenje.info/files/wp-content/uploads/2017/06/sanofi-kodeks-o-objavljivanju.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
naouel.tamazirt@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,5,{first}.{last},,,,,,,,http://sanofi.dz/dam/jcr:110b63b1-17c4-4a8e-91e0-fbf0b9cc6941/cp4.pdf,http://sanofi.dz/dam/jcr:1c19a7b2-d6c9-4ea3-b2f9-317669d0a1da/cp10.pdf,http://sanofi.dz/dam/jcr:5cc05b5e-8c27-4430-9e36-30a18b4b4b00/cp1.pdf,http://sanofi.dz/dam/jcr:5f874f3f-6bde-4fa3-afcc-dc329cf39340/cp7.pdf,http://sanofi.dz/dam/jcr:6ed4e5d7-a908-4508-bd30-331eb5961cd9/cp12.pdf,,,,,,,,,,,,,,,,,,,,,,,,
info.lv@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://farmacija-mic.lv/sanofi-butiska-informacija-par-plaquenil-un-covid-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chcquality.ro@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://antinevralgic.ro/contact/index.php,http://dulcolax.ro/contact.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
chcro.medical_info@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,Support,,,,,http://antinevralgic.ro/contact/index.php,http://dulcolax.ro/contact.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
helena.mejerland@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://klekoon.com/joce/joue-appel-offre-suede-harnosand-produits-pharmaceutiques-10320838.htm,,,,,,,,,,,,,,,,,,,,,,,,,,,,
copay.program@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://careconnectpss.com/dam/jcr:09c38894-4b06-43be-9903-58942f79efb9/srt%20careconnectpss%20co-pay%20program%20application-mat-us-2105019_v1.0.pdf,http://careconnectpss.com/dam/jcr:5dde10e8-41df-42bf-9364-8fba46b60652/ert%20careconnectpss%20co-pay%20program%20application_mat-us-2104184.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
magdalena.lugowska@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://sanofi.pl/dam/jcr:25c1e8da-e05b-4efd-b00b-c43f63d11182/nota%20metodologiczna%20wersja%20polska%202021.pdf,http://sanofi.pl/dam/jcr:807ff044-d125-48b6-8d18-4b2db5838349/nota%20metodologiczna%20eng%202021.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
publicaffairs@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Writing & communication,,,,,http://sanofi.co.jp/dam/jcr:e4cfbab7-797f-467b-8c5f-97875589eac3/2022_donation_initiative.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
grippech@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://sanofi.ch/de/uber-uns/gesundheitslosungen/impfstoffe,http://sanofi.ch/fr/nous-connaitre/solutions-de-sante/vaccins,,,,,,,,,,,,,,,,,,,,,,,,,,,
kaveeta.jayaraaman@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:73c0e2ed-3b40-45d7-a1bc-be9753343821/its%20flu%20season%20%20sanofi%20pasteur%20intensifies%20its%20fight%20to%20prevent%20influenza.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
phalgunahari.jandhyala@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,5,{first}.{last},,,,,,,,http://sanofi.in/dam/jcr:001c0ba1-5cb5-4c8e-a51a-d2716ba00699/shantha%20biotechnics%20inactivated%20polio%20vaccine%20ipv%20completes%20delivery%20of%2020%20million%20doses.pdf,http://sanofi.in/dam/jcr:113e4cf4-841f-4172-baa5-4c8d3ad97fda/who%20approves%20cholera%20vaccine%20from%20shantha%20biotechnics%20for%20use%20at%20temperatures%20as%20high%20as%2040c.pdf,http://sanofi.in/dam/jcr:2c91a1f9-8213-436d-b24b-b4d0949c173c/slide%204%20press%20release%20shantha%20biotechnics%20inactivated%20polio%20vaccine%20%20shanipv.pdf,http://sanofi.in/dam/jcr:3fd452f8-d5d6-4e23-9aa1-f4c1c70f7bde/sanofi%20launches%20combiflam%20icyhot%20pain%20relief%20topical%20in%20india.pdf,http://sanofi.in/dam/jcr:8993d907-5cfd-40fe-b162-9e7ee371e837/slide%204%20press%20release%20shantha%20biotechnics%20inactivated%20polio%20vaccine%20%20shanipv.pdf,,,,,,,,,,,,,,,,,,,,,,,,
chuang.lu@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://eurekaselect.com/journal/72/editorial-board,http://benthamscience.com/journals/drug-metabolism-and-bioanalysis-letters/editorial-board,,,,,,,,,,,,,,,,,,,,,,,,,,,
vaccinationisprotection@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://myicid.com/_files/ugd/6bbc7e_1ec82ff25c144ec786c539e8670f7e87.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
askvis@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://cristoph-de-caermichael.skyrock.com/19.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
doris.madlberger@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.at/dam/jcr:514ea1e2-491d-483c-8fbf-d817f97fae88/170529_pm%20sanofi%20genzyme_welt%20ms%20tag%202017.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
boskjoedt.rafn@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.dk/dam/jcr:fc4292d4-e86a-466c-9573-12f631322cee/myozyme---safety-information-packet.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
eumedinfo.gz@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://pharmacafennica.fi/supportmaterial/download/109033436/sv,http://sanofi.dk/dam/jcr:e973bbe1-2a80-466e-a0c1-5e417fe53ccf/nexviadyme%20-%20immunotest%20serviceguide%20til%20l%c3%a6ger%20og%20sundhedspersonale.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,
radicaciongenfar.bogta@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
gu_sbs_p2p_externals@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
dz_externals_services_invoices@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
it.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
fr.supplierenablement@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
opella-facturas@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/chc-suppliers/chc-invoicing,http://suppliers.sanofi.com/fr/fournisseurs-chc/facturation-chc,,,,,,,,,,,,,,,,,,,,,,,,,,,
vaccineshoppe.svc@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://customposters.vaccineshoppe.com,,,,,,,,,,,,,,,,,,,,,,,,,,,,
info.ch@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://ig-nephrologie.ch/download/sgn-2019_final_program.pdf,,,,,,,,,,,,,,,,,,,,,,,,,,,,
finland@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://pharmacafennica.fi/supportmaterial/download/105322751/fi,http://fimea.fi/documents/160140/3649702/lemtrada_patient_guide_a5_fi_v2_lowres.pdf/d0268e7c-2c18-c500-0bda-88d25bdbc9a6,,,,,,,,,,,,,,,,,,,,,,,,,,,
katariina.pousar@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://fimea.fi/documents/160140/1454401/myyntiluvan+haltijan+kommentit_isatuksimabi_.pdf/36bce3f5-ad00-05c0-c383-82869b160bde,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tyutyunar.ext@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://medpred.ru/companies/sanofi,http://medpred.ru/companies/sanofi/reviews,http://medpred.ru/companies/sanofi/vacancies,,,,,,,,,,,,,,,,,,,,,,,,,,
robert.tullidge@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://floridaent.org/2020-florida-combined-otolaryngology-meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,
quality.pk@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,4,{first}.{last},,,,,,,,http://sanofi.com.pk/dam/jcr:0cf3c241-7e21-4fef-8fd1-09b20815b9af/q4-2013.pdf,http://sanofi.com.pk/dam/jcr:8152ff61-63b3-44cc-8bca-d7c8a71234cc/q4-2015.pdf,http://sanofi.com.pk/dam/jcr:a35f9a7f-c36b-4f1f-aca5-88283d904d01/q4-2016.pdf,http://sanofi.com.pk/en/quality-concerns,,,,,,,,,,,,,,,,,,,,,,,,,
qurat.ulain@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://job.net.pk/job/assistant-manager-quality-assurance-non-sterile-3679,,,,,,,,,,,,,,,,,,,,,,,,,,,,
qality.info@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,Support,,,,,http://aptk.kz/lekarstvennye-sredstva-i-bad/nevrologiya-i-psihiatriya/antidepressanty/amitriptilin-25-mg-50-tabletki,http://ksbd.ru/herpes/moshchnyi-neiroleptik-hlorprotiksen-instrukciya-po-primeneniyu,,,,,,,,,,,,,,,,,,,,,,,,,,,
chc_selfmedic@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,5,{first}.{last},,,,,,,,http://selfmedic.de,http://selfmedic.de/allgemeine-teilnahmebedingungen-der-thomae-akademie,http://selfmedic.de/allgemeine-teilnahmebedingungen-der-thomae-akademie-live-online-fortbildungen,http://selfmedic.de/formular-whitepaper/google-my-business,http://selfmedic.de/thomae-akademie/seminare/uebersicht,,,,,,,,,,,,,,,,,,,,,,,,
xinran.yang@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://bs.ecust.edu.cn/career/detail/oid/2-4279963/m/zpxx,http://top3camgirls.com/career/detail/oid/2-4279963/m/mbazpxx,http://top3camgirls.com/career/detail/oid/2-4279963/m/zpxx,,,,,,,,,,,,,,,,,,,,,,,,,,
amillionconversations@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,4,{first}.{last},,,,,,,,http://sanofi.com/en/our-responsibility/equality-and-inclusiveness/a-million-conversations,http://sanofi.com/en/our-responsibility/equality-and-inclusiveness/global-poll,http://sanofi.com/fr/notre-responsabilite/notre-engagement-pour-la-parite-et-linclusion/global-poll,http://sanofi.com/fr/notre-responsabilite/notre-engagement-pour-la-parite-et-linclusion/un-million-de-conversations,,,,,,,,,,,,,,,,,,,,,,,,,
sri-na@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,5,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/collaboration-and-awards/north-america,http://sanofi.com/en/science-and-innovation/collaboration-and-awards/north-america/iawards,http://sanofi.com/en/science-and-innovation/collaboration-and-awards/north-america/idea-itech,http://sanofi.com/fr/science-et-innovation/collaboration-et-awards/amerique-du-nord,http://sanofi.com/fr/science-et-innovation/collaboration-et-awards/amerique-du-nord/iawards,,,,,,,,,,,,,,,,,,,,,,,,
oncologybd@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/oncology,,,,,,,,,,,,,,,,,,,,,,,,,,,,
digitalbd@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/digital,,,,,,,,,,,,,,,,,,,,,,,,,,,,
technologybd@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.com/en/science-and-innovation/partnering/areas-of-interests/technology-platform,,,,,,,,,,,,,,,,,,,,,,,,,,,,
za.mslondemand@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://medicalacademic.co.za/cardiology/are-you-aiming-at-the-right-target,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lactacyd.hk@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://lactacyd.hk,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sece_sbs_p2p@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
quality.no@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://sanofi.no/no/om-oss/kontaktinformasjon,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pt-mitosyl@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://mitosyl.pt,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ngmedinfo@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,Support,,,,,http://sanofi.com.ng/en,http://sanofi.com.ng,,,,,,,,,,,,,,,,,,,,,,,,,,,
usrbdmedical@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://coldagglutinindisease.org/observational-study,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pv-taiwan@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,4,{first}.{last},,,,,,,,http://sanofi.com.tw/dam/jcr:0b29401c-20d5-40ae-ac25-c13f35cc0885/20200713.pdf,http://sanofi.com.tw/dam/jcr:7f7b9bb6-aa41-4d27-8839-b02b7bbb4fcd/20200713.pdf,http://sanofi.com.tw/zh/about-us/contact-us,http://sanofi.com.tw/zh/our-responsibility,,,,,,,,,,,,,,,,,,,,,,,,,
uk-internet-enquiries@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Writing & communication,,,,,http://domainc.co.uk/site/sanofi.co.uk,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tomoaki.yoshida@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://cad-net.jp/index.php/seminar/detail/1377,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ufficiostampa@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://superando.it/2021/04/20/un-premio-a-quellelefantino-blu-che-parla-di-malattie-metaboliche-ereditarie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
fabienne.muller-colusso@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://reseau-chu.org/article/medecins-chercheurs-managers-1ere-promotion-diplomee-a-nancy,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofiquality.il@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,5,{first}.{last},,,,,,,,http://campus.sanofi/il/science/diabetes,http://campus.sanofi/il/science/nasal-polyps,http://campus.sanofi/il/science/type-2-inflammation,http://campus.sanofi/il/science/vaccines,http://campus.sanofi/il,,,,,,,,,,,,,,,,,,,,,,,,
info.norway@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://minsanofi.no/login,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vera.zinovieva@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,4,{first}.{last},,,,,,,,http://apteka.ru/product/essencziale-forte-n-300-mg-180-sht-kapsuly-5e3271cf65b5ab0001655c0c,http://apteka.ru/product/no-shpa-40-mg-24-sht-blister-tabletki-629509cb40212c41696f8008,http://apteka.ru/product/essencziale-forte-n-300-mg-90-sht-kapsuly-5e3274f4f5a9ae000140e2c5,http://apteka.ru/product/magne-v6-forte-40-sht-tabletki-pokrytye-plenochnoj-obolochkoj-62cbe9c4fd2ed3fb1b1c1d78,,,,,,,,,,,,,,,,,,,,,,,,,
gdpr.greece@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://sanofi.gr/el/forma-epikinonias,http://sanofi.gr/el/prostasia-prosopikon-dedomenon,,,,,,,,,,,,,,,,,,,,,,,,,,,
christophe.galibert@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://community.softwarefx.com/topic/2664-re-random-no-image-display-under-netscape,,,,,,,,,,,,,,,,,,,,,,,,,,,,
premio.sanofivacunas@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://difusionconcausa.com/convocatoria-premio-vacunar-para-dar-oportunidades,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chandani.palshetkar@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://pdfcoffee.com/431806660-consolidated-email-list-2-xlsx-pdf-free.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
nobutaka.ohsako@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://lcde-nagasaki.jp/category/tani/page/3,http://lcde-nagasaki.jp/news,,,,,,,,,,,,,,,,,,,,,,,,,,,
gulf.pharmacovigilance@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,5,{first}.{last},,,,,,,,http://campus.sanofi/bh/science/multiple-sclerosis/cutting-edge-science/2022/a-promising-biomarker-in-ms-neurofilament-light-chain,http://campus.sanofi/bh/science/vaccines/influenza/cutting-edge-science/2022/influenza-focus-on-elderly,http://campus.sanofi/om/patient-support,http://campus.sanofi/ae/events/diabetes/2022/innovation-of-iglarlexi-in-intensification,http://campus.sanofi/bh/science/prurigo-nodularis/cutting-edge-science/2022/mechanism-of-prurigo-nodularis-disease,,,,,,,,,,,,,,,,,,,,,,,,
atopybook@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.co.kr/ko/newsroom/notice/2022-01-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,
claudia.marloff@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://fachkraeftesicherer.de/vorbereitet-in-mutterschutz-und-elternzeit,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bestellungdental@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://frag-pip.de/produktreports/ultracain-hoechst-bewaehrt-seit-45-jahren,,,,,,,,,,,,,,,,,,,,,,,,,,,,
valeriya.babchenko.ext@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,3,{first}.{last},,,,,,,,http://medpred.ru/companies/sanofi/reviews,http://medpred.ru/companies/sanofi/vacancies,http://medpred.ru/companies/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,
takahiro.ohaku@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://chibaog.org/researchlist/3432,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gxp.caucasian@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://apteka.103.by/magne-b62-instruktsiya,http://apteka.103.by/lantus-solostar-instruktsiya,,,,,,,,,,,,,,,,,,,,,,,,,,,
samir.jegham@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://congres-seco.fr/seco-58-2,,,,,,,,,,,,,,,,,,,,,,,,,,,,
durguesh.angle@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://nipmpune.com/chapter-chairman.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zoran.doder@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://touchendocrinology.com/diabetes/journal-articles/insulin-glulisine-in-pregnancy-experience-from-clinical-trials-and-post-marketing-surveillance,,,,,,,,,,,,,,,,,,,,,,,,,,,,
es-farmacovigilancia-opella@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://lizipaina.es/contacto,http://bisolherbal.es/contacta-con-nosotros,http://pharmaton.es/contacto,,,,,,,,,,,,,,,,,,,,,,,,,,
jobs-pakistan@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,HR,,,,,http://jobssection.com/job/assistant-manager-quality-assurance-non-sterile,,,,,,,,,,,,,,,,,,,,,,,,,,,,
infokymab@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,5,{first}.{last},,,Support,,,,,http://kymab.com/data-protection,http://kymab.com/contact,http://kymab.com/about-us/people,http://kymab.com/privacy-and-cookie-policy,http://kymab.com,,,,,,,,,,,,,,,,,,,,,,,,
laura.diegodelrio@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://asebio.com/en/members/directory/sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,
scott.tabot@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://ce.mayo.edu/content/exhibitor-sanofi-genzyme-virtual-exhibit-hall-hematology-review-2021,,,,,,,,,,,,,,,,,,,,,,,,,,,,
site-crb.communication@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://ville-antony.fr/cartographie-interactive/developpement-economique/les-entreprises/acteurs/sanofi-aventis,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cathy.cantalloube@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://ajtmh.org/content/journals/10.4269/ajtmh.16-0731,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rarediseaseregistries@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,5,{first}.{last},,,,,,,,http://adc.bmj.com/content/106/7/674.alerts,http://adc.bmj.com/content/106/7/674.altmetrics,http://adc.bmj.com/content/106/7/674.info,http://adc.bmj.com/content/106/7/674.responses,http://adc.bmj.com/content/106/7/674.share,,,,,,,,,,,,,,,,,,,,,,,,
tomohiro.iwano@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://cad-net.jp/index.php/seminar/detail/1310,,,,,,,,,,,,,,,,,,,,,,,,,,,,
anis.benabderrazik@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,5,{first}.{last},,,,,,,,http://allo-docteur.com.tn/fr/ariana/3034-industries-pharmaceutiques/ben-arous.html,http://allo-docteur.com.tn/fr/mahdia/2459-industries-pharmaceutiques/ben-arous.html,http://allo-docteur.com.tn/fr/kairaoun/2620-industries-pharmaceutiques/ben-arous.html,http://allo-docteur.com.tn/fr/nabeul/2959-industries-pharmaceutiques/ben-arous.html,http://allo-docteur.com.tn/fr/tunis/2966-industries-pharmaceutiques/ben-arous.html,,,,,,,,,,,,,,,,,,,,,,,,
chcdpo.romania@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.ro/ro/angajamentul-nostru/etica-si-transparenta/confidentialitatea-datelor-personale,,,,,,,,,,,,,,,,,,,,,,,,,,,,
akio.ohneda@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2021_kanto.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kazuya.sugiyama@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2022_online.html,http://jaden1996.com/workshop/application/application_2021_online.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
itakeshi.asai@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2021_online.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vincentdepaul.gobou@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://letogolais.com/togo-fait-face-a-une-nette-recrudescence-de-la-meningite,http://info-communication.com/fr/2397981742-journee-mondiale-contre-la-meningite-une-journee-pour-intensifier-la-lutte-contre-cette-maladie-potentiellement-mortelle,,,,,,,,,,,,,,,,,,,,,,,,,,,
pt-medinfochc@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://sanofi.pt/pt,http://sanofi.pt,,,,,,,,,,,,,,,,,,,,,,,,,,,
darakunthy.bun@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
fr_einvoicingcegedim@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://suppliers.sanofi.com/en/standards-and-procedures/invoicing,http://suppliers.sanofi.com/fr/politiques-et-procedures/processus-de-facturation,,,,,,,,,,,,,,,,,,,,,,,,,,,
sandrineguendoul@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://rh.newstank.fr/article/view/132900/sanofi-signature-accord-specifique-accompagnement-fins-mandats-syndicaux.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
datenschutz.at@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://sanofi.at/datenschutz,http://sanofi.at/de/datenschutz,,,,,,,,,,,,,,,,,,,,,,,,,,,
hiring.drh@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://concourstunisie.com/2022/08/08/sanofi-2022,http://tunisietravail.net/category/entreprise-a-la-une/page/3,,,,,,,,,,,,,,,,,,,,,,,,,,,
catherine.huoi@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://ijidonline.com/article/s1201-9712(22)00053-4/fulltext,http://mymedr.afpm.org.my/publications/66953,,,,,,,,,,,,,,,,,,,,,,,,,,,
lataillade@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://e-pediatrie.org/e-pediatrie/le-programme/comite-scientifique-scientifique,,,,,,,,,,,,,,,,,,,,,,,,,,,,
marlene.assemien@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://e-pediatrie.org/e-pediatrie/le-programme/comite-scientifique-scientifique,,,,,,,,,,,,,,,,,,,,,,,,,,,,
janni.larsen@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://scleroseforeningen.dk/nyheder/deltagere-soeges-til-undersoegelse-om-hverdagen-med-infusionsbehandlinger,,,,,,,,,,,,,,,,,,,,,,,,,,,,
miranda.boekbinder@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sportgeneeskunde.com/sanofi-organiseert-injectie-workshop-intra-articulaire-therapie,,,,,,,,,,,,,,,,,,,,,,,,,,,,
arzneimittelsicherheit@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://forum.knime.com/t/xml-to-excel-conversion-display-several-attributes-that-have-the-same-key-xpath-node-and-xml-structure/64476,http://diabetologie-online.de/a/sanofi-wichtiges-update-zu-quensyl-und-covid-2131618,,,,,,,,,,,,,,,,,,,,,,,,,,,
order.entry@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://clair.be/plaquenil-hydroxychloroquine,,,,,,,,,,,,,,,,,,,,,,,,,,,,
frahoechst-gmbh@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.de/de/sanofi-in-deutschland/hoechst-gmbh/kontakt,,,,,,,,,,,,,,,,,,,,,,,,,,,,
beth.kramli@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://emag.co.uk/jerome-bettis-sanofi-us-and-allergy-foundation-launch-severe-life-threatening-allergies-quiz,,,,,,,,,,,,,,,,,,,,,,,,,,,,
neuropad@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://neuropad.com/deutschland,,,,,,,,,,,,,,,,,,,,,,,,,,,,
lactacyd.mexico@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,5,{first}.{last},,,,,,,,http://lactacyd.mx/challenge04,http://lactacyd.mx/challenge05,http://lactacyd.mx/challenge06,http://lactacyd.mx/challenge07,http://lactacyd.mx,,,,,,,,,,,,,,,,,,,,,,,,
michael.mourez@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://cripaservices.com/repertoire,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cl-cepal@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://fichier-pdf.fr/2013/12/04/comiteethiqueea17-juin2013-257221-1,http://fichier-pdf.fr/2013/12/04/comiteethiqueea17-juin2013-257221-1-1,,,,,,,,,,,,,,,,,,,,,,,,,,,
joao.ialamov@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://blog.oobj.com.br/cadastrar-ie-substituto-tributario,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance.dz@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://sanofi.dz/fr/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
diana.cerovski@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://studentski.hr/studenti/financije/najnovija-ponuda-poslova-satnice-i-do-80-kuna,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gisel.lopez-ext@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://fichier-pdf.fr/2012/11/16/educaci-n-rol-de-las-institcuones-y-desarrollo-gesti-n-15-11-12-pag-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,
individualshareholders@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,4,{first}.{last},,,,,,,,http://sanofi.com/fr/investisseurs/rapports-et-publications/publications-actionnaires/e-lettre-mars-2017,http://headquarterlocation.com/biotechnology,http://sanofi.com/fr/investisseurs/rapports-et-publications/publications-actionnaires/e-lettre-mars-2019,http://sanofi.com/en/investors/contact,,,,,,,,,,,,,,,,,,,,,,,,,
sebastien.trichot@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://a3p.org/impact-of-annex-1-revision-on-new-vial-filling-line-at-sanofi-pasteur-marcy-letoile,,,,,,,,,,,,,,,,,,,,,,,,,,,,
epilepsy.russia@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://epilepsyinfo.ru/clinics,,,,,,,,,,,,,,,,,,,,,,,,,,,,
relations-actionnaires@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,Writing & communication,,,,,http://fr.slideshare.net/sanofi/201703-lille,http://npaherault.blogspot.com/2013/04/le-double-langage-des-dirigeants-de.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
wat.intouch@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://sanofi.ie/en/contact,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tender_pasteur@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://euskadi.eus/web01-s2osa/es/contenidos/anuncio_contratacion/expjaso23558/es_doc/es_arch_expjaso23558.html,http://euskadi.eus/web01-s2osa/es/contenidos/anuncio_contratacion/expjaso14800/es_doc/es_arch_expjaso14800.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
quality.ro@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,3,{first}.{last},,,,,,,,http://campus.sanofi/ro,http://sanofi.ro/ro/angajamentul-nostru/etica-si-transparenta,http://sanofi.ro/ro/contact,,,,,,,,,,,,,,,,,,,,,,,,,,
info.medicalafo@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,Support,,,,,http://sanofi.ci/fr/nos-programmes/accompagner-les-professionnels-de-sante/information-medicale/informations-sur-le-thiocolchicoside,http://sanofi.ci/fr/nos-programmes/accompagner-les-professionnels-de-sante/information-medicale/informations-sur-le-valproate-et-grossesse,,,,,,,,,,,,,,,,,,,,,,,,,,,
centralasia.communication@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,2,{first}.{last},,,,,,,,http://hard-life.kz/2812-vsemirnyj-den-allergologa-pochemu-jeta-professija-vse-bolee-aktualna.html,http://zhardem.kz/news/17514,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanie.sesay@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://hic-vac.org/members/members-profiles/dr-sanie-sesay,,,,,,,,,,,,,,,,,,,,,,,,,,,,
chantal.varvarande@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://annoncesapaelm.blogspot.com/2014/02/trabajo-en-practicas-stage-de.html,http://annoncesapaelm.blogspot.com/search/label/stages%2f%20pr%c3%a1cticas,,,,,,,,,,,,,,,,,,,,,,,,,,,
sanofi@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,5,{first}.{last},,,,,,,,http://medicamentosplmchile.com/productos/allegra_120_mg_comprimidos_recubiertos.htm,http://medicamentosplmchile.com/productos/allegra_susp_30mg_suspension_oral.htm,http://medicamentosplmchile.com/productos/vitac_comprimidos_efervescentes.htm,http://medicamentosplmchile.com/productos/amaryl_m_comprimidos.htm,http://medicamentosplmchile.com/productos/duo_cvp_jarabe.htm,,,,,,,,,,,,,,,,,,,,,,,,
bich-phuong.humez@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://dmatheorynet.blogspot.com/2018/07,http://dmatheorynet.blogspot.com/2018/07/dmanet-phd-program-in-engineering_27.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
tilaus@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://sanofi.fi/dam/jcr:a1d81cc8-9259-4221-a516-71d2b2664c89/tiedotteet-terveydenhuollon-ammattilaisille.pdf,http://pharmacafennica.fi/safetynotice/56487663,http://pharmacafennica.fi/safetynotice/33797488,,,,,,,,,,,,,,,,,,,,,,,,,,
yasuhiro.uyama@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
istuho.mizobata@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2013.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zhenming.shun@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://stat.fsu.edu/the-department/faculty-listing2,http://stat.fsu.edu/department/faculty-listing,,,,,,,,,,,,,,,,,,,,,,,,,,,
michaelene.shelley@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://wccanp.enpnetwork.com/nurse-practitioner-news/153001-maximizing-diabetes-treatment-options-in-t2dm-dinner-opportunity-for-diabetes-providers,,,,,,,,,,,,,,,,,,,,,,,,,,,,
vasily.komin@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://myshared.ru/slide/1287305,,,,,,,,,,,,,,,,,,,,,,,,,,,,
paragelia.greece@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://greekotc.blogspot.com/2016/10/mucothiol-adult-sugar-free-syr-250mg-5ml.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pt-eventos@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://projectoartemis.blogs.sapo.pt/2014/08,http://perdagestacional.forumeiros.com/t3025-workshop-hospital-cuf-descobertas-luto-na-perda-gestacional,http://projectoartemis.blogs.sapo.pt/36977.html,,,,,,,,,,,,,,,,,,,,,,,,,,
michiaki.hattori@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application_2016.html,http://jaden1996.com/workshop/application/application_2017_kanto.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
kojiro.kikuchi@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://jaden1996.com/workshop/application/application_2017_kanto.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
cz-zamestnani@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://sanofi.cz/zamestnani,http://sanofi.cz/cs/zamestnani,,,,,,,,,,,,,,,,,,,,,,,,,,,
comitedigitalmx@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://histiacil.com.mx/aviso-legal,,,,,,,,,,,,,,,,,,,,,,,,,,,,
pharmacovigilance-ua@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://sanofi.ua/uk/contacts,http://farmaco.kiev.ua/eng/pricelist.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
callcenter@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,,,,,,http://selfmedic.de/datenschutz,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gladys.coppet@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://cdurable.info/special-gestion-durable-de-l-eau.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
laurence.demachy@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://capindus.com/offre-de-poste,http://ednh.fr/offre-de-stage-de-sensibilisation-la-dietetique-croissy-beaubourg-77,,,,,,,,,,,,,,,,,,,,,,,,,,,
carine.sroujian@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,3,{first}.{last},,,,,,,,http://sanoficanada.fr.mediaroom.com/neostrata-semaine-mondiale-mode-mastercard,http://newswire.ca/news-releases/skin-care-brand-neostrata-canada-joins-forces-with-canadian-activewear-brand-lole-517386011.html,http://pr.com/press-release/547466,,,,,,,,,,,,,,,,,,,,,,,,,,
ch.canada-consumercare@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,3,{first}.{last},,,,,,,,http://recalls-rappels.canada.ca/fr/avis-rappel/produits-contenant-ranitidine-rappeles-en-raison-impurete-nitrosamine,http://lelezard.com/communique-18978598.html,http://feistyfrugalandfabulous.com/2018/03/this-winter-ditch-the-itch-with-gold-bond,,,,,,,,,,,,,,,,,,,,,,,,,,
tanguy.loheac@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,2,{first}.{last},,,,,,,,http://lists.w3.org/Archives/Public/w3c-wai-ig/2012JanMar/0025.html,http://lists.w3.org/Archives/Public/w3c-wai-ig/2012JanMar/0027.html,,,,,,,,,,,,,,,,,,,,,,,,,,,
myra.primaduri@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,1,{first}.{last},,,,,,,,http://lokerterbaru2012.blogspot.com/2013/06/lowongan-kerja-medical-representative.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
es-internetsitescontact@sanofi.com,sanofi.com,Sanofi,,,,,,75,generic,1,{first}.{last},,,Support,,,,,http://bisolvon.es/como-tratar-el-resfriado-y-la-gripe,,,,,,,,,,,,,,,,,,,,,,,,,,,,
kristen.galfetti@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,4,{first}.{last},,,,,,,,http://prnewswire.com/news-releases/sanofi-biosurgery-product-maci--demonstrates-statistically-significant-clinical-outcomes-compared-to-microfracture-162188095.html,http://biospace.com/article/releases/-b-sanofi-biosurgery-b-product-maci-and-0174-demonstrates-statistically-significant-clinical-outcomes-compared-to-microfracture-,http://biospace.com/News/sanofi-biosurgery-product-maci0174-demonstrates/266712,http://biospace.com/news/sanofi-biosurgery-product-maci0174-demonstrates/266712,,,,,,,,,,,,,,,,,,,,,,,,,
cressida.toro@sanofi.com,sanofi.com,Sanofi,,,,,,75,personal,5,{first}.{last},,,,,,,,http://wipo.int/pressroom/zh/articles/2011/article_0026.html,http://wipo.int/pressroom/ru/articles/2011/article_0026.html,http://wipo.int/pressroom/en/articles/2011/article_0026.html,http://wipo.int/pressroom/es/articles/2011/article_0026.html,http://wipo.int/pressroom/fr/articles/2011/article_0026.html,,,,,,,,,,,,,,,,,,,,,,,,
mark.broenstrup@sanofi.com,sanofi.com,Sanofi,,,,,,74,personal,1,{first}.{last},,,,,,,,http://pubs.rsc.org/en/content/articlelanding/2014/np/c3np70058e,,,,,,,,,,,,,,,,,,,,,,,,,,,,
zhongqi.ji@sanofi.com,sanofi.com,Sanofi,,,,,,74,personal,1,{first}.{last},,,,,,,,http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
djihane.merhab@sanofi.com,sanofi.com,Sanofi,,,,,,74,personal,1,{first}.{last},,,,,,,,http://businesswire.com/news/home/20160408005485/fr,,,,,,,,,,,,,,,,,,,,,,,,,,,,
alan.brindell@sanofi.com,sanofi.com,Sanofi,,,,,,74,personal,1,{first}.{last},,,,,,,,http://prnewswire.com/news-releases/sanofi-pasteur-launches-imojev-first-single-dose-vaccine-against-japanese-encephalitis-in-australia-182744251.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
asuka.ozaki@sanofi.com,sanofi.com,Sanofi,,,,,,73,personal,1,{first}.{last},,,,,,,,http://atherosclerosis-journal.com/article/s0021-9150(18)31168-7/fulltext,,,,,,,,,,,,,,,,,,,,,,,,,,,,
sandra.fagerstromalm@sanofi.com,sanofi.com,Sanofi,,,,,,73,personal,1,{first}.{last},,,,,,,,http://mynewsdesk.com/se/sanofi/pressreleases/new-therapy-significantly-reduces-risk-of-repeat-heart-attack-and-death-78117,,,,,,,,,,,,,,,,,,,,,,,,,,,,
tine.zeindler@sanofi.com,sanofi.com,Sanofi,,,,,,73,personal,1,{first}.{last},,,,,,,,http://newswire.ca/fr/news-releases/le-cancer-de-la-prostate--ce-que-vous-devez-savoir-510328881.html,,,,,,,,,,,,,,,,,,,,,,,,,,,,
maria-francesca.evaristi@sanofi.com,sanofi.com,Sanofi,,,,,,72,personal,1,{first}.{last},,,,,,,,http://biorxiv.org/content/10.1101/2021.09.14.460397v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
bo.piela@sanofi.com,sanofi.com,Sanofi,,,,,,72,personal,1,{first}.{last},,,,,,,,http://businesswire.com/news/home/20180226005971/en/kendall-square%e2%80%99s-north-plaza-cambridge-ma-renamed,,,,,,,,,,,,,,,,,,,,,,,,,,,,
monique.gouverneur@sanofi.com,sanofi.com,Sanofi,,,,,,72,personal,1,{first}.{last},,,,,,,,http://presseportal.de/pm/119817/3697929,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rania.boiron@sanofi.com,sanofi.com,Sanofi,,,,,,71,personal,1,{first}.{last},,,,,,,,http://medrxiv.org/content/10.1101/2020.05.15.20103101v1,,,,,,,,,,,,,,,,,,,,,,,,,,,,
allstar.india@sanofi.com,sanofi.com,Sanofi,,,,,,71,personal,1,{first}.{last},,,,,,,,http://ratemyarea.com/basketball-courts-in-brandon-fl,,,,,,,,,,,,,,,,,,,,,,,,,,,,
michael.szeps@sanofi.com,sanofi.com,Sanofi,,,,,,71,personal,1,{first}.{last},,,,,,,,http://mynewsdesk.com/se/sanofi/pressreleases/sanofi-faar-europeiskt-godkaennande-foer-zaltrap-aflibercept-foer-behandling-av-metastaserad-kolorektal-cancer-834136,,,,,,,,,,,,,,,,,,,,,,,,,,,,
reception-a.ukraine@sanofi.com,sanofi.com,Sanofi,,,,,,70,generic,1,{first}.{last},,,Writing & communication,,,,,http://letsearch.ru/host/ua,,,,,,,,,,,,,,,,,,,,,,,,,,,,
juventas.telsinskas@sanofi.com,sanofi.com,Sanofi,,,,,,70,personal,1,{first}.{last},,,,,,,,http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
rajula.gaur@sanofi.com,sanofi.com,Sanofi,,,,,,70,personal,1,{first}.{last},,,,,,,,http://frontiersin.org/articles/10.3389/fneur.2013.00169/full,,,,,,,,,,,,,,,,,,,,,,,,,,,,
